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Chapter 1. The Resveratrol Family of Oligomeric Natural Products 
 Resveratrol is a small polyphenol which gives rise to a uniquely diverse family of 
oligomers, both form an architectural and a pharmacological standpoint.  The impressive scope 
of resveratrol’s beneficial effects has brought its oligomers to the attention of the scientific 
community, however, as often is the case with natural products, these more complex structures 
are difficult to obtain from natural sources.  This chapter introduces the structural diversity of the 
family and its collective pharmacological potential, to then highlight the synthetic efforts 
targeting resveratrol’s oligomers to date.  Finally, our group’s strategy for the programmable 
synthesis of the resveratrol class is laid out, with emphasis on the already-accomplished 
synthesis of numerous dimeric cores in the family, and an outline of the remaining challenges, to 
be tackled in the following chapters.            
Chapter 2. Development of a Universal Method of Trans-dihydrobenzofuran Installation 
for the Resveratrol Class, Empowered by Regioselective Electrophilic Aromatic 
Brominations 
 Numerous resveratrol oligomers with highly promising bioactivities contain trans-
disposed dihydrofuran architectures.  In order for the potential role of this heterocyclic motif as a 
pharmacophore in the class to be explored, we would need to develop synthetic ways to install it 
regio- and diastereoselectively on a variety of structurally diverse lower-order cores in the 
family.  This chapter describes the development of such a method, one that employs electrophilic 
 
 
aromatic bromination to achieve regiocontrol.  Use of a quinonemethide as the final intermediate 
prior to the cyclization of the heterocycle allows access to trans-dihydrofuran materials with 
excellent diastereoselectivity.  This synthetic approach has allowed access to three trimers and 
two tetramers in the family to date, one being the cytotoxic vaticanol C.       
Chapter 3. Directed Lithiation as a Tool for Regioselective Dihydrofuran Installation on 
Advanced Resveratrol Oligomers 
 The limitation of installing dihydrofuran units relying upon electrophilic aromatic 
bromination as the functionalization tool is the restricted range of accessible positions.  This 
mechanism can only deliver functional handles at one of the three possible positions that bear 
dihydrofuran units in the resveratrol class.  Using directed lithiation of judiciously protected 
materials we were able to achieve the remaining functionalization patterns required for 
regioselective trans-dihydrofuran appendage at all of the possible positions in the family.  Three 
additional natural products, one dimer and two trimers, were synthesized in this expansion of the 
scope of our method described in Chapter 2.        
Chapter 4. Explorations into the Selectivity of Permethylated Ampelopsin F in 
Electrophilic Aromatic Bromination Reactions 
 Highly regioselective functionalizations of the non-symmetrical dimeric core of 
ampelopsin F, were exploited in Chapter 2 for the synthesis of two different trimeric materials.  
Conjectural hypotheses accounting for this divergent selectivity are explored in this final chapter.  
The intrinsic site of electrophilic aromatic bromination of protected ampelopsin F appears to be 
facilitated by a slight steric accessibility preference, reinforced by a productive halogen bonding 
interaction.  The opposite regioselectivity, observed in the reaction with a cationic source of 
 
 
electrophilic bromine developed by our group, appears to be a result of the larger size of this 
reagent impeding its participation in such a halogen bonding interaction, and of its ability to 
potentially coordinate to an appropriately positioned aryl ring that could facilitate bromination by 
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 Resveratrol (1) is a relatively simple polyphenolic secondary 
metabolite synthesized by more than 70 species throughout the plant kingdom 
as part of their primary chemical defense mechanisms.  Studies of the 
biological effects of resveratrol (1) have shown great potential for the 
amelioration of both common and debilitating diseases such as cancer, 
cardiovascular disease and diabetes in mouse models, while concurrently leading to an active 
debate over its exact molecular target and its efficacy in humans.  The special chemical structure 
of this molecule, with an extended conjugated π system, allows plants to oligomerize it into a set 
of compounds with wildly diverse architectures (such as 7, 8, 10–21 in Figure 1.4).  While 
preliminary studies have shown promising biological activity for these compounds as well, 
significantly less effort has been devoted to the study of the therapeutic potential of these 
oligomers.  This fact is a consequence of the challenges in achieving their isolation from natural 
sources in any useful quantity and of the paucity of ways to access them synthetically.  
This first chapter introduces the structural diversity of the family and explores the data 
available so far on its collective pharmacological potential.  A collection of initial biomimetic 
explorations has shed some light upon the biosynthesis of this class of polyphenols and has 
revealed efficient routes to access a small number of simple dimeric members of the family.  
Total synthesis has also contributed creative and efficient methods for the synthesis of several 
more complex dimers.  These approaches and the molecules they yielded are also briefly 
discussed.  Finally, we present three synthetic strategies with broader applications within the 








generate blueprints for the synthesis of the vast majority of oligomers in the family.  This work 
and opening chapter will set the stage for the key goals of my thesis research which are: a) 
regioselective functionalizations of resveratrol cores, and b) installation of trans-dihydrofuran 
units at these marked positions.        
1.2 Isolation and Biosynthesis of Resveratrol 
 Resveratrol (1) was originally isolated in 1940 by Takaoka from the roots of white 
hellebore, Veratrum grandiflorum,1 and then again in 1967 by Hillis from the roots of the 
Japanese knotweed, Polygonum cuspidatum.2  This later plant has long been used as a folk 
medicine for fungal infections, inflammations, liver, heart and blood vessel diseases.2b  Since 
these initial studies, resveratrol (1) has been isolated from more than 70 plants, from 31 genera 
and 12 families3, including peanuts4, blueberries5 and, most notably, red grapes, making it one of 
the more widely distributed molecules in nature.6     
The biosynthetic pathway for the production of resveratrol (1) in plants (Scheme 1.1) 
involves four enzymes: phenylalanine ammonia lyase, cinnamate 4-hydroxylase, 
hydroxycinnamoyl CoA ligase and stilbene synthase.  The first three are general members of the 
phenylpropanoid synthesis pathway in plants, leading to the vast majority of the polyphenolic 
compounds found in nature.4  The last one, stilbene synthase (STS) is specific for the synthesis 
of resveratrol.  In the first stage of the biosynthesis phenylalanine (2) is primed for the action of 
STS by an initial deamination and then a hydroxylation of the aromatic ring.  Upon activation of 
STS, resveratrol (1) is synthesized by condensation of p-coumaryl CoA (5) with three units of 
malonyl CoA to forge the 3,5-dihydroxyphenyl ring.6-7  The STS enzyme is not constitutively 





abiotic.8  Resveratrol (1) is thus a phytoalexin, i.e. a molecule produced by plants when under 
attack.  As such, resveratrol (1) cannot be found in healthy grapevine leaves9, but fungal 
infection, nutrient deprivation, mechanical damage, and UV radiation10 – but not sunlight itself11 
–  all lead to an increase in resveratrol production, presumably by the activation of STS.7  Indeed, 
upregulation of both the STS activity and resveratrol production has been confirmed upon 
inoculation of grapevines with the pathogen Botrytis cinerea.7, 12  The maximum concentration of 
resveratrol, however, is not obtained at the site of infection, but in the regions surrounding it, 
likely in an attempt to prevent further invasion by the pathogen.13  Species with constitutively 
active STS also show higher resistance to fungal infections, supporting the importance of 
resveratrol production for the plant’s survival.14  This observation has led to the engineering of 
the STS gene into several plants14, including tobacco.7  Resveratrol is largely produced to fight 
infection and indeed its antifungal and antimicrobial activity15 support its ability to do so.7     
 


































3: cinnamic acid 4: p-coumaric acid






1.3 Beneficial Effects and Mechanism of Action of Resveratrol 
The initial characterization of resveratrol (1) as a phytoalexin of red grapes16, and the 
general desire of the field to remove polyphenols from any sample for screening, led to the 
unraveling of resveratrol’s full biological potential taking well over five decades from the time of 
its initial isolation.  As this small metabolite is produced by red grapes, mostly in the skins, an 
important source of resveratrol within the human diet is red wine, which contains 1.5–3 mg/L.7, 
17  The observation that people in certain regions of France, who drink red wine regularly, have 
lower cholesterol and fewer cardiovascular problems despite their high-fat diet has been called 
“the French paradox”.18  In 1992, this health benefit of red wine was attributed to its resveratrol 
content, since it is a compound largely absent from white wine and grape juice (not fermented 
with grape skins), and thus the interest in this molecule began a dramatic rise.17, 18b  Since then, 
this small polyphenol has been keenly investigated in several thousand studies due to its ability 
to prevent or ameliorate numerous illnesses, including cardiovascular disease19, ischemic 
injuries20 and cancer3, as well as exhibit beneficial platelet aggregation inhibitory21, 
neuroprotective22 and antiaging23 effects in mice and lower order organisms.5  Numerous clinical 
trials are underway, evaluating resveratrol’s potential for ameliorating metabolic diseases and 
cognitive impairments, as well as several types of cancer.  
A seminal paper on the beneficial effects of resveratrol came from Jung’s laboratory in 
1997.3  This study showed that resveratrol is highly effective in preventing initiation, promotion, 
and proliferation of skin cancer tumors in assays for a two-step carcinogenesis model at low 
micromolar concentrations.  Additionally, topical application of resveratrol protected mice from 





study for the potential of resveratrol as a chemopreventive agent in humans have certainly 
sparked the interest of the scientific community.   
The observation that the effects of resveratrol as a cardioprotective, neuroprotective, and 
chemopreventive agent3, 5, 24 seemed to parallel those observed on calorie-restricted diets25 
started a very productive research program in the laboratory of David Sinclair.  His hypothesis 
states that the similarity between resveratrol’s action and the general effects of calorie restriction 
stems from the activation of the same family of enzymes, namely the sirtuins which are a large 
family of NAD+-dependent deacetylase enzymes, conserved from bacteria to mammals, 
responsible for a wide range of cellular processes including DNA repair, gene silencing, and 
metabolic regulation.26  Overexpression of Sirt1, the most common sirtuin in mice, has been 
shown to protect animals from age-related phenotypes, such as type II diabetes,27 cancer28 and 
Alzheimer’s disease29.  Two very important substrates of sirtuins are the tumor suppressor p53, 
which is inactivated by deacetylation and thus delays apoptosis, and PGC-1α, which has the 
ability to upregulate mitochondrial biogenesis and to reduce reactive oxygen species (ROS) 
production (Scheme 1.2).  Both of these proteins have been implicated in the positive 
biochemical effects of resveratrol and can provide a possible link between the production of this 
polyphenol by plants and its effects on animals.  Plants produce resveratrol (1) as a response to 
dehydration, nutrient deprivation, UV radiation and pathogens6-7, and this molecule could be 
involved in triggering a sirtuin-mediated stress response in nearby organisms allowing them to 
respond better to a deteriorating environment by delaying apoptosis and reducing oxidative 
stress.23c  If this hypothesis is correct, then plant secondary metabolites are an excellent source of 






Scheme 1.2 Beneficial effects of resveratrol's presumed action as a sirtuin activator 
 
The first proof of resveratrol’s ability to activate the sirtuins and the beneficial effects of 
this interaction were obtained in the budding yeast Saccharomyces cerevisiae.23c  Sinclair, 
Howitz, and co-workers showed that resveratrol can increase the life span of these organisms to 
the tune of 70% by stabilizing their DNA.  A lack of additive effect upon supplementing the low 
calorie diet with resveratrol confirmed the activation of the same pathway.  The effects of 
resveratrol are believed to be sirtuin-dependent, as no effect was observed on Sir2-null yeast.  
The antioxidant properties of resveratrol are most likely not the cause of its beneficial effects.  
Several molecules were tested in this study, and their effects on sirtuins showed no correlation 
with their respective antioxidant abilities.23c  
Moving on to multicellular eukaryotic organisms which possess mitochondrial function, 
Sinclair showed in 2004 that the lifespan increase was also observed in Drosophila 
melanogaster, but only by 15%.23b  Studies performed in collaboration with the NIH, on more 
than 500 mice, using extensive in vivo and ex vivo analysis of organ function and 
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revealed its ability to delay age-related degeneration and functional decline and lead to a gene 
expression profile very similar to that of mice on a calorie restriction diet.  Mice treated with this 
small polyphenol lived a healthier and more energetic life whether they were on a standard diet 
or on a high calorie one.  The mice on a high calorie diet had a reduced lifespan.  Resveratrol 
was able to extend this shorter lifespan by 20%, but had no effects on the lifespan of mice on a 
standard diet.   
As the body of work on the in vivo effects of resveratrol is growing, its direct molecular 
target remains controversial.  In vitro assays showed that resveratrol decreases the Michaelis-
Menten constant for sirtuins’ binding of acetylated substrates up to 35 times.  Furthermore, at 0.5 
µM, resveratrol can induce the deacetylation of the tumor suppressor p53 in an in vivo 
fluorescence-based deacetylation assay using peptides tagged with the fleur-de-lys fluorophore in 
both osteosarcoma and human embryonic kidney cell lines.23c  In 2009, Beher and co-workers 
showed that the effect of resveratrol on activating sirtuins is dependent on the presence of the 
fleur-de-lys fluorescent tag on the substrates.31  In the absence of this tag, the substrate proteins 
tested were not substrates of the sirtuin.  The conclusion of the study was that resveratrol does 
not directly activate sirtuins, but that an indirect effect on these deacetylases could be involved.  
Critically though, Beher introduced AMPK as an important player in the pathway influenced by 
resveratrol.  AMPK is a key regulator of whole-body metabolism which, upon activation, leads 
to an increase in NAD+ and thus to a downstream activation of sirtuins (Figure 1.1, left).   
Since then, two schools of thought have emerged on the exact molecular target of 
resveratrol.  While both agree that the pathway highlighted in Figure 1.1 is being affected by 





study from Chung’s laboratory proposed an indirect activation of sirtuins downstream of AMPK 
(Figure 1.1, left).32  The real molecular targets of resveratrol were found to be 
phosphodiesterases (PDEs), enzymes that hydrolyze cAMP.  By competitively inhibiting PDEs, 
a 50 µM concentration of resveratrol activates cAMP signaling, which leads to downstream 
activation of AMPK and upregulation of Sirt1.  Ultimately, PGC-1α is activated by deacetylation 
and its activity leads to an increase in mitochondrial biogenesis and a reduction of cellular ROS, 
which are responsible for the in vivo effects of resveratrol.   
 
Figure 1.1 Proposed mechanisms of action for resveratrol 
 
Later in 2012, Sinclair introduced the first mouse model for inducible Sirt1 knock out, 






































enzyme in murine models.26b  At a 250 µM concentration of resveratrol, AMPK could be 
activated in the absence of the Sirt1 gene.  Nevertheless, in the absence of Sirt1, no effect on 
mitochondrial biogenesis is observed regardless of the AMPK activation.  Knocking out AMPK 
also annuls the effects of Sirt1 overexpression, suggesting a circular relationship between the 
activation of these two enzymes which appear to play crucial roles in the beneficial effects of 
resveratrol (Figure 1.1, right).  The debate over their order of activation continues to this day.   
The latest mechanistic explanation for resveratrol’s activity came in 2013 from Sinclair’s 
laboratory in which an allosteric activation hypothesis was proposed.  The bulky and lipophilic 
fluorophore that was believed to lead to artificial activation of Sirt1 in the in vitro assay23c 
actually mimicked the presence of certain large nonpolar amino acids found in several critical 
substrates of sirtuins.33  Additionally, this work identified a region in the N-terminal domain of 
the enzyme that appears to be removed from the catalytic site, but whose absence annihilates 
resveratrol’s effects.  This region was proposed to bind resveratrol and lead to allosteric 
activation of the enzyme, even at a 25 µM concentration of resveratrol, a dose at which AMPK 
and PDE are not activated.  The observed decrease in KM of the sirtuin for the substrate23c would 
thus be consistent with this allosteric activation theory.  
The mechanism of action of resveratrol is still under investigation but the identification 
of the pathway it affects (Figure 1.1) is extremely important.  The translation of resveratrol’s 
effect to humans would have a huge impact in today’s society burdened by cardiovascular 
disease, diabetes, and the early development of cancer.  More potent analogues of resveratrol, or 
other small molecule activators of this pathway, would essentially act as calorie-restriction 





restriction without the need for what is, for many, a difficult-to-maintain lifestyle.5  Looking for 
more potent analogs of resveratrol, the scientific community has become interested in the 
extremely rich collection of oligomers that stem from this small secondary metabolite.  Indeed, 
over 40 resveratrol oligomers and glycoside derivatives have been isolated from red wine, 
suggesting that the benefits demonstrated by this beverage might already be positive effects of 
these more complex secondary metabolites in humans34, while several hundred more have come 
from additional plant species.     
1.4 Isolation and Biosynthesis of the Oligomeric Family of Natural Products 
The first oligomer in the class was isolated in 196535 and its structure was elucidated in 
1966 by X-ray crystallography of its permethylated dibromide.36  This oligomer was 
hopeaphenol (7, Figure 1.2).  In 1976, Pryce and Langcake isolated resveratrol (1), ε-viniferin 
(8) and α-viniferin (9) and determined their antifungal activity as phytoalexins.9, 11, 37  The 
number of oligomers isolated grew exponentially over the ensuing decades, particularly with the 
development of new mass spectroscopy and 2D NMR techniques.38  To date, more than 500 
oligomers have been isolated from various plants, including grapes, legumes, and pines39; while 
most have only been evaluated in a couple of assays, their biological potential already appears to 






Figure 1.2 The first resveratrol oligomers isolated 
 
While resveratrol has documented antibiotic and antifungal activity9, 15, as well as UV 
radiation protective capabilities11, 40, its production is ultimately deleterious to the plant for two 
reasons: 1) it diverts resources from the synthesis of other useful cellular components, and 2) its 
presence is presumed to inhibit photosynthesis.6  While the first drawback is unavoidable, the 
second downside of using resveratrol as a defensive agent can be circumvented by either 
isolating it to non-photosynthetic tissues, such as roots and stem, or by metabolizing it to 
oligomers (Figure 1.3).  These higher-order structures appear to not affect photosynthesis, and 
can potentially help the plant fight a foreign pathogen more effectively due to their different 







































Figure 1.3 Biosynthesis of resveratrol oligomers in plants 
 
By successive coupling reactions initiated by phenolic oxidations with laccases and 
peroxidases6, 39, resveratrol (1) is oligomerized relatively quickly to architecturally diverse 
structures, as shown in Figure 1.4 (7, 8, 10–21), when a plant is stressed.  The implication of 
enzymes at some point in their biosynthesis is supported by the large number of oligomers that 
are isolated as enantiopure materials, some even as opposite antipodes from different plants,41 as 
well as by analogy with the biosynthesis of lignins.42,43   Similar to horseradish peroxidase in 
neolignans,42 grape peroxidases have been found to change their spatial and temporal 
transcription profiles, and thus may be able to perform highly specialized functions such as 
resveratrol oxidation in case of biotic or abiotic attack on the plant.44  A specific peroxidase 
isozyme that shows high affinity for resveratrol under optimal conditions for its oxidation has 
been identified, further supporting the involvement of such enzymes in oligomerization.45  In 
addition to the presence of enzymes capable of generating resveratrol radicals, scaffolding 





















probably involved, once again following the same principle as for the lignin biosynthesis 
mentioned earlier.43  
 






























































































































































The reason nature has probably chosen resveratrol (1) as part of a very common first-line 
defense mechanism parallels our interest in it from a synthetic organic perspective and lies 
within the structure of this molecule.  This very simple polyphenol can easily generate radicals 
by hydrogen abstraction and these radicals can quickly adopt a number of resonance forms due 
to its conjugated π system (Scheme 1.3).39  Thus, multiple reactive species can be generated 
almost instantaneously leading to a huge number of coupling possibilities and the potential for 
accessing great architectural diversity (selected structures in Figure 1.4).  Indeed, oligomers 
isolated thus far range from dimers (8, 10–14 in Figure 1.4) all the way to the octamer 
vateriaphenol A (21).  As the biological activity of these oligomers changes significantly with 
minor structural modifications (Tables 1.1–1.2), this shotgun approach to the oligomerization of 
resveratrol seems designed to ensure the plant’s survival when faced with new pathogens in the 
sense that hopefully one of the compounds produced has the right structure-function relationship 
needed for useful activity.  
 
Scheme 1.3 Radicals resulting from the oxidation of resveratrol 
 
1.5 Biological Potential of the Oligomers 
Hundreds of resveratrol oligomers have been isolated to date from numerous plants in 























Leguminosae.46  Preliminary studies have shown that the family collectively possesses broad 
pharmacological potential.  The polyphenolic nature of the resveratrol collection imparts 
antioxidant activity46, with the presence of a trans-olefin increasing this potency.  In addition, 
mixed oligomers of resveratrol with more oxidized stilbene scaffolds, especially those that 
contain a catechol motif, appear to be the most effective at fighting oxidative stress.46  
Resveratrol oligomers, however, are much more than pedestrian radical scavengers.  Anti-
bacterial, anti-fungal, anti-inflammatory, anti-carcinogenic, cytotoxic, and hepatoprotective 
effects have also been uncovered for these compounds.38   
Originally believed to be phytoalexins of grapes, several of the oligomers in the family 
display anti-bacterial and anti-fungal activity, generally with higher potency then resveratrol 
itself.15  While the anti-fungal effects are critically important to plants, the anti-microbial activity 
bears pharmacological potential as new strains of bacteria, many of which are resistant to 
classical antibiotics, are constantly emerging.  For example, hemsleyanol D (27 in Figure 1.5), a 
resveratrol tetramer bearing two dihydrofuran units, is active against methicillin-resistant 
Staphylococcus aureus.47  The anti-inflammatory and anti-carcinogenic activity of the resveratrol 
derivatives appear to stem from their ability to inhibit 5-lipoxygenase and cyclooxygenase, two 
extremely important enzymes in the synthesis of inflammatory cytokines.38  In addition, protein 
kinase C as well as tumor necrosis factor α inhibitors have been isolated from the resveratrol 






Figure 1.5 Structures of selected bioactive resveratrol oligomers 
 
Initially believed to be a characteristic exclusive to resveratrol dimers, such as pallidol 
(14) and δ-viniferin (28, Figure 1.5)48, cytotoxic properties were soon discovered to exist at 
higher potencies in the larger molecules in the class, with vaticanol C (29) being the leading 
example.  This tetramer has shown activity against ten cancer cell lines at low micromolar 
concentrations.49  The hepatoprotective effects of Ampelopsis brevipedunculata, a plant used in 
oriental folk medicine to treat liver disorders, have also been attributed to resveratrol oligomers, 

























































and its oligomers50 has led to a strong interest of the cosmetic industry for these polyphenols, 
both for their use as skin whitening agents and for the treatment of pigmentation disorders.  
After this global look at the range of effects in the resveratrol class, we will try to 
evaluate the relationship between the structural complexity of the oligomers and their 
bioactivities.  The number of resveratrol oligomers is huge for a comprehensive analysis of their 
beneficial effects, so the molecules that are highlighted here are ones that were either synthesized 
by our group or that represent near term goals for future synthetic efforts in our resveratrol 
research project.  Tables 1.1–1.2 present selected examples of the biological effects of these 
oligomers and attempt to showcase the documented increase in potency and specificity of the 
oligomers’ bioactivity with the corresponding increase in size and presence of dihydrofuran units 
as these molecules become larger.51  Critically, two architectural motifs seem to contribute 
substantially to the bioactivity of these oligomers: 1) the trans-stilbene olefin, an important 
factor in the antioxidant activity as well, and 2) the presence of dihydrofuran units, especially in 






Table 1.1 Examples of biological activity of selected dimers in the resveratrol class 
Entry  Oligomer Structure Biological Activity 
1 
 
• inhibitor of fatty acid synthase (IC50 = 7.5 µM)52 
2 
 
• lipase inhibitor53  
• suppresses the increase in blood glucose after oral administration 
of glucose in rats53 
3 
 
• inhibitor of fatty acid synthase (IC50 = 11.1 µM)52-53 
• activator of 5HT6R via the ERK1/2 pathway54 
4 
 
• lipid peroxidase inhibitor (IC50 = 29 µM)55  
• superoxide scavenger (IC50 = 26 µM)55 
5 
 
• moderate cytotoxicity against human promyelocytic leukemia, 
human lung adenocarcinoma and breast cancer (IC50 = 45-68 
µM)56 
• lipooxigenase inhibitory activity (IC50 = 62 µM)51d 
6 
 
• potent neuroprotective57 
• angiotensin II type 1 receptor antagonist  
• (IC50 = 30 µM)58 
7 
 
• neuroprotective effect against glutamate-induced neurotoxicity59 
• ACE inhibitor (IC50 = 35 µM)51f 
• cytotoxic against P338 cells (leukemia cell line)  
(IC50  = 18 mM)60 
• HMG-CoA reductase inhibitor IC50 = 232 µM61 
• protects against mutant Htt-induced SIRT3 (mitochondria sirtuin) 
depletion62  
• increases SIRT3 levels, activates AMPK and replenished the 
NAD+ levels62   






















































Table 1.2  Examples of biological activity of selected trimers and tetramers in the resveratrol 
class 
Entry Structure of Oligomer Biological Activity 
8 
 
• moderate cytotoxicity against human promyelocytic 
leukemia (IC50 = 78 µM)56 
• inhibits plasma glucose elevation after sucrose loading 




• crude plant extract stimulates the proliferation, 
maturation and differentiation of osteoblasts in vitro65 
• pure material cytotoxic against HL60 cells in part by 
induction of apoptosis (IC50 = 10 µM)66 
10 
 
• crude plant extract stimulates the proliferation, 
maturation and differentiation of osteoblasts in vitro67 
11 
 
• crude plant extract antihepatotoxic activity in cultured 
hepatocytes injured with CCl4 or D-galactosamine68 
12 
 
• cytotoxic against epithelial cells of human cervical 




• topoisomerase II inhibitor at 0.02 µg/mL (control 
etoposide 70 µg/mL)70 
14 
 
• apoptosis-inducer in colon cancer cell lines49a, b and 
leukemia cell lines49b, c (IC50 = 3-10 µM) 
• active against neuroblastoma and prostate cancer cell 
lines49b 
• upregulates hepatic expression of PPAR-α-responsive 
genes in a PPAR-α-dependent manner63 
• represses the expression of COX2 in several cancer cell 
lines63 






















































































• inhibits apoptosis at 1-10 µM in rat ventricular myocite 
cultures51c 
• inhibits vitisin A-induced apoptosis51c 
• cytotoxic against P338 cells (leukemia cell line) (IC50 = 
5.2 µM)71 
• cytotoxic against breast cancer, lung carcinoma, ovarian 
cancer and osteosarcoma cell lines  
(IC50 = 4.2-20 µM)72 
• strong inhibitory effect on the biosynthesis of 
proinflammatory cytokine leukotriene B4     (IC50 = 10 
µM)73 




• induces apoptosis in rat ventricular myocite cultures at 
30-300 nM51c 
• HMG-CoA inhibitor (IC50 = 42 µM)61 
• strong inhibitory effect on the biosynthesis of 
proinflammatory cytokine leukotriene B4 (LTB4) at 10 
µM (63% inhibition)73 
• ACE inhibitor (IC50 = 6.3 µM) (better than captopril)75 
• almost complete inhibition of AB-induced cell death at 
50 µM76 
• prevents β-amyloid aggregation77 



































The simplest dimers (Table 1.1), i.e. those without a dihydrofuran unit (entries 1–3) and 
gnetin F (32, entry 4), which possesses the dihydrofuran unit but not the stilbene double bond, 
have rather limited biological activities, mostly as antioxidant and as fatty acid synthase 
inhibitors.  However, with the presence of both the dihydrofuran and the stilbene double bond 
(entries 5–7), the pharmacologic potential increases and cytotoxicity, as well as cardioprotective 
and neuroprotective effects, begin to appear.  The activity of the trimers (Table 1.2) which 
possess a dihydrofuran unit, but no double bond, appears to be comparable in complexity to that 
of gnetin F (32); the exception in this trend is carasiphenol C (34), which did show cytotoxic 
activity (Note: the study uses the name gnetin I for this structure).66  Moving up to tetramers 
(Table 1.2), the pharmacological range expands dramatically and marked cytotoxicity at low 
micromolar concentrations appears (entries 12–16) for most compounds.  Even though these 
larger oligomers may display better membrane permeability due to a slight increase in 
hydrophobicity, the presence of the dihydrofuran unit in so many of the oligomers warrants, in 
our opinion, the investigation of its specific role as a pharmacophore.        
While promising, most of the data available to date on the bioactivity of resveratrol 
oligomers is from in vitro work.38  So far, the mechanisms of action of these larger compounds 
appear to be diverse and unrelated to the sirtuins overall.  Both ε-viniferin (8) and vaticanol C 
(29) were directly investigated for SIRT1 activation abilities and were found to be inactive.63  
Very little is known about the details of the bioactivity displayed by the higher-order structures 
in the family.  Accessing reasonable amounts of the oligomers in the family should allow not 
only for a broader evaluation of their bioactivities, but also for more in depth mechanistic 
studies, as isolation efforts involving kilograms of plant material often afford only a few 





The polyphenolic nature of these molecules makes them non-ideal as drug candidates, 
since they are likely to have low oral bioavailabilities, but understanding their mechanism of 
action could unravel novel pathways implicated in the development or the prevention of a wide 
range of diseases.  The broad range of biological systems that appear to be affected by 
resveratrol and its oligomers is thus extremely promising, whether or not drug candidates would 
be derived from the original polyphenols.  These polar materials could also be of use for topical 
application, such as in cosmetics.    
1.6 Biomimetic Approaches to the Synthesis of Oligomers 
The pharmacological potential demonstrated by oligomers derived from resveratrol in 
preliminary studies (vide supra) as well as the possibility of the family hiding analogs of 
resveratrol with higher potency for its beneficial effects have prompted a quest for efficient 
methods to synthesize these secondary metabolites.  These efforts will be described in this and 
the following sections, noting that the initial studies relied on the biosynthetic pathways 
proposed for the family involving laccases and peroxidases.6   
1.6.1 Radical-Based Biomimetic Explorations 
Inspired by their biogenesis, the first laboratory efforts towards the synthesis of 
resveratrol oligomers attempted to use horseradish peroxidase (HRP) and hydrogen peroxide.  
The inaugural report dates to 1977, and describes the transformation of resveratrol (1) into 
racemic δ-viniferin (28) in 41% yield (Scheme 1.4).79  The experiment was meant to support the 
biosynthetic hypothesis for the synthesis of ε-viniferin (8), where it was believed that resveratrol 
(1) dimerizes to 8 under the influence of peroxidases, analogous to the phenylpropanoid lignan 





the radical couplings of resveratrol.  This study was only the first of many attempts where 
dimerization of resveratrol (1) under radical conditions led to δ-viniferin (28), but ε-viniferin (8) 
remained elusive (Scheme 1.4).  While enzymatic reactions do show a preference for the 
formation of δ-viniferin (28), it is often synthesized unselectively80, or in moderate to low yield 
(Scheme 1.4)81.  Both the selectivity and the yield can, however, be optimized with enough 
variation in reaction conditions.  The first pH optimization reported improved the selectivity, but 
the yield remained around 20% at pH 4.5.82  Further work revealed that basic conditions (pH of 
8.0) could improve this yield dramatically to 93%.83  An excellent yield of 92% and great 
selectivity for δ-viniferin (28) was also obtained with incorporation of Mn2+ into HRP.84  The 
treatment of resveratrol (1) with laccases and peroxidases can therefore be an efficient way to 
access the δ-viniferin dimer (28).  Additionally, while initial radical conditions with 2,2-
diphenyl-1-picryhydrazyl (DPPH) generated δ-viniferin (28) in only 8% yield85, one-electron 
oxidants such as AgOAc86, Ag2O86, MnO280b, or FeCl380b proved to be highly efficient for its 
synthesis as well, with yields of up 97%.  The conditions and corresponding yields for the 
dimerization of resveratrol (1) into δ-viniferin (28) are summarized in Scheme 1.4.     
A recent and interesting study from Velu et al., building on these works, attempted to 
rationalize and predict ways to manipulate the reaction conditions to access different dimers 
regio and chemo-selectively.87  They concluded that soft one-electron oxidants in nonpolar 
solvents are ideal for the synthesis of δ-viniferin (28), while hard oxidants in polar solvents 
should lead to ε-viniferin (8).  Indeed, the latter has been synthesized selectively in 30% yield 






Scheme 1.4 Biomimetic dimerizations of resveratrol (1) to δ-viniferin (28) and ε-viniferin (8) 
 
A few other dimers in the family (Figure 1.6, top row) can be synthesized 
biomimetically, but the yields and the selectivities are generally quite low.80b, 83-84  Furthermore, 
the resulting mixtures from these synthetic efforts typically require extensive HPLC purifications 

















HRP + H2O2 (pH 8.0)
HRP + H2O2 (pH 4.5)
































Figure 1.6 Oligomers of resveratrol accessible by biomimetic syntheses 
 
Moving on to higher-order oligomers, the dimer ε-viniferin (8) becomes an important 
player.  After its postulated intermediacy in the synthesis of many dihydrofuran-containing 
oligomers15, several studies have attempted to expose it to HRP, with or without additional 
resveratrol (1) present, to see if these paper-based ideas could be reduced to practice.  In general 
the results were once again mixtures of natural and unnatural oligomers, with the natural ones 
obtained drawn in Figure 1.6.89  While in general the yields and selectivities of such biomimetic 
explorations are low (Scheme 1.5 A), one report of a dimerization of ε-viniferin (8) in the 








































































































(8) into vitisin B (41) with relatively good selectivity in 40% yield (Scheme 1.5 B).86a  Just like 
the dimerization of resveratrol (1), which preferentially leads to δ-viniferin (28) over ε-viniferin 
(8), the monophenolic stilbene aryl ring appears to form the most stable radical and allows for 
the appendage of the new dihydrofuran motif at that position (41 in Figure 1.7).86a   
 






























































50 ºC, 2 h
8: ε-viniferin
1.1% yield 8.5% yield








1.6.2 Cation-Based Biomimetic Explorations 
Outside of radical chemistry, extensive work on structure determination of the higher 
order oligomers was done by Niwa and his coworkers by exploring cation-based biogenetic 
routes (Scheme 1.6).90   Critically, by exposing enantiopure ε-viniferin (8) to different acid 
sources they managed to bias the composition of the final mixture and access ampelopsins B 
(10), D (45) and F (12) in yields ranging from 6 to 38%.  In addition, an acid-induced 
rearrangement was shown to convert (-)-vitisin B (41) into (+)-vitisin A (20) in almost 
quantitative yield.89a   
 



























































HCl 38% yield 8% yield
TfOH in MeOH 14% yield 21% yield
13% yield 6% yield 19% yield









1.6.3 Implications for the Biosynthesis of Resveratrol Oligomers   
 As shown above, the biosynthesis of the resveratrol oligomer collection probably 
involves the formation of radicals and their oligomerization and rearrangement under radical 
and/or cationic conditions. The biomimetic dimerizations of resveratrol under enzymatic 
conditions, leading to either δ−viniferin (28)80a or ε-viniferin (8)83, however, produce racemic 
material.  Thus, in addition to peroxidases, scaffolding enzymes must be involved in the 
biosynthesis of ε-viniferin (8), a dimer which is often isolated as chiral material from plants.76 
The formation of higher order oligomers, especially those containing the dihydrofuran 
architecture, remains debatable.  Certain studies suggest the synthesis of chiral ε-viniferin (8) 
and its implication in the synthesis of numerous other oligomers as enantiopure materials, with 
this simple dimer (8) serving as the as a source of the dihydrofuran motif.80b, 89a  Several studies 
have shown that enantiopure ε-viniferin (8) can indeed be further oligomerized under the 
influence of HRP with single enantiomers of the resulting tetramers being formed.89a, 89c  
Enantiopure ε-viniferin (8) has also been shown to rearrange stereoselectivity into other dimers 
(vide supra), including ampelopsin F (12).  Furthermore, the right pair of ε-viniferin (8) and 
ampelopsin F (12) enantiomers was isolated from Cotylelobium melanoxylon64, supporting the 
importance of ε-viniferin (8) as the branching point in the biogenesis of resveratrol oligomers.  
Or, put differently, if nature invests energy in the chiral production of a more complex material, 
it is probably 8, and its chirality can rapidly lead to the rest of the family if uncontrolled 







Figure 1.7 Structures of atypical dihydrofuran-containing resveratrol oligomers 
 
However, the existence of dihydrofuran rings that are either attached at different 
positions on the resveratrol core, such as δ-viniferin (28) and gnetin C (33), display cis-
stereochemistry (amurensin D, 46) or that have the C2 and C3 dihydrofuran aryl rings switched 
(suffruticosol B, 47) suggests that if ε-viniferin (8) is indeed a branching point in the synthesis of 
the resveratrol oligomers, other parallel pathways can also be at play.  Looking at the collection 
of molecules in the class that contain dihydrofuran units, one can envision a more complex 
oligomerization strategy.  As shown by Niwa’s work, the reactive dimer ε-viniferin (8) can 
rearrange to give new dimeric cores, ones without the dihydrofuran architecture.  Further 
oligomerization by addition of dihydrofuran units onto these new dimers or onto ε-viniferin (8) 
itself could generate the multitude of structures in the class.  Therefore, while ε-viniferin (8) 
could be an important source of dihydrofuran units in the family, oligomerization of other 
materials with addition of resveratrol as this heterocyclic motif should also be possible.  A 
biomimetic study that exposed parthenocissin A (48) and quadrangularin A (31), two dimers in 
the family, to resveratrol (1) under peroxidase conditions has indeed led to dihydrofuran-





























Scheme 1.7 Oligomerization of resveratrol dimers 48 and 31 into dihydrofuran-containing 
trimers 
 
1.7 Synthetic Approaches to the Synthesis of Resveratrol Oligomers 
1.7.1 Modifications of Biomimetic Syntheses 
While the biomimetic explorations have been extremely useful in the elucidation of the 
biogenetic pathways involved in resveratrol oligomerization, they have had limited success in 
allowing access to the resveratrol family overall in terms of breadth of structures and selectivity 
of the reaction processes deployed.  Even though they provide highly efficient ways for the 






















































31: quadrangularin A 51: laetevirenol C 52: laetevirenol D





oligomers remain quite difficult and entire portions of the collection have not been observed 
through such chemistry.    
 
Scheme 1.8 Biomimetic dimerizations of altered resveratrol substrates 
 
One creative way to tame the biomimetic dimerizations, while preserving their potential 
efficiency and extremely low step count, is to modify the substrates to allow for improved 
regioselectivity by masking certain phenols.  Using a dimethyl-protected variant of resveratrol, 
for instance, Velu et al. obtained protected derivatives of pallidol (54) and ampelopsin F (55) in 
10% and 7% yield respectively (Scheme 1.8 A); these materials were not observed without the 
phenol protection.87  The most notable synthesis in this category is that of quadrangularin A (31) 
by Hou and co-workers (Scheme 1.8 B),92  where the use of the bulky t-butyl groups forced the 
more stable radical, the one formed on the monohydroxy aryl ring, to adopt the quinonemethide 
resonance form as the reactive species.  This strategy blocked the documented propensity of 
resveratrol (1) to dimerize into δ-viniferin (28), essentially managing to generate a single radical 



































































selective synthesis of the indane core, as the isolable quinonemethide 57 in 35% yield; this 
material was then swiftly elaborated into the natural dimer quadrangularin A (31).  Interestingly, 
the same conditions employed in the synthesis of quadrangularin A (31) appear to give very 
different results in the hands of the Li group, this time leading to ampelopsin F derivatives 61 
and 62 (Scheme 1.9).93       
 
Scheme 1.9 Biomimetic dimerizations of altered resveratrol substrates 
 
1.7.2 Methodologies Based on Palladium-catalyzed Couplings 
While the quadrangularin A (31, Scheme 1.8) synthesis described above is highly 
efficient, it is difficult to reproduce, as evidenced by the study presented in Scheme 1.9.  In 



































































biomimetic oligomerizations to the synthesis of higher-order oligomers would also be close to 
impossible as noted already.  Thus, most current synthetic efforts have therefore moved on to 
rational design predicated on the assembly of simple targets through the aegis of retrosynthetic 
analysis.   
For instance, the presence of numerous aryl rings in the dimeric resveratrol oligomers has 
inspired chemists to draw from the extensive literature and methodology of palladium-based 
couplings.  Scheme 1.10 showcases such an example.  Here, in Chiummiento’s synthesis of 
protected anigopreissin A (71), the furan core was built by a Sonogashira coupling, followed by 
an interesting iodine-promoted cyclization.94  Aryl iodine 66 was then used in a Suzuki coupling 
to complete the 2,3-disubstituted-furan motif 68.  Elaboration of the methyl ester handle in 
compound 68 into an aldehyde allowed the final stilbene domain to be constructed by a Wittig 
olefination.   
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Paucifloral F (76), an oligomer bearing only three aryl rings (most likely due to an 
oxidative cleavage of the alkene-containing dimer ampelopsin D [45, Scheme 1.6]), has been 
synthesized in several creative ways.  First, the Chen group accessed this molecule by a Heck 
cyclization [Pd(OAc)2] of aryl bromide 74 (Scheme 1.11).95  Reduction of the indenone core, 
followed by epimerization of the hydrogen alpha to the ketone, afforded the desired trans 
indanone of the target.  A final deprotection then generated paucifloral F (76).           
 
Scheme 1.11 Chen's synthesis of paucifloral F (76) 
 
Using the alkyne version of resveratrol 77 as a starting point, Sarpong et al. have 
accessed both paucifloral F (76)96 and protected derivatives of quadrangularin A (82) and 
pallidol (83)97 by employing two different palladium-catalyzed methodologies (Scheme 1.12).  
The first was a Larock cyclization that generated the regioisomeric indenones 75 and 79 in 81% 
overall yield.  Reduction and epimerization of isomer 75, followed by a unique deprotection 






























    CeCl3 • 7 H2O
c) Pd(OAc)2, PPh3
    K2CO3, 80 ºC
59% yield
d) PtO2, H2










with permethylated resveratrol bromide 81, leading to compound 82, a protected and oxidized 
analog of the dimer quadrangularin A (31 in Scheme 1.8) in 53% yield.  Using FeCl3 as an 
oxidant, a fully unsaturated pallidol core (83) was obtained.    
 
Scheme 1.12 Sarpong's synthesis of paucifloral F (76), quadrangularin A derivative 82 and 
pallidol derivative 83 
 
Finally in 2012, by combining palladium catalysis to build the appropriately substituted 
anthracene core 86, with Friedel–Crafts attack upon a benzylic carbocation/quinonemethide to 
access the indane core, the Heo group synthesized laetevirenol A (92, Scheme 1.13).98  The 
second part of the synthesis is closely related to our group’s strategy of accessing the resveratrol 
dimers, work which was published in 200799 and an approach which will be detailed in a later 
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76: paucifloral F83: permethylated pallidol
derivative
e) FeCl3 • 6 H2O 38% yield
b) H2, Pd/C
    KOH87% yield
c) BBr3













Scheme 1.13 Heo’s synthesis of laetevirenol A (92) 
 
1.7.3 Synthesis of Unusual Dimers Hopeahainol A and Hopeanol 
The syntheses presented above have all focused on accessing resveratrol cores possessing 
an indane system.  In 2006 and 2008, two dimers with unprecedented cores, hopeahainol A (98) 
and hopeanol (99), were isolated and their cytotoxic and acetylcholinesterase inhibitory effects 
were documented.100  The Nicolaou group published an elegant synthesis of these two natural 
products in 2009, employing two cascade reactions to elaborate ester 95 into the complex core of 
96 (Scheme 1.14).101  As shown, Lewis acid-mediated Friedel–Crafts attack upon the epoxide in 
compound 96, followed by oxidation and deprotection, afforded the quinonemethide structure of 
hopeahainol A (98).  An efficient transformation of hopeahainol A (98) upon exposure to 
NaOMe generated hopeanol (99) in 80% yield, establishing a biosynthetic connection between 
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Scheme 1.14 Nicolaou's synthesis of hopeahainol A (98) and hopeanol (99) 
 
1.7.4 Asymmetric Syntheses of Paucifloral F 
Paucifloral F (76) has not only been targeted in racemic syntheses, but two asymmetric 
methodologies have also been developed to allow its synthesis as enantiopure material (Scheme 
1.15 – 1.16).102  These two schemes describe the only two asymmetric syntheses of resveratrol 
oligomers reported to date.  Both methods use indanone 102 as the stereogenic source.  The Heo 
group employed an enzymatic stereoselective reduction of indenone 101 to access compound 
102 with 99% e.e (Scheme 1.15).  This intermediate was then subjected to a stereoselective 
































































Scheme 1.15 Asymmetric syntheses of paucifloral F (76) 
 
Flynn’s synthesis of paucifloral F (76) employed chiral oxazolidinone auxiliaries to 
access both enantiomers of the natural product (Scheme 1.16).102a  Key enones 107 and 110 were 
synthesized by reductive couplings of the organotin reagents derived from chiral alkynes 104 and 
108 with acyl chloride 105, followed by a “torquoselective Nazarov cyclization” to the 
indanones.  Reductive removal of the chiral auxiliary afforded the 2 enantiomers of indanone 
102, intermediates which could be elaborated into paucifloral F (76) as shown in the Heo 





























76: (+)-paucifloral F 80
102101100
a) PdCl2, PPh3
    K2CO3
92% yield
b) baker's yeast 
    α-D-glucose
    1 M NaOH















Scheme 1.16 Flynn's asymmetric synthesis of paucifloral F (76) 
 
1.7.5 Broad Scope Synthetic Strategies 
Most of the approaches described above have targeted single oligomers.  While the value 
of such studies in teaching the scientific community about the reactivity and about the properties 
of these molecules is irrefutable, they do not appear to offer solutions pertinent for a reliable 
synthesis of the entire family.   
In 2009, Kim and Choi disclosed the synthesis of three protected natural products, two of 
which contained a novel seven-membered ring core.  They employed a bismuth-catalyzed 
dehydrative cyclization to access a furan derivative, this time with the C3 aryl substituent in 
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substituent of furan 112.  A similar olefination strategy as the once used by Chiummiento was 
utilized to convert aldehyde 112 into protected viniferifuran (114) in almost quantitative yield.  
The highlight of this synthesis is aldehyde 112’s ability to act as a branching point for the 
synthesis of permethylated viniferifuran (114), but also of protected malibatol A (116) and 
shoreaphenol (118), two dimers containing seven-membered rings.  A Corey-Chaykovsky 
epoxidation, leading to the trans-epoxide, followed by a bismuth-catalyzed Friedel–Crafts attack 
on this resulting intermediate closed the seven-membered ring.  One of the resulting 
diastereomers was protected malibatol A (116), while oxidation of both of them generated 
protected shoreaphenol (118).  Diastereomer 117 underwent an epimerization at the alpha carbon 
to the ketone under the acidic reaction conditions to also afford permethylated shoreaphenol 
(118).  
 
Scheme 1.17 Kim and Choi’s synthesis of permethylated viniferifuran (114), malibatol A (116) 
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A very recent paper from the Studer group in 2014 presents a highly modular approach to 
resveratrol dimers (Scheme 1.18).104  While this approach only delivers indane cores as well, it 
displays great potential in terms of the synthesis of analogs of the three accessible dimers.  
Starting with indene carboxylic acid 121, the Studer group employed a palladium-catalyzed 
decarboxylative arylation to install the C3 substituent.  Both aryl iodides 122 and 125 can be 
used in this reaction, leading to two different cores in the family.  The C2 substituent is appended 
by an impressive oxidative Heck reaction, mediated by nitroxide.  The desired trans relationship 
between the pendant aryl rings and the exocyclic olefin are both ensured by this strategy, leading 
to the cores of quadrangularin A (31) and ampelopsin D (45).  Finally hydroboration, followed 
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1.8 Programmable Approach to the Synthesis of the Resveratrol Class 
The strategies presented above have provided efficient ways to access the indane cores in 
the resveratrol family of oligomers, as well as some very creative ways to approach some of the 
complex cores in the family, such as hopeahainol A (98) and hopeanol (99).  A unified approach 
that would allow access to the diversity of dimers, as well as to the higher order oligomers in the 
family, would take the scientific community much closer to understanding the structure-function 
relationship in this family of natural products and thus be able to harness its therapeutic potential.  
Our laboratory has been seeking such a family-level solution for the synthesis of the resveratrol 
oligomeric class, one that goes well beyond any of the approaches described in the previous 
section.   
1.8.1 Selective Synthesis of Resveratrol Dimers 
As most of the architectural diversity in the family arises at the dimer level, an efficient 
strategy to access these cores selectively was first developed (Scheme 1.19, Goal #1).  The 
existence of natural products in the class that are oxidative cleavage products of dimers and only 
possess three rings, such as paucifloral F (76), has inspired the development of triaryl alcohol 
129, as the key launching point for controlled synthesis.  Four versions of this alcohol, with 
different phenol substitution patterns on the two highlighted aryl rings, have allowed our group 
to access nearly 20 dimeric oligomers, some of which are highlighted in Scheme 1.19.  The 
facile access to these triaryl alcohols, with no chromatographic purifications required in their 
synthesis, further increases their synthetic value.  Critically, the stilbene double bond can act as a 
nucleophile and lead to indane cores (31, 76 and 131), or it can be activated by electrophiles to 





activation of the olefins in 31 and 45 (Scheme 1.20) for new Friedel–Crafts attacks by electron-
rich aryl rings led to the bicycles of ampelopsin F (12) and pallidol (14).  To date, this strategy, 
reported first in 2007,99, 105 represents the only general way to access the structural diversity of 






















































130: diptoindonesin D 131: isoampelopsin D











































































































































The bicyclic pallidol (14) and ampelopsin F (12) will be important dimers in the 
following chapters, so their synthesis is briefly discussed here.  The syntheses of both pallidol 
(14) and ampelopsin F (12, Scheme 1.19) start from other protected dimeric natural products, 
namely quadrangularin A (124) and ampelopsin D (128).  Activation of the olefin with an 
electrophile was envisioned to allow the formation of the electrophilic para-quinonemethide, 
which would then be attacked by the more nucleophilic ring pendant to the indane core to close 
the bicycle by a Friedel–Crafts alkylation (Scheme 1.20).   
 
Scheme 1.20 Formation of bicyclic dimeric cores by electrophilic activation of olefins followed 
by Friedel–Crafts alkylation 
 
The first electrophile tested was a proton since this species would afford the desired 
product directly, but this approach only led to the isomerization of the olefin from its exocyclic 
position in structures 124 and 128, to a tetrasubstituted endocyclic alternative.  Looking at the 
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permethylated ampelopsin D (128, Scheme 1.20), the productive attack onto the electrophile 
would have to happen from the more hindered face of the alkene.  Therefore, in order for the 
desired reaction to occur, the electrophile has to be able to equilibrate from the more accessible 
face to the more hindered one.  Additionally, the electrophile must also be easy to replace with a 
hydrogen atom after the cyclization.  With these requirements in mind, electrophilic bromine was 
chosen as the formation of bromonium ions is known to be reversible106 and reductive 
dehalogenation methods abound in the literature.   
Using NBS or molecular bromine as the sources of electrophilic bromine, it soon became 
apparent that the electronic wealth of rings A and B makes them more nucleophilic than the 
olefin itself (Scheme 1.21).  However, these processes could proceed cleanly with selective 
bromination of first ring A and then ring B was observed, with the first equivalent of NBS 
leading exclusively to monobromide 143 (Scheme 1.21).  One equivalent of molecular bromine 
led to the formation dibromide 144 in 83% yield; the second equivalent of electrophilic bromine 
is likely generated by air oxidation of the bromide anion, as confirmed by the different 
reactivities observed with or without O2 present.107  It was only the third equivalent of NBS, or 
the second equivalent of molecular bromine, that finally engaged the olefin and allowed the 
bicycle 147 to form with excellent diastereoselectivity.  Lithium halogen exchange followed by 







Scheme 1.21 Synthesis of pallidol (14) from permethylated quadrangularin A (124) 
 
The synthesis of ampelopsin F (12) proceeded in a similar fashion, once again with initial 
bromination of ring A within permethylated ampelopsin D (128, Scheme 1.22), followed by 
bromination of ring B and finally formation of the quinonemethide and cyclization.  The bicyclic 
tribromide could be reductively dehalogenated under radical conditions to afford permethylated 
ampelopsin F (153) in 82% yield.  A final deprotection of the phenolic methyl ethers afforded 
the natural product (12).  Upon repeating this published synthesis on much larger scale, we 
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could certainly be obtained, however, we often encountered the formation of a side product, 
generally in ~ 1:1 ratio with our desired material (152).  The structure of this side product was 
determined by X-ray crystallography to be that shown in Scheme 1.23, compound 156.   
 
Scheme 1.22 Synthesis of ampelopsin F (12) from permethylated ampelopsin D (128) 
 
Side product 156 is selectively formed in the reaction of dibromide 150 with 




































































c) NBS ( 2 equiv)










73% yield 85% yield
47% yield
Reagents and conditions: a) NBS (1.0 equiv), CH2Cl2, -78 ºC to 23 ºC, 4 h, 73% yield; b) NBS (2.1 equiv), CH2Cl2, 0 ºC to 23 ºC, 
4 h, 85% yield; c) NBS (2.1 equiv), CH2Cl2, 23 ºC, 20 min, then Br2 (0.8 equiv), 0 ºC, 2 min, 47% yield; d) TMS3SiH (11.0 equiv), 
AIBN (1.1 equiv), toluene, 80 ºC, overnight, 82% yield; e) (from published results) BBr3 (12.0 equiv), CH2Cl2, 0 ºC, 4h, then 25 ºC, 






formation of the two cyclized tribromides 152 and 156, each one arising from a different 
diastereomer of the bromonium ion.   
 
Scheme 1.23 Rationale for the formation of tribromides 152 and 156 
 
While bromonium isomer 154 is probably the kinetic product, due to the favorable attack 
on the opposite side of ring C, it is actually the other diastereomer, 157, that leads to the desired 
ampelopsin F core 152.  The equilibration of the kinetic bromonium ion (154) to its isomer is 
therefore required for our synthetic pathway.  While bromonium formation is reversible, the rate 































































































the final product composition.  The formation of the quinonemethide is supported by the 
excellent diastereoselectivity of this type of cyclizations, leading to both permethylated 
ampelopsin F (153) or to permethylated pallidol (148) as single diastereomers.  A potential 
explanation for the striking difference between the reactivity of NBS and Br2, and that of BDSB 
likely stems from the cationic nature of this latter reagent.  Its positively charged electrophile 
could polarize the entire conjugated π system and lead to the formation of the quinonemethide 
almost instantaneously, potentially bypassing the bromonium ion.  The quinonemethide resulting 
from an approach of the electrophile on the more sterically accessible face generates an 
extremely sterically strained structure, with the eclipsed conformation shown in Figure 1.8, 
encouraging a fast Friedel–Crafts attack from the less nucleophilic, but properly positioned ring 
C.  On the other hand, the neutral NBS and Br2 must likely proceed through the bromonium ion, 
which can rearrange prior to the quinonemethide formation, leading to a thermodynamic mixture 
of final products. 
 























1.8.2 Synthesis of Unusual Frameworks in the Family 
While the strategy described in Scheme 1.19 should allow access to the majority of the 
structures in the family, there are several unique oxidized cores in the family with promising 
bioactivities100, 109 that would require more tailored synthetic strategies.  The dimers hopeanol 
(99), hopeahainols A (98) and D (162) and heimiol A (13) represent examples of such cores 
(Scheme 1.24). 
Both syntheses start with our triaryl alcohol 129, with variable protecting groups on the 
monohydroxy aryl ring.  The synthesis of hopeahainol D (162) and heimiol A (13) was 
accomplished by an electrophilic iodine-induced double cyclization of carboxylic acid 158 into 
the bridged lactone 159.110  IDSI108, the iodine analog of BDSB, a reagent developed in the 
Snyder group for inducing polyene cyclizations, was the only reagent of the ones tested that 
afforded this transformation, due to its unique preference for the stilbene alkene over the 
electron-rich aromatic rings.  After a protecting group switch for facile final deprotection, the last 
aryl ring was appended and the benzylic alcohol was diastereoselectively reduced.  Final 
deprotection allowed access to hopeahainol D (162), which was epimerized under Lewis acidic 
condition to generate heimiol A (13).  This final step was a clever use of the steric strain of 
hopeahainol D (162), which allowed the quinonemethide formed by the exposure of the ether to 
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For the synthesis of hopeahainol A (98) and hopeanol (99)111, a biomimetic formation of 
the seven-membered ring by an acid-induced Friedel–Crafts alkylation, leading to compound 
163, was employed.  Installation of the quaternary center in 166 was approached by initial 
homologation of the ketone, with the subsequent addition of the fourth aryl ring as a nucleophile 
leading to the vicinal dihydroxy intermediate 164.  After extensive experimentation, chiral 
phosphoric acid 165 was found to affect the desired pinacol rearrangement with >18:1 d.r. at the 
aldehyde 166 starting with an almost equal mixture of diastereomers of the precursor diol.  
Oxidation of the aldehyde 166 and deprotection generated lactone 167.  Oxidation of the 
permethylated lactone (structure not shown) could generate permethylated hopeahainol A, but its 
deprotection could not be achieved.  A global protecting group switch from methyl to benzyl 
ethers allowed the final deprotection of the oxidized material and delivered the desired natural 
product hopeahainol A (98).  The final transformation of hopeahainol A (98) into hopeanol (99) 
was achieved following exposure to NaOMe, as described by Nicolaou in his synthesis of these 
natural resveratrol dimers.101    
The syntheses of the unique cores described above, together with our divergent method 
for the synthesis of the classical dimers, bring almost all of the dimers in the family within reach.  
A similar level of accessibility of the larger oligomers was our next objective.    
1.8.3 Outline of the Strategy Targeting Higher-Order Oligomers  
With the synthesis of a multitude of dimers and related analogs in the family completed, 
we turned our attention to the larger members if the class.  As mentioned in the sections 
discussing the structure of the oligomers, the trans-dihydrobenzofuran is a widely represented 





studies.51  While the dimer ε-viniferin (8) has been proposed to be the source of the dihydrofuran 
motif in the family,15 we believe that a biosynthetic pathway that relies on a late stage 
installation of the dihydrofuran unit is more likely to be involved, at least for many of the more 
complex bicyclic cores.  Both the isolation from the same plant of a set of dimer, trimer and 
tetramer112 which could arise from the sequential addition of dihydrofuran units, and the 
biomimetic study that showed the formation of trimers by the installation of dihydrofuran units 
onto dimers (Scheme 1.7)91 support such a hypothesis.  We decided to follow a similar approach 
in our next endeavor, the installation of dihydrofuran units onto monomeric and dimeric cores in 
the resveratrol family to access trimers and tetramers. 
Before appending this heterocyclic motif, we would first need to selectively functionalize 
the position where the new carbon-carbon bond attaching C3 of the dihydrofuran unit to the 
original core would form.  As shown in Scheme 1.19, the positions that would need to be 
accessed regioselectively appear quite similar (132–137, Scheme 1.19), and their differentiation 
thus became our next goal (Goal #2 in Scheme 1.19).  With appropriate functional handles in 
place, the final challenge would be the development of a robust and universally applicable 
method to append the dihydrofuran motif (Goal #3 in Scheme 1.19) wherein access to different 
stereochemical configurations would be needed on frameworks that already are chiral.  These 
last two goals were the focus of my thesis research, and my efforts towards their accomplishment 
will be detailed in the following chapters.  
1.9 Conclusions 
Resveratrol and its oligomers represent a family of great architectural and 





polyphenols for their survival, the chances that they can be used to impact human health are 
certainly worth the exploration.  However, access to these complex and highly polar molecules 
from natural sources is difficult and inefficient.  Furthermore, the development of analogs from 
these materials, which are available in minute quantities, would be quite limited.  Organic 
synthesis, with its rational design abilities, presents a very promising alternative for accessing a 
library of resveratrol oligomers.  This chapter has presented the biological potential of the family 
and the methods applied to date in the synthetic efforts towards these molecules.  Critically, we 
ended by introducing the Snyder group’s strategic approach to the controlled synthesis of these 
oligomers and presented our accomplishments in Goal #1 of Scheme 1.19, namely the selective 
synthesis of almost twenty dimers and related analogs.  The remainder of this thesis will detail 
some of our efforts towards Goals #2 and #3, efforts which should render the availability of any 
member of the oligomeric class a distinct possibility, especially on scales not accessible from 
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1.11 Experimental Procedures  
General Procedures. All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise noted. Dry tetrahydrofuran (THF), 
toluene, benzene, diethyl ether (Et2O) and dichloromethane were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns.  
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated.  Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light as visualizing agent, and an ethanolic solution of 
phosphomolybdic acid and cerium sulfate, and heat as developing agents. SiliCycle silica gel 
(60, academic grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
Preparative thin-layer chromatography separations were carried out on 0.50 mm E. Merck silica 
gel plates (60F-254).  NMR spectra were recorded on Bruker 300, 400, 500 and 600 MHz 
instruments and calibrated using residual undeuterated solvent as an internal reference.  The 
following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = 
triplet, br = broad, app = apparent.  IR spectra were recorded on a Perkin-Elmer 1000 series FT-
IR spectrometer.  High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (fast 
atom bombardment) and APCI (atmospheric pressure chemical ionization) techniques. 
 Abbreviations. MeCN = acetonitrile, AIBN = azobisisobutyronitrile, EtOAc = ethyl 





Permethylated ampelopsin D (128) was synthesized according to our published 
procedure.105  Permethylated ampelopsin D 128.  1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 
2.1 Hz, 1 H), 7.18 (s, 2 H), 7.09 (d, J = 1.6 Hz, 1 H), 6.83 (d, J = 2.0 Hz, 1 H), 6.82–6.75 (m, 
2H), 6.75–6.67 (m, 2 H), 6.32 (d, J = 2.0 Hz, 1 H), 6.28 (d, J = 2.3 Hz, 2 H), 6.26 (dd, J = 2.5, 
1.9 Hz, 1 H), 4.35 (s, 1H), 4.24 (d, J = 1.1 Hz, 1 H), 3.93 (s, 3 H), 3.75 (s, 3 H), 3.73 (s, 3 H), 
3.70 (s, 6 H), 3.61 (s, 3 H). 
Permethylated ampelopsin D monobromide 149.  Permethylated ampelopsin D (128, 
0.006 g, 0.012 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (1.0 mL) and the solution was 
cooled to 78 ºC.  Solid NBS (0.002 g, 0.012 mmol, 1.0 equiv) was added to the solution at 78 
ºC and the solution was allowed to warm to 25 ºC over 4 h.  Upon completion, the reaction was 
quenched with saturated aqueous Na2SO3 (2 mL) and saturated aqueous NaHCO3 (2 mL) and 
extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were washed with water (3 mL) 
and brine (3 mL), dried (MgSO4), and concentrated to afford the crude product as a yellow oil.  
This crude material was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford the desired monobromide 149 (0.005 g, 73% yield) as an off-
white foam.  149: IR (film) νmax 3001, 2932, 2836, 2545, 2038, 1886, 1591, 1509, 1458, 1431, 
1393, 1329, 1248, 1203, 1177, 1155, 1102, 1065, 1032, 934, 890, 870, 829, 810, 784, 737, 696, 
642, 628, 533, 467 cm-1;1H NMR (500 MHz, CDCl3) δ 8.06 (s, 1 H), 7.18 (d, J = 8.6 Hz, 2 H), 
7.14 (d, J = 8.7 Hz, 2 H), 6.83 (d, J = 8.7 Hz, 2 H), 6.72 (d, J = 8.8 Hz, 2 H), 6.35 (s, 1H), 6.32 
(d, J = 2.3 Hz, 2 H), 6.24 (t, J = 2.3 Hz, 1 H), 4.33 (s, 1 H), 4.19 (s, 1 H), 3.93 (s, 3 H), 3.77 (s, 3 





157.2, 156.3, 147.4, 142.4, 142.0, 137.6, 130.4, 130.0, 128.9, 128.3, 127.7, 114.4, 113.8, 105.3, 
98.1, 97.6, 96.4, 58.0, 57.2, 57.1, 55.7, 55.4, 55.3. 
Permethylated ampelopsin D dibromide 150.  Permethylated ampelopsin D (128, 
0.165 g, 0.306 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (80 mL) and the solution was 
cooled to 0 ºC.  Solid NBS (0.113 g, 0.635 mmol, 2.1 equiv) was added at 0 ºC and the solution 
was allowed to warm to 25 ºC over 4 h.  Upon completion, the reaction was quenched with 
saturated aqueous Na2SO3 (30 mL) and saturated aqueous NaHCO3 (30 mL) and extracted with 
CH2Cl2 (3 × 100 mL).  The combined organic layers were washed with water (50 mL) and brine 
(50 mL), dried (MgSO4), and concentrated to afford the crude product as a yellow oil.  This 
crude material was purified by flash column chromatography (silica gel, hexanes:EtOAc, 
4:1→3:2) to afford the desired dibromide 150 (0.182 g, 85% yield) as an off-white foam.  150: 
1H NMR (300 MHz, CDCl3) δ 8.02 (s, 1 H), 7.33 (d, J = 8.7 Hz, 2 H), 7.12 (d, J = 8.8 Hz, 2 H), 
6.83 (d, J = 8.7 Hz, 2 H), 6.72 (d, J = 8.8 Hz, 2 H), 6.36 (s, 1 H), 6.28 (d, J = 2.8 Hz, 1 H), 5.95 
(d, J = 2.7 Hz, 1 H), 4.87 (s, 1 H), 4.20 (s, 1 H), 3.95 (s, 3 H), 3.85 (s, 3 H), 3.77 (s, 3 H), 3.73 (s, 
3 H), 3.62 (s, 3 H), 3.55 (s, 3 H). 
Tribromide 152.  Permethylated ampelopsin D (128, 1.10 g, 2.04 mmol, 1.0 equiv) was 
dissolved in dry CH2Cl2 (500 mL) at 25 ºC.  Solid NBS (0.767 g, 4.3 mmol, 2.1 equiv) was 
added to the solution at 25 ºC and the reaction was allowed to stir for 20 min.  After the 
formation of the dibromide 150 was confirmed by TLC, the reaction mixture was cooled to 0 ºC 
and Br2 (0.084 mL, 1.64 mmol, 0.8 equiv) was added to the reaction mixture.  The reaction was 
allowed to stir for 2 min at 0 ºC and was then quenched with saturated aqueous Na2SO3 (100 
mL) and saturated aqueous NaHCO3 (100 mL), poured into water and extracted with CH2Cl2 (3 





dried (MgSO4), and concentrated to afford the crude product as an orange amorphous solid.  This 
crude material triturated with MeCN to afford the desired tribromide 152 as a light pink solid 
(0.744 g, 47% yield) together with side product 156.  152: 1H NMR (300 MHz, CDCl3) δ 7.18 
(d, J = 8.0 Hz, 2 H), 6.85 (d, J = 8.8 Hz, 2 H), 6.81 (d, J = 9.1 Hz, 2 H), 6.66 (d, J = 8.8 Hz, 2 H), 
6.37 (s, 1 H), 6.20 (s, 1 H), 5.12 (s, 1 H), 4.78 (s, 1 H), 4.22 (s, 1 H), 3.88 (s, 3 H), 3.83 (s, 3 H), 
3.81 (s, 5 H), 3.71 (s, 3 H), 3.32 (s, 3 H).  156: 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.5 
Hz, 1 H), 6.926.73 (m, 3 H), 6.47 (d, J = 2.5 Hz, 1 H), 6.42 (s, 1 H), 6.38 (d, J = 2.8 Hz, 1 H), 
6.03 (d, J = 2.8 Hz, 1 H), 5.61 (s, 1 H), 5.08 (s, 1 H), 4.33 (s, 1 H), 3.93 (s, 3 H), 3.90 (s, 3 H), 
3.77 (s, 3 H), 3.66 (d, J = 1.3 Hz, 6 H), 3.57 (s, 3 H). 
Permethylated ampelopsin F 153.  Tribromide 152 (1.25 g, 1.6 mmol, 1.0 equiv) was 
dissolved in dry toluene (200 mL) and the solution was degassed at 25 ºC with argon bubbling 
for 15 min.  (TMS)3SiH (5.4 mL, 17.5 mmol, 11.0 equiv) and solid AIBN (0.281 g, 1.7 mmol, 
1.1 equiv) were added sequentially at 25 ºC and the reaction mixture was heated to 80 ºC 
overnight.  Upon completion, the reaction mixture was concentrated to afford the crude product 
as an orange oil.  The crude material was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1→7:3) to afford permethylated ampelopsin F (153, 0.710 g, 82% yield) as a 
light pink amorphous solid.  153: Rf = 0.69 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 2997, 
2936, 2835, 1604, 1511, 1487, 1462, 1319, 1248, 1206, 1176, 1140, 1091, 1037, 832 cm-1 ; 1H 
NMR (400 MHz, CDCl3) δ 7.11 (d, J = 8.4 Hz, 2 H), 6.84 (d, J = 8.4 Hz, 2 H), 6.83 (d, J = 8.8 
Hz, 2 H), 6.66 (d, J = 8.8 Hz, 2 H), 6.58 (d, J = 1.6 Hz, 1 H), 6.53 (d, J = 2.0 Hz, 1 H), 6.26 (d, J 
= 2.4 Hz, 1 H), 6.19 (d, J = 1.6 Hz, 1 H), 4.22 (s, 1 H), 4.19 (s, 1 H), 3.84 (s, 3 H), 3.81 (s, 3 H), 





CDCl3) δ 160.6, 159.6, 159.0, 157.7, 157.6, 155.0, 146.2, 145.6, 139.2, 135.6, 129.8, 128.8, 
128.6, 115.9, 113.5, 103.1, 101.5, 97.1 (2 C), 57.3, 55.6, 55.5, 55.4, 55.3, 55.2, 49.9, 49.1, 46.3; 













































Chapter 2 -  Development of a Universal Method of Dihydrobenzofuran Installation for the 








An overwhelming majority of the oligomers in the resveratrol class contain a trans-
disposed dihydrobenzofuran, a motif whose presence appears to correlate with an increase in 
biological potency.1  Therefore, understanding the potential role of this motif as a 
pharmacophore relies upon the ability to control its installation on diverse cores in the family at 
several different positions on an individual framework.  Our group has already developed 
methods that allow selective access to dimeric cores, such as protected ampelopsin F (2) and 
pallidol (3 in Scheme 2.1), as documented in the previous chapter.  Building on these oligomers, 
our goal was to achieve the installation of dihydrofuran units by a late-stage attachment onto 
these lower-order cores; critically, pursuing this tactic would require the development of a 
regioselective synthesis of this motif on fragments with pre-existing chirality and potentially 
uncontrolled patterns of reactivity.  This chapter introduces an approach based on electrophilic 
aromatic brominations as a means to selectively install functional handles onto several 
resveratrol cores and details efforts to develop a robust, iterative and predictable method to 








Scheme 2.1 The Snyder group approach for the synthesis of resveratrol oligomers 
 
2.2 Dihydrofuran Installation Patterns in the Resveratrol Oligomeric Family 
There are only three possible positions for the attachment of the dihydrofuran architecture 
in the resveratrol class, as the linkage needs to be ortho to a phenol, in order to generate the final 
heterocycle.  These positions are numbered on resveratrol (6) as shown in Scheme 2.2.  Most 
oligomers appear to arise from the attachment of this unit at the equivalent of position 1, on the 
more electron-rich aryl ring, ortho to one of the phenols and para to the other one.  However, 
natural products such as gnetin C (8)2 and δ-viniferin (9)3, in which the carbon-carbon bond 
attaching the dihydrofuran has formed at positions 2 and 3 respectively, do exist in the 






























3: permethylated pallidol 5: carasiphenol C













Scheme 2.2 Dihydrofuran installation patterns in the resveratrol class 
 
2.3 Biosynthesis of Dihydrofuran-containing Oligomers in the Resveratrol Class 
The biosynthetic pathways that lead to resveratrol oligomers have not been completely 
elucidated.  In 1993, Sotheeswaran and Pasupathy divided the structures in the family into two 
groups, the first containing molecules that display at least one dihydrofuran motif, and the 
second being those that do not.4  At that time, only one oligomer containing the dihydrofuran 
unit at position 2 had been isolated (gnetin I); all the rest bore this architectural motif at position 
1.  As such, they postulated ε-viniferin (7) as the key intermediate, and source of dihydrofuran 
motif, for all the oligomers in the initial classification group.  Moreover, reasonable arrow 
pushing mechanisms could be drawn to explain the formation of several larger oligomers from 
that compound (7).  In time, biomimetic studies that presented actual transformations of ε-
viniferin (7) into various oligomers bearing dihydrofuran units followed, further supporting this 
hypothesis.5   
However, a careful examination of the resveratrol oligomers isolated to date reveals not 



































that bears this motif at position 1 several recent isolates that cannot derive from ε-viniferin (7).  
Compounds 10 and 11 (Figure 2.1 A) are such examples, materials possessing both cis-disposed 
dihydrofuran units (10 and 11) and a swap in the aryl substituents at C2 and C3 (10).  While ε-
viniferin (7) can certainly not be ruled out as an intermediate in the synthesis of certain 
resveratrol oligomers, other parallel synthetic pathways are most likely at work as well as, as 
noted in the previous chapter.   
The level of control in the oligomerization of resveratrol is unknown, but given the speed 
with which these materials are made following environmental stress, and given for example, the 
selection of oligomers isolated from Caragana sinica6 (Figure 2.1 B), a certain lack of control 
becomes apparent.  An iterative addition of resveratrol units in the oligomerization of these 
material can be inferred from the selected oligomers from Cenchrus echinatus L (Figure 2.1 C).7  
Starting with the dimer pallidol (12), dihydrofuran units seem to be added sequentially leading to 







Figure 2.1 A: Oligomers with unusual dihydrofuran groups; B: Isolates from Caragana sinica; 
C: Isolates from Cenchrus echinatus L 
 
Because of this apparent absence of control in adding resveratrol itself, we strived to 
























































































A Anomalous dihydrofuran installations
B Selected oligomers isolated from Caragana sinica










at positions 1-3 (Scheme 2.2).  With a diverse collection of dimers available8, one goal was to 
find a way to achieve their regioselective functionalization at positions 1-3, and then elaborate 
the ensuing functional handles in an iterative way into trans-dihydrofuran architectures by a 
robust and reliable approach.  Although both components were viewed as challenging, we 
decided to focus our initial efforts on the dihydrofuran formation. 
2.4 2,3 – Disubstituted Dihydrobenzofuran Synthesis Methods  
The 2,3-dihydrobenzofuran is a well-represented motif in both bioactive natural products 
and pharmaceuticals.9  As a result, numerous methods to synthesize this heterocyclic architecture 
have been developed, many affording highly functionalized and complex products.9  What we 
needed was a method that would allow appendage of dihydrofuran units onto a pre-existing 
polyphenolic core, essentially by forging the C3–C4 and the C2–O bonds (Scheme 2.3).  
Methods that target these two bond formation events as the final disconnection are therefore 
briefly reviewed in this section (Schemes 2.4–2.6).  Critically, we expected the synthesis of the 
stilbene, or of an appropriately functionalized variant of it, to arise from reactions similar to 
those employed in the controlled syntheses of lower order oligomers, as discussed in Chapter 1.   
 






























Quinone-based methods for the installation of trans-dihydrobenzofurans, which can often 
forge both the C3–C4 and the C2–O bonds in one-pot, are relatively efficient and quite 
diastereoselective10.  Regiocontrol is achieved by appropriate substitution of quinones (23), or 
quinone-like reactive species (26), whether they are used as reagents10a, b or generated in situ10c, 
10f (Scheme 2.4).  This approach, however, relies on the ability of the aryl ring in the final 
dihydrobenzofuran (ring A in 16, Scheme 2.3) to itself generate a quinone, a luxury our cores do 
not permit with the 3,5-diphenoxy ring system.  A more stepwise installation would thus need to 
be developed.      
 









































up to 71% yield
32-66% yield
21-75% yield
A: J.O.C. 1991, 56, 1979
B: J.A.C.S. 1988, 110, 7931
    enantioselective version J.O.C. 1999, 64, 2391
C: Org. Lett. 2006, 8, 3919






Outside of quinones, several methods target C3–C4 bond formation as the last step 
(Scheme 2.5); the majority of these approaches employ a 5-exo cyclization of an allyl ether to 
forge the dihydrofuran.  For example, the reductive radical cyclization of 32 into 33 relied upon 
the high nucleophilicity of C3, part of the allylic ether olefin, to intercept the electrophilic radical 
generated at C4.11  An enantioselective anionic cyclization was shown by Barluenga et al. to not 
only allow the closing of the dihydrofuran in 35, but also the installation of additional functional 
handles as electrophilic species.12  A similar strategy, this time under palladium catalysis, 
utilized a tandem cyclization Suzuki cross-coupling to generate great complexity as expressed in 
structures such as 40.13  The olefin could also be activated by epoxidation (43), allowing for the 
installation of a functional handle at C2.14  However, forging the C3–C4 bond last would not be 
valid for the construction of our desired dihydrobenzofuran for two reasons.  First, with the 
exception of Jørgensen’s organocatalytic methodology leading to 4414, the C2 position remains 
unsubstituted in these approaches.  Second, in order to have an olefin at the appropriate position, 
the 3,5-dihydroxy aryl ring of resveratrol would have to generate a quinonemethide which, again, 
would be impossible due to its phenol substitution pattern relative to the adjoining alkene (ring B 







Scheme 2.5 Synthesis of dihydrobenzofurans by final construction of the C3–C4 bond 
 
The other general approach, one based on forming the C2–O bond last (Scheme 2.6), 
appeared much more promising.  Specifically, activation and substitution of an alcohol at C2 has 
been shown to lead to the desired dihydrofuran, noting that simple ionization of this alcohol 
under acidic conditions afforded a ~ 2:1 ratio of trans 46:cis 47 dihydrobenzofurans15.  A switch 
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5016) did, however, impart excellent diastereocontrol.  Once again, 5-exo attack on an olefin at 
C2 proved to be a viable way to effect cyclization.  Critically, that olefin could be activated by 
electrophiles (proton for the synthesis of 58,17 molecular iodine for 6018 or by epoxidation for 
52→5319 and 55→5620).  Finally, transition metal-catalyzed methodologies for the closure of this 
bond were also developed, as evidenced by Hayashi’s transformation of 61 into 62.21  Thus with 
this general range of reactions and the ability of the 4-hydroxyaryl ring of resveratrol (ring C in 
17, Scheme 2.3) to generate a quinonemethide electrophile at C2, this type of disconnection 
greatly inspired our efforts for the development of our own method of dihydrofuran construction, 
one specifically adapted to our cores and based on an array of attempts which highlight that the 
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2.5 Dihydrofuran Installation Method Development 
The installation of the dihydrofuran motif in the resveratrol class is, essentially, the 
appendage of a new resveratrol unit onto pre-existing cores.  Our first strategy targeted the 
attachment of the entire resveratrol piece in one fell swoop.  To achieve this end, two new bonds 
would be required:  the C2 position has to be connected to the phenol oxygen at C5, and C3 must 
join with C4.  We decided to use a simple phenol, such as 16 (Scheme 2.7 A), as a model to 
assess the ability to incorporate an aryl ring of what would become the dihydrobenzofuran with 
fully functional material.  This compound was expected to behave as a nucleophile at the phenol 
and at C4, and to lead to an installation of the dihydrofuran at position 1 (Scheme 2.2), with the 
new C-C bond ortho to one of the phenols and para to the other.  This pattern is the most 
common in the class by far, so we believed that focusing on it first, and later adapting our 
resulting approach to the other patterns, would be a reasonable course of action.   
 
Scheme 2.7 A: Reactive centers on phenolic ring 16 and on protected resveratrol 17;   B: 







































Looking at a resonance form of protected resveratrol 17, it becomes apparent that the C2 
position is electrophilic, and thus the first bond formed could take advantage of the 
nucleophilicity of the phenol domain of 16 and bring them together (Scheme 2.7 A).  In order for 
this process to occur, activation of the double bond with an electrophile was first attempted.  
Unfortunately, both proton and electrophilic bromine sources did not achieve the desired 
reaction, with the first leading to decomposition and the latter to halogenation of the electron-
rich 3,5-dimethoxy aryl ring in permethylated resveratrol (63, Scheme 2.7 B).   
Next, we attempted to activate the stilbene olefin of permethylated resveratrol (63) by 
epoxidation, but, once again, the more electron-rich 3,5-dimethoxyaryl ring was oxidized.  
Fortunately, switching to acetate protecting groups for the phenols tamed the propensity for that 
electrophilic aromatic bromination, and allowed the synthesis of a halohydrin to be achieved 
with NBS and water; this intermediate was then treated with base to afford epoxide 68 (Scheme 
2.8).  Opening of this epoxide under Lewis acidic activation in the presence of 3-hydroxyanisole 
(65) allowed the formation of one of the bonds required for the dihydrofuran installation, namely 
that between the phenol and C2.  Attempts to ionize the alcohol at C3 within intermediate 70, 
however, only lead to decomposition products, under both protic and Lewis acidic conditions.  
While this alcohol was benzylic, the two meta acetoxy groups could act inductively as electron 









Scheme 2.8 Attempts to build the dihydrofuran unit starting from the stilbene 
 
Moving next to a stepwise approach to the construction of the full resveratrol unit, we 
decided to approach C3–C4 bond formation first (73 in Scheme 2.9), then build the resveratrol 
piece, and finally close the dihydrofuran ring by an attack of the phenol at C5 onto a 
quinonemethide electrophile generated to activate the C2 position, (i.e. 74).   
 




































Reagents and conditions: a) NBS (1.5 equiv), THF:H2O 1:1, 0 ºC for 30 min, 50 ºC for 5 h; b) 
K2CO3 (0.5 equiv), THF:H2O 1:1, 25 ºC, 30 min, 49% yield over 2 steps; c) 65 (0.8 equiv), TiCl4 (1.0 
equiv), CH2Cl2, 25 ºC, 18 h, 43% yield.
49% yield































In more specific terms, if we could generate an anion at C4 (76 in Scheme 2.10), this 
would attack protected 3,5-dihydrodybenzaldehyde and forge the C3-C4 bond, while leaving a 
bisbenzylic alcohol as a handle for further elaboration.  Oxidation to ketone 77 would render the 
C3 position more electrophilic and the rest of the resveratrol piece could be attached as a 
benzylic nucleophile.  With the carbon framework in place, deoxygenation of the bisbenzylic 
alcohol, followed by a benzylic oxidation should generate quinonemethide 74.  Attack of the 
phenol at the electrophilic C2 and deprotection should close the desired dihydrobenzofuran 75.  
Overall, while several steps in length, the process in Scheme 2.10 was one we felt could be 
adapted to many systems, dependent primarily on the ability to generate the functional handles as 
defined in one example as 72.    
 
Scheme 2.10 Proposed synthetic route to the trans-dihydrofuran architecture 
 
To begin testing this synthetic pathway, we first needed to be able to install the functional 
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a halogen atom at that position could serve this role.  As observed when we were attempting to 
activate the stilbene olefin (Scheme 2.7 B), electrophilic aromatic bromination occurs selectively 
at position 1 leading to monobromide 78 in 94% yield (Scheme 2.11).  Thus, starting with 
permethylated resveratrol 63, NBS was used to synthesize bromide 78.  Lithium-halogen 
exchange, followed by the addition of the resulting anion into 3,5-dimethoxybenzaldehyde (79) 
and oxidation, afforded ketone 80 in 81% yield.8a, b  Before proceeding with the development of 
the remaining steps, we decided to reduce the stilbene double bond in ketone 80, as it usually 
introduces acid instability and might hamper our attempt to develop the dihydrofuran installation 
sequence, giving us maximal possibility to develop a sequence we could later assess with 
compounds containing such a double bond.     
 
Scheme 2.11 Elaboration of permethylated resveratrol to triaryl ketone 80 
 
Surprisingly, reduced ketone 81 proved to be unreactive in the presence of organolithium, 
Grignard, and organozinc reagents (Scheme 2.12).  Attempts to activate the ketone for that 
addition as a hydrazone, an oxime, or by hydrogen bonding to the ortho-free phenol (81 with R = 





















Reagents and conditions: a) NBS (1.0 equiv), CH2Cl2, -78 to 25 ºC, 5 h, 93 % yield; b) (from 
published results) nBuLi (1.05 equiv), THF, -78 ºC, 20 min; then 79 (1.0 equiv), -78 ºC, 1 h, 25 ºC, 4 h, 






supporting the non-electrophilic character of this ketone.  Twisting the ketone out of conjugation 
with the aryl ring bearing the electron-donating ortho and para phenols by differentially 
protecting the ortho one with a bulky group (81 with R = Bn, TBS, Boc) also proved futile.  
Seemingly, the electronic wealth and congested environment made this ketone completely 
unreactive to any nucleophilic species except for methyl lithium, which successfully added when 
ten equivalents were used in THF at 25 ºC.  
 
Scheme 2.12 Unreactive bisbenzylic ketone 81 
 
2.6 Endocyclic trans-Dihydrofuran Installation Method 
The cyclic seven-membered ring ketone 83, obtained in two steps form the common 
triaryl alcohol 1, did, however, accommodate the attack of a benzylic Grignard reagent.  In this 
case, we believe that the cyclic structure of ketone 83 results in a non-planar arrangement, one 
preventing the electron-donating methoxy groups of the aryl ring from decreasing the 
electrophilicity of the carbonyl.  Unfortunately, despite success in the addition, further 
manipulations of the resulting alcohol 85, were unsuccessful in leading to the full dihydrofuran 






















Scheme 2.13 Grignard addition into cyclic ketone 83 
 
2.6.1 Synthesis of Ampelopsin B  
A creative solution to this challenge was ultimately found by Dr. Christos Stathakis and 
Dr. Yunqing Lin in our group.  As shown in Scheme 2.14, the bisbenzylic ketone functionality 
was replaced by a stable quinonemethide in the form of 87, a species which preserved the 
electrophilicity at that same carbon, but circumvented the need for a reduction following the 
Grignard attack (Scheme 2.14).  Deprotected ketone 86 was protected with TBS groups, with the 
exception of the phenol ortho to the carbonyl group, which remained free due to hydrogen 
bonding to the sp2 oxygen.22  This protecting group scheme was advantageous since it would 
allow for mild deprotection conditions in the presence of the dihydrofuran unit, and would 
preserve the nucleophilicity of the free phenol required for cyclization.  Next, reduction of the 
ketone led to the formation of quinonemethide 87 by an in situ dehydration.  Addition of 
benzylic Grignard reagent 88, followed by the benzyl ether deprotection, provided intermediate 
89.  The free para phenol of this new product facilitated the benzylic oxidation leading to a 


























the desired trans-dihydrofuran.  A final deprotection afforded the natural dimer ampelopsin B 
(90) in work which has not been published yet (a further optimization is required).  
 
Scheme 2.14 Synthesis of ampelopsin B (90) 
 
2.6.2 Synthesis of Vaticanol A 
The same synthetic strategy was recently applied to the synthesis of vaticanol A (95)24, a 
highly complex trimer in the resveratrol family (Scheme 2.15).  Once again, a quinonemethide 
was used as a surrogate for the electrophilic benzylic ketone.  In the key steps of the sequence, 
cyclic ketone 91 (as a mixture of diastereomers) was reduced and the transient quinonemethide 
generated by treatment of the ensuing alcohol with acid was intercepted by benzylic Grignard 














































formed C-C bond, with diastereomers 92 taken forward and subjected to second quinonemethide 
formation now targeting cyclization to the final dihydrofuran.  Pleasingly, the benzylic oxidation 
proceeded smoothly with DDQ, and the quinonemethide was attacked by the free phenol to 
afford the core of vaticanol A in the form of 94.  Deprotection of the permethylated compound 
afforded the highly complex trimer vaticanol A (95), a resveratrol trimer with cytotoxic and anti-
diabetic bioactivity.25     
 
Scheme 2.15 Snyder's synthesis of vaticanol A (95) 
 
Critically, however, while the method developed for the synthesis of ampelopsin B (90) 
can successfully generate endocyclic dihydrofuran units, even on highly complex cores, such as 
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experiments performed by Dr. Christos Stathakis, and later by Dr. Andreas Gollner in our group, 
showed that on cores where the aryl ring at C3 of the dihydrofuran was not constrained in 
attachment to a seven-membered ring, this benzylic functionalization was not possible.  Given 
that the majority of the dihydrofuran units in the resveratrol class are exocyclic, such as 
carasiphenols B and C (4 and 5 in Scheme 2.1), we returned to the quest for a way to 
functionalize non-cyclic bisbenzylic ketones and generate the needed dihydrofurans, with 80 
being the simplest such ketone.       
2.7 Exocyclic trans-Dihydrofuran Installation Method 
The success of MeLi addition inspired a homologation protocol via an initial Corey-
Chaykovsky epoxidation,26 followed by a Lewis acid-induced rearrangement to the aldehyde27 
(Scheme 2.16).  When used in gross excess (10 equivalents), the Corey ylide managed to engage 
ketone 80 and allowed us to access the less hindered and more reactive aldehyde electrophile 
98.8d  This homologation, developed by Dr. Nathan Wright for the synthesis of heimiol A 
(123),8d enabled us to proceed towards the completion of the desired carbon framework.  In 
addition, it circumvented the need for the reduction of the benzylic alcohol at C3 that would have 
formed in the attack of a benzylic nucleophile on the ketone 80 (Scheme 2.10) and the final 
benzylic oxidation, a transformation that has proven difficult to achieve at times28 on some of our 
polyphenolic cores.  By using the aldehyde electrophile, the nucleophilic attack would lead to an 
alcohol at C2, affording the perfect functional handle for the final cyclization to our desired 







Scheme 2.16 Homologation of unreactive ketone 80 
        
2.7.1 Synthesis of Gnetin F 
Moving forward, we now needed to attach the final aryl ring of the resveratrol piece.  
However, before proceeding to complete the carbon framework, we decided to change the 
protecting groups.  We had sometimes observed instability of the dimeric natural products 
containing reactive groups to the BBr3 conditions required for methyl ether deprotection, and we 
wanted to proactively prevent such difficulties here, especially given that dihydrofuran units are 
known to be acid-sensitive.  Thus, the mild conditions typically used for the deprotection of 
benzyl ethers recommended them for our synthesis, noting that possible cleavage of the 





























Reagents and conditions: a) Me3SI (10.0 equiv), nBuLi (9.0 equiv), THF, 0 ºC, 1 h; b) 






However, the electrophilic aromatic bromination leading to monobromide 78 did not proceed 
directly with benzyl protecting groups.  Therefore, we chose the stable triaryl ketone 81 as the 
optimal intermediate for a global exchange of protecting groups from methyl ethers to more 
readily cleaved benzyl ethers.  As shown in Scheme 2.17, the homologation sequence to the new 
aldehyde (99) proceeded smoothly in 69% yield.  The addition of the final aryl ring as 4-
benzyloxyphenyl Grignard reagent 100 allowed us to complete the entire resveratrol piece.  The 
only remaining steps now to be developed were cyclization and deprotection.   
 
Scheme 2.17 Final dihydrofuran installation strategy and synthesis of gnetin F (101) 
 
While a one-pot procedure taking advantage of Lewis acidic conditions to deprotect the 
benzyl ethers as well as ionize the alcohol at C2 and cyclize seemed appealing, diastereocontrol 
was expected to be problematic.  As mentioned earlier in the reaction of alcohol 45 with pTsOH, 
a precursor which led to a 2:1 mixture of the trans:cis diastereomers (Scheme 2.6)15, a simple 
carbocation at C2 should likely be avoided, given that such a structure (103 in Scheme 2.18) 























f) H2, 30% Pd/C
g) Amberlite  
    IR-12-OH
101: gnetin F




Reagents and conditions: a) BBr3 (20.5 equiv), CH2Cl2, 25 ºC, 19 h, 95%; b) BnBr (30.0 equiv), K2CO3 (30.0 equiv), 
TBAI (1.5 equiv), acetone, 70 ºC,overnight, 84% yield; c) nBuLi (8.0 equiv), Me3Si (10.0 equiv), THF, 0 ºC, 2 min; then 
ketone (1.0 equiv), 0 ºC, 20 min; d) ZnI2 (2.5 equiv), benzene, 25 ºC, 1 h, 77% yield over 2 steps; e) 100 (5.0 equiv), 







the aryl ring at C2 could easily form quinonemethide 104 (Scheme 2.18), and having that phenol 
already deprotected at the time of the alcohol ionization should facilitate this stabilization (107).  
We therefore decided to fully deprotect the benzyl ethers in 102 under non-acidic conditions by 
hydrogenation.29  This process was meant to afford alcohol 105 without ionizing the benzylic 
alcohol.   
 
Scheme 2.18 Mechanistic rationale for deprotection prior to cyclization of the 
dihydrobenzofuran 
 
Indeed, carefully controlled hydrogenation of 102 deprotected the phenols without 





























































glyceollin I (112 in Scheme 2.19), who used basic conditions to generate quinonemethide 110 
and attack it with a phenol29, we exposed the resulting intermediate (105) to mild acid to close 
the dihydrofuran ring.  This strategy led to the exclusive formation of trans-gnetin F (101) in 10 
steps and 32% yield overall from monobromide 78 (Scheme 2.17).  
 
Scheme 2.19 Erhardt's synthesis of (-) glyceollin I (112) 
 
We had therefore accomplished the total synthesis of the resveratrol dimer gnetin F (101) 
with regio- and diastereoselective installation of the dihydrofuran.  In addition, while our gnetin 
F (101) synthesis showcased the ability to append an exocyclic dihydrofuran unit at position 1 
(Scheme 2.2), it was expected to also work for the other positions as well, provided that we could 
generate the initial anion ortho to the key phenol (76 in Scheme 2.10).  Next, we wanted to test 
the applicability of this method to the synthesis of more complex dihydrofuran-containing 
oligomers in the family.  In order to do so, we would need to identify methods, reagents and/or 
catalysts that could regioselectively install the needed functional handles on our diverse dimeric 
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2.8 Pattern 1 for Dihydrofuran Installation 
2.8.1 Selective Functionalization of Permethylated Resveratrol Dimers 
With the NBS bromination of permethylated resveratrol 63 being highly selective for the 
ring bearing two phenols, ortho to one phenol and para to the other,8e we wondered whether the 
same functionalization pattern would be observed on the dimeric cores in the family.  In 
addition, bromination is highly susceptible to Hammett’s substituent effects given its reaction 
constant of -12,30 so regioselectivity should, in principle, be tunable by varying the 
substituents/protecting groups of the phenols on the aryl rings, if the intrinsic selectivity does not 
favor the desired positions.   
 
Scheme 2.20 Selective functionalization of a symmetrical permethylated resveratrol dimer 
 
The first dimer we tested was a symmetrical one, permethylated pallidol (3).  This 
bicyclic dimer displayed the same selectivity as resveratrol.31  NBS smoothly brominated ring A 
to afford monobromide 113 in 47% yield, with the only other product obtained being dibromide 
114 in 23% yield (Scheme 2.20).  Once again, the more sterically hindered position on ring A 









































electronic wealth of the system and the distance between the two activated rings A lead to facile 
dibromination (i.e. bromination of one ring does not impact the reactivity rate of the other). 
We then moved on to explore non-symmetrical dimers in the family.  Permethylated 
ampelopsin D (115) and quadrangularin A (118) display two dimethoxyaryl rings which differ in 
the number of alkyl substituents.  As expected, the dialkyl-substituted rings C and E8b get 
brominated preferentially over the monoalkyl-substituted rings D and F (Scheme 2.21 A).  
Permethylated ampelopsin F (2) and heimiol A (123),8d however, posses two dimethoxy, dialkyl-
substituted rings (G and H in 2, and I and J in 123, respectively).  Fortuitously, both of these 
nonsymmetrical substrates also showed excellent selectivity for rings G31 and I, respectively, 
over rings H and J.  Monobromides 121 and 124 were obtained in 95% and 97% yields.  For all 
four dimers in Scheme 2.21, treatment with two equivalents of brominating reagent led to the 







Scheme 2.21 Selective functionalization of non-symmetrical permethylated resveratrol dimers 
 
With monobromides 121 and 113, as well as dibromides 122 and 114 in hand we 
proceeded to expand the scope of our dihydrofuran installation method on these highly complex 




























































































































































Scheme 2.22 Monobromides 121 and 113 and dibromides 122 and 114 as precursors for natural 
products 
 
2.8.2 Elaboration of the Dimer Ampelopsin F into the Trimer Carasiphenol B    
Carasiphenol B (4) was first isolated in 2004 by Wang and co-workers from the aerial 
part of Caragana sinica.6a  The root of this common Chinese plant has been used as folk 
medicine for treating asthenia syndrome, hypertension, bruises, and contused wounds.6c  
Numerous oligostilbenes which exhibit estrogenic activity have been isolated from this plant, 
with the root extract having a stimulatory effect on the proliferation and maturation of 
osteoblasts in vitro.6a  Carasiphenol B (4) is a trimer of resveratrol, which can be envisioned to 




































































































shown that NBS can selectively functionalize the permethylated dimer ampelopsin F (2), 
marking the perfect position for the attachment of this heterocycle.  We thus started with 
bromide 121 and attempted to apply the same sequence that had been developed for the synthesis 
of gnetin F (101, Scheme 2.17) as described earlier.  The bicyclic core of ampelopsin F was 
expected to introduce some new challenges, specifically due to the steric hindrance of 
elaborating bromide 121 and to the need for diastereocontrol in aldehyde generation relative to 
the pre-existing chirality of the core.  
 
Scheme 2.23 Proposed synthesis of carasiphenol B (4) starting from protected ampelopsin F (2) 
 
Lithium-halogen exchange starting with bromide 121 generated an anion that added 
smoothly into aldehyde 79 (Scheme 2.24).  Oxidation of the resulting alcohol then afforded 
ketone 128.  Pleasingly, subsequent global deprotection and benzyl reprotection proceeded 
smoothly, yielding ketone 129 in 75% yield.  This intermediate was then homologated using our 
standard procedure relying on Corey-Chaykovsky epoxidation followed by a Lewis acid-
mediated rearrangement to aldehyde 130.  In this case, ketone 129 required 18 equivalents of the 
ylide to achieve a successful and high-yielding attack at this extremely encumbered position.  
Critically, the steric restrictions of the system allowed aldehyde 130 to form as a single 






































prevented by the steric strain associated with the formation of an sp2 center at the bisbenzylic 
position and by the electronic wealth of the adjacent aromatic ring.  With these key operations 
complete, subsequent addition of 3 equivalents the 4-benzyloxyphenyl Grignard reagent 100 
afforded benzylic alcohol 131.  This seemingly facile addition was complicated by a challenging 
separation of the product from the phenol side-product resulting from oxidation of the Grignard 
reagent, presumably by adventitious O2 present in the solvent.  Pleasingly, degassing of the 
aldehyde solution prevented this oxidation and allowed the purification of alcohol 131 to be 
achieved readily.  Global debenzylation was then achieved by performing our hydrogenation 
using 30% Pd/C.  The hydrogenation was started in a 1:1 mixture of EtOAc and MeOH for 
substrate solubility, and the solvent was gradually changed to higher MeOH concentration to 
accelerate the progress of the reaction.  As expected, careful monitoring was required to prevent 
reduction of the benzylic alcohol and thus the loss of the key functionality at that position needed 
for the final closure.  With success achieved in this transformation, however, exposure of the 
resulting deprotected alcohol to mild acidic conditions (Amberlite in MeOH at 25 ºC) generated 
the trans diastereomer of the dihydrobenzofuran exclusively.  The final purification was 
performed by HPLC, as preparative thin layer chromatography gave poor mass recovery.  








Scheme 2.24 Synthesis of the trimer carasiphenol B (4) 
 
Before concluding this section, it is worthwhile noting that the electronic wealth and the 
highly congested environment of the substrates in the resveratrol class were detrimental to the 
functionalization of ketone 81 (Scheme 2.12), but turned out to be invaluable for the 
stereochemical robustness of aldehyde 130.  This outcome is of crucial importance for the 
synthesis of the natural diastereomer of the dihydrofuran, as both stereocenters in the final 
heterocycle are determined by the initial aldehyde stereochemistry.  In the case of aldehyde 130, 
the Grignard attack results in the formation of a single alcohol diastereomer (131), probably 














































































d) K2CO3, BnBr, 
    TBAI
Reagents and conditions: a) nBuLi (1.6 M in hexanes, 1.3 equiv), THF, -78 ºC, 10 min, then 79 (3.0 equiv), THF, -78 ºC, 2 h, -
78 ºC to 25 ºC, 2 h, 58% yield; b) NaHCO3 (21.0 equiv), DMP (2.3 equiv), CH2Cl2, 25 ºC, 1 h, 97% yield; c) BBr3 (1.0 M in 
CH2Cl2, 40.0 equiv), CH2Cl2, sealed tube, 70 ºC, 5 d, 96% yield; d) K2CO3 (40.0 equiv), BnBr (43 equiv), n-Bu4NI (2.0 equiv), 
acetone, 70 ºC, 15 h, 78% yield, e) Me3SI (20.0 equiv),  nBuLi (1.6 M in hexanes, 16.0 equiv), THF, 0 ºC, 2 min, then 129, 0 ºC, 1 
h; f) ZnI2 (31.0 equiv), benzene, 25 ºC, 1 h, 94% yield over 2 steps; g) 100 (1.0 M in THF, 6.0 equiv), THF, 25 ºC, 1 h, 68% yield; 
h) H2, 30% Pd/C, EtOAc:MeOH (1:1) to MeOH, 25 ºC, 12 h, then Amberlite IR-12OH, 25 ºC, 1 h, 89% yield over 2 steps.
89% yield 68% yield
94% yield






to a carbocation that can be easily stabilized to generate quinonemethide 136.  Minimizing allylic 
strain before the phenol attack then led to excellent diastereocontrol for the trans diastereomer of 
carasiphenol B (4, Scheme 2.25). 
 
Scheme 2.25 Diastereocontrol in the elaboration of the aldehyde 130 to the trans-dihydrofuran 
of carasiphenol B (4) 
 
2.8.3 Elaboration of the Dimer Ampelopsin F into the Trimer Ampelopsin G   
With the synthesis of carasiphenol B (4) complete, we next turned our attention to the 
other trimer derived from the ampelopsin F dimer, ampelopsin G (138).  This oligomer was 
isolated in 1993 from Ampelopsis brevipedunculata, a plant that has been used for the treatment 
of hepatitis and liver cirrhosis in Oriental medicine.32  Its extract exhibits hepatoprotective 




































































ampelopsin G (138) using our general approach, the new monobromide 137 (Scheme 2.26) 
would have to be accessed.   
 
Scheme 2.26 Divergent approach for the synthesis of carasiphenol B (4) and ampelopsin G (138) 
from permethylated ampelopsin F (2) 
 
As noted earlier and redrawn below (Scheme 2.27), bromination of permethylated 
ampelopsin F (2) with NBS cleanly led to monobromide 121 in 95% yield. We therefore 
proceeded to probe the selectivity of other electrophilic sources of bromine.  All the reagents 
tested (Br2, NBAc, NBSac34, TBCO) also afforded monobromide 121 with variable degree of 
conversion (see Scheme 2.27 and Experimental Table 2.5 in the Experimental Procedures 
























































F (2) for electrophilic aromatic substitution is on ring A.  From examination of plastic models, as 
well as from theoretical calculations performed by Dr. Adel ElSohly, rings A and B should be 
equally nucleophilic.  Possible explanations for this unexpected selectivity will be discussed in 
Chapter 4.  
 
Scheme 2.27 Intrinsic EAS selectivity for permethylated ampelopsin F (2) 
 
Permethylated ampelopsin F (2) itself was obtained by the reductive dehalogenation of 
the intermediate tribromide 139 (Chapter 1, Scheme 1.22).8a, b  As we could not seemingly install 
the bromine functional handle at the desired position on ring B, we next attempted to selectively 
remove the other two bromine atoms, namely the aliphatic one and the one on ring A, from 
tribromide 139.  Pleasingly, a Ru(bpy)3Cl2-catalyzed reductive dehalogenation developed by the 
Stephenson group, removed the aliphatic bromide.35  Lithium halogen exchange using only one 
equivalent of nBuLi was then attempted on the resulting dibromide 122, but unfortunately the 






































Scheme 2.28 Attempts to reduce tribromide 139 to monobromide 137 
 
The inspiration for the solution to this challenge came from the result of the bromination 
of permethylated ampelopsin F (2) with a complex of Br2 with collidine ([Collidine2Br]OTf)36.  
This cationic reagent allowed access to a 1:1 mixture of the two monobromides 121 and 137.  
We decided to follow this lead and try [BrEt2S][BrSbCl5] (BDSB), an electrophilic bromine 
source developed in our laboratory for polyene cyclizations.37  BDSB displays excellent 
reactivity and control in bromination reactions, particularly of alkenes, relying on a highly 
polarized bromine-bromine bond activated concomitantly by a Lewis acid (SbCl5) and by a 
Lewis base (SEt2).  This reagent had previously demonstrated different reactivity from NBS in 
the cyclization leading to tribromide 139 (Chapter 1, Scheme 1.23).  To our pleasant surprise, 
BDSB gave the desired monobromide 137 in 74% yield on more than 0.5 g of permethylated 
ampelopsin F (2), and with minimal contamination from monobromide 121.  Hypotheses on this 
unique preference of BDSB for ring B will also be discussed in Chapter 4 where other 
a) Ru(bpy)3Cl2,
    HCOOH,















































Reagents and conditions: a) TMS3SiH (11.0 equiv), AIBN (1.1 equiv), toluene, 80 ºC, overnight, 82% yield; b) Ru(bpy)3Cl2 
• 7 H2O (0.1 equiv), HCO2H (20.0 equiv), iPr2NEt (20.0 equiv), 15 W fluroescent lamp, 25 ºC, 15 h, 89% yield; c) nBuLi (1.1 







substituents and results can be presented to achieve a fuller analysis of this unique, regioselective 
process.    
 
Scheme 2.29 Attempts to synthesize monobromide 137 
 
For now, though, we will focus on the elaboration of this new material (137).  As shown 
in Scheme 2.30, we followed the same synthetic sequence as described above for the synthesis of 
carasiphenol B (4) and accessed ketone 140 in 74% yield.  Deprotection of this ketone turned out 
to be significantly more challenging than that of the previous carasiphenol B synthesis (i.e. 128, 
Scheme 2.24.).  After 10 days of refluxing ketone 140 in a 1.0 M BBr3 solution in CH2Cl2 in a 
sealed tube, only 44% of the material was fully deprotected; the remaining material balance 
(54% yield) was a monomethylated derivative.  This material could be recycled, but it first 





























































deprotected ketone was then perbenzylated and elaborated to aldehyde 141.  The original Corey-
Chaykovsky epoxidation conditions using nBuLi as base led to decomposition of the benzylated 
ketone.  Fortunately, an alternative procedure rose to the task, one relying on the use of KOtBu 
instead.38  At this new site on the bicyclic core, the aldehyde formed in a 1:1 diastereomeric 
ratio, with the sterically unencumbered environment apparently leading to a lack of substrate bias 
in the epoxide rearrangement.  The two aldehyde diastereomers could be separated by HPLC. 
These materials were extremely difficult to epimerize under both basic and acidic conditions, 
with KHMDS being the only reagent that achieved the desired transformation.  What this 
experiment suggests is that the observed composition of the aldehyde mixture is not a 
thermodynamic one, with the substrate structure at the critical rearrangement step to the aldehyde 
playing a key role in the ratio of diastereomers obtained in the kinetic hydride transfer (the 
epoxides are believed to be obtained as single diastereomers based on crude NMRs, however 
their instability prevented clear characterization and assignment).  Each of the aldehydes 
obtained was elaborated separately towards the dihydrofuran-containing compound.  The final 
aryl nucleophile was used as a lithium derivative in this case to facilitate the purification of the 
benzylic alcohol.  Final deprotection and cyclization under acidic condition afforded ampelopsin 







Scheme 2.30 Synthesis of the trimer ampelopsin G (138) 
 
Similarly, the unnatural diastereomer of ampelopsin G (144), with the trans-dihydrofuran 
displaying the opposite relative stereochemistry to the core, was synthesized from the aldehyde 
isomer 143 (Scheme 2.31).  The trans stereochemistry in the unnatural diastereomer was 
assigned based on the coupling constant of the dihydrobenzofuran protons.39  In both cases, the 
robustness of the aldehyde stereocenter and its key role in diastereocontrol for the entire 






h) H2, Pd/C; H
c) BBr3
d) K2CO3, BnBr, 











































Reagents and conditions: a) nBuLi (1.6 M in hexanes, 1.1 equiv), THF, -78 ºC, 10 min, then 79 
(2.5 equiv), THF, -78 ºC, 2 h, -78 ºC to 25 ºC, 1.5 h, 83% yield; b) NaHCO3 (16.0 equiv), DMP (4.3 
equiv), CH2Cl2, 25 ºC, 10 min, 89% yield; c) BBr3 (1.0 M in CH2Cl2, 117.0 equiv), CH2Cl2, sealed 
tube, 70 ºC, 10 days, 44% yield; d) K2CO3 (40 equiv), BnBr (43 equiv), nBu4NI (2.0 equiv), 
acetone, 70 ºC, 12 h, 86% yield, e) Me3SI (3.5 equiv), KOt-Bu (1.0 M in THF, 3.0 equiv), 
THF:DMSO 1:3, 12 ºC, 1 min, then ketone, 12 ºC, 15 min; f) ZnI2 (4.0 equiv), benzene, 25 ºC, 1 h, 
73% yield over 2 steps; g) 142 (20.0 equiv), nBuLi (1.6 M in hexanes, 18 equiv), THF, -78 ºC, 20 
min, then 141, -78 ºC, 15 min, -78 ºC to 25 ºC, 2 min, 76% yield; h) H2, 30% Pd/C, EtOAc:MeOH 












Scheme 2.31 Diastereocontrol imparted by the aldehyde stereocenter onto the dihydrofuran 
formation 
 
In addition to the ampelopsin F-derived trimers carasiphenol B (4) and ampelopsin G 
(138), our dihydrofuran method installation sequence also allowed for syntheses of the pallidol-
derived trimer carasiphenol C (5), as well as the tetramers derived from both cores, vaticanol C 
(126) and ampelopsin H (127) (Figure 2.2).31  These three natural products (as well as a couple 
unnatural analogs) were synthesized by Dr. Andreas Gollner.  The range of natural products 
accessible by this approach is auspicious for its ability to act as a universal method for appending 
dihydrofuran units in the oligomeric family, depending clearly on having a bromine functional 
handle on the right initial position.  As the goal of developing a method to append dihydrofuran 
units was to provide access to the pharmacological potential of the family, the synthesis of 
vaticanol C (126), a potent apoptosis-inducing cytotoxic agent,40 may be the crowning 













































Figure 2.2 Additional natural products synthesized using our dihydrofuran installation method 
 
2.8.4 A More Scalable Synthesis of Protected Dihydrofuran-containing Oligomers 
In the preceding section, we have shown that we can achieve selective functionalizations 
on permethylated resveratrol (Scheme 2.11) and on permethylated dimers 2, 3, 115, 118, 123 
(Scheme 2.20 and Scheme 2.21).  These functionalizations have allowed us to synthesize dimers, 
trimers, and tetramers within the family in a controllable, iterative and predictable way.  In order 
to move on to the largest molecules in the class, we would need to expand the selectivity of our 
halogenative functionalizations to trimers and larger materials.  While our dihydrofuran 
installation sequence has been developed with access to deprotected natural products in mind, 
these explorations would appear to require access to permethylated materials.  As such, the 
protecting group switch from methyl to easily-deprotected benzyl ethers becomes highly 
inefficient if we need to methylate the resulting dihydrofuran-containing materials at the end of 
the sequence.  By targeting permethylated materials directly, we should be able to avoid this 
global deprotection/reprotection strategy.  We therefore proceeded to develop an altered method 













































required for the cyclization of the heterocycle with appropriate diastereocontrol, in hopes of 
laying the groundwork for future synthetic endeavors to reach even more complex materials. 
At its core, two phenols are key for the formation of the trans-dihydrobenzofuran: the 
one that serves as a nucleophile in closing the final heterocycle and the one at the para position 
of the pendant aryl ring at its C2 (149 in Scheme 2.32) which facilitates the electrophile 
generation.  Both of them need to be free from protecting groups to achieve the final cyclization 
with appropriate diastereocontrol.  We decided to try and use benzyl protecting groups on 
selectively just those two key phenols, as they could be easily deprotected in the presence of 
methyl ethers and the hydrogenation reaction conditions themselves should be compatible with 
the remaining functional groups in our late-stage intermediates.   Critically, the ability of the 
ketone within 145 to facilitate the selective deprotection of the ortho phenol by hydrogen 
bonding could allow for the formation of a monodeprotected intermediate,41 which could be 
reprotected to install the first benzyl group.  The second benzyl-protected phenol would come 
from the 4-benzyloxyphenyl Grignard reagent 100.  The resulting alcohol (148) could then be 
hydrogenated and activated by acid to generate quinonemethide 150, ready to afford trans 
dihydrofuran 151 in situ.  Final methyl protection of the free phenol should generate the 








Scheme 2.32  Differential protection of the two key phenol groups for the installation of the 
trans-dihydrobenzofuran 
 
The first step of this approach would be the selective deprotection of the phenol adjacent 
to the ketone functional group.  We have already taken advantage of this phenomenon in making 
the ketones we used to test the benzylic nucleophile addition (81, Scheme 2.12).  Pleasingly, 
selective demethylation could also be achieved on the more complex ketones 128 and 140, as 
shown in Scheme 2.33.  All of these monohydroxy ketones were then benzylated and elaborated 
into the corresponding aldehydes (154, 156 and 158).  The same diastereocontrol was imparted 
by the substrate on these materials as on the previously shown perbenzylated ones in the 


































































Scheme 2.33 Elaboration of permethylated ketones into differentially protected aldehydes 
 
We then decided to complete the synthesis of permethylated carasiphenol B (160) to 
serve as proof of principle.  This structure could then be used to probe the selectivity in a 
reaction with BDSB on a core that preserves the configuration of the two aryl rings on the right 
side of the molecule which we suspected might be crucial to the observed selectivity on 
permethylated ampelopsin F (2 in Scheme 2.29).  The same sequence of reactions was employed, 

























































































61% yield 61% yield
Reagents and conditions: a) BBr3 (2.0 equiv), CH2Cl2, -78 ºC, 10 min, 88% yield; b) BnBr (8.0 equiv), K2CO3 (5.0 equiv), 
TBAI (0.4 equiv), acetone, 70 ºC, overnight, 88% yield; c) Me3SI (4.0 equiv), nBuLi (1.6 M in hexanes, 3.3 equiv), THF, 0 ºC, 1 
h; d) ZnI2 (1.1 equiv), benzene, 25 ºC, 1 h, 99% yield over 2 steps; d) BBr3 (1.3 equiv), CH2Cl2, -78 ºC, 30 min, 91% yield; e) 
BnBr (84 equiv), K2CO3 (6.0 equiv), TBAI (0.5 equiv), acetone, 70 ºC, overnight, 67% yield; g) Me3SI (34.0 equiv), KOtBu (30.0 
equiv), DMSO:THF 3:1, 8 ºC, 2 min, then 155, 11 ºC, 3.5 h; h) ZnI2 (9.0 equiv), benzene, 25 ºC, 1 h, 61% yield  over 2 steps; i) 
BBr3 (3.0 equiv), CH2Cl2, -78 ºC, 10 min, 75% yield; j) BnBr (9.2 equiv), K2CO3 (6.3 equiv), TBAI (0.5 equiv), 70 ºC, overnight, 
42% yield; k) Me3SI (3.5 equiv), KOtBu (3.0 equiv), DMSO:THF 3:1, 12 ºC, 2 min, then 157, 12 ºC, 15 min; l) ZnI2 (1.1 equiv), 






product (160) was generated, with the lack of deprotected polyphenols’ purifications 
significantly facilitating the material throughput versus previous efforts.   
 
Scheme 2.34 Synthesis of permethylated carasiphenol B (160) 
 
To test the importance of the free phenol on the ring at C2 for diastereocontrol in the 
cyclization of the dihydrofuran we targeted alcohol 162.  To access it we added 4-
methoxyphenylmagnesium bromide (161) into aldehyde 156 and deprotected the benzyl ether.  
Cyclization of alcohol 162 afforded a 1:1 mixture of cis:trans permethylated carasiphenol B, 
supporting the difficulty of the quinonemethide formation without a free phenol at the para 
position on the aryl ring at C2 and/or the absence of any opportunity for acidic equilibration of 


































156 159 160: permethylated carasiphenol B
a) 100
b) H2, 10% Pd/C
c) Amberlite





Reagents and conditions: a) 100 (7.0 equiv), THF, 25 ºC, overnight, 71% yield; b) H2, 10% Pd/C, EtOAc:MeOH 1:1, 25 ºC, 2 h; c) Amberlite IR-







Scheme 2.35 Importance of the free phenol on the aryl ring at C2 of the dihydrofuran on 
diastereocontrol 
 
The deprotection of the two benzyl groups and the cyclization to the dihydrofuran were 
initially performed a two-step procedure (Scheme 2.34).  As benzyl ethers are significantly easier 
to cleave that methyl ethers, Lewis acidic conditions at low temperature were expected to allow 
for selective deprotection as well as ionization of the alcohol in the same timeframe as the 
unraveling of the free phenol of the aryl ring at C2 of the dihydrobenzofuran.  Indeed, treatment 
of the benzylic alcohol resulting from the addition of 100 into aldehyde 156 with BBr3 for 10 
min at –78 ºC permitted the formation of the dihydrofuran architecture with excellent 
diastereocontrol for the trans isomer.  One important application of this one-pot 
































163160: permethylated carasiphenol B
a) 161





Reagents and conditions: a) 161 (8.0 equiv), THF, 25 ºC, 4 h; b) H2, 10% Pd/C, EtOAc:MeOH 1:1, 25 ºC, 30 




















compound that cannot be obtained by our usual synthesis, as the electron-rich stilbene olefin gets 
hydrogenated before the benzyl ether deprotection can occur.    
Following the sequence of steps highlighted in Scheme 2.36, we did manage to gain 
access to permethylated ε-viniferin (166), a potentially important compound for the development 
of the methodology required to synthesize some of the largest and most bioactive oligomers in 
the family, such as vitisin A1b, c, 1e, 5a, 42 (167, Scheme 2.36).   
 


















































Reagents and conditions: a) BBr3 (1.2 equiv), CH2Cl2, -78 ºC, overnight, 89% yield; b) BnBr (8.9 equiv), K2CO3 (6.3 
equiv), TBAI (0.5 equiv), acetone, 70 ºC, overnight, 76% yield; c) Me3SI (20.0 equiv), nBuLi (16.0 equiv), THF, 0 ºC, 2 min, 
then 164, 0 ºC, 1 h; d) ZnI2 (1.0 equiv), benzene, 25 ºC, 1 h, 53% yield; e) 100 (6.5 equiv), THF, 25 ºC, 2 h, 49% yield; f) 
BBr3 (5.3 equiv), CH2Cl2, -78 ºC, 30 min, 40% yield; g) MeI (100.0 equiv), K2CO3 (37.0 equiv), acetone, 70 ºC, overnight, 
70% yield.







2.8.5  Selective Functionalizations of Permethylated Resveratrol Trimers 
With facile access to permethylated higher-order materials, we could now evaluate the 
ability to achieve selective functionalizations on even more complex structures.  Three 
permethylated trimers were prepared: permethylated carasiphenol B (160), by the method 
described in Scheme 2.34, as well as leachianol E (168)43 (whose synthesis will be discussed in 
Chapter 3) and carasiphenol C (169)6b by direct protection of the natural products.  The 
selectivity observed for their bromination with NBS and BDSB is highlighted in Figure 2.3.  All 
trimers were brominated at position 1 (Scheme 2.2) with both reagents, just like the dimers, 
showing a preference for the electronically-favored dimethoxy, dialkyl-substituted aryl rings 
over the sterically more accessible dimethoxy, monoalkyl ones.  Selective functionalizations 
were observed with BDSB on all cores and with NBS on permethylated carasiphenol C (169).  
On protected carasiphenol B (160), NBS generated a 3:1 mixture of monobromides, still favoring 
the BDSB-preferred ring B.  Selective bromination is thus attainable on trimeric cores as well, 
with BDSB displaying excellent selectivity on these complex cores.  On protected carasiphenol 
B (160) NBS hinted at the possibility for a different regioselectivity which could potentially be 







Figure 2.3 Selective functionalization of permethylated carasiphenol B (160), leachianol E (168) 
and carasiphenol C (169) 
 
2.8.6 Synthesis of a New Common Intermediate 
A highly promising application of the dihydrofuran installation method was developed by 
my talented colleague Dr. Nathan Wright.  He appended the trans-dihydrofuran unit onto a 
single aryl ring with a benzylic alcohol as a functional handle for further elaboration, essentially 
synthesizing what has become the next generation common intermediate for the synthesis of 
dihydrofuran-containing oligomers of resveratrol.  Use of alcohol 172 (Scheme 2.37) could lead 
to both endo- and exo-cyclic dihydrofuran architectures at position 1 (Scheme 2.2).  To date, this 
method has already allowed access to four natural products (Scheme 2.37), including the 
extremely reactive and sensitive dimer ε-viniferin (7), and carasiphenol A (173), a trimer 


















































Building on the efficient method our group had developed for the controlled synthesis of 
varied dimers in the family of resveratrol oligomers, as mentioned in this chapter, we have 
developed regio- and diastereoselective tools to synthesize higher-order oligomers by the 
appendage of trans-dihydrofuran units, moving closer to a complete blueprint for the synthesis of 
the entire class.   
Electrophilic aromatic bromination was used as a powerful tool for regioselective 



















174: α-OMe, hopeahainol E

























shown on resveratrol itself as well as on five dimers and three trimeric members in the family.  
Using BDSB, a cationic source of bromine developed in our laboratory for polyene cyclizations, 
we were able to overcome the intrinsic bias of the ampelopsin F core (2) for electrophilic 
aromatic bromination in one of the most positionally selective reactions achieved to date. 
A robust and highly diastereoselective method for elaborating aromatic bromides with 
ortho phenols into trans-dihydrobenzofuran units has also been developed.  This sequence of 
eight synthetic steps was productive on two structurally different dimeric cores, ampelopsin F (2) 
and pallidol (3), and in both cases delivered the desired trimeric and tetrameric natural products.  
Finally, a more scalable method to access permethylated natural products bearing the 
dihydrofuran heterocycle was also developed to facilitate further studies towards more complex 
materials.   
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2.12 Experimental Procedures 
General Procedures. All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise noted. Dry tetrahydrofuran (THF), 
toluene, benzene, diethyl ether (Et2O) and dichloromethane were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns.  
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated.  Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light as visualizing agent, and an ethanolic solution of 
phosphomolybdic acid and cerium sulfate, and heat as developing agents. SiliCycle silica gel 
(60, academic grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
Preparative thin-layer chromatography separations were carried out on 0.50 mm E. Merck silica 
gel plates (60F-254).  NMR spectra were recorded on Bruker 300, 400, 500, 600 and 800 MHz 
instruments and calibrated using residual undeuterated solvent as an internal reference.  The 
following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = 
triplet, br = broad, app = apparent.  IR spectra were recorded on a Perkin-Elmer 1000 series FT-
IR spectrometer.  High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (fast 
atom bombardment) and APCI (atmospheric pressure chemical ionization) techniques. 
 Abbreviations. Ac2O = acetic anhydride, BDSB = bromodiethylsulfonium 





2,2’-bipyridine, DMAP = 4-dimethylaminopyridine, DMF = N,N-dimethylformamide, DMSO = 
dimethylsulfoxide, EtOAc = ethyl acetate, HMBC = heteronuclear multiple-bond correlation, 
HPLC = high-pressure liquid chromatography, HSQC = heteronuclear single quantum 
coherence, iPr2NEt = N,N-diisopropylethylamine, KOtBu = potassium tert-butoxide, LRMS = 
low resolution mass spectroscopy, mCPBA = meta-chloroperbenzoic acid, Me2SO4 = dimethyl 
sulfate, Me3SI = trimethylsulfonium iodide, MeI = iodomethane, MeLi = methyl lithium, MeOH 
= methanol, NBA = N-bromoacetamide, NBS = N-bromosuccinimide, NBSac = N-
bromosaccharin, nBu4NI = tetrabutylammonium iodide, nBuLi = n-butyllithium, OTf = 
trifluoromethanesulfonate, TBCO = 2,4,4,6-tetrabromocyclohexa-2,5-dienone, TBS = tert-
butyldimethylsilyl, TBSCl = tert-butyldimethylsilyl chloride, TEA = triethylamine. 
2.12.1 Dihydrofuran Installation Method Development 
 
Experimental Scheme 2.1 Attempts to activate the olefin in 63 
 
Permethylated resveratrol 63 (prepared according to the published procedure1): 1H 
NMR (300 MHz, CDCl3) δ 7.51–7.42 (m, 2 H), 7.07 (d, J = 16.2 Hz, 1 H), 6.96–6.89 (m, 3 H), 
6.68 (d, J = 2.3 Hz, 2 H), 6.41 (t, J = 2.3 Hz, 1 H), 3.84 (s, 6 H), 3.83 (s, 3 H). 
Permethylated resveratrol bromide 78: Permethylated resveratrol (63, 0.04 g, 0.148 
















This solution was cooled to 0 ºC and NBS (0.04 g, 0.222 mmol, 1.5 equiv) was added in three 
equal portions over 15 min.  The resulting reaction mixture was stirred at 0 ºC for 30 min and 
was then heated to 50 ºC for 5 h.  Upon completion, the reaction was quenched with saturated 
aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and 
extracted with EtOAc (3 × 10 mL).  The combined organic layers were washed with water (5 
mL) and brine (5 mL), dried (MgSO4), filtered and concentrated to afford monobromide 78 
(>90% in the crude product).  78: 1H NMR (400 MHz, CDCl3) δ 7.52–7.48 (m, 2 H), 7.40 (d, J = 
16.2 Hz, 1 H), 6.97 (d, J = 16.2 Hz, 1 H), 6.91 (d, J = 8.8 Hz, 2 H), 6.80 (d, J = 2.7 Hz, 1 H), 
6.42 (d, J = 2.7 Hz, 1 H), 3.89 (s, 3 H), 3.86 (s, 3 H), 3.84 (s, 3 H). 
Phenol S1: Permethylated resveratrol (63, 0.032 g, 0.12 mmol, 1.0 equiv) was dissolved 
in CH2Cl2 (2 mL).  NaHCO3 (0.05 g, 0.6 mmol, 5.0 equiv) and mCPBA (0.042 g, 0.24 mmol, 2.0 
equiv) were added sequentially to this solution at 25 ºC.  The reaction was allowed to stir at this 
temperature for 1 h.  Upon completion, the reaction was quenched with saturated aqueous 
Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted 
with EtOAc (3 × 10 mL).  The combined organic layers were washed with water (5 mL) and 
brine (5 mL), dried (MgSO4), filtered and concentrated to afford a crude mixture with phenol S1 
as the major product.  S1: 1H NMR (400 MHz, CDCl3) δ 7.53–7.43 (m, 2 H), 7.30 (dd, J = 16.4, 
0.5 Hz, 1 H), 7.09 (d, J = 16.4 Hz, 1 H), 6.89 (d, J = 8.8 Hz, 2 H), 6.67 (d, J = 2.7 Hz, 1 H), 6.41 






Experimental Scheme 2.2 Synthesis of peracetylated stilbene epoxide 68 
 
Peracetylated resveratrol 67:  Resveratrol (6, 0.076 g, 0.33 mmol, 1.0 equiv) was 
dissolved in pyridine (2 mL) and acetic anhydride (2 mL, 21.1 mmol, 64.0 equiv) was added to 
the solution at 25 ºC.  The reaction was allowed to stir at that temperature for 8 h.  Upon 
completion, the reaction was quenched with saturated aqueous NaHCO3 (10 mL), poured into 
water (10 mL) and extracted with CH2Cl2 (5 × 30 mL).  The combined organic layers were 
washed with water (20 mL) and brine (20 mL), dried (MgSO4) and concentrated to afford 
peracetylated resveratrol 67 (0.106 g, 90% yield) that was taken forward without additional 
purification.  67: 1H NMR (400 MHz, acetone-d6) δ 7.69 (d, J = 8.6 Hz, 2 H), 7.36 (d, J = 16.4 
Hz, 1 H), 7.32 (d, J = 2.1 Hz, 2 H), 7.25 (d, J = 16.4 Hz, 1 H), 7.23–7.18 (m, 2 H), 6.95 (t, J = 
2.1 Hz, 1 H), 2.35 (s, 7 H), 2.32 (s, 3 H). 
Epoxide 68:  Peracetylated resveratrol (67, 0.08 g, 0.23 mmol, 1.0 equiv) was dissolved 
in a mixture of 1:1 mixture of THF and water (5 mL total).  This solution was cooled to 0 ºC and 
NBS (0.06 g, 0.34 mmol, 1.5 equiv) was added in three equal portions over 15 min.  The 
resulting reaction mixture was stirred at 0 ºC for 30 min and was then heated to 50 ºC for 5 h.  
Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 


























mL).  The combined organic layers were washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered and concentrated.  The crude mixture was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 1:1) to afford halohydrin S2.  S2: 1H NMR (400 
MHz, CDCl3) δ 7.28 (s, 1 H), 7.26 (s, 1 H), 7.03 (d, J = 8.6 Hz, 1 H), 7.00 (d, J = 2.1 Hz, 2 H), 
6.89 (t, J = 2.1 Hz, 1 H), 5.12 (dd, J = 6.4, 3.0 Hz, 1 H), 4.97 (d, J = 6.3 Hz, 1 H), 4.36–4.33 (m, 
0.5 H) 2.28 (s, 3 H), 2.27 (s, 5 H).  The resulting halohydrin S2 was dissolved in a 1:1 mixture of 
THF and water (5 mL) and K2CO3 (0.016 g, 0.12 mmol, 0.5 equiv) was added slowly to the 
solution.  After 30 min the reaction was quenched with NH4Cl (10 mL), poured into water (10 
mL) and extracted with EtOAc (3 × 10 mL).  The combined organic layers were washed with 
water (10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The crude mixture 
was purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 1:1) to afford 
epoxide 68 (0.041 g, 49% yield over two steps).  1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 8.5 
Hz, 2 H), 7.10 (d, J = 8.6 Hz, 2 H), 6.97 (d, J = 2.1 Hz, 2 H), 6.89 (t, J = 2.1 Hz, 1 H), 3.82 (d, J 
= 1.3 Hz, 2 H), 2.31 (s, 3 H), 2.30 (s, 6 H). 
Alcohol 70: Epoxide 68 (0.026 g, 0.07 mmol, 1.2 equiv) was azeotroped (3 × 2 mL) and 
then dissolved in dry CH2Cl2 (2 mL).  3-methoxy-phenol (65, 6 µL, 0.06 mmol, 1.0 equiv) was 
added and the solution was allowed to stir for 5 min.  TiCl4 (1.0 M in CH2Cl2, 0.07 mL, 0.07 
mmol, 1.2 equiv) was then added and the reaction mixture was allowed to stir for 18 h.  Upon 
completion, the reaction was quenched with NaHCO3 (5 mL), poured into water (5 mL) and 
extracted with EtOAc (3 × 10 mL).  The combined organic layers were washed with water (10 
mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The crude mixture was 





alcohol 70 (0.015 g, 43% yield).  70: 1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.6 Hz, 2 H), 
7.14–7.09 (m, 1 H), 6.98 (d, J = 8.6 Hz, 2 H), 6.80 (t, J = 2.2 Hz, 1 H), 6.73 (d, J = 2.1 Hz, 2 H), 
6.51–6.46 (m, 1 H), 6.45–6.40 (m, 1 H), 6.39 (d, J = 1.4 Hz, 1 H), 4.95 (d, J = 7.4 Hz, 1 H), 4.88 
(d, J = 7.1 Hz, 1 H), 3.77 (s, 3 H), 2.27 (s, 3 H), 2.24 (s, 6 H). 
2.12.2 Synthesis of Ketones 81 
Monobromide 78: Permethylated resveratrol (63, 0.247 g, 0.91 mmol, 1.0 equiv) was 
dissolved in dry CH2Cl2 (50 mL) and the solution was cooled to –78 ºC.  NBS (0.162 g, 0.91 
mmol, 1.0 equiv) was added as a solid to this solution at –78 ºC and the reaction was allowed to 
warm to 25 ºC over 5 h.  Upon completion, the reaction was quenched with saturated aqueous 
Na2SO3 (30 mL) and saturated aqueous NaHCO3 (30 mL), poured into water (30 mL) and 
extracted with CH2Cl2 (3 × 50 mL).  The combined organic layers were washed with water (30 
mL) and brine (30 mL), dried (MgSO4), filtered and concentrated to afford monobromide 78 
(0.296 g, 93% yield).  
Ketone 80.  Ketone 80 was prepared according to our previously published protocol.1   
80: 1H NMR (400 MHz, CDCl3) δ 7.28 (s, 1 H), 7.25 (s, 1 H), 7.02–6.95 (m, 3 H), 6.83 (d, J = 
2.1 Hz, 1 H), 6.80 (d, J = 8.8 Hz, 1 H), 6.74 (d, J = 16.1 Hz, 1 H), 6.63 (t, J = 2.3 Hz, 1 H), 6.42 
(d, J = 2.1 Hz, 1 H), 3.91 (s, 3 H), 3.79 (s, 6 H), 3.79 (s, 3 H), 3.68 (s, 3 H). 
Reduced Ketone 81.  Ketone 80 (1.70 g, 3.9 mmol, 1.0 equiv) was dissolved in a 1:1 
mixture of EtOAc: MeOH (70 mL total) and 10% Pd/C (0.27 g) was added to the solution.  The 
reaction was allowed to stir for 24 h under a H2 (balloon) atmosphere.  Upon completion, the 





solution was concentrated to afford the desired permethylated ketone 81 (1.52 g, 89% yield).  81: 
Rf = 0.53 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 3001, 2938, 2837, 2360, 2340, 1667, 
1600, 1512, 1458, 1424, 1318, 1300, 1246, 1203, 1156, 1083, 1063, 1035, 987, 926, 831, 651 
cm-1; 1H NMR (400 MHz, CDCl3) δ 6.98 (d, J = 2.4 Hz, 2 H), 6.97 (d, J = 8.0 Hz, 2 H), 6.75 (d, 
J = 8.4 Hz, 2 H), 6.65 (t, J = 2.4 Hz, 1 H), 6.38 (d, J = 2.0 Hz, 1 H), 6.35 (d, J = 2.0 Hz, 1 H), 
3.80 (s, 3 H), 3.79 (s, 6 H), 3.75 (s, 3 H), 3.66 (s, 3 H), 2.78–2.74 (m, 2 H), 2.71–2.67 (m, 2 H); 
13C NMR (100 MHz, CHCl3) δ 197.3, 161.1, 160.7, 158.1, 157.8, 141.7, 140.3, 133.5, 129.2, 
121.6, 113.6, 107.1, 106.1, 105.4, 96.3, 55.6, 55.4 (2 C), 55.3, 55.1, 36.5, 35.7; HRMS (FAB+) 
calcd for C26H28O6+ [M+] 436.1886, found 436.1888. 
 
Experimental Scheme 2.3 Structures of differentially protected ketones 81 
 
Monodeprotected Ketone S3: Permethylated ketone 81 (0.118 g, 0.27 mmol, 1.0 equiv) 
was dissolved in dry CH2Cl2 (3 mL).  The solution was cooled to –78 ºC and BBr3 (1.0 M in 
CH2Cl2, 0.54 mL, 0.54 mmol, 2.0 equiv) was added dropwise to the solution.  The bright yellow 
reaction mixture was allowed to stir at that temperature for 10 min.  Upon completion, the 
reaction was diluted with EtOAc (5 mL), quenched with saturated aqueous NaHCO3 (5 mL), 
poured into water (5 mL), and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 





























the crude ketone S3 (0.100 g, 88% yield) which was carried forward without additional 
purification.  S3: 1H NMR (400 MHz, CDCl3) δ 10.14 (s, 1 H), 6.77 (d, J = 2.3 Hz, 2 H), 6.72 (d, 
J = 1.6 Hz, 4 H), 6.64 (t, J = 2.3 Hz, 1 H), 6.41 (d, J = 2.5 Hz, 1 H), 6.36 (d, J = 2.5 Hz, 1 H), 
3.83 (s, 3H), 3.81–3.76 (m, 6 H), 3.75 (d, J = 0.7 Hz, 3 H), 2.57 (s, 4 H).  
Monobenzylated ketone 153: Monodeprotected ketone S3 (0.100 g, 0.20 mmol, 1.0 
equiv) was dissolved in dry acetone (3 mL).  K2CO3 (0.135 g, 0.98 mmol, 5.0 equiv), BnBr (0.19 
mL, 1.56 mmol, 8.0 equiv) and nBu4NI (0.029 g, 0.08 mmol, 0.4 equiv) were added sequentially 
to the solution at 25 ºC.  The reaction mixture was then heated to 70 ºC overnight.  Upon 
completion, the reaction was quenched with saturated aqueous NH4Cl (10 mL), poured into 
water (10 mL), and extracted with CH2Cl2 (3 × 20 mL).  The combined organic layers were 
washed with water (15 mL), brine (15 mL), dried (MgSO4), filtered and concentrated to afford 
the crude ketone 153.  This crude material was purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 9:1 →7:3) to afford the desired monobenzylated ketone 153 (0.100 g, 88% 
yield).  153: 1H NMR (400 MHz, CDCl3) δ 7.39–7.35 (m, 1 H), 7.24–7.17 (m, 3 H), 7.03–6.97 
(m, 5 H), 6.96 (d, J = 2.2 Hz, 2 H), 6.80–6.72 (m, 2 H), 6.65 (t, J = 2.2 Hz, 1 H), 6.39 (d, J = 2.0 
Hz, 1 H), 6.36 (d, J = 2.1 Hz, 1 H), 4.94 (d, J = 1.5 Hz, 2 H), 3.78 (d, J = 1.6 Hz, 6 H), 3.77 (s, 3 
H), 3.75 (d, J = 1.7 Hz, 4 H), 2.77 (t, J = 2.2 Hz, 4 H). 
Boc-protected ketone S4:  Monodeprotected ketone S3 (0.015 g, 0.035 mmol, 1.0 equiv) 
was dissolved in hexanes (0.05 mL).  Boc2O (0.008 g, 0.036 mmol, 1.02 equiv) and DMAP 
(0.0002 g, 0.002 mmol, 0.05 equiv) were added sequentially to the solution and the reaction was 
allowed to stir for 30 min.  Upon completion, the reaction mixture was partitioned between brine 





mL).  The combined organic layers were washed with saturated aqueous NaHCO3 (5 mL), water 
(10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated to afford Boc-protected 
ketone S4 (0.011 g, 71 % yield).  S4:  1H NMR (400 MHz, CDCl3) δ 6.96 (d, J = 8.6 Hz, 2 H), 
6.93 (d, J = 2.4 Hz, 2 H), 6.74 (d, J = 8.6 Hz, 2 H), 6.66 (d, J = 2.4 Hz, 1 H), 6.63 (t, J = 2.4 Hz, 
1 H), 6.62 (d, J = 2.3 Hz, 1 H), 3.80 (s, 4 H), 3.78 (s, 6 H), 3.74 (s, 3 H), 2.77 (q, J = 2.5 Hz, 4 
H), 1.32 (s, 9 H). 
TBS-protected ketone S5: Monodeprotected ketone S3 (0.013 g, 0.030 mmol, 1.0 equiv) 
was dissolved in CH2Cl2 (0.14 mL).  TEA (8 µL) was added and the solution was cooled to 0 ºC.  
A solution of TBSCl (0.048 g, 0.32 mmol, 10.6 equiv) in dry CH2Cl2 (0.06 mL) was added at 0 
ºC and the reaction was allowed to warm to 25 ºC and stir for 24 h.  Upon completion, the 
reaction was quenched with saturated aqueous NH4Cl (5 mL), poured into waster (5 mL) and 
extracted with EtOAc (3 × 5 mL).  The combined organic layers were washed with water (5 mL) 
and brine (5 mL), dried (MgSO4), filtered and concentrated to afford TBS-protected ketone S5 
(0.013 g, 81 %).  S5: 1H NMR (400 MHz, CDCl3) δ 7.03–6.91 (m, 4 H), 6.74 (d, J = 8.6 Hz, 2 
H), 6.61 (t, J = 2.4 Hz, 1 H), 6.37 (d, J = 2.3 Hz, 1 H), 6.24 (d, J = 2.2 Hz, 1 H), 3.78 (s, 6 H), 
3.77 (s, 3 H), 3.75 (s, 3 H), 2.72 (d, J = 3.4 Hz, 4 H), 0.66 (s, 9 H), 0.09 (s, 6 H). 
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Alcohol S6: Triaryl ketone 80 (0.017 g, 0.04 mmol, 1.0 equiv) was azeotroped with 
benzene (3 × 1 mL) and dissolved in dry THF (2 mL).  MeLi solution (1.6 M in diethyl ether, 
0.25 ml, 0.4 mmol, 10.0 equiv) was added to the solution and the reaction was allowed to stir at 
25 ºC overnight.  Upon completion, the reaction was quenched with saturated aqueous NH4Cl (5 
mL), poured into water (5 mL) and extracted with EtOAc (3 × 10 mL).  The combined organic 
layers were washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered and concentrated.  
The desired alcohol S6 was obtained as the main product in the crude material (>80 % of the 
crude mixture by NMR).  Attempts to purify this material led to decomposition.  S6: 1H NMR 
(400 MHz, CDCl3) δ 7.31–7.21 (m, 2 H), 7.12 (d, J = 15.9 Hz, 1 H), 6.91–6.82 (m, 2 H), 6.58–
6.52 (m, 4 H), 6.46 (d, J = 2.6 Hz, 1 H), 6.33–6.25 (m, 1 H), 5.11 (d, J = 4.6 Hz, 1 H), 3.83 (s, 3 
H), 3.81 (s, 3 H), 3.73 (s, 6 H), 3.68 (s, 3 H), 1.92 (s, 3 H).  
Aldehyde 98: nBuLi (1.6 M in hexanes, 2.0 mL, 3.2 mmol, 9.0 equiv) was added to a 
slurry of Me3SI (0.740 g, 3.6 mmol, 10.0 equiv) in THF (18 mL) cooled to 0 ºC, and the reaction 
was stirred at that temperature for 2 min.  A solution of permethylated ketone 80 (0.155 g, 0.36 
mmol, 1.0 equiv) in THF (6 mL) was added dropwise on the sides of flask over 2 min and the 
reaction was stirred at 0 ºC for 30 min.  Upon completion, the reaction contents were quenched 
with saturated aqueous NH4Cl (20 mL), poured into water (20 mL) and extracted with EtOAc (3 
× 40 mL).  The combined organic layers were then washed with water (30 mL) and brine (30 
mL), dried (MgSO4), filtered and concentrated.  The resultant epoxide 96 was carried forward 
without purification.  96: 1H NMR (400 MHz, CDCl3) δ 7.40–7.31 (m, 3 H), 6.93 (d, J = 16.2 
Hz, 1 H), 6.86–6.81 (m, 2 H), 6.80 (d, J = 2.3 Hz, 1 H), 6.47 (d, J = 2.3 Hz, 2 H), 6.43 (d, J = 2.3 





1 H), 3.15 (d, J = 5.8 Hz, 1 H).  Epoxide 96 was dissolved in dry benzene (15 mL) and ZnI2 
(0.186 g, 0.58 mmol, 1.6 equiv) was added as a solid.  The reaction was allowed to stir at 25 ºC 
for 5 min.  Upon completion, the reaction was quenched with water (10 mL) and extracted with 
EtOAc (3 × 20 mL).  The combined organic layers were washed with water (10 mL) and brine 
(10 mL), dried (MgSO4), filtered and concentrated.  The resulting yellow oil was purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 10:1→5:1) to afford aldehyde 98 
(0.102, 63% yield over two steps).  98: 1H NMR (400 MHz, CDCl3) δ 9.83 (s, 1 H), 7.38–7.29 
(m, 2 H), 6.99 (d, J = 16.0 Hz, 1 H), 6.91–6.80 (m, 3 H), 6.76 (d, J = 2.4 Hz, 1 H), 6.48 (d, J = 
2.5 Hz, 1 H), 6.42–6.33 (m, 2 H), 4.93 (s, 1 H), 3.87 (s, 3 H), 3.81 (s, 3 H), 3.78 (s, 3 H), 3.73 (s, 
6 H).   
2.12.3 Synthesis of Gnetin F (101) 
Reactions in this section were performed by Dr. Andreas Gollner.  
Perbenzylated Aldehyde 99.  BBr3 (1.0 M in CH2Cl2, 15 mL, 20.5 equiv) was added to 
neat permethylated ketone 81 (0.32 g, 0.73 mmol, 1.0 equiv) at 25 ºC and the reaction mixture 
was allowed to stir for 19 h.  Upon completion, the reaction was quenched with water (20 mL) 
and extracted with EtOAc (3 × 20 mL).  The combined organic layers were washed with water 
(10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated to afford the deprotected 
ketone (0.255 g, 95% yield), which was used without further purification.  This intermediate 
ketone (0.23 g, 0.63 mmol, 1.0 equiv) was dissolved in dry acetone (3 mL) and solid K2CO3 (2.6 
g, 18.81 mmol, 30.0 equiv), BnBr (2.23 mL, 18.8 mmol, 30.0 equiv) and solid nBu4NI (0.345 g, 
0.95 mmol, 1.5 equiv) were added sequentially to the solution.  The reaction mixture was heated 





(20 mL), poured into water (30 mL) and extracted with CH2Cl2 (3 × 30 mL).  The combined 
organic layers were washed with water (20 mL) and brine (20 mL), dried (MgSO4), filtered and 
concentrated to afford the crude perbenzylated ketone.  This crude product was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 10:1→5:1) to afford the desired ketone 
perbenzylated (0.431 g, 84% yield) as a yellow foam.  nBuLi (1.6 M in hexanes, 0.92 mL, 1.47 
mmol, 8.0 equiv) was added to a slurry of Me3SI (0.378 g, 1.84 mmol, 10.0 equiv) in THF (5 
mL) cooled to 0 ºC, and the reaction was stirred at that temperature for 2 min.  A solution of 
perbenzylated ketone (0.15 g, 0.18 mmol, 1.0 equiv) in THF (2 mL) was added dropwise on the 
sides of flask over 2 min and the reaction was stirred at 0 ºC for 20 min.  Upon completion, the 
reaction contents were quenched with saturated aqueous NH4Cl (10 mL) and extracted with 
EtOAc (3 × 20 mL).  The combined organic layers were then washed with water (10 mL) and 
brine (10 mL), dried (MgSO4), filtered and concentrated.  The resultant epoxide was carried 
forward without purification.  This epoxide was dissolved in dry benzene (3 mL) and ZnI2 (0.14 
g, 0.44 mmol, 2.5 equiv) was added as a solid.  The reaction was allowed to stir at 25 ºC for 1 h.  
Upon completion, the reaction was quenched with water (10 mL) and extracted with EtOAc (3 × 
20 mL).  The combined organic layers were washed with water (10 mL) and brine (10 mL), dried 
(MgSO4), filtered and concentrated.  The resulting yellow oil was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 10:1→5:1) to afford aldehyde 99 (0.117, 77% 
yield).  99: Rf = 0.63 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 3062, 3031, 2930, 2869, 
1721, 1602, 1510, 1453, 1378, 1295, 1237, 1154, 1059, 1027, 910, 830, 737, 697, 633 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 9.75 (s, 1 H), 7.50–7.28 (m, 20 H), 7.19 (dd, J = 7.2, 2.1 Hz, 2 H), 





1 H), 6.42 (d, J = 2.2 Hz, 2 H), 5.00 (d, J = 3.2 Hz, 4 H), 4.94 (d, J = 6.0 Hz, 2 H), 4.91 (d, J = 
2.1 Hz, 4 H), 4.66 (s, 1 H), 2.86–2.73 (m, 2 H), 2.66 (m, 2 H); 13C NMR (100 MHz, CHCl3) 
δ 200.7, 160.0, 159.1, 157.2, 156.9, 143.6, 139.7, 137.1, 136.8, 136.7, 136.1, 133.6, 129.4, 128.6, 
128.5, 128.5, 128.1, 127.9, 127.9, 127.6, 127.6, 127.4, 127.4, 117.9, 114.7, 108.3, 108.0, 100.6, 
98.9, 70.6, 70.2, 70.0, 70.0, 56.7, 36.4, 36.1; HRMS (FAB+) calcd for C57H50O6+ [M+] 830.3607, 
found 830.3605. 
Gnetin F (101).  To a degassed solution of aldehyde 99 (0.106 g, 0.12 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C was added 4–benzyloxyphenylmagnesium bromide (100, 1.0 M in THF, 
0.64 mmol, 5.0 equiv), and the resultant reaction mixture was stirred overnight at 25 °C.  Upon 
completion, the reaction contents were quenched with saturated aqueous NH4Cl (10 mL), poured 
into water (10 mL), and extracted with EtOAc (3 × 10 mL).  The combined organic layers were 
washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The 
resultant crude product was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 10:1→5:1) to afford the protected alcohol (0.075 g, 62% yield) as an off-white 
solid.  This alcohol (0.075 g, 0.07 mmol, 1.0 equiv) was dissolved in a mixture of 1:1 
EtOAc:MeOH (4 mL total) and solid Pd/C (30%, 12 mg) was added.  H2 (balloon) was then 
bubbled directly through the stirred reaction mixture for 30 min.  Additional MeOH was added to 
replace any evaporated solvent to rereach ~ 4 mL reaction volume.  The reaction was then stirred 
under H2 overnight.  Upon completion, the reaction solution was filtered through simple 
filtration paper to remove Pd/C and washed with EtOAc (3 × 5 mL).  Upon concentration of the 
organic layer the desired monodeprotected alcohol was obtained and this intermediate was 





MeOH × 5) was added to the filtrate and the resultant mixture was stirred at 25 °C for 1 h.  When 
this operation was complete, the solution was filtered through simple filtration papered to 
remove the Amberlite, and the filtrate was concentrated directly to afford crude 101, which was 
purified by preparative reverse-phase HPLC chromatography (conditions could not be located) 
and led to trans-gnetin F (101, 0.006 g, 74% yield). 101: Rf = 0.52 (silica gel, CH2Cl2:MeOH, 
4:1); IR (film) νmax 3374, 2953, 2361, 1722, 1613, 1515, 1439, 1363, 1229, 1157, 1032, 837 cm-
1; 1H NMR (400 MHz, acetone-d6) δ 7.16 (d, J = 8.5 Hz, 2 H), 6.85 (dd, J = 8.6, 7.0 Hz, 4 H), 
6.69 (d, J = 8.5 Hz, 2 H), 6.32 (d, J = 2.2 Hz, 1 H), 6.30 (t, J = 2.2 Hz, 1 H), 6.28 (d, J = 2.1 Hz, 
1 H), 6.21 (d, J = 2.2 Hz, 2 H), 5.36 (d, J = 5.8 Hz, 1 H), 4.22 (d, J = 5.8 Hz, 1 H), 2.64–2.38 (m, 
4 H); 13C NMR (100 MHz, CHCl3) δ 162.1, 159.8 (d), 159.5 (d), 158.2 (d), 156.3, 147.4, 141.0, 
133.9, 133.4, 130.3 (d), 128.8, 128.1, 120.2, 116.1 (d), 115.8 (d), 109.3 (d), 107.1 (d), 102.0 (t), 
95.6 (d), 94.0, 57.1, 36.5, 36.1; LRMS (FAB-) calcd for C28H24O6+ [M+] 456.16, found 456.10.  
All spectroscopic data for 101 match that reported by Lins and co-workers.2  For a direct 






Experimental Table 2.1 Comparison of 1H NMR for gnetin F (101) 
1H Literature 1H Observed 
Chemical Shift Appearance Chemical Shift Appearance 
7.14 d, J = 8.5 Hz, 2 H 7.16 d, J = 8.4 Hz, 2 H 
6.89 d, J = 8.5 Hz, 2 H 6.86 d, J = 8.8 Hz, 2 H 
6.82 d, J = 8.5 Hz, 2 H 6.84 d, J = 8.0 Hz, 2 H 
6.66 d, J = 8.5 Hz, 2 H 6.69 d, J = 8.4 Hz, 2 H 
6.3 d, J = 2 Hz, 1 H 6.32 d, J = 2 Hz, 1 H 
6.28 t, J = 2 Hz, 1 H 6.3 t, J = 2 Hz, 1 H 
6.26 d, J = 2 Hz, 1 H 6.28 d, J = 2 Hz, 1 H 
6.2 d, J = 2 Hz, 2 H 6.21 d, J = 2 Hz, 2 H 
5.34 d, J = 6 Hz, 1 H 5.36 d, J = 5.6 Hz, 1 H 
4.19 d, J = 6 Hz, 1 H 4.22 d, J = 5.6 Hz, 1 H 






Experimental Table 2.2 Comparison of 13C NMR for gnetin F (101) 
13C Literature 
13C Observed 
Recalibrated Acetone at 29.8 ppm 
161.7 161.8 162.1 
159.7 159.5 159.8 
159.1 159.2 159.5 
157.8 157.9 158.2 
155.9 156.0 156.3 
147.1 147.1 147.4 
140.7 140.7 141.0 
133.5 133.6 133.9 
132.2 133.1 133.4 
130.2 129.9 130.2 
127.8 127.8 128.1 
120.0 119.9 120.2 
116.0 115.8 116.1 
115.6 115.5 115.8 
109.2 109.0 109.3 
107.0 106.8 107.1 
101.9 101.6 101.9 
95.4 95.3 95.6 
93.8 93.7 94.0 
56.8 56.8 57.1 
36.7 36.2 36.5 
 
2.12.4 Selective Functionalization of Permethylated Resveratrol Dimers 
The permethylated pallidol (3) functionalizations were performed by Dr. Andreas Gollner 
and were previously published.3 
The permethylated ampelopsin D 115 functionalizations can be found in Chapter 1 
(Scheme1.22, compounds 128, 143 and 144).  
The permethylated quadrangularin A 118 functionalizations were previously published 





2.12.4.1 Permethylated Ampelopsin F (2) Selective Functionalizations   
Permethylated ampelopsin F (2) was synthesized according to published procedures.1   
For characterization data please see Chapter 1, compound 153.   
Monobromide 121.  Permethylated ampelopsin F (2, 0.034 g, 0.063 mmol, 1.0 equiv) 
was dissolved in CH2Cl2 (1.5 mL), cooled to –78 °C, and then NBS (0.010 g, 0.056 mmol, 0.9 
equiv) was added in a single portion.  The resultant solution was stirred at –78 °C for 1 h and 
then was warmed to 25 °C over the course of 2 h.  Upon completion, the reaction contents were 
quenched with saturated aqueous NaHCO3 (5 mL) and saturated aqueous Na2SO3 (5 mL), poured 
into water (5 mL), and extracted with EtOAc (3 × 10 mL).  The combined organic layers were 
then dried (MgSO4), filtered, and concentrated.  The resultant amorphous product was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→1:1) to afford bromide 121 
(0.037 g, 95% yield) as an off-white foam.  In general in these experiments, it is worth noting 
that the NBS used was not recrystallized from the commercial sample; upon dissolution we 
always observed some yellow coloration indicating the presence of Br2 which had the same 
selectivity in bromination pattern as NBS.  For this reason, we always observed some over 
halogenation relative to the amount of NBS used, accounting here for the yield observed.  121: 
Rf = 0.64 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 2935, 2835, 1598, 1511, 1488, 1461, 
1434, 1321, 1249, 1204, 1178, 1148, 1133, 1075, 1036, 830, 779 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.06 (d, J = 8.4 Hz, 2 H), 6.84 (d, J = 8.4 Hz, 2 H), 6.81 (d, J = 8.8 Hz, 2 H), 6.65 (d, J 
= 8.8 Hz, 2 H), 6.56 (d, J = 1.6 Hz, 1 H), 6.30 (s, 1 H), 6.18 (d, J = 2.0 Hz, 1 H), 4.98 (s, 1 H), 
4.24 (d, J = 1.6 Hz, 1 H), 3.88 (s, 3 H), 3.80 (s, 3 H), 3.77 (s, 3 H), 3.72 (s, 3 H), 3.68 (s, 4 H), 





155.2, 146.3, 145.2, 139.1, 135,3, 128.8, 128.7 (2 C), 118.3, 113.9, 113.5, 102.3, 101.1, 97.1, 
95.4, 57.1, 56.5, 55.6 (2 C), 55.3 (2 C), 49.8, 47.9, 46.4; HRMS (FAB) calcd for C34H33BrO6+ 
[M+] 616.1461, found 616.1471 (for 79Br).  We note that a large-scale run of this reaction 
performed with 0.590 g of 2 provided 0.730 g of an 8:1 mixture of 121 and 122 following 
extraction that was free of other impurities; this result accounts for a total of 0.640 g of 121 (88% 
yield) and 0.090 g (12% yield) of 122.  Again, the overall level of purity for the NBS here 
dictated the amount of halogenation observed using 0.9 equivalents of NBS. 
Dibromide 122.  Permethylated ampelopsin F (2, 0.178 g, 0.330 mmol, 1.0 equiv) was 
dissolved in THF (6 mL), cooled to –78 °C, and then NBS (0.117 g, 0.660 mmol, 2.0 equiv) was 
added in a single portion.  The resultant solution was stirred at –78 °C for 2 h.  Upon completion, 
the reaction contents were quenched with saturated aqueous NaHCO3 (15 mL), poured into water 
(5 mL), and extracted with EtOAc (2 × 10 mL).  The combined organic layers were then dried 
(MgSO4), filtered, and concentrated.  The resultant crude product mixture was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 10:1→4:1) to afford dibromide 122 (0.229 
g,  99% yield) as a an off-white solid.  122: Rf = 0.32 (silica gel, hexanes:EtOAc, 2:1); IR (film) 
νmax 2999, 2935, 2835, 1607, 1585, 1510, 1461, 1433, 1321, 1249, 1218, 1204, 1179, 1151, 
1140, 1076, 1035 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.12 (d, J = 8.2 Hz, 2 H), 6.87 (d, J = 8.3 
Hz, 2 H), 6.82 (d, J = 8.3 Hz, 2 H), 6.68 (d, J = 8.3 Hz, 2 H), 6.32 (s, 1 H), 6.19 (s, 1 H), 5.08 (s, 
1 H), 4.37 (s, 1 H), 3.88 (s, 3 H), 3.83 (s, 3 H), 3.79 (s, 3 H), 3.73 (s, 3 H), 3.68 (br s, 5 H), 3.45 
(s, 3 H); 13C NMR (100 MHz, CDCl3) δ 158.4, 157.8, 157.5, 156.0, 155.1, 154.6, 145.9, 144.4, 





55.5, 55.4, 55.2, 55.1, 49.7, 48.8, 43.6; HRMS (FAB) calcd for C34H32O6Br2+ [M+] 694.0566, 
found 694.0543 (for 79Br). 
2.12.4.2 Permethylated Heimiol A (123) Selective Functionalizations   
Permethylated Heimiol 123.  Permethylated heimiol A was synthesized according to our 
published procedure.4  123: Rf = 0.70 (silica gel, hexanes:EtOAc, 10:3); IR (film) νmax 3002, 
2926, 2853, 2839, 1606, 1510, 1463, 1300, 1247, 1213, 1199, 1172, 1145, 1094, 1035, 1001, 
945, 913, 834, 788, 734, 636 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.17 (d, J = 8.4 Hz, 2 H), 6.93 
(d, J = 8.8 Hz, 2 H), 6.83 (d, J = 8.8 Hz, 2 H), 6.68 (d, J = 8.8 Hz, 2 H), 6.53 (d, J = 2.4 Hz, 1 H), 
6.48 (d, J = 2.4 Hz, 1 H), 6.31 (d, J = 2.4 Hz, 1 H), 6.25 (d, J = 2.8 Hz, 1 H), 5.66 (s, 1 H), 5.07 
(d, J = 3.2 Hz, 1 H), 4.37 (d, J = 3.2 Hz, 1 H), 4.31 (s, 1 H), 3.82 (s, 6 H), 3.82 (s, 3 H), 3.78 (s, 3 
H), 3.72 (s, 3 H), 3.62 (s, 3 H), 3.39 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 160.0, 159.5, 159.1, 
158.7, 157.8, 156.5, 145.6, 141.0, 137.4, 136.5, 128.9, 127.3, 119.0, 118.8, 113.5, 113.3, 104.8, 
102.1, 98.2, 97.6, 80.9, 80.8, 56.0, 55.6, 55.6, 55.4, 55.3, 55.3, 50.1, 46.0; HRMS (FAB+) calcd 
for C34H35O7+ [M+] 555.2383, found 555.2387. 
 
Experimental Scheme 2.5 HMBC correlations for structural assignment of 124 
 
Monobromide 124.  A solution of permethylated heimiol A (123, 0.0066 g, 0.012 mmol, 
















was added as a solid to this solution at –78 ºC.  The reaction mixture was allowed to warm to 25 
ºC over 5 h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 
mL) and saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with 
CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (5 mL) and brine (5 
mL), dried (MgSO4), filtered and concentrated.  The resulting crude oil was purified by 
preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford monobromide 
124 (0.0074 g, 97% yield).  The only other contaminants visible in the crude NMR were 
unreacted starting material and dibromide 125.  124: Rf = 0.63 (silica gel, hexanes:EtOAc, 7:3); 
IR (film) νmax 2960, 2923, 2853, 1610, 1587, 1510, 1463, 1323, 1247, 1207, 1175, 1147, 1108, 
1077, 1035, 1002, 946, 831, 788 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.13 (d, J = 8.4 Hz, 2 H), 
7.00 (d, J = 8.8 Hz, 2 H), 6.82 (d, J = 8.8 Hz, 2 H), 6.70 (d, J = 8.8 Hz, 2 H), 6.51 (d, J = 2.0 Hz, 
1 H), 6.29 (s, 1 H), 6.28 (d, J = 2.4 Hz, 1 H), 5.62 (s, 1 H), 5.53 (s, 1 H), 5.05 (d, J = 3.2 Hz, 1 
H), 4.43 (d, J = 3.2 Hz, 1 H), 3.86 (s, 3 H), 3.82 (s, 3 H), 3.77 (s, 3 H), 3.72 (s, 3 H), 3.61 (s, 3 
H), 3.39 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 159.7, 158.6, 158.6, 157.9, 157.2, 155.4, 144.4, 
141.2, 137.2, 136.4, 128.9, 127.1, 121.3, 118.2, 113.6, 113.4, 104.3, 101.7, 98.1, 96.0, 80.2 (2 
C), 56.5, 55.9, 55.9, 55.6, 55.3, 55.3, 50.7, 43.5; HRMS could not be obtained. 
Dibromide 125: A solution of permethylated heimiol A (123, 0.003 g, 0.0054 mmol, 1.0 
equiv) in dry CH2Cl2 (1 mL) was cooled to –78 ºC.  NBS (0.0019 g, 0.012 mmol, 2.3 equiv) was 
added as a solid to this solution at –78 ºC.  The reaction mixture was allowed to warm to 25 ºC 
over 5 h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (3 mL) 
and saturated aqueous NaHCO3 (3 mL), poured into water (3 mL) and extracted with CH2Cl2 (3 





(MgSO4), filtered and concentrated.  The resulting crude oil was purified by preparative thin 
layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford dibromide 125 (0.0032 g, 83% 
yield).  125: Rf = 0.59 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3002, 2932, 2838, 1587, 
1509, 1461, 1434, 1392, 1325, 1246, 1207, 1174, 1154, 1100, 1076, 1033, 1001, 982, 962, 946, 
858, 814, 786, 735, 703, 670, 652, 605, 546 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.16 (d, J = 8.0 
Hz, 2 H), 7.03 (d, J = 8.4 Hz, 2 H), 6.83 (d, J = 8.0 Hz, 2 H), 6.71 (d, J = 8.0 Hz, 2 H), 6.32 (s, 1 
H), 6.31 (s, 1 H), 5.64 (s, 2 H), 5.57 (s, 1 H), 4.48 (d, J = 3.2 Hz, 1 H), 3.87 (s, 6 H), 3.78 (s, 3 
H), 3.73 (s, 3 H), 3.64 (s, 3 H), 3.41 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 158.8, 158.7, 157.9, 
156.3, 155.5, 155.4, 144.0, 140.3, 137.0, 136.0, 128.7, 127.0, 120.8, 119.6, 116.1, 113.6, 113.4, 
104.1, 96.5, 96.1, 80.2, 79.0, 56.5 (2 C), 56.4, 55.9, 55.4, 55.3, 48.5, 43.4; HRMS could not be 
obtained. 
2.12.5 Total Synthesis of Carasiphenol B (4) 
Ketone 128.  Monobromide 121 (0.053 g, 0.086 mmol, 1.0 equiv) was azeotroped with 
benzene (3 × 3 mL), dissolved in THF (1.5 mL), and then cooled to -78 °C.  Next, nBuLi (1.6 M 
in hexanes, 0.067 mL, 0.107 mmol, 1.25 equiv) was added dropwise over the course of 5 min 
and the reaction mixture was stirred at -78 °C for an additional 10 min, ultimately yielding a 
solution with a slight yellow color.  A solution of benzene-azeotroped (3 × 3 mL) 3,5-
dimethoxybenzaldehyde (79, 0.043 g, 0.257 mmol, 3.0 equiv) in THF (1.5 mL) was then added 
dropwise over 5 min at –78 °C.  After stirring the resultant solution for an additional 2 h at –78 
°C, the reaction was then allowed to slowly warm to 25 °C over the course of 2 h.  Upon 
completion, the reaction contents were quenched with saturated aqueous NH4Cl (5 mL), poured 





dried (MgSO4), filtered, and concentrated.  The resultant crude yellow oil was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 4:1→1:1) to afford the desired alcohol 
product as a mixture of diastereomers (0.035 g, 58% yield) as an off-white solid, alongside 
debrominated permethylated ampelopsin F (2) (0.012 g, 26% yield).  After repeating this 
reaction several times, the mixture of alcohol diastereomers (0.237 g, 0.336 mmol, 1.0 equiv) 
was dissolved in CH2Cl2 (8 mL) and solid NaHCO3 (0.600 g, 7.14 mmol, 21 equiv) and Dess–
Martin periodinane (0.330 g, 0.778 mmol, 2.3 equiv) were added sequentially at 25 °C.  The 
resultant mixture was stirred at 25 °C for 1 h.  Upon completion, the reaction contents were 
quenched with saturated aqueous Na2SO3 (40 mL) and the resultant slurry was stirred for an 
additional 20 min at 25 °C before being poured into water (20 mL) and extracted with EtOAc (3 
× 50 mL).  The combined organic layers were then washed with water (20 mL) and brine (20 
mL), dried (MgSO4), filtered, and concentrated to afford ketone 128 (0.230 g, 97% yield) as a 
white amorphous solid.  128: Rf = 0.38 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 2935, 
2836, 1723, 1661, 1589, 1511, 1460, 1428, 1316, 1249, 1204, 1178, 1155, 1111, 1080, 1036, 
832, 758, 737 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.13 (d, J = 8.4 Hz, 2 H), 7.04 (br s, 2 H), 
6.82 (d, J = 8.4 Hz, 2 H), 6.75 (d, J = 8.8 Hz, 2 H), 6.65 (t, J = 2.4 Hz, 1 H), 6.58 (d, J = 8.8 Hz, 
2 H), 6.56 (d, J = 1.6 Hz, 1 H), 6.27 (s, 1 H), 5.99 (d, J = 2.0 Hz, 1H), 4.46 (br s, 1 H), 4.28 (d, J 
= 1.6 Hz, 1 H), 3.80 (s, 9 H), 3.78 (s, 1 H), 3.76 (s, 3 H), 3.64 (s, 3 H), 3.62 (s, 3 H), 3.50 (s, 3 
H), 3.41 (s, 1 H), 2.97 (br s, 3 H); 13C NMR (100 MHz, CDCl3) δ 196.5, 160.9, 160.8, 160.7, 
157.9, 157.8, 157.6, 155.1, 146.4, 145.4, 141.9, 139.4, 135.4, 129.2, 129.0, 128.8, 118.9, 117.4, 
113.7, 113.6, 107.6, 105.4, 100.8, 96.4, 94.1, 56.5, 56.0, 55.9, 55.7, 55.6 (2 C), 55.4, 54.0, 49.9, 






Experimental Scheme 2.6 Structure of deprotected ketone S7 
 
Deprotected Ketone S7.  Permethylated ketone 128 (0.230 g, 0.327 mmol, 1.0 equiv) 
was dissolved in a minimal amount of CH2Cl2 (1 mL), transferred to a sealable reaction vessel, 
and then BBr3 (1.0 M in CH2Cl2, 13.0 mL, 13.0 mmol, 40 equiv) was added quickly in a single 
portion at 25 °C.  The resulting reddish-brown reaction mixture was then heated at 70 °C for 5 d.  
Upon completion, the reaction contents were cooled to 25 °C and quenched with the addition of 
saturated aqueous NaHCO3 (20 mL).  After stirring the resultant biphasic mixture for an 
additional 10 min at 25 °C, the reaction contents were poured into water (20 mL), extracted with 
EtOAc (5 × 40 mL), dried (MgSO4), filtered, and concentrated.  The resultant orange oil was 
purified by flash column chromatography (silica gel, CH2Cl2:MeOH, 10:1→3:1) to afford the 
deprotected ketone S7 (0.185 g, 96% yield) as a yellow amorphous solid.  S7: Rf = 0.66 
(CH2Cl2:MeOH, 4:1); IR (film) νmax 3297, 2978, 2937, 1697, 1596, 1512, 1443, 1358, 1343, 
1237, 1159, 1005, 836, 792 cm-1; 1H NMR (400 MHz, acetone-d6) δ 9.32 (s, 1 H), 8.65 (br s, 4 
H), 8.06 (br s, 2H), 7.19 (d, J = 8.4 Hz, 2 H), 7.01 (d, J = 2.0 Hz, 2 H), 6.84 (d, J = 8.8 Hz, 2 H), 
6.70 (d, J = 8.4 Hz, 2 H), 6.66 (t, J = 2.2 Hz, 1 H), 6.59 (d, J = 2.0 Hz, 1 H), 6.56 (d, J = 8.4 Hz, 
2 H), 6.37 (s, 1 H), 6.11 (d, J = 2.0 Hz, 1 H), 4.32 (d, J = 1.6 Hz, 1 H), 4.16 (s, 1 H), 3.71 (s, 1 















154.7, 153.2, 146.8, 145.6, 141.9, 137.3, 134.0, 128.9, 128.2, 124.9, 114.9, 114.7, 114.4, 108.3, 
107.5, 103.2, 101.6, 101.1, 56.3, 49.2, 46.6, 46.0; HRMS (FAB) calcd for C35H26O9+ [M+] 
590.5755, found 590.1580. 
Perbenzylated Ketone 129.  Solid K2CO3 (0.430 g, 3.11 mmol, 40 equiv), BnBr (0.576 
g, 3.368 mmol, 43 equiv) and nBu4NI (0.058 g, 0.157 mmol, 2.0 equiv) were added sequentially 
to a solution of the deprotected ketone S7 (0.046 g, 0.078 mmol, 1.0 equiv) in dry acetone (1 
mL) at 25 °C.  The resultant reaction mixture was then heated at 70 ºC for 15 h.  Upon 
completion, the reaction contents were cooled to 25 °C, quenched with the addition of saturated 
NH4Cl (5 mL), poured into water (5 mL), and extracted with EtOAc (3 × 10 mL).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated.  The resultant crude orange oil 
was purified by flash column chromatography (silica gel, hexanes:EtOAc, 10:1→5:1) to afford 
perbenzylated ketone 129 (0.080 g, 78% yield) as a yellow oil.  129: Rf = 0.65 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax 3031, 2927, 1661, 1588, 1508, 1454, 1377, 1295, 1244, 
1156, 1110, 1083, 1061, 1028, 833, 736, 696 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 
1.6 Hz, 1 H), 7.39–7.29 (m, 37 H), 7.23–7.12 (m, 13 H), 7.02–6.99 (m, 5 H), 6.95 (d, J = 8.8 Hz, 
2 H), 6.85 (d, J = 8.0 Hz, 2 H), 6.76 (d, J = 8.8 Hz, 2 H), 6.72 (d, J = 7.2 Hz, 2 H), 6.68–6.74 (m, 
2 H), 6.66–6.65 (m, 2 H), 6.64 (d, J = 1.6 Hz, 1 H), 6.32 (s, 1 H), 6.14 (d, J = 2.0 Hz, 1 H), 5.08 
(s, 2 H), 4.98–4.95 (m, 5 H), 4.91–4.87 (m, 6 H), 4.83–4.62 (m, 6 H), 4.40 (d, J = 1.6 Hz, 1 H), 
3.90 (s, 1 H), 3.43 (br s, 1 H); 13C NMR (100 MHz, CDCl3) δ 196.6, 159.9, 159.6, 159.4, 157.2, 
157.0, 156.5, 153.6, 146.4, 145.5, 142.4, 139.6, 137.5, 137.4, 137.1 (2 C), 137.0, 136.6, 136.5 (2 
C), 130.4, 129.1, 128.7 (2 C), 128.6, 128.3, 128.2, 128.1, 128.0 (2 C), 127.9, 127.8, 127.7 (2 C), 





C), 70.3 (2 C), 70.0, 69.9, 68.7, 56.7, 50.0, 46.8, 44.2; MS (FAB) calcd for C91H74O9+ [M+H+] 
1311.5, found 1311.4. 
Aldehyde 130.  To a slurry of Me3SI (0.032 g, 0.156 mmol, 20 equiv) in THF (1 mL) at 0 
°C was added nBuLi (1.6 M in hexanes, 0.080 mL, 0.128 mmol, 16 equiv) dropwise over the 
course of 2 min, and the reaction mixture was stirred at 0 °C for an additional 2 min.  A solution 
of ketone 129 (0.011 g, 0.008 mmol, 1.0 equiv) in THF (1 mL) was then added dropwise over 
the course of 2 min at 0 °C, and the resultant solution was stirred for an additional 1 h at 0 °C.  
Upon completion, the reaction contents were quenched at 0 °C with the addition of saturated 
aqueous NH4Cl (5 mL), poured into water (5 mL), and extracted with EtOAc (3 × 5 mL).  The 
combined organic layers were dried (MgSO4), filtered, and concentrated to give the desired 
crude epoxide as a yellow oil.  Next, the crude epoxide was immediately dissolved in benzene 
(0.5 mL) and solid ZnI2 (0.080 g, 0.251 mmol, 31 equiv) was added at 25 °C.  The resultant 
reaction mixture was stirred at 25 °C for 1 h.  Upon completion, the reaction contents were 
quenched with water (5 mL) and extracted with EtOAc (3 × 5 mL).  The combined organic 
layers were then dried (MgSO4), filtered, and concentrated.  The resultant crude yellow oil was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 10:1→3:1) to afford 
aldehyde 130 as an amorphous solid (0.010 g, 94% yield) as a single diastereoisomer.  130: Rf = 
0.61 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3031, 2922, 1724, 1594, 1509, 1454, 1378, 
1300, 1243, 1157, 1124, 1060, 1027, 830, 737, 697 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.52 (s, 
1 H), 7.45–7.27 (m, 36 H), 7.22–7.13 (m, 2 H), 7.15 (d, J = 7.6 Hz, 2 H), 7.08 (d, J = 8.8 Hz, 2 
H), 6.89 (d, J = 8.8 Hz, 2 H), 6.72 (d, J = 1.6 Hz, 1 H), 6.69 (d, J = 7.6 Hz, 2 H), 6.67 (s, 3 H), 





4.85 (m, 15 H), 4.68 (d, J = 11.6 Hz, 1 H), 4.60 (d, J = 11.6 Hz, 1 H), 4.43 (s, 1 H), 4.33 (s, 1 H), 
3.58 (s, 1 H), 3.42 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 199.7, 160.1, 157.9, 157.1 (2 C), 
155.3, 154.2, 146.7, 146.2, 140.9, 139.9, 137.3, 137.1, 136.8, 136.6, 135.6, 129.0, 128.9, 128.7 
(3 C), 128.6, 128.3 (2 C), 128.2, 128.1 (2 C), 128.0 (2 C), 127.8, 127.7, 127.6, 127.5, 127.2, 
117.8, 115.3, 114.7, 114.4, 108.7, 102.8, 100.9, 98.9, 96.7, 70.9, 70.6, 70.4, 70.2 (2 C), 69.9, 
69.8, 57.2, 55.8, 50.0, 46.8, 45.9; MS (FAB) calcd for C92H77O9+ [M+H+] 1325.6, found 1325.4. 
Carasiphenol B (4).  To a solution of aldehyde 130 (0.045 g, 0.034 mmol, 1.0 equiv) in 
THF (4 mL) at 25 °C was added 4-benzyloxyphenylmagnesium bromide (100, 1.0 M in THF, 
0.200 mL, 0.2 mmol, 6 equiv), and the resultant solution was stirred for 1 h at 25 °C.  Upon 
completion, the reaction contents were quenched with saturated aqueous NH4Cl (10 mL), poured 
into water (5 mL), and extracted with EtOAc (3 × 10 mL).  The combined organic layers were 
then dried (MgSO4), filtered, and concentrated.  The resultant crude oil was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 5:1→1:1) to afford alcohol 131 as a white 
solid (0.035 g, 68% yield) and as a single diastereomer.  131: Rf = 0.50 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax  3493, 3062, 3031, 2922, 2866, 1592, 1509, 1454, 1377, 
1298, 1241, 1173, 1117, 1061, 1026, 829, 736, 697 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.43 (d, 
J = 7.2 Hz, 5 H), 7.36–7.32 (m, 30 H), 7.20 (d, J = 8.8 Hz, 2 H), 7.20–7.08 (m, 10 H), 7.03 (d, J 
= 8.4 Hz, 2 H), 6.86 (d, J = 8.4 Hz, 2 H), 6.72 (d, J = 1.6 Hz, 1 H), 6.69 (d, J = 8.4 Hz, 2 H), 6.68 
(d, J = 8.4 Hz, 2 H), 6.63 (d, J = 8.8 Hz, 2 H), 6.48 (d, J = 2.4 Hz, 2 H), 6.47 (s, 1 H), 6.38 (t, J = 
2.4 Hz, 1 H), 6.28 (d, J = 1.6 Hz, 1 H), 5.45 (d, J = 10.0 Hz, 1 H), 5.13–5.00 (m, 7 H), 4.91 (s, 4 
H), 4.86 (s, 3 H), 4.74–4.69 (m, 5 H), 4.58 (d, J = 11.6 Hz, 1 H), 4.38 (s, 1 H), 3.67 (s, 1 H), 3.39 





147.7, 145.7, 140.3, 137.5, 137.4, 137.2 (2 C), 137.1, 137.0, 136.9, 136.0, 129.8, 129.0, 128.9, 
128.7 (2 C), 128.6, 128.4, 128.3 (2 C), 128.1, 128.0, 127.8 (2 C), 127.7, 127.6 (3 C), 127.5, 
127.3, 126.8, 118.3, 117.9, 114.7, 114.5 (2 C), 108.5, 103.7, 100.3, 97.2, 73.9, 71.2, 70.6, 70.2, 
70.0 (2 C), 69.9, 69.8, 55.8, 52.0, 50.7, 47.2, 46.6, 29.8; MS (FAB) calcd for C105H88O10+ [M+] 
1509.8, found 1508.4.  Alcohol 131 (6.0 mg, 0.004 mmol, 1.0 equiv) was dissolved in a mixture 
of EtOAc:MeOH (1:1, 3 mL) and solid Pd/C (30%, 5.0 mg) was added.  H2 was then bubbled 
directly through the stirred reaction mixture for 30 min.  Once complete, some additional MeOH 
was added to replace any evaporated solvent to rereach ~3 mL reaction volume and the reaction 
mixture was stirred under H2 (balloon) for 2 h.  H2 was bubbled through the stirred reaction 
mixture again for 30 min and the reaction mixture again was refilled with MeOH to account for 
lost solvent.  The reaction was stirred under H2 at 25 ºC for 12 h.  Upon completion, the reaction 
solution was filtered through simple filtration paper to remove Pd/C and washed with MeOH (2 
mL).  Next, Amberlite (IR-12OH, 0.100 g, pre-washed with MeOH 5 times) was added to the 
filtrate and the resultant mixture was stirred at 25 °C for 1 h.  When this operation was complete, 
the solution was filtered through simple filtration paper to remove the Amberlite, and the filtrate 
was concentrated directly to afford carasiphenol B (4, 2.4 mg, 89%) as a white solid, with a 
scrupulously pure analytical sample obtained by reverse-phase HPLC (Shimadzu Epic C18, 5µ, 
250 X 9.6 mm, retention time = 10.3 min, 55% water in MeOH).  4: Rf = 0.74 (silica gel, 
CH2Cl2:MeOH, 4:1); IR (film) νmax 3323, 2968, 2925, 2853, 1696, 1606, 1512, 1453, 1366, 
1333, 1238, 1165, 1120, 1084, 1013, 834 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.43 (s, 1 H), 8.22 
(s, 2 H), 8.12 (s, 1 H), 8.06 (s, 1 H), 7.94 (s, 1 H), 7.88 (s, 1 H), 7.57 (s, 1 H), 7.25 (d, J = 8.8 Hz, 
2 H), 7.16 (d, J = 8.4 Hz, 2 H), 6.84 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 6.61 (d, J = 





(t, J = 2.0 Hz, 1 H), 6.19 (s, 1 H), 6.14 (d, J = 2.0 Hz, 1 H), 5.44 (d, J = 6.0 Hz, 1 H), 4.97 (d, J = 
6.4 Hz, 1 H), 4.26 (d, J = 1.6 Hz, 1 H), 4.06 (s, 1 H), 3.56 (s, 1 H), 3.43 (s, 1 H); 13C NMR (100 
MHz, CDCl3) δ 159.9, 159.8, 158.6, 158.2, 157.9, 156.2, 156.1, 153.5, 153.4, 148.5, 144.1, 
138.8, 135.2, 134.3, 130.0, 129.3, 128.6, 127.1, 117.8, 116.1, 115.7, 115.4, 114.8, 107.4, 103.9, 
102.0, 101.8, 95.9, 94.4, 56.8, 56.4, 49.6, 47.8, 46.7; HRMS (FAB) calcd for C42H32O9+ [M+] 
680.6981, found 680.2025.  All spectroscopic data for 4 match that reported by Hu and co-






Experimental Table 2.3 Comparison of 1H NMR for carasiphenol B (4) 
1H Literature 1H Observed 
Chemical Shift Appearance Chemical Shift Appearance 
  
8.43 s, 1 H 
  
8.22 s, 2 H 
  
8.12 s, 1 H 
  
8.06 s, 1 H 
  
7.94 s, 1 H 
  
7.88 s, 1 H 
  
7.57 s, 1 H 
7.20 d, J = 8.3 Hz, 2 H 7.25 d, J = 8.8 Hz, 2 H 
7.10 d, J = 8.2 Hz, 2 H 7.16 d, J = 8.4 Hz, 2 H 
6.81 d, J = 8.5 Hz, 2 H 6.84 d, J = 8.4 Hz, 2 H 
6.74 d, J = 8.2 Hz, 2 H 6.79 d, J = 8.4 Hz, 2 H 
6.56 d, J = 1.4 Hz, 1 H 6.61 d, J = 2.0 Hz, 1 H 
6.56 d, J = 8.6 Hz, 2 H 6.61 d, J = 8.4 Hz, 2 H 
6.45 d, J = 8.6 Hz, 2 H 6.49 d, J = 8.4 Hz, 2 H 
6.37 d, J = 1.8 Hz, 1 H 6.43 d, J = 2.4 Hz, 2 H 
6.31 t, J = 1.8 Hz, 1 H 6.35 t, J = 2.0 Hz, 1 H 
6.15 s, 1H 6.19 s, 1 H 
6.09 d, J = 1.1 Hz, 1 H 6.14 d, J = 2.0 Hz, 1 H 
5.38 d, J = 6.3 Hz, 1 H 5.44 d, J = 6.0 Hz, 1 H 
4.93 d, J = 6.3 Hz, 1 H 4.97 d, J = 6.4 Hz, 1 H 
4.20 bs, 1 H 4.26 d, J = 1.6 Hz, 1 H 
4.01 s, 1 H 4.06 s, 1 H 
3.51 s, 1 H 3.56 s, 1 H 







Experimental Table 2.4 Comparison of 13C NMR for carasiphenol B (4) 
13C Literature 
13C Observed 
Recalibrated Acetone at 29.8 ppm 
160.1 160.1 159.9 
160.0 160.0 159.8 
158.5 158.8 158.6 
158.1 158.4 158.2 
158.1 158.1 157.9 
156.4 156.5 156.3 
156.3 156.3 156.1 
153.7 153.7 153.5 
148.7 148.7 148.5 
144.4 144.3 144.1 
139.0 139.0 138.8 
135.4 135.4 135.2 
134.4 134.6 134.4 
130.2 130.2 130.0 
129.6 129.5 129.3 
128.9 128.8 128.6 
127.0 127.3 127.1 
118.0 118.0 117.8 
116.4 116.3 116.1 
116.0 115.9 115.7 
115.7 115.6 115.4 
115.0 115.0 114.8 
107.6 107.6 107.4 






2.12.6 Attempts to Synthesize Monobromide 137 
Experimental Table 2.5 Electrophilic bromine sources and their selectivity on permethylated 
ampelopsin F (2) 
Reagent  
(# equiv) 
    
Br2 (0.2) 4.5 1 - 3 
NBAc (1.5) - 1 - 10 
NBSac (1.5) - 1 - 1.4 
TBCO (1.1) - 4.5 - 1 
[Collidine2Br]OTf 
(0.5) 14.5 4.5 4 1 
 
Reaction with molecular bromine.  Permethylated ampelopsin F (2, 0.0145 g, 0.027 
mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (6 mL).  The solution was cooled to –78 ºC and 
Br2 (0.06 mL of 0.1 M solution in CH2Cl2, 0.0055 mmol, 0.2 equiv) was added and the reaction 
was allowed to stir at that temperature for 30 min.  Upon completion, the reaction was quenched 
with saturated aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into 
water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were 
washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The 
crude mixture contained a 4.5:1:3 ratio of 2:121:122. 
Reaction with N-bromoacetamide.  Permethylated ampelopsin F (2, 0.0145 g, 0.027 
mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (5 mL).  The solution was cooled to –78 ºC and 
N-bromoacetamide (0.006 g, 0.04 mmol, 1.5 equiv) was added as a solid and the reaction was 
allowed to warm to 25 ºC over 3 h.  Upon completion, the reaction was quenched with saturated 































extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with water (10 
mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The crude mixture contained 
a 1:10 ratio of 121:122.  
Reaction with N-bromosaccharin.  Permethylated ampelopsin F (2, 0.006 g, 0.011 
mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (3 mL).  The solution was cooled to –78 ºC and 
N-bromosaccharin (0.0045 g, 0.016 mmol, 1.5 equiv) was added as a solid and the reaction was 
allowed to warm to 25 ºC over 3 h.  The reaction was run in the dark to prevent radical 
formation.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) 
and saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 
× 10 mL).  The combined organic layers were washed with water (10 mL) and brine (10 mL), 
dried (MgSO4), filtered and concentrated.  The crude mixture contained a 1:1.4 ratio of 121:122. 
Reaction with TBCO.  Permethylated ampelopsin F (2, 0.016 g, 0.03 mmol, 1.0 equiv) 
was dissolved in dry CH2Cl2 (3 mL).  The solution was cooled to –78 ºC and TBCO (0.013 g, 
0.032 mmol, 1.1 equiv) was added as a solid and the reaction was allowed to warm to 25 ºC over 
3 h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 
mL).  The combined organic layers were washed with water (10 mL) and brine (10 mL), dried 
(MgSO4), filtered and concentrated.  The crude mixture contained a 4.5:1 ratio of 121:122. 
Reaction with [Collidine2Br](OTf).  Permethylated ampelopsin F (2, 0.007 g, 0.013 
mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (5 mL).  The solution was cooled to –78 ºC and 
[Collidine2Br](OTf) (0.003 g, 0.0064 mmol, 0.5 equiv) was added as a solid and the reaction was 





completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and saturated 
aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  
The combined organic layers were washed with water (10 mL) and brine (10 mL), dried 
(MgSO4), filtered and concentrated.  The crude mixture contained a 14.5:4.5:4:1 ratio of 
2:121:137:122. 
Dibromide 122.  A round-bottomed flask was charged sequentially with 
Ru(bpy)3Cl2•7H2O (2.0 mg, 0.003 mmol, 0.1 equiv), tribromide 139 (0.025 g, 0.033 mmol, 1.0 
equiv), iPr2NEt (0.011 mL, 0.650 mmol, 20 equiv), and formic acid (0.032 mL, 0.650 mmol, 20 
equiv).  Finally, DMF (2.5 mL) was added at 25 °C and the resultant mixture was degassed by 
argon sparging for 20 min, and placed at a distance of ~10 cm from a 15 W fluorescent lamp.2  
After turning the lamp on and stirring at 25 °C for 15 h, the reaction contents were poured into 
saturated aqueous NaHCO3 (10 mL) and extracted with EtOAc (3 × 10 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.  The resultant crude product 
mixture was purified by flash column chromatography (silica gel, hexanes:EtOAc, 10:1→4:1) to 
afford dibromide 122 (0.020 g, 89% yield) as a white solid. 
Monobromide 121.  Dibromide 122 (0.086 g, 0.124 mmol, 1.0 equiv) was dissolved in 
dry THF (20 mL) and the solution was cooled to –78 ºC.  nBuLi (1.6 M in hexanes, 0.086 mL, 
0.137 mmol, 1.1 equiv) was added dropwise to the solution and the reaction was allowed to stir 
for 3 min.  Upon completion, the reaction was quenched with saturated aqueous NH4Cl (10 mL), 
poured into water (10 mL) and extracted with CH2Cl2 (3 × 15 mL).  The combined organic layers 
were washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  





thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford monobromide 121 (0.044 g, 
54% yield). 
Monobromide 137.  Permethylated ampelopsin F (2, 0.560 g, 1.04 mmol, 1.0 equiv) was 
dissolved in CH2Cl2 (20 mL), cooled to –78 °C, and then BDSB (0.516 g, 0.94 mmol, 0.9 equiv) 
was added in a single portion.  The resultant solution was stirred at –78 °C for 2 h.  Upon 
completion, the reaction contents were quenched with saturated aqueous NaHCO3 (20 mL) and 
saturated aqueous Na2SO3 (50 mL), and extracted with EtOAc (2 × 50 mL).  The combined 
organic layers were then dried (MgSO4), filtered, and concentrated.  The resultant amorphous 
product was purified by flash column chromatography (silica gel, hexanes:EtOAc, 10:1→4:1) to 
afford bromide 137 contaminated with a trace of dibromide 122 (0.560 g total, 0.500 g 137 based 
on NMR integration, 78% yield, 85% yield based on recovered starting material) as an 
amorphous off-white solid and recovered permethylated ampelopsin F (2, 0.045 g, 8%).  An 
analytical sample was obtained by running the reaction less to completion as the dibromide 
cannot be separated.  [Note: the large scale reaction was run to test the robustness of the method; 
key is to note that monobromide 121 was not detected by NMR analysis].  137: Rf = 0.56 (silica 
gel, hexanes:EtOAc, 1:1); IR (film) νmax 2935, 2835, 1606, 1583, 1510, 1462, 1434, 1336, 1320, 
1248, 1209, 1178, 1140, 1080, 1036, 966, 830 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.15 (d, J = 
8.8 Hz, 2 H), 6.84 (d, J = 8.4 Hz, 2 H), 6.81 (d, J = 8.4 Hz, 2 H), 6.66 (d, J = 8.8 Hz, 2 H), 6.50 
(d, J = 2.4 Hz, 1 H), 6.27 (d, J = 2.4 Hz, 1 H), 6.19 (s, 1 H), 4.34 (s, 1 H), 4.25 (s, 1 H), 3.83 (s, 3 
H), 3.83 (s, 3 H), 3.79 (s, 3 H), 3.75 (s, 3 H), 3.69 (s, 1 H), 3.69 (s, 4 H), 3.44 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 159.7, 159.1, 157.9, 157.7, 156.0, 154.1, 145.6, 145.5, 138.8, 135.0, 130.0, 





C), 51.0, 49.2, 43.7; HRMS (FAB) calcd for C34H33BrO6+ [M+] 616.1461, found 616.1465 (for 
79Br).  
Dibromide 122.  Monobromide 137 (0.015 g, 0.024 mmol, 1.0 equiv) was dissolved in 
CH2Cl2 (10 mL), cooled to -78 °C, and then BDSB (0.014 g, 0.025 mmol, 1.1 equiv) was added 
in a single portion.  The resultant solution was stirred at –78 °C for 2 h.  Upon completion, the 
reaction contents were quenched with saturated aqueous NaHCO3 (10 mL) and saturated aqueous 
Na2SO3 (10 mL), and extracted with EtOAc (2 × 10 mL).  The combined organic layers were 
then dried (MgSO4), filtered, and concentrated.  The resultant amorphous product was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 10:1→4:1) to afford dibromide 122 
(0.016 g, 99% yield) as an amorphous off-white solid.  
2.12.7 Total Synthesis of Ampelopsin G (138) 
Permethylated Ketone 140.  Monobromide 137 (0.360 g, 0.583 mmol, 1.0 equiv) was 
azeotroped with benzene (3 × 10 mL), dissolved in THF (20 mL), and then cooled to –78 °C.  
Next, nBuLi (1.6 M in hexanes, 0.4 mL, 0.6413 mmol, 1.1 equiv) was added dropwise over the 
course of 5 min and the reaction mixture was stirred at –78 °C for an additional 10 min, 
ultimately yielding a solution with a slight yellow color.  A solution of benzene-azeotroped (3 × 
5 mL) 3,5-dimethoxybenzaldehyde (79, 0.242 g, 1.457 mmol, 2.5 equiv) in THF (4 mL) was 
then added dropwise over 5 min at -78 °C.  After stirring the resulting solution for an additional 
2 h at –78 °C, the reaction was then allowed to slowly warm to 25 ºC over the course of 1.5 h.  
Upon completion, the reaction contents were quenched with saturated aqueous NH4Cl (30 mL), 
and extracted with EtOAc (4 × 20 mL).  The combined organic layers were then dried (MgSO4), 





chromatography (silica gel, hexanes:EtOAc, 4:1→1:1) to afford the desired alcohol as a mixture 
of diastereomers (0.340 g, 83% yield) as a white solid.  The mixture of diastereomers (0.340 g, 
0.482 mmol, 1.0 equiv) was dissolved in CH2Cl2 (10 mL) and solid NaHCO3 (0.632 g, 7.578 
mmol, 16 equiv) and Dess–Martin periodinane (0.876 g, 2.064 mmol, 4.3 equiv) were added 
sequentially at 25 °C.  The resultant reaction mixture was stirred at 25 °C for 10 min.  Upon 
completion, the reaction contents were quenched with saturated aqueous Na2SO3 (30 mL) and the 
resulting slurry was stirred for an additional 20 min at 25 ºC before being poured into water (50 
mL) and extracted with EtOAc (3 × 50 mL).  The combined organic layers were then washed 
with saturated aqueous NaHCO3 (50 mL) and brine (50 mL), dried (MgSO4), filtered, and 
concentrated to afford ketone 140 (0.303 g, 89% yield) as an off-white foam.  140: Rf = 0.42 
(silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 2937, 2836, 1735, 1659, 1599, 1511, 1461, 1318, 
1300, 1249, 1206, 1156, 1034, 829, 738 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.96 (d, J = 8.4 Hz, 
2 H), 6.89 (d, J = 2.0 Hz, 2 H), 6.85 (d, J = 8.8 Hz, 2 H), 6.71 (d, J = 8.8 Hz, 2 H), 6.64 (d, J = 
8.8 Hz, 2 H), 6.63 (t, J = 2.0 Hz, 1 H), 6.53 (d, J = 2.0 Hz, 1 H), 6.26 (d, J = 2.4 Hz, 1 H), 6.19 
(s, 1 H), 4.36 (br s, 1 H), 4.21 (s, 1 H), 3.84 (s, 3 H), 3.82 (s, 3 H), 3.74 (s, 9 H), 3.68 (s, 3 H), 
3.67 (s, 1 H), 3.60 (s, 3 H), 3.44 (s, 1 H), 3.42 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 196.5, 
160.8, 159.8, 159.0, 158.5, 157.8, 157.4, 156.3, 145.4, 145.3, 141.5, 139.1, 135.0, 129.1, 128.8, 
128.6, 118.8, 116.1, 113.5, 113.3, 107.0, 105.7, 103.1, 97.1, 94.3, 56.2, 55.6, 55.5 (2 C), 55.3 (2 








Experimental Scheme 2.7 Structures of ketones S8 and S9 
 
Deprotected Ketone S8.  Permethylated ketone 140 (0.300 g, 0.430 mmol, 1.0 equiv) 
was dissolved in a minimal amount of CH2Cl2 (1.0 mL), transferred to a sealable reaction vessel, 
and then BBr3 (1.0 M in CH2Cl2, 50 mL, 50 mmol, 117 equiv) was added quickly in a single 
portion at 25 ºC.  The resulting reddish-brown reaction mixture was then heated to 70 °C for 10 
d.  Upon completion, the reaction contents were cooled to 25 °C and quenched with the addition 
of H2O (100 mL).  After stirring the biphasic mixture for an additional 10 min at 25 ºC, the 
reaction contents were extracted with EtOAc (5 × 40 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant orange oil was purified by preparative thin layer chromatography 
(silica gel, CH2Cl2:MeOH, 6:1) to afford the deprotected ketone S8 (0.110 g, 44% yield) as a 
yellow foam, along with a monomethylated congener (0.140 g, 54% yield); this latter material 
could be recycled through a reprotection/deprotection sequence.  S8: Rf = 0.68 (silica gel, 
CH2Cl2:MeOH, 4:1); IR (film) νmax 3338, 3027, 2971, 2924, 1697, 1595, 1512, 1453, 1448, 
1364, 1340, 1297, 1229, 1171, 1142, 867 cm-1; 1H NMR (400 MHz, acetone-d6) δ 6.90–6.85 (m, 
4 H), 6.74–6.63 (m, 7 H), 6.52 (br s, 1 H), 6.24 (s, 1 H), 6.21(d, J = 2.0 Hz, 1 H), 4.27 (s, 1 H), 
4.20 (s, 1 H), 3.64 (s, 1 H), 3.60 (s, 1 H); 13C NMR (100 MHz, acetone-d6) δ 198.2, 160.3, 158.5, 























114.5, 114.4, 112.2, 107.2, 106.0, 104.9, 101.6, 101.1, 55.7, 48.8, 48.3, 44.7; HRMS (FAB) 
calcd for C35H26O9- [M-] 590.58, found 589.01. 
Perbenzylated Ketone S9.  Solid K2CO3 (1.00 g, 7.237 mmol, 39 equiv), BnBr (1.48 g, 
8.408 mmol, 45 equiv) and nBu4NI (0.140 g, 0.191 mmol, 1.1 equiv) were added sequentially to 
a solution of the deprotected ketone S8 (0.110 g, 0.187 mmol, 1.0 equiv) in dry acetone (4 mL) 
at 25 °C.  The resultant reaction mixture was heated at 70 ºC for 12 h.  Upon completion, the 
reaction contents were cooled to 25 °C, quenched with the addition of saturated aqueous NH4Cl 
(5 mL) and extracted with EtOAc (3 × 10 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated.  The resultant crude orange oil was purified by preparative 
thin layer chromatography (silica gel, hexanes:EtOAc, 3:2) to afford perbenzylated ketone S9 
(0.210 g, 86% yield) as a yellow oil.  S9: Rf  = 0.63 (silica gel, hexanes:EtOAc, 7:3); IR (film) 
νmax 3031, 2868, 1659, 1599, 1508, 1453, 1295, 1241, 1175, 1147, 1058, 1026, 736, 696 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.43–7.29 (m, 32 H), 7.16–7.06 (m, 9 H), 6.96 (d, J = 8.8 Hz, 2 
H), 6.96 (d, J = 2.4 Hz, 2 H), 6.85 (d, J = 8.8 Hz, 2 H), 6.84–6.82 (m, 2 H), 6.75 (d, J = 8.8 Hz, 2 
H), 6.83 (t, J =  Hz, 1 H), 6.66 (d, J = 7.2 Hz, 2 H), 6.63 (d, J = 2.4 Hz, 1 H), 6.43 (d, J = 2.0 Hz, 
1 H), 6.22 (s, 1 H), 5.05 (s, 4 H), 5.02 (s, 1 H), 4.98 (s, 1 H), 4.91 (s, 4 H), 4.86 (s, 2 H), 4.72–
4.60 (m, 4 H), 4.54 (br s, 1 H), 4.30 (s, 1 H), 3.81 (s, 1 H), 3.65 (s, 1 H); 13C NMR (100 MHz, 
CDCl3) δ  196.6, 160.1, 158.7, 158.3, 157.9, 157.1, 155.6, 146.4, 145.5, 142.4, 139.6, 137.6,  
137.3, 137.0,136.9 (2 C), 136.6, 135.3, 130.4, 129.2, 128.8, 128.7 (2 C), 128.6, 128.3, 128.2, 
128.1 (2 C), 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.3, 126.9 (2 C), 119.2, 116.6, 114.6, 
114.5, 107.8, 107.0, 103.7, 99.1, 96.7, 70.7, 70.3 (2 C), 70.2, 70.0 (2 C), 69.5, 54.5, 50.1, 49.7, 





Aldehyde 141.  To a slurry of Me3SI (4 mg, 0.019 mmol, 3.5 equiv) in THF/DMSO 1:3 
(2 mL) at 12 ºC was added KOtBu (1.0 M in THF, 0.016 mL, 0.016 mmol, 3.0 equiv) dropwise 
over the course of 1 min, and the reaction mixture was stirred at 12 ºC for an additional 1 min.  A 
solution of ketone S9 (7 mg, 0.005 mmol, 1.0 equiv) in DMSO (0.25 mL) was then added 
dropwise over the course of 1 min, and the resultant solution was stirred for an additional 15 min 
at 12 ºC.  Upon completion, the reaction contents were quenched at 12 ºC with the addition of 
water (5 mL) and brine (5 mL), and extracted with diethyl ether (3 × 5 mL).  The combined 
organic layers were washed with water (5 × 20 mL) and brine (3 × 20 mL), dried (MgSO4), 
filtered, and concentrated to give the desired crude epoxide as a yellow oil.  Next, the crude 
epoxide was immediately dissolved in benzene (0.75 mL) and solid ZnI2 (7 mg, 0.02 mmol, 4 
equiv) was added at 25 ºC.  The resultant solution was stirred at 25 ºC for 1 h.  Upon completion, 
the reaction contents were quenched with water (5 mL) and extracted with EtOAc (3 × 10 mL).  
The combined organic layers were then washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered, and concentrated.  The resulting crude yellow oil was purified by preparative 
thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford aldehyde 141 and its 
diastereomer 143 (epimeric at the α carbon of the aldehyde, 0.0052 g, 73% yield) as a mixture of 
diastereomers (1:1 based on 1H NMR) and as a white solid.  The pure aldehydes were obtained 
by reverse-phase HPLC (Shimadzu Epic C18, 5µ, 250 x 9.6 mm; retention time for 141 = 39.0 
min, for 143 = 36.0 min, 5% H2O in MeCN).  141: Rf  = 0.61 (silica gel, hexanes:EtOAc, 7:3); 
IR (film) νmax 3031, 2918, 1718, 1602, 1508, 1454, 1378, 1314, 1242, 1147, 1110, 1063, 1027, 
737, 696 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.94 (s, 1 H), 7.43–7.24 (m, 25 H), 7.18–7.10 (m, 





2.0 Hz, 1 H), 6.56 (d, J = 8.4 Hz, 2 H), 6.50–6.48 (m, 2 H), 6.43 (d, J = 2.4 Hz, 1 H), 6.32 (s, 1 
H), 5.03–4.78 (m, 13 H), 4.70 (dd, J = 28 Hz, 16.4 Hz, 2 H), 4.34 (s, 1 H), 4.25 (s, 1 H), 3.80 (s, 
1 H), 3.56 (s, 1 H);  13C NMR (100 MHz, CDCl3) δ 199.9, 160.3, 158.7,  157.0, 
156.3, 153.8, 146.6, 145.7, 139.6, 139.4, 137.5, 137.3,136.9,  136.5, 134.9, 130.0, 129.0, 128.9, 1
28.8, 128.7 (3 C), 128.6, 128.2, 128.1, 128.0 (2 C), 127.9, 127.8, 127.7, 127.6, 127.5 (2 C), 
127.1, 116.2, 115.5, 114.8, 114.3, 114.1, 108.1, 105.6, 103.7, 101.3, 99.1, 97.4, 71.1, 70.3, 70.2, 
70.0 (2 C), 69.8, 69.6, 59.1, 53.5, 50.7, 49.6, 45.5; MS (FAB) calcd for C92H77O9+ [M+H+] 
1324.6, found 1325.7.  143: Rf  = 0.61 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3063, 
3032, 1721, 1603, 1508, 1454, 1379, 1313, 1297, 1241, 1176, 1155, 1111, 1063, 1027, 734, 696 
cm-1; 1H NMR (400 MHz, CDCl3) δ 9.87 (s, 1H), 7.45–7.28 (m, 25 H), 7.24–7.22 (m, 6 H), 
7.13–7.04 (m, 5 H), 6.91 (d, J = 8.8 Hz, 2 H), 6.88 (d, J = 8.8 Hz, 2 H), 6.80 (d, J = 1.6 Hz, 2 H), 
6.76 (d, J = 8.8 Hz, 2 H), 6.63 (d, J = 2.0 Hz, 1 H), 6.57 (d, J = 7.2 Hz, 2 H), 6.39 (d, J = 8.8 Hz, 
2 H), 6.35 (d, J = 2.4 Hz, 1 H), 6.29 (s, 1 H), 6.28 (t, J = 2.0 Hz, 1 H), 5.04–4.90 (m, 9 H), 4.81–
4.73 m, 3H), 4.68–4.64 (m, 3 H), 4.53 (dd, J = 23.2, 11.6 Hz, 2 H), 4.31 (s, 1 H), 3.90 (s, 1 H), 
3.82 (s, 1 H), 3.58 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 200.0, 160.1, 158.3, 158.2, 157.0, 
156.9, 156.5, 153.4, 145.9, 145.8, 139.4, 139.1, 137.3, 137.2, 137.1, 136.8, 136.4, 135.2, 130.4, 
128.9, 128.6, 128.5 (3 C), 128.4, 128.0, 127.9 (2 C), 127.8 (2 C), 127.7, 127.6, 127.4 (2 C), 
127.3 (3 C), 127.1, 126.6, 116.2, 115.5, 114.5, 114.4, 107.8, 103.6, 101.0, 99.0, 97.3, 71.0, 70.0 
(2 C), 69.9, 69.8 (2 C), 69.2, 58.2, 54.8, 50.1, 49.2, 44.7; MS (FAB) calcd for C92H77O9+ [M+H+] 
1325.6, found 1325.7. 
Ampelopsin G (138).  To a degassed solution of 4-benzyloxyphenyl bromide (142, 0.020 





mL, 0.11 mmol, 18 equiv) dropwise over the course of 1 min, and the resultant solution was 
stirred at –78 ºC for 20 min.  A degassed solution of aldehyde 141 (7.5 mg, 0.006 mmol, 1.0 
equiv) in THF (0.5 mL) was added dropwise to the above solution over the course of 2 min at –
78 ºC.  The reaction was stirred at –78 ºC for 15 min, before being removed from the ice bath for 
2 min.  Upon completion, the reaction contents were quenched with water (5 mL) and extracted 
with EtOAc (3 × 5 mL).  The combined organic layers were then dried (MgSO4), filtered and 
concentrated.  The resultant yellow crude oil was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the desired alcohol as a mixture of 
diastereomers (6.5 mg, 76% yield) and as a white solid.  This intermediate alcohol mixture (6.5 
mg, 0.004 mmol, 1.0 equiv) was dissolved in a mixture of EtOAc:MeOH (1:1, 2 mL) and solid 
Pd/C (30%, 4.0 mg) was added.  H2 was then bubbled directly through the stirred reaction 
mixture for 30 min.  Once complete, some additional MeOH was added to replace any 
evaporated solvent to rereach ~3 mL reaction volume and the reaction mixture was stirred under 
H2 (balloon) at 25 ºC for 12 h.  Upon completion, the reaction solution was filtered through 
simple filtration paper to remove Pd/C and washed with MeOH (2 mL).  Next, Amberlite (IR-
12OH, 0.100 g pre-washed with MeOH 5 times) was added to the filtrate and the resultant 
mixture was stirred at 25 °C for 20 min.  When this operation was complete, the solution was 
filtered through simple filtration paper to remove the Amberlite, and the filtrate was concentrated 
directly to afford ampelopsin G (138, 2.0 mg, 69%) as a white solid, with a scrupulously pure 
analytical sample obtained by reverse-phase HPLC (Shimadzu Epic C18, 5µ, 250 x 9.6 mm, 
retention time = 10.5 min, 55% water in MeOH).  138: Rf  = 0.62 (silica gel, CH2Cl2:MeOH, 
7:3); IR (film) νmax 3352, 2923, 2853, 1694, 1662, 1611, 1513, 1449, 1365, 1258, 1158, 1083, 





7.90 (s, 1 H), 7.88 (s, 1 H), 7.28 (s, 1 H), 7.26 (d, J = 8.4 Hz, 2 H), 7.01 (d, J = 8.4 Hz, 2 H), 6.86 
(d, J = 8.4 Hz, 2 H), 6.72 (d, J = 8.4 Hz, 2 H), 6.68 (d, J = 8.4 Hz, 2 H), 6.62 (d, J = 8.8 Hz, 2 H), 
6.56 (d, J = 2.0 Hz, 2 H), 6.50 (d, J = 2.0 Hz, 1 H), 6.37 (t, J = 2.0 Hz, 1 H), 6.19 (d, J = 2.4 Hz, 
1 H), 6.11 (s, 1 H), 5.62 (d, J = 8.0 Hz, 1 H), 4.58 (d, J = 7.6 Hz, 1 H), 4.18 (s, 1 H), 4.12 (s, 1 
H), 3.56 (s, 1 H), 3.18 (s, 1 H); 13C NMR (100 MHz, acetone-d6) δ 161.2, 160.0, 159.9, 158.2, 
157.9, 157.3, 156.1, 156.0, 153.3, 147.8, 146.0, 142.5, 138.1, 134.6, 133.5, 130.0, 129.6, 128.9, 
128.2, 118.8, 116.2, 116.1, 115.7, 115.6, 115.5, 113.3, 108.1, 108.0, 105.8, 102.4, 102.0, 96.3, 
94.2, 57.7, 52.0, 51.5, 50.5, 45.0; HRMS (FAB) calcd for C42H32O9+ [M+] 680.7, found 680.4.  
All spectroscopic data for 138 match that reported by Oshima and co-workers.6  For a direct 






Experimental Table 2.6 Comparison of 1H NMR for ampelopsin G (138) 
1H Literature 1H Observed 
Chemical Shift Appearance Chemical Shift Chemical Shift 
  
8.37 s, 1 H 
  
8.27 s, 1 H 
  
7.99 s, 1 H 
  
7.90 s, 1 H 
  
7.88 s, 1 H 
  
7.28 s, 1 H 
7.24 d, J = 8.5 Hz, 2 H 7.26 d, J = 8.4 Hz, 2 H 
6.99 d, J = 7.5 Hz, 2 H 7.01 d, J = 8.4 Hz, 2 H 
6.84 d, J = 7.5 Hz, 2 H 6.86 d, J = 8.4 Hz, 2 H 
6.70 d, J = 8.5 Hz, 2 H 6.72 d, J = 8.4 Hz, 2 H 
6.66 d, J = 7.5 Hz, 2 H 6.68 d, J = 8.4 Hz, 2 H 
6.60 d, J = 8.5 Hz, 2 H 6.62 d, J = 8.8 Hz, 2 H 
6.54 d, J = 2.0 Hz, 2 H 6.56 d, J = 2.0 Hz, 2 H 
6.48 d, J =I 2.0 Hz, 1 H 6.50 d, J = 2.0 Hz, 1 H 
6.35 t, J = 2.0 Hz, 1 H 6.37 t, J = 2.0 Hz, 1 H 
6.18 d, J = 2.0 Hz, 1 H 6.19 d, J = 2.4 Hz, 1 H 
6.10 s, 1 H 6.11 s, 1 H 
5.60 d, J = 8.0 Hz, 1 H 5.62 d, J = 8.0 Hz, 1 H 
4.55 d, J = 8.0 Hz, 1 H 4.58 d, J = 7.6 Hz, 1 H 
4.15 br d, J = 1.0 Hz, 1 H 4.18 s, 1 H 
4.09 bs, 1 H 4.12 s, 1 H 
3.53 bs, 1 H 3.56 s, 1 H 







Experimental Table 2.7 Comparison of 13C NMR for ampelopsin G (138) 
13C Literature 
13C Observed 
Recalibrated Acetone at 29.8 ppm 
163.6 161.6 161.2 
160.4 160.4 160.0 
160.4 160.3 159.9 
158.6 158.6 158.2 
158.3 158.3 157.9 
157.7 157.7 157.3 
156.5 156.5 156.1 
156.5 156.4 156.0 
153.7 153.7 153.3 
148.2 148.2 147.8 
146.3 146.4 146.0 
142.9 142.9 142.5 
138.5 138.5 138.1 
134.9 135.0 134.6 
133.8 133.9 133.5 
130.4 130.4 130.0 
130.0 130.0 129.6 
129.3 129.3 128.9 
128.5 128.6 128.2 
119.2 119.2 118.8 
116.5 116.6 116.2 
116.5 116.5 116.1 
116.1 116.1 115.7 
116.0 116.0 115.6 
116.0 115.9 115.5 
113.7 113.7 113.3 
108.5 108.5 108.1 
108.5 108.4 108.0 
106.2 106.2 105.8 
102.8 102.8 102.4 
102.4 102.4 102.0 
96.6 96.7 96.3 
94.6 94.6 94.2 
58.1 58.1 57.7 
52.4 52.4 52.0 
51.0 51.9 51.5 
50.9 50.9 50.5 






2.12.8 A More Scalable Permethylated Oligomer Synthesis 
 
Experimental Scheme 2.8 Structure of ketones S10 and S11 
 
Aldehyde 154.  A slurry of Me3SI (0.053 g, 0.26 mmol, 4.0 equiv) in dry THF (2 mL) 
was cooled to 0 ºC.  nBuLi (1.6 M in hexanes, 0.13 mL, 0.21 mmol, 3.3 equiv) was added to this 
slurry and the reaction mixture was allowed to stir at 0 ºC for 2 min.  A solution of ketone 153 
(0.033 g, 0.064 mmol, 1.0 equiv) in dry THF (1.5 mL) was added to the Corey ylide and the 
reaction was allowed to stir at 0 ºC for 1 h.  Upon completion, the reaction was quenched with 
saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted with EtOAc (3 × 10 
mL).  The combined organic layers were washed with water (5 mL), brine (5 mL), dried 
(MgSO4) and concentrated to afford the crude epoxide (0.033 g, 98 % yield), which was carried 
forward without additional purification.  This intermediate (0.033 g, 0.063 mmol, 1.0 equiv) was 
dissolved in dry benzene (5 mL) and ZnI2 (0.022 g, 0.069 mmol, 1.1 equiv) was added to the 
solution at 25 ºC.  The reaction was allowed to stir for 1 h.  Upon completion, the reaction was 
quenched with water (10 mL) and extracted with EtOAc (3 × 15 mL).  The combined organic 
layers were washed with water (10 mL), brine (10 mL), dried (MgSO4), filtered and concentrated 
to afford the crude aldehyde 154 as a yellow amorphous solid (0.033 g, 99% yield).  This crude 
material was carried forward without purification.  154: 1H NMR (400 MHz, CDCl3) δ 9.77 (s, 1 
























Hz, 2 H), 6.47 (d, J = 2.4 Hz, 1 H), 6.39 (d, J = 2.4 Hz, 1 H), 6.36 (d, J = 2.2 Hz, 1 H), 6.33 (d, J 
= 2.2 Hz, 2 H), 5.01 (s, 2 H), 4.67 (s, 1 H), 3.78 (s, 3 H), 3.76 (s, 3 H), 3.69 (s, 6 H), 2.93–2.78 
(m, 2 H), 2.76–2.60 (m, 2 H). 
Monobenzylated Ketone 155.  Permethylated ketone 128 (0.442 g, 0.63 mmol, 1.0 
equiv) was dissolved in dry CH2Cl2 (25 mL) and cooled to –78 ºC.  BBr3 (1.0 M, 0.82 mL, 1.3 
equiv) was added dropwise to the solution at –78 ºC and the reaction mixture was allowed to stir 
at that temperature for 30 min.  Upon completion the reaction was quenched with water (10 mL) 
and extracted with EtOAc (3 × 25 mL).  The combined organic layers were washed with water 
(10 mL), brine (10 mL), dried (MgSO4), filtered and concentrated to afford the monodeprotected 
ketone S10 (0.396 g, 91% yield), which was used without further purification.  S10: 1H NMR 
(500 MHz, CDCl3) δ 10.47 (s, 1 H), 7.18 (d, J = 8.6 Hz, 2 H), 6.99 (s, 2 H), 6.83 (d, J = 8.6 Hz, 
2 H), 6.65 (t, J = 2.3 Hz, 1 H), 6.56 (d, J = 1.9 Hz, 1 H), 6.53–6.42 (m, 4 H), 6.32 (s, 1 H), 6.04 
(d, J = 1.9 Hz, 1 H), 4.18 (d, J = 2.0 Hz, 1 H), 4.08 (s, 1 H), 3.83 (s, 6 H), 3.81 (s, 3 H), 3.75 (s, 3 
H), 3.65 (s, 1 H), 3.63 (s, 3 H), 3.59 (s, 3 H), 3.52 (s, 3 H), 3.48 (d, J = 2.1 Hz, 1 H); 13C NMR 
(125 MHz, CDCl3) δ 199.7, 163.4, 161.1, 160.9, 157.8, 157.7, 155.2, 147.8, 146.2, 144.1, 138.5, 
134.7, 128.8, 128.6, 128.4, 116.6, 113.7, 113.2, 112.9, 104.8, 101.0, 97.9, 96.7, 55.7, 55.6, 55.4, 
55.2, 55.1, 54.6, 48.2, 48.1, 46.1.  Ketone S10 (0.170 g, 0.25 mmol, 1.0 equiv) was dissolved in 
dry acetone (5 mL) and solid K2CO3 (0.214 g, 1.6 mmol, 6.0 equiv), BnBr (0.25 mL, 2.1 mmol, 
8.4 equiv) and solid nBu4NI (0.044g, 0.12 mmol, 0.5 equiv) were sequentially added to the 
solution.  The reaction mixture was heated to 70 ºC overnight.  Upon completion, the reaction 
was quenched with saturated aqueous NH4Cl (10 mL), poured into water (10 mL) and extracted 





(10 mL), dried (MgSO4), filtered and concentrated to afford the crude monobenzylated ketone 
155 as a bright yellow oil.  This crude product was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 9:1→3:1) to afford the desired ketone 155 (0.130 g, 67% yield) as a 
yellow foam.  155: Rf = 0.34 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3364, 3000, 2936, 
2836, 1665, 1587, 1510, 1489, 1460, 1426, 1383, 1315, 1298, 1249, 1202, 1178, 1154, 1134, 
1110, 1075, 1036, 975, 927, 832, 778, 740, 700, 612, 534 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.10 (d, J = 2.0 Hz, 2 H), 7.09 (d, J = 1.6 Hz, 1 H), 7.04 (d, J = 8.8 Hz, 2 H), 6.94 (broad s, 1 
H), 6.82–6.80 (m, 2 H), 6.74 (d, J = 8.8 Hz, 2 H), 6.69 (d, J = 8.8 Hz, 2 H), 6.66 (t, J = 2.4 Hz, 1 
H), 6.50 (d, J = 8.8 Hz, 2 H), 6.47 (d, J = 2.0 Hz, 1 H), 6.21 (s, 1 H), 5.92 (d, J = 1.6 Hz, 1 H), 
4.84 (d, J = 12.0 Hz, 1 H), 4.73 (d, J = 12.0 Hz, 1 H), 4.51 (s, 1 H), 4.20 (d, J = 1.6 Hz, 1 H) 3.72 
(s, 3 H), 3.70 (s, 3 H), 3.68 (s, 6 H), 3.64 (s, 3 H), 3.54 (s, 3 H), 3.51 (s, 3 H), 3.33 (s, 1 H), 2.88 
(s, 3 H); 13C NMR (100 MHz, CHCl3) δ 196.6, 160.8, 160.7, 160.5, 157.7, 157.7, 156.6, 154.8, 
146.1, 145.5, 142.2, 139.1, 136.7, 135.3, 129.2, 128.8, 128.7, 128.5, 128.3, 127.7, 127.0, 119.2, 
117.6, 113.6, 113.4, 105.0, 100.7, 96.2, 95.1, 70.5, 56.5, 55.8, 55.5, 55.5, 55.4, 55.2, 53.8, 49.7, 
46.6, 44.1; HRMS (FAB+) calcd for C49H46O9+ [M+] 778.3142 , found 778.3120. 
Aldehyde 156.  KOtBu (1.0 M in THF, 3 mL, 30.0 equiv) was added to a slurry of Me3SI 
(0.705 g, 3.4 mmol, 34.0 equiv) in a 3:1 mixture of dry DMSO:THF (12 mL DMSO, 4 mL THF) 
cooled to 8 ºC and the reaction was stirred at that temperature for 2 min.  A solution of 
monobenzylated ketone 155 (0.075 g, 0.1 mmol, 1.0 equiv) in dry DMSO (7.5 mL) was added 
dropwise on the sides of flask over 2 min and the reaction was stirred between 8 and 11 ºC for 
3.5 h.  Upon completion, the reaction contents were quenched with saturated aqueous NH4Cl (10 





layers were then washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and 
concentrated.  The resultant epoxide (0.066 mg, 0.09 mmol, 1.0 equiv) was carried forward 
without purification.  This epoxide was dissolved in dry benzene (5 mL) and ZnI2 (0.265 g, 0.83 
mmol, 9.0 equiv) was added as a solid.  The reaction was allowed to stir at 25 ºC for 1 h.  Upon 
completion, the reaction was quenched with water (5 mL) and extracted with EtOAc (3 × 15 
mL).  The combined organic layers were washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered and concentrated.  The resulting yellow oil was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1→3:1) to afford aldehyde 156 (0.045 g, 61% 
yield over 2 steps) as a single  diastereomer.  156: Rf = 0.37 (silica gel, CH2Cl2:MeOH, 4:1); IR 
(film) νmax 3356, 3201, 3002, 2930, 2837, 1666, 1601, 1510, 1462, 1398, 1315, 1249, 1202, 
1178, 1154, 1131, 1072, 1036, 831, 780, 742, 698, 569 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.82 
(s, 1 H), 7.36–7.28 (m, 5 H), 7.06 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.8 Hz, 2 H), 6.70 (d, J = 8.8 
Hz, 2 H), 6.61 (d, J = 8.0 Hz, 2 H), 6.59 (d, J = 2.0 Hz, 2 H), 6.41 (t, J = 2.0 Hz, 1 H), 6.39 (s, 1 
H), 6.21 (d, J = 2.0 Hz, 1 H), 5.61 (s, 1 H), 5.07 (d, J = 12.0 Hz, 1 H), 5.02 (d, J = 12.9 Hz, 1 H), 
4.45 (s, 1 H), 4.24 (d, J = 2.0 Hz, 1 H), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.74 (s, 3 H), 3.72 (s, 6 H), 
3.66 (s, 3 H), 3.57 (s, 1 H), 3.40 (s, 4 H); 13C NMR (100 MHz, CHCl3) δ 201.2, 161.0, 160.9, 
158.9, 157.8, 157.6, 155.5, 154.9, 146.3, 145.9, 140.8, 139.2, 136.6, 135.4, 128.7, 128.6, 128.4, 
128.2, 127.7, 117.5, 115.2, 113.5, 107.7, 101.4, 99.3, 96.8, 95.8, 70.9, 60.5, 56.8, 56.0, 55.7, 
55.4, 55.4, 55.3, 55.3, 55.2, 49.5, 46.7, 45.9; HRMS (FAB+) calcd for C50H48O9+ [M+] 792.3298, 
found 792.3316. 
Monobenzylated ketone 157: Permethylated ketone 140 (0.083 g, 0.118 mmol, 1.0 





in CH2Cl2, 0.36 mL, 0.36 mmol, 3.0 equiv) was added dropwise to the solution.  The bright 
yellow reaction mixture was allowed to stir at that temperature for 10 min.  Upon completion, the 
reaction was diluted with EtOAc (5 mL), quenched with saturated aqueous NaHCO3 (5 mL), 
poured into water (5 mL), and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were combined, washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered and 
concentrated to afford the crude ketone S11 (0.061 g, 75% yield), which was carried forward 
without additional purification.  S11: 1H NMR (400 MHz, CDCl3) δ 11.73 (s, 1 H), 6.71 (dd, J = 
2.5, 1.1 Hz, 1 H), 6.69 (s, 3 H), 6.64 (d, J = 8.8 Hz, 2 H), 6.60–6.55 (m, 3 H), 6.46 (d, J = 2.4 Hz, 
1 H), 6.34 (s, 1 H), 6.22 (d, J = 2.5 Hz, 1 H), 4.24 (s, 1 H), 3.90 (s, 3 H), 3.85 (d, J = 1.9 Hz, 1 
H), 3.81 (s, 3 H), 3.77 (s, 3 H), 3.73 (s, 3 H), 3.57 (s, 7 H), 3.50 (s, 1 H), 3.41 (s, 3 H), 3.19 (dd, J 
= 1.9, 1.0 Hz, 1 H). Monodeprotected ketone S11 (0.061 g, 0.089 mmol, 1.0 equiv) was 
dissolved in dry acetone (2 mL).  K2CO3 (0.078 g, 0.56 mmol, 6.3 equiv), BnBr (0.10 mL, 0.82 
mmol, 9.2 equiv) and nBu4NI (0.016 g, 0.044 mmol, 0.5 equiv) were added sequentially to the 
solution at 25 ºC.  The reaction mixture was then heated to 70 ºC overnight.  Upon completion, 
the reaction was quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL), and 
extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers washed with water (5 mL) and 
brine (5 mL), dried (MgSO4), filtered and concentrated to afford the crude ketone 157.  This 
crude material was purified by flash column chromatography (silica gel, hexanes:EtOAc, 
9:1→7:3) to afford the desired monobenzylated ketone 157 (0.029 g, 42% yield.  157: 1H NMR 
(400 MHz, CDCl3) δ 7.43–7.34 (m, 4 H), 7.34–7.28 (m, 1 H), 7.23–7.19 (m, 2 H), 7.19–7.16 (m, 
2 H), 7.07–7.00 (m, 2 H), 6.96–6.90 (m, 3 H), 6.88 (dd, J = 4.0, 2.7 Hz, 2 H), 6.79–6.71 (m, 2 





4.70 (d, J = 4.0 Hz, 2 H), 4.45 (d, J = 1.8 Hz, 1 H), 4.23 (s, 1 H), 3.85 (d, J = 1.1 Hz, 3 H), 3.77 
(s, 3 H), 3.75 (d, J = 1.2 Hz, 3 H), 3.72 (d, J = 1.1 Hz, 6 H), 3.69 (d, J = 1.2 Hz, 3 H), 3.58 (t, J = 
1.5 Hz, 1 H), 3.43 (s, 3 H).
Aldehyde 158.  To a slurry of Me3SI (0.028 g, 0.13 mmol, 3.5 equiv) in THF/DMSO 1:3 
(8 mL) at 12 ºC was added KOtBu (1.0 M in THF, 0.12 mL, 0.12 mmol, 3.0 equiv) dropwise 
over the course of 1 min, and the reaction mixture was stirred at 12 ºC for an additional 1 min.  A 
solution of ketone 157 (0.029 g, 0.037 mmol, 1.0 equiv) in DMSO (1 mL) was then added 
dropwise over the course of 1 min, and the resultant solution was stirred for an additional 15 min 
at 12 ºC.  Upon completion, the reaction contents were quenched at 12 ºC with the addition of 
water (5 mL) and brine (5 mL), and extracted with diethyl ether (3 × 10 mL).  The combined 
organic layers were washed with water (5 × 10 mL) and brine (3 × 10 mL), dried (MgSO4), 
filtered, and concentrated to afford the desired crude epoxide as a yellow oil.  Next, the crude 
epoxide was immediately dissolved in benzene (2.0 mL) and solid ZnI2 (0.048 g, 0.15 mmol, 4.0 
equiv) was added at 25 ºC.  The resultant solution was stirred at 25 ºC for 1 h.  Upon completion, 
the reaction contents were quenched with water (5 mL) and extracted with EtOAc (3 × 10 mL).  
The combined organic layers were then washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered, and concentrated.  The resulting crude product was purified by preparative 
thin layer chromatography (silca gel, hexanes:EtOAc, 7:3) to afford aldehyde 158 (0.013 g, 44% 
yield), as a mixture of diastereomers (1:1 based on 1H NMR) epimeric at the α carbon of the 
aldehyde.  Aldehyde 158:  1H NMR (400 MHz, CDCl3) δ 9.99 (d, J = 1.3 Hz, 1 H), 9.97 (d, J = 
1.3 Hz, 1 H), 7.41–7.34 (m, 6 H), 7.34–7.27 (m, 9 H), 7.20 (ddd, J = 16.3, 7.5, 1.9 Hz, 4 H), 7.09 





H), 6.73 (d, J = 8.8 Hz, 2 H), 6.68 (d, J = 8.7 Hz, 2 H), 6.61 (d, J = 8.6 Hz, 2 H), 6.53 (d, J = 2.4 
Hz, 1 H), 6.51 (d, J = 2.5 Hz, 1 H), 6.50–6.45 (m, 2 H), 6.39–6.34 (m, 8 H), 6.30 (d, J = 6.4 Hz, 
2 H), 6.28 (d, J = 2.5 Hz, 1 H), 6.22 (d, J = 2.4 Hz, 1 H), 5.06–4.98 (m, 2 H), 4.96 (d, J = 2.0 Hz, 
3 H), 4.92 (s, 2 H), 4.87 (d, J = 13.3 Hz, 1 H), 4.70 (s, 2 H), 4.67 (s, 1 H), 4.30 (s, 1 H), 4.22 (s, 1 
H), 4.18 (s, 1 H), 3.84 (s, 4 H), 3.83 (s, 5 H), 3.80 (s, 1 H), 3.77 (s, 3 H), 3.76 (s, 3 H), 3.72 (s, 2 
H), 3.70 (d, J = 1.7 Hz, 5 H), 3.65 (s, 9 H), 3.62 (d, J = 1.8 Hz, 7 H), 3.58 (d, J = 1.1 Hz, 1 H), 
3.55 (s, 1 H), 3.50 (s, 1 H), 3.45 (s, 4 H), 3.33 (s, 4 H). 
2.12.8.1 Synthesis of Permethylated Carasiphenol B (160) 
 
Experimental Scheme 2.9 Structure of alcohol S12 
 
Monodeprotected permethylated carasiphenol (159).  To a degassed solution of 
aldehyde 156 (0.063 g, 0.084 mmol, 1.0 equiv) in THF (5 mL) at 25 °C was added 4–
benzyloxyphenylmagnesium bromide (100, 1.0 M in THF, 0.56 mL, 7 equiv), and the resultant 
reaction mixture was stirred overnight at 25 °C.  Upon completion, the reaction contents were 
quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL), and extracted with 
EtOAc (3 × 10 mL).  The combined organic layers were washed with water (5 mL) and brine (5 

















preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the protected 
alcohol S12 (0.055 g, 71% yield) as an off-white amorphous solid.  S12: 1H NMR (400 MHz, 
CDCl3) δ 7.54–7.49 (m, 2 H), 7.48–7.29 (m, 10 H), 7.00 (d, J = 8.6 Hz, 2 H), 6.88 (d, J = 8.7 Hz, 
2 H), 6.82 (d, J = 8.7 Hz, 2 H), 6.77 (d, J = 8.7 Hz, 2 H), 6.72 (d, J = 2.0 Hz, 1 H), 6.67 (d, J = 
8.7 Hz, 1 H), 6.42 (s, 1 H), 6.38 (d, J = 2.3 Hz, 2 H), 6.24 (d, J = 2.0 Hz, 1 H), 6.18 (t, J = 2.3 
Hz, 1 H), 5.92 (dd, J = 10.4, 8.2 Hz, 1 H), 5.36 (d, J = 10.5 Hz, 1 H), 5.18–5.10 (m, 1 H), 5.07 
(d, J = 10.9 Hz, 1 H), 5.02 (s, 2 H), 4.94 (s, 1 H), 4.32 (d, J = 1.8 Hz, 1 H), 3.83 (s, 3 H), 3.77 (s, 
3 H), 3.70 (s, 3 H), 3.67 (s, 3 H), 3.66 (s, 1 H), 3.53 (s, 6 H), 3.44 (d, J = 1.9 Hz, 1 H), 3.38 (s, 3 
H), 3.01 (d, J = 8.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 160.9, 160.1, 158.1, 158.1, 157.9, 
157.5, 156.7, 154.9, 147.7, 145.4, 145.3, 139.8, 137.3, 137.98, 135.82, 128.85, 128.79, 128.77, 
128.74, 128.66, 128.42, 128.32, 128.16, 127.99, 127.88, 127.57, 118.21, 117.68, 115.27, 114.73, 
113.56, 113.47, 107.19, 101.55, 98.63, 97.0, 96.5, 77.5, 77.2, 76.8, 73.9, 71.2, 70.1, 55.7, 55.6, 
55.5, 55.4, 55.3, 55.3, 55.1, 51.5, 50.4, 47.0, 46.60.  Alcohol S12 (0.0022 g, 0.023 mmol, 1.0 
equiv) was dissolved in a mixture of EtOAc and MeOH (1.6 mL MeOH, 5 mL EtOAc) and solid 
Pd/C (10%, 0.004 g) was added.  H2 was then bubbled directly through the stirred reaction 
mixture for 2 h.  Upon completion, the reaction solution was filtered through simple filtration 
paper to remove Pd/C and washed with EtOAc (3 × 10 mL).  Upon concentration of the organic 
layer the desired deprotected alcohol was obtained (0.018 g, 99% yield) and this intermediate 
was carried forward without any further purification.  Next, Amberlite (IR-12OH, 0.01 g, pre-
washed with MeOH × 5) was added to the filtrate and the resultant mixture was stirred at 25 °C 
for 1 h.  When this operation was complete, the solution was filtered through simple filtration 
paper to remove the Amberlite, and the filtrate was concentrated directly to afford crude 





hexanes:EtOAc, 7:3) leading to intermediate 159 (0.0014 g, 79% yield).  159: Rf = 0.15 (silica 
gel, hexanes:EtOAc, 7:3); IR (film) νmax 3372, 3200, 2921, 2837, 1668, 1603, 1511, 1464, 1335, 
1248, 1203, 1159, 1132, 1104, 1069, 1036, 832 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.22 (d, J = 
8.0 Hz, 2 H), 7.10 (d, J = 8.4 Hz, 2 H), 6.81 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 6.61 
(s, 1 H), 6.54–6.51 (m, 6 H), 6.43 (s, 1 H), 6.32 (s, 1 H), 6.10 (s, 1 H), 5.53 (d, J = 5.2 Hz, 1 H), 
4.85 (d, J = 5.2 Hz, 1 H), 4.22 (s, 1 H), 3.93 (s, 1 H), 3.80 (s, 9 H), 3.78 (s, 3 H), 3.63 (s, 3 H), 
3.44 (s, 1 H), 3.44 (s, 7 H); 13C NMR (100 MHz, CHCl3) δ 161.3 (2 C), 160.6, 159.8, 159.2, 
157.6, 155.7, 155.0, 147.1, 146.4, 142.4, 139.4, 135.2, 134.9, 128.8, 128.4, 127.5, 116.6, 115.9, 
115.5, 113.5, 113.3, 106.1, 101.1, 99.0, 96.7, 93.1, 92.3, 56.6, 55.6, 55.5, 55.5, 55.4, 55.2, 54.7, 
48.9, 46.6, 45.7; HRMS (FAB+) calcd for C49H46O9+ [M+] 778.3142, found 778.3154. 
Permethylated Carasiphenol B 160.  Derivative 159 (0.020 g, 0.025 mmol, 1.0 equiv) 
was dissolved in dry acetone (3.0 mL).  Solid K2CO3 (0.035 g, 0.25 mmol, 10.0 equiv) and MeI 
(0.05 mL, 0.75 mmol, 30.0 equiv) were added sequentially to the solution and the reaction was 
heated at 70 ºC overnight.  Upon completion, the reaction was quenched with saturated aqueous 
NH4Cl (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic 
layers were combined, washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered 
and concentrated.  The resulting crude product was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford permethylated carasiphenol B (160, 
0.020 g, 98% yield) as a white foam.  160: Rf = 0.23 (silica gel, hexanes:EtOAc, 7:3); IR (film) 
νmax 2960, 2924, 2852, 1732, 1605, 1511, 1463, 1248, 1302, 1203, 1158, 1102, 1072, 1034, 803 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2 H), 7.09 (d, J = 8.8 Hz, 2 H), 6.87 (d, 





2.4 Hz, 2 H), 6.42 (broad s, 1 H), 6.31 (s, 1 H), 6.10 (d, J = 1.6 Hz, 1 H), 5.53 (d, J = 5.2 Hz, 1 
H), 4.86 (d, J = 5.2 Hz, 1 H), 4.21 (d, J = 1.6 Hz, 1 H), 3.92 (s, 1 H), 3.81 (s, 4 H), 3.79 (s, 9 H), 
3.78 (s, 3 H), 3.63 (s, 3 H), 3.49 (s, 1 H), 3.45 (s, 3 H), 3.44 (s, 3 H); 13C NMR (100 MHz, 
CHCl3) δ 161.4 (2 C), 160.6, 159.8, 159.6, 159.3, 157.6 (2 C), 155.0, 147.2, 146.4, 142.3, 139.4, 
135.2, 134.8, 128.8, 128.4, 127.3, 116.6, 115.8, 114.1, 113.5, 113.3, 106.0, 101.1, 98.9, 96.7, 
93.1, 92.3, 56.5, 55.6 (2 C), 55.5 (2 C), 55.5, 55.4, 55.2, 54.8, 48.9, 46.6, 45.7; HRMS (FAB+) 
calcd for C50H48O9+ [M+] 792.3298, found 792.3322. 
 
Experimental Scheme 2.10 Structure of alcohol S13 
 
Alcohol 162.  Aldehyde 156 (0.002 g, 0.0025 mmol, 1.0 equiv) was azeotroped with 
benzene (3 × 1 mL) and dissolved in dry THF (0.2 mL).  4-methoxyphenylmagnesium bromide 
(161, 1 M in THF, 0.02 mL, 0.02 mmol, 7.9 equiv) was added to the solution and the reaction 
was allowed to stir at 25 ºC for 4 h.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (1 mL), poured into water (1 mL) and extracted with EtOAc (3 × 3 mL).  The 
combined organic layers were washed with water (3 mL) and brine (3 mL), dried (MgSO4), 
filtered and concentrated.  The resulting crude product was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the desired alcohol S13.  S13: 1H 

















H), 6.98 (d, J = 8.9 Hz, 2 H), 6.84–6.79 (m, 2 H), 6.77 (d, J = 6.1 Hz, 1 H), 6.74 (s, 1 H), 6.71 (d, 
J = 1.9 Hz, 1 H), 6.65 (d, J = 8.7 Hz, 2 H), 6.41 (s, 1 H), 6.36 (d, J = 2.3 Hz, 2 H), 6.23 (d, J = 
2.0 Hz, 1 H), 6.16 (t, J = 2.2 Hz, 1 H), 5.97–5.83 (m, 1 H), 5.34 (d, J = 10.5 Hz, 1 H), 5.12 (d, J 
= 10.9 Hz, 1 H), 5.06 (d, J = 10.8 Hz, 1 H), 4.93 (s, 1 H), 4.63 (d, J = 5.7 Hz, 1 H), 4.31 (s, 1H), 
3.83–3.81 (m, 6 H), 3.81 (s, 1 H), 3.76 (s, 3 H), 3.75 (s, 3 H), 3.69 (s, 3 H), 3.67 (s, 3 H), 3.64 (s, 
1 H), 3.51 (s, 6 H), 3.50 (s, 1 H), 3.49 (s, 2 H), 3.47 (s, 2 H), 3.45 (s, 1 H), 3.42 (d, J = 1.8 Hz, 1 
H), 3.37 (s, 3 H), 3.02 (d, J = 8.6 Hz, 1 H).  Alcohol S13 was dissolved in a 4:1 mixture of 
MeOH and EtOAc (2.5 mL total) and 10% Pd/C (0.003 g) was added.  The reaction was allowed 
to stir under H2 (balloon) for 30 min.  Upon completion, the solid catalyst was filtered through 
simple filtration paper and the filtrate was concentrated to afford the desired alcohol 162 (0.001 
g, 49% yield over 2 steps).  162: 1H NMR (400 MHz, CDCl3) δ 7.52 (s, 1 H), 7.38 (d, J = 8.6 Hz, 
2 H), 7.10 (d, J = 8.5 Hz, 1 H), 7.01–6.93 (m, 3 H), 6.82 (d, J = 8.6 Hz, 1 H), 6.75 (d, J = 10.0 
Hz, 3 H), 6.69 (d, J = 2.0 Hz, 1 H), 6.57–6.51 (m, 4 H), 6.43 (s, 3 H), 6.17 (s, 2 H), 5.67 (s, 1 H), 
5.58 (s, 1 H), 4.38 (s, 1 H), 4.26 (s, 1 H), 3.83 (s, 3 H), 3.79 (s, 1 H), 3.77 (s, 6 H), 3.75 (s, 3 H), 
3.74 (s, 3 H), 3.65 (s, 3 H), 3.55 (s, 3 H), 3.36 (s, 1 H), 3.33 (s, 3 H), 3.28 (s, 1 H), 3.11 (s, 1 H), 
2.66–2.54 (m, 1 H). 
Cyclization of alcohol 162.  Alcohol 162 (0.001 g, 0.0012 mmol, 1.0 equiv) was 
dissolved in MeOH (2 mL) and Amberlite (IR-12OH, 0.05 g pre-washed with MeOH five times) 
was added to the solution.  The reaction was allowed to stir at 25 ºC for 1 h.  Upon completion, 
the Amberlite was filtered and the filtrate was concentrated to afford a 1:1 mixture of 160:163.  
The crude NMR showed distinct diagnostic peaks for each of the dihydrofuran diastereomers.  





selected dihydrofuran ring protons (400 MHz, CDCl3) δ 5.97 (d, J = 8.8 Hz, 1 H, 163), 5.53 (d, J 
= 5.3 Hz, 1 H, 160), 4.99 (d, J = 8.7 Hz, 1 H, 163), 4.85 (d, J = 5.3 Hz, 1 H, 160). 
2.12.8.2 Synthesis of Permethylated ε-Viniferin (166) 
 
Experimental Scheme 2.11 Supplementary structures for the synthesis of protected εviniferin 
(160) 
 
Monodeprotected Ketone S14: Permethylated ketone 80 (0.170 g, 0.39 mmol, 1.0 
equiv) was dissolved in dry CH2Cl2 (10 mL).  The solution was cooled to –78 ºC and BBr3 (1.0 
M in CH2Cl2, 0.47 mL, 0.47 mmol, 1.2 equiv) was added dropwise to the solution.  The bright 
yellow reaction mixture was allowed to stir at that temperature for 10 min.  Upon completion, the 
reaction was diluted with EtOAc (5 mL), quenched with saturated aqueous NaHCO3 (5 mL), 
poured into water (5 mL), and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were combined, washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered and 
concentrated to afford the crude ketone S14 (0.146 g, 89% yield) which was carried forward 
without additional purification.  S14: 1H NMR (400 MHz, CDCl3) δ 11.49 (s, 1 H), 6.89 (d, J = 
8.7 Hz, 2 H), 6.76–6.70 (m, 4 H), 6.70–6.61 (m, 2 H), 6.52–6.43 (m, 3 H), 3.88 (s, 3 H), 3.78 (s, 
















Monobenzylated Ketone 164: Monodeprotected ketone S14 (0.146 g, 0.35 mmol, 1.0 
equiv) was dissolved in dry acetone (10 mL).  K2CO3 (0.300 g, 2.2 mmol, 6.3 equiv), BnBr (0.37 
mL, 3.12 mmol, 8.9 equiv) and nBu4NI (0.058 g, 0.16 mmol, 0.5 equiv) were added sequentially 
to the solution at 25 ºC.  The reaction mixture was then heated to 70 ºC overnight.  Upon 
completion, the reaction was quenched with saturated aqueous NH4Cl (10 mL), poured into 
water (10 mL), and extracted with CH2Cl2 (3 × 20 mL).  The combined organic layers were 
combined, washed with water (15 mL), brine (15 mL), dried (MgSO4), filtered and concentrated 
to afford the crude ketone 164.  This crude material was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1→7:3) to afford the desired monobenzylated 
ketone 164 (0.135 g, 76% yield).  164: 1H NMR (300 MHz, CDCl3) δ 7.31 (d, J = 8.7 Hz, 2 H), 
7.25–7.15 (m, 3 H), 7.03 (d, J = 8.1 Hz, 1 H), 6.99 (d, J = 2.3 Hz, 3 H), 6.87 (d, J = 1.8 Hz, 2 H), 
6.82 (d, J = 8.8 Hz, 2 H), 6.65 (t, J = 2.3 Hz, 1 H), 6.44 (d, J = 2.1 Hz, 1 H), 4.96 (s, 2 H), 3.88 
(s, 3 H), 3.78 (d, J = 1.2 Hz, 9 H). 
Aldehyde 165.  A slurry of Me3SI (0.560 g, 2.75 mmol, 20.0 equiv) in dry THF (9 mL) 
was cooled to 0 ºC.  nBuLi (1.6 M in hexanes, 1.4 mL, 2.2 mol, 16.0 equiv) was added to this 
slurry and the reaction mixture was allowed to stir at 0 ºC for 2 min.  A solution of ketone 164 
(0.070 g, 0.14 mmol, 1.0 equiv) in dry THF (9 mL) was added to the Corey ylide and the 
reaction was allowed to stir at 0 ºC for 1 h.  Upon completion, the reaction was quenched with 
saturated aqueous NH4Cl (15 mL), poured into water (15 mL) and extracted with EtOAc (3 × 30 
mL).  The combined organic layers were washed with water (15 mL), brine (15 mL), dried 
(MgSO4) and concentrated to afford the crude epoxide S15, which was carried forward without 





H), 6.95 (d, J = 16.2 Hz, 1 H), 6.89–6.83 (m, 2 H), 6.82 (s, 1 H), 6.53 (d, J = 2.3 Hz, 2 H), 6.49 
(d, J = 2.3 Hz, 1 H), 6.34 (s, 1 H), 3.86 (s, 3 H), 3.81 (s, 3 H), 3.70 (s, 6 H), 3.34 (d, J = 5.9 Hz, 1 
H), 3.17 (d, J = 5.9 Hz, 1 H).  This intermediate was dissolved in dry benzene (13 mL) and ZnI2 
(0.043 g, 0.14 mmol, 1.0 equiv) was added to the solution at 25 ºC.  The reaction was allowed to 
stir for 1 h.  Upon completion, the reaction was quenched with water (10 mL) and extracted with 
EtOAc (3 × 20 mL).  The combined organic layers were washed with water (10 mL), brine (10 
mL), dried (MgSO4), filtered and concentrated to afford the crude aldehyde 165.  This material 
was purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford 
the desired aldehyde 165 as a yellow amorphous solid (0.039 g, 53% yield over 2 steps).  165: 1H 
NMR (400 MHz, CDCl3) δ 9.87 (s, 1 H), 7.41–7.27 (m, 7 H), 7.04 (d, J = 15.9 Hz, 1 H), 6.91–
6.84 (m, 3 H), 6.77 (d, J = 2.4 Hz, 1 H), 6.54 (d, J = 2.4 Hz, 1 H), 6.41 (d, J = 2.2 Hz, 2 H), 6.37 
(t, J = 2.2 Hz, 1 H), 5.05 (s, 2 H), 5.00 (s, 1 H), 3.85 (s, 3 H), 3.82 (s, 3 H), 3.69 (s, 6 H). 
 Permethylated ε-viniferin (166).  Aldehyde 165 (0.037 g, 0.07 mmol, 1.0 equiv) was 
dissolved in dry THF (3 mL) and 4-benzyloxyphenylmagnesium bromide (100, 1.0 M in THF, 
0.46 mL, 0.46 mmol, 6.5 equiv) was added dropwise.  The reaction was allowed to stir at 25 ºC 
for 2 h.  Upon completion, the reaction was quenched with saturated aqueous NH4Cl (5 mL), 
poured into water (5 mL) and extracted with EtOAc (3 × 10 mL).  The combined organic layers 
were washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered and concentrated to afford 
the crude product as a yellow oil.  This crude material was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the benzylic alcohol as an off-white 
amorphous solid (0.024 g, 49% yield).  This intermediate (0.024 g, 0.034 mmol, 1.0 equiv) was 





0.18 mL, 0.18 mmol, 5.3 equiv) was added dropwise to this solution and the reaction was 
allowed to stir at –78 ºC for 30 min.  Upon completion, the reaction was diluted with EtOAc (3 
mL), quenched with saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted 
with EtOAc (3 × 10 mL).  The combined organic layers were washed with water (5 mL), brine (5 
mL), dried (MgSO4), filtered and concentrated to afford the crude product as an orange oil.  This 
crude material was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford the monodeprotected closed dihydrofuran as an off-white 
amorphous solid (0.007 g, 40 % yield).  This intermediate (0.007 g, 0.014 mmol, 1.0 equiv) was 
then dissolved in dry acetone (0.6 mL) and K2CO3 (0.072 g, 0.52 mmol, 37 equiv) and MeI (0.09 
mL, 1.45 mmol, 100 equiv) were added sequentially at 25 ºC.  The resulting reaction mixture 
was then heated overnight at 70 ºC.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The 
combined organic layers were washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered 
and concentrated to afford the crude product as a yellow oil.  This crude material was purified by 
preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford permethylated 
ε-viniferin 166 as a yellow amorphous solid (0.005 g, 70% yield).  166: 1H NMR (400 MHz, 
CDCl3) δ 7.27 (s, 1 H), 7.25 (s, 1 H), 7.13 (d, J = 8.7 Hz, 2 H), 6.91–6.84 (m, 3 H), 6.78 (d, J = 
8.7 Hz, 2 H), 6.73 (d, J = 2.2 Hz, 1 H), 6.59 (d, J = 16.3 Hz, 1 H), 6.47 (d, J = 2.2 Hz, 1 H), 6.36 
(s, 3 H), 5.52 (d, J = 6.0 Hz, 1 H), 4.51 (d, J = 6.0 Hz, 1 H), 3.86 (s, 3 H), 3.80 (s, 3 H), 3.78 (s, 3 





2.12.9 Selective Functionalizations of Resveratrol Trimers 
 
Experimental Scheme 2.12 Supplementary structures for trimers’ brominations 
 
Reaction of permethylated carasiphenol B (160) with NBS.  Permethylated 
carasiphenol B (160, 0.011 g, 0.014 mmol) was dissolved in dry CH2Cl2 (3.0 mL) and cooled to 
–78 ºC.  NBS (0.0022 g as a solution in 1.1 mL dry CH2Cl2, 0.012 mmol, 0.9 equiv) was added 
























































































reaction was quenched with saturated aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 
mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were 
combined, washed with water (5 mL) and brine (5 mL), dried (MgSO4), filtered and 
concentrated.  The resulting crude oil (160:S16:S17:S18 1.6:1.0:3.1:1.3 by crude NMR integral 
ratios) was purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to 
afford S17 (0.0035 g, 31% yield), an inseparable mixture of S16 and S18*, as well as starting 
material (0.002 g, 16% yield).  Both bromides S16 and S17 appear unstable to silica gel. 
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford S16 (0.0014 g, 10% yield) and S18 (0.004 g, 33% yield).   
  Reaction of permethylated carasiphenol B (160) with BDSB.  Permethylated 
carasiphenol B (160, 0.010 g, 0.013 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (2.0 mL) and 
cooled to –78 ºC.  BDSB (0.006 g, 0.011 mmol, 0.9 equiv) was added as a solid to the solution 
and the reaction was allowed to stir at –78 ºC for 2 h.  Upon completion, the reaction was 
quenched with saturated aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured 
into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were combined, 
washed with water (5 mL) and brine (5 mL), dried (MgSO4), filtered and concentrated.  The 
resulting crude yellow oil was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford monobromide S167 (0.007 g, 62% yield).  
Permethylated Carasiphenol B Bromide S16.  Rf = 0.24 (silica gel, hexanes:EtOAc, 
7:3); IR (film) νmax 3356, 3200, 2919, 2850, 1717, 1665, 1606, 1511, 1460, 1391, 1327, 1249, 
1202, 1177, 1163, 1132, 1082, 1036, 976, 834, 614, 570, 460 cm-1; 1H NMR (400 MHz, CDCl3) 





Hz, 2 H), 6.59 (d, J = 1.6 Hz, 1 H), 6.53 (s, 4 H), 6.46 (d, J = 2.8 Hz, 1 H), 6.35 (d, J = 2.8 Hz, 1 
H), 6.30 (s, 1 H), 6.14 (d, J = 2.0 Hz, 1 H), 5.58 (d, J = 3.6 Hz, 1 H), 5.40 (d, J = 3.6 Hz, 1 H), 
4.25 (s, 1 H), 3.90 (s, 3 H),  3.81 (s, 3 H), 3.80 (s, 3 H), 3.79 (s, 3 H), 3.77 (s, 3 H), 3.75 (s, 1 H), 
3.62 (s, 3 H), 3.52 (s, 1 H), 3.51 (s, 3 H), 3.45 (s, 3 H), 3.43 (d, J = 2.8 Hz, 1 H); HRMS (FAB+) 
calcd for C50H47O9Br+ [M+] 870.2403, found 870.2374.  
Permethylated Carasiphenol B Bromide S17.  Rf = 0.17 (silica gel, hexanes:EtOAc, 
7:3); IR (film) νmax 2960, 2924, 2852, 1726, 1607, 1511, 1463, 1338, 1249, 1205, 1181, 1159, 
1105, 1072, 1036, 833, 766, 751 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 9.5 Hz, 2 H), 
7.14 (d, J = 8.5 Hz, 2 H), 6.88 (d, J = 9.0 Hz, 2 H), 6.80 (d, J = 8.5 Hz, 2 H), 6.54 (d, J = 9.0 Hz, 
2 H), 6.51 (d, J = 7.5 Hz, 2 H), 6.51 (s, 1 H), 6.45 (d, J = 2.0 Hz, 2 H), 6.34 (s, 1 H), 6.11 (s, 1 
H), 5.56 (d, J = 5.5 Hz, 1 H), 4.80 (d, J = 5.0 Hz, 1 H), 4.34 (s, 1 H), 3.99 (s, 1 H), 3.82 (s, 3 H), 
3.81 (s, 3 H), 3.80 (s, 6 H), 3.78 (s, 3 H), 3.71 (s, 1 H), 3.63 (s, 3 H), 3.47 (s, 1 H), 3.46 (s, 3 H), 
3.45 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 161.4, 159.9, 159.6, 159.3, 157.6, 155.9, 154.1, 
147.0, 146.2, 141.6, 139.1, 134.7, 134.5, 132.0, 128.8, 128.7, 128.4, 127.2, 116.6, 115.6, 114.1, 
113.5, 113.4, 106.1, 99.4, 98.9, 95.2, 93.0, 92.5, 56.8, 56.6, 55.5 (2 C), 55.5, 55.4, 55.4, 55.2, 
55.1, 48.3, 47.5, 44.0; HRMS (FAB+) calcd for C50H47O9Br+ [M+] 870.2403, found 879.2408 
(for 79Br). 
Permethylated Carasiphenol Dibromide S18.  Rf = 0.32 (silica gel, hexanes:EtOAc, 
7:3); IR (film) νmax 2999, 2961, 2924, 2853, 2839, 1608, 1586, 1511, 1462, 1339, 1248, 1165, 
1081, 1036, 831, 810 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.5 Hz, 2 H), 7.16 (d, J = 
8.5 Hz, 2 H), 6.84 (d, J = 8.5 Hz, 2 H), 6.80 (d, J = 8.5 Hz, 2 H), 6.54 (d, J = 9.0 Hz, 2 H), 6.51 





H), 5.53 (d, J = 4.0 Hz, 1 H), 5.42 (d, J = 3.5 Hz, 1 H), 4.38 (s, 1 H), 3.91 (s, 3 H), 3.85 (s, 3 H), 
3.81 (d, J = 2.5 Hz, 1 H), 3.80 (s, 3 H), 3.80 (s, 3 H), 3.78 (s, 3 H), 3.71 (s, 1 H), 3.63 (s, 3 H), 
3.51 (s, 3 H), 3.50 (s, 1 H), 3.46 (s, 3 H); 13C NMR (125 MHz, CHCl3) δ 160.3, 160.2, 159.8, 
159.6, 157.8, 157.7, 157.2, 156.0, 154.1, 145.8, 145.8, 141.6, 139.0, 134.7, 134.5, 128.7, 128.4, 
127.9, 116.2, 115.5, 113.9, 113.6, 113.5, 106.1, 105.2, 104.8, 99.3, 99.0, 95.1, 92.7, 56.6, 56.6, 
56.2, 55.5, 55.5, 55.4, 55.4, 55.2, 55.1, 54.1, 48.5, 47.6, 43.9; HRMS (FAB+) calcd for 
C50H46O9Br2+ [M+] 948.1509, found 948.1487. 
Permethylated Leachianol E 168.  A 1:1 mixture of leachianol D (S19):leachianol E 
(S20) (1:1) (0.006 g, 0.009 mmol, 1.0 equiv) was dissolved in dry acetone (3 mL).  Solid K2CO3 
(0.015 g, 0.11 mmol, 12.3 equiv) and MeI (0.03 mL, 0.48 mmol, 54.7 equiv) were added 
sequentially to the solution and the reaction was heated at 70 ºC overnight.  Upon completion, 
the reaction was quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and 
extracted with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (5 
mL) and brine (5 mL), dried (MgSO4), filtered and concentrated.  The resulting crude oil was 
purified by preparative thin layer chromatography (silica gel, hexanes:CHCl3, 1:4) to afford 
permethylated leachianol D (S21) (0.003 g, 42% yield) and permethylated leachianol E 168 
(0.003 g, 42% yield).  S21: Rf = 0.44 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2921, 2855, 
1607, 1596, 1510, 1465, 1429, 1332, 1305, 1249, 1205, 1178, 1160, 1145 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.27 (d, J = 2.4 Hz, 1 H), 7.25 (s, 1 H), 7.04 (d, J = 4.1 Hz, 2 H), 7.02 (d, J = 4.0 
Hz, 2 H), 6.88 (d, J = 8.7 Hz, 3 H), 6.79 (d, J = 8.6 Hz, 2 H), 6.75 (d, J = 8.6 Hz, 2 H), 6.69 (d, J 
= 2.0 Hz, 1 H), 6.32–6.27 (m, 2 H), 6.19 (d, J = 2.2 Hz, 2 H), 5.39 (d, J = 6.2 Hz, 1 H), 4.63 (s, 1 





H), 3.75 (s, 3 H), 3.64 (s, 4 H), 3.63 (s, 7 H), 3.24 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 162.5, 
161.4, 161.1, 159.7, 158.0, 158.0, 157.3, 153.8, 149.8, 148.8, 145.3, 138.6, 138.0, 133.8, 128.2, 
128.2, 128.1, 127.3, 125.3, 117.1, 114.2, 113.9, 113.9, 105.4, 100.4, 100.2, 100.1, 99.4, 97.8, 
93.0, 77.5, 77.4, 77.2, 76.8, 60.1, 59.4, 59.0, 56.8, 55.8, 55.5, 55.4, 55.4, 53.9, 53.8, 29.9, 17.6; 
HRMS (FAB+) calcd for C50H48O9+ [M+] 792.3298, found 792.3292.  168. Rf = 0.44 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax 2925, 2852, 1720, 1598, 1510, 1461, 1429, 1327, 1301, 
1250, 1202, 1174, 1155, 1109, 1034, 922, 830, 737, 702, 613, 551, 504 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.17 (d, J = 7.0 Hz, 2 H), 7.10 (d, J = 7.0 Hz, 2 H), 6.85–6.81 (m, 4 H), 6.70–
6.68 (s, 3 H), 6.62 (d, J = 7.0 Hz, 2 H), 6.57 (s, 1 H), 6.32 (s, 4 H), 5.95 (d, J = 3.5 Hz, 1 H), 4.68 
(s, 1 H), 4.61 (s, 1 H), 4.25 (d, J = 3.5 Hz, 1 H), 4.17 (d, J = 6.5 Hz, 1 H), 4.09 (d, J = 6.5 Hz, 1 
H), 3.88 (s, 3 H), 3.81 (s, 3 H), 3.78 (s, 3 H), 3.73 (s, 9H), 3.68 (s, 3 H), 3.65 (s, 3 H); 13C NMR 
(100 MHz, CHCl3) δ 161.5, 161.0, 159.0, 158.2, 158.0, 157.4, 157.2, 157.0, 149.4, 148.8, 145.9, 
138.4, 138.0, 134.6, 128.7, 128.3, 126.0, 125.2, 119.9, 115.0, 114.0, 113.9, 113.7, 106.0, 100.3, 
99.7, 98.4, 98.0, 92.4, 60.5, 59.6, 56.4, 55.7, 55.6, 55.5, 55.5, 55.4, 55.4, 55.3, 54.3, 54.0; HRMS 
(FAB+) calcd for C50H48O9+ [M+] 792.3298, found 792.3314.   
Permethylated Leachianol E Bromide S22.  Permethylated leachianol E (168, 0.003 g, 
0.004 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to –78 ºC.  BDSB 
(0.0016 g, 0.003 mmol, 0.7 equiv) was added as a solid to the solution and the reaction was 
allowed to stir at –78 ºC for 30 min.  Upon completion, the reaction was quenched with saturated 
aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and 
extracted with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (10 





purified by preparative thin layer chromatography (silica gel, hexanes:CHCl3, 1:4) to afford 
bromide S22 (0.003 g, 86% yield).  S22: Rf = 0.27 (silica gel, hexanes:EtOAc, 7:3); IR (film) 
νmax 3003, 2958, 2925, 2853, 2836, 1597, 1510, 1463, 1432, 1331, 1302, 1249, 1204, 1175, 
1154, 1111, 1080, 1035, 830, 695, 541 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 
2 H), 7.07 (d, J = 8.8 Hz, 2 H), 6.85 (d, J = 8.8 Hz, 2 H), 6.82 (d, J = 8.8 Hz, 2 H), 6.57 (d, J = 
8.8 Hz, 2 H), 6.52 (s, 1 H), 6.51 (d, J = 8.4 Hz, 2 H), 6.37 (s, 1 H), 6.35 (d, J = 2.0 Hz, 2 H), 6.32 
(d, J = 2.4 Hz, 1 H), 5.48 (d, J = 3.6 Hz, 1 H), 5.01 (s, 1 H), 4.68 (s, 1 H), 4.34 (d, J = 7.6 Hz, 1 
H), 4.20 (d, J = 2.8 Hz, 1 H), 4.19 (d, J = 8.0 Hz, 1 H), 3.92 (s, 3 H), 3.81 (s, 3 H), 3.78 (s, 3 H), 
3.75 (s, 6 H), 3.72 (s, 3 H), 3.68 (s, 3 H), 3.67 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 161.0 (2 
C), 159.8, 158.1, 158.1, 157.4, 157.1, 156.7, 156.2, 148.7, 147.4, 146.1, 138.5, 138.5, 134.7, 
129.2, 128.2, 127.5, 125.6, 120.7, 115.1, 113.9, 113.8, 113.7, 105.9, 99.3, 98.2, 96.2, 92.1, 61.5, 
59.7, 57.0, 56.2, 55.9, 55.7, 55.6, 55.5 (2 C), 55.4, 55.3, 52.4; HRMS (FAB+) calcd for 
C50H48O9Br+ [M+] 871.2482, found 871.2503 (for 79Br). 
The following three reactions were performed by Dr. Andreas Gollner.   
Permethylated Carasiphenol C 169.  Carasiphenol C (5, 0.015 g, 0.022 mmol, 1.0 
equiv) was dissolved in dry acetone (2 mL).  Solid K2CO3 (0.200 g, 1.44 mmol, 66.0 equiv) and 
Me2SO4 (0.2 mL, 2.10 mmol, 96.0 equiv) were added sequentially to the solution and the 
reaction was refluxed overnight.  Upon completion, the reaction was quenched with water (3 
mL) and extracted with EtOAc (3 × 5 mL).  The organic layers were combined, washed with 
water (3 mL) and brine (3 mL), dried (MgSO4), filtered and concentrated.  This crude mixture of 
product and residual Me2SO4 was dissolved in acetone (1.5 mL) and MeOH (70 µL) and K2CO3 





the reaction was quenched with water (5 mL) and extracted with EtOAc (3 × 5 mL).  The organic 
layers were combined, washed with water (5 mL) and brine (5 mL), dried (MgSO4), filtered and 
concentrated.  The resulting crude product was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 3:2) to afford permethylated carasiphenol C (169, 
0.012 g, 69% yield).  169: Rf = 0.36 silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 2997, 2932, 
2835, 1598, 1511, 1463, 1329, 1301, 1249, 1202, 1175, 1157, 1107, 1036, 989, 829 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.8 Hz, 2 H), 7.03 (d, J = 8.4 Hz, 2 H), 6.93 (d, J = 8.4 
Hz, 2 H), 6.78 (d, J = 8.4 Hz, 2 H), 6.67 (s, 1 H), 6.49 (d, J = 8.8 Hz, 2 H), 6.39 (d, J = 8.4 Hz, 2 
H), 6.38 (s, 1 H), 6.32 (s, 3 H), 6.24 (d, J = 1.2 Hz, 1 H), 5.40 (d, J = 8.0 Hz, 1 H), 4.82 (d, J = 
8.0 Hz, 1 H), 4.63 (s, 1 H), 4.32 (s, 1 H), 3.85–3.83 (m, 7 H), 3.78 (s, 3 H), 3.69–3.68 (m, 7 H), 
3.66 (s, 3 H), 3.64 (s, 3 H), 3.57 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 162.1, 161.2, 161.1, 
159.6, 157.8, 157.4, 157.3, 156.9, 148.3, 143.7, 143.5, 138.2, 136.9, 133.2, 128.0, 128.0, 127.6, 
125.8, 125.0, 115.8, 114.0, 113.7, 113.0, 106.1, 100.2, 99.4, 97.7, 93.7, 93.0, 59.4, 58.5, 56.8, 
55.6, 55.4, 55.3, 55.3, 55.2, 55.1, 55.0, 52.8, 50.2; HRMS (FAB+) calcd for C50H48O9+ [M+] 
792.3298, found 792.3308. 
Permethylated Carasiphenol C Bromide S23.  Permethylated carasiphenol C (169, 
0.003 g, 0.0038 mmol, 1.0 equiv) was dissolved in dry THF (1 mL) and cooled to –78 ºC.  NBS 
(0.0005 g, 0.0027 mmol, 0.7 mmol) was added dropwise as a stock solution in THF (47 µL of 
solution) to the solution and the reaction was allowed to stir at –78 ºC for 5 h.  Upon completion, 
the reaction was quenched with water (5 mL) and extracted with EtOAc (3 × 5 mL).  The organic 
layers were combined, washed with water (5 mL) and brine (5 mL), dried (MgSO4), filtered and 





(silica gel, hexanes:EtOAc, 7:3) to afford monobromide S23 (0.0023g, 70% yield) and recovered 
starting material (169, 0.0008 g, 27% yield).  Alternatively, permethylated carasiphenol C (169, 
0.003 g, 0.0038 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (1 mL) and cooled to –78 ºC.  
BDSB (0.0021 g, 0.0038, 1.0 equiv) was added as a solid to the solution and the reaction was 
allowed to stir at –78 ºC for 3 h.  Upon completion, the reaction was quenched with saturated 
aqueous NaHCO3 (3 mL), poured into water (3 mL) and extracted with EtOAc (3 × 5 mL).  The 
organic layers were combined, washed with water (3 mL) and brine (3 mL), dried (MgSO4), 
filtered and concentrated.  The resulting crude oil was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford monobromide S23 (0.0029 g, 90% 
yield).  S23: Rf = 0.28 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 2998, 2933, 2835, 2361, 
2342, 1609, 1596, 1510, 1463, 1331, 1301, 1249, 1203, 1177, 1156, 1109, 1067, 1036, 988, 828, 
780, 669 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.37 (d, J = 8.8 Hz, 2 H), 7.20 (d, J = 8.4 Hz, 2 H), 
6.97 (d, J = 8.8 Hz, 2 H), 6.80 (d, J = 8.8 Hz, 2 H), 6.54 (d, J = 8.8 Hz, 2 H), 6.50 (d, J = 8.8 Hz, 
2 H), 6.38 (s, 1 H), 6.31–6.29 (m, 4 H), 5.44 (d, J = 8.0 Hz, 1 H), 5.09 (s, 1 H), 4.83 (d, J = 8.0 
Hz, 1 H), 4.39 (s, 1 H), 4.05 (d, J = 6.8 Hz, 1 H), 3.89 (s, 3 H), 3.88 (s, 3 H), 3.80 (s, 3 H), 3.77 
(d, J = 6.8 Hz, 1 H), 3.70 (s, 3 H), 3.69 (s, 6 H), 3.64 (s, 3 H), 3.62 (s, 3 H); 13C NMR (100 MHz, 
CHCl3) δ 161.9, 161.1 (2 C), 159.6, 157.7, 157.5, 157.1, 156.7, 155.9, 146.5, 143.4, 143.0, 
138.7, 136.9, 133.2, 128.3. 128.1, 127.5, 126.5, 115.5, 114.0, 113.4, 113.0, 106.1, 100.0, 99.3, 
96.1, 93.6, 93.0, 61.4, 57.3, 56.9, 56.8, 55.4, 55.4, 55.3, 55.2, 55.2, 55.1, 52.0, 51.0; HRMS 
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Chapter 3 -  Directed Lithiation as a Tool for Regioselective Dihydrofuran Installation on 






Chapter 2 has introduced our regioselective method of appending new resveratrol units 
onto monomeric and dimeric cores in the form of trans-dihydrobenzofurans by using aromatic 
bromides as positional markers.  These functional handles can be added by electrophilic aromatic 
substitution if they are located on the more nucleophilic ring A of resveratrol (1), ortho to only 
one of the phenols (position 1 in Figure 3.1 A).  The other hydrogen atom on ring A, as well as 
the one ortho to the phenol on ring B (positions 2 and 3 in Figure 3.1 A), remain elusive when 
this approach is used for bromine incorporation.  While dihydrofuran installation at these 
alternate positions is less common in the resveratrol family, it is represented in several natural 
products, such as 2–5 (Figure 3.1 B), some of which do possess potent bioactivities.  In addition 
to accessing such natural products, if we are to more fully understand the structure-function 
relationships conferred by the presence of this motif, we need to develop selective methods to 
affix dihydrofuran rings at all of these possible sites.  As detailed in this chapter, a switch from 
electrophilic bromination to directed lithiation in unique formats has allowed us to install 
functional handles at both positions 2 and 3 on protected resveratrol derivatives.  In addition, 
three natural products with dihydrofuran units at position 2, one dimer and two trimers, were also 
synthesized, validating the potential universality of our dihydrofuran installation method 






Figure 3.1 A: Positions of installation of dihydrofuran units in the resveratrol class and methods 
to functionalize them; B: Examples of natural products with the dihydrofuran installed at 
positions 2 and 3 
 
3.2 Biosynthesis and Biological Activity of Resveratrol Oligomers Containing 
Dihydrofuran Units Attached at Positions 2 and 3 
The simplest members of the resveratrol family bearing dihydrofuran units at positions 2 
and 3 are gnetin C (2) and δ-viniferin (4).  Their proposed biosynthesis is presented in Scheme 
3.1.  Initially believed to be only a dimer found in synthetic efforts in the laboratory, δ-viniferin 
(4) is actually a dimer produced by a multitude of plants.1  This fact is not surprising, as most of 
the biomimetic conditions employed in an attempt to synthesize ε-viniferin (8) have generated 



























































rationalized by the stability of the radicals involved in its biogenesis, as well as that leading to 
the other dimers drawn in Scheme 3.1.     

Scheme 3.1 Combinations of resveratrol radicals leading to dimers 2, 4 and 8 
 
Density functional theory studies on resveratrol’s (1) antioxidant mechanism have 
revealed that the phenol on ring B generates a more stable radical (9) than those on ring A (7 and 
10 in Scheme 3.1).2  These conclusions were based on the calculated bond lengths in the various 
resonance structures of the radicals, as well as on their spin density and unpaired electron 
distribution.  Radical 6, which can easily derive from 9, can be envisioned to serve as the source 
of the dihydrofuran aliphatic carbons C2 and C3 and of the two pendant aryl rings for all three 
dimers.  The factor that seems to determine which of the dimers forms (i.e. 2, 4 and 8 in Scheme 
3.1) appears to be dictated by the partner radical.  As radical 9 is the most stable, δ-viniferin (4) 











































for half of their structures, are thus in existence in reduced equilibrium proportion, decreasing the 
likelihood of their being a reactive partner.   
The stilbene olefin most likely contributes to the stability of the radical required for the 
installation of the dihydrofuran unit at position 3, as the vast majority of oligomers in this group 
still possess it.  The low incidence of this pattern in the resveratrol class of oligomers is probably 
a consequence of the high reactivity of that olefin, as shown previously, in Chapter 1, by our 
synthesis of dimeric cores, where it was used to great effect.  
Some of the oligomers exhibiting dihydrofurans at these atypical positions display quite 
remarkable biological effects (Figure 3.2).  Potent antibacterial activity has been reported for 
compounds bearing dihydrofurans at position 23, most notable among these studies being the 
effects of gnetin E (11) and gnemonol B (12) against vancomycin-resistant Enterococci and 
methicillin-resistant Staphylococcus aureus.3b, c  In addition, gnetin E (11) was shown to increase 
the potency of gentamycin, while reducing its nephrotoxicity.3d  Amurensin L (13), displaying 
the heterocyclic motif at position 3, has been shown to act as an antagonist of the histamine 
receptor,4 an unusual effect among resveratrol oligomers more generally.  These unconventional 
pathways of oligomerization can conceal unique pharmacological potential, and gaining access 







Figure 3.2 Selected bioactive natural products with dihydrofurans at positions 2 and 3 
 
3.3 Initial Attempts to Access ortho-Bromophenols on the Resveratrol Cores 
The cores in the resveratrol family contain several highly electron-rich aromatic rings.  
As a result, one of their main modes of reactivity is that of serving as nucleophiles in 
electrophilic aromatic substitution chemistry.  Electronically, these cores should prefer to react at 
one of the aryl rings that contains two protected phenols.  All of the substrates we have tested so 
far have functionalized the position that is ortho to one of these two phenols and para to the 
other, in other words position 1 (Figure 3.1 A).  Achieving the desired selectivity for positions 2 
and 3 by electrophilic aromatic substitution would thus appear be impossible on permethylated 
substrates, as position 2 is disfavored due to inherent substrate bias as long as position 1 is 
available, and position 3 is electronically disfavored.   
In unprotected form, phenols are excellent activating groups for electrophilic aromatic 














































Regiocontrol for the latter is easier to obtain, as it parallels the steric preference of the system.5  
The best strategy for ortho bromination stems from another important attribute of phenols: their 
well known6 ability to act as hydrogen bond donors.  Combining these two traits, we first 
examined the functionalization at positions 2 and 3 by using the phenol’s hydrogen bonding 
ability to bring the brominating reagent in close proximity and then its activating effect to 
facilitate the ortho bromination. 
While electrophilic aromatic bromination is faster in more polar solvents,7 the hydrogen 
bonding interaction between the phenol donor and the halogen acceptor that we needed to exploit 
is strongest in nonpolar solvents.  As a result, solvents such as CH2Cl28, CS29 and CCl410 are 
often employed when the presence of this noncovalent interaction is beneficial.  As our 
permethylated cores are generally highly soluble in CH2Cl2, the least toxic and challenging to 
utilize of the three solvents, we opted for it in our original investigations.    
We now required a free phenol on a reasonably complex core to set out with these 
investigations.  Our first model was ketone 14, a material which could be obtained from its 
permethylated variant through selective deprotection of the phenol ortho to the carbonyl due to 
hydrogen bonding stabilization of the ensuing hydroxyl.  Because the presence of the 
neighboring ketone should decrease the nucleophilicity of both rings A and B and should thus 
decrease the overall rate of electrophilic aromatic bromination, we felt our free phenol might 
have a chance at directing an incoming electrophile.  The first reagent we attempted for this new 
functionalization was NBS.  Pleasingly, it delivered the desired product (15), albeit in a 3:4 ratio 






Scheme 3.2 Phenol-directed NBS bromination of ketone 14 
 
The formation of monobromide 15 supported the ability of phenols to direct ortho 
bromination even in the presence of several other activating methoxy substituents.  Model ketone 
14 was designed to mimic the general complexity of the cores we were looking to functionalize, 
and could in principle be elaborated to trimeric derivatives.  The approach would be slightly 
different that we have shown in Chapter 2, with the functional handle being installed during the 
dimeric core synthesis, taking advantage of the presence of functional groups, i.e. the ketone, 
that would not be present at the final dimer level.  From the functionalized dimer, the same 
method as described in Chapter 2 could then be employed to append the dihydrofuran at the 
appropriate position.   
Yet, while proving the principle of possible position 2 functionalization, that process with 
ketone 14 relied on a protecting group pattern which required the presence of the ortho carbonyl 
group for installation, decreasing its overall generality and applicability to certain frameworks.  
This strategy would also be unable to afford some dimeric structures, for instance the 
antibacterial3a gnetin C (2).  Consequently, we elected to a work with a simpler model (16, 



























substitution.  As perbenzylated resveratrol does not react with NBS, we hoped our system would 
allow bromination within this substrate on ring E, at position 3.  
Following literature precedent10 for the synthesis of ortho-bromophenols with the para 
position blocked, such as 16, we attempted brominations using a number of 
bromodialkylsulfonium ions (Scheme 3.3).  These types or reagents are mild and highly selective 
on many activated aryl rings, as found in a thorough study comparing this methodology to 
several others available for regioselective brominations.10  Their excellent ortho selectivity, 
especially on cores with the position para to the phenol blocked, can be accounted for by an 
interaction between the cationic reagent and the lone pairs on the phenol oxygen.  However, on 
our model substrate (16, Scheme 3.2), neither the in situ generated bromodimethylsulfonium 
from hydrogen bromide and dimethyl sulfoxide (Scheme 3.3),10-11 nor our stable 
bromodiethylsulfonium variant (BDSB)12 led to successful brominations, complex inseparable 
mixtures being observed.  The desymmetrization of the aliphatic benzyl 1H NMR peaks 
suggested the implication of reactions on the more electronically rich ring D, as well as potential 
benzylic bromination.  Our final attempt at pursuing this strategy explored the use of 
electrophilic bromination sources in more nonpolar solvents, give that it has been shown that the 
polarity of the solvent can have a dramatic impact upon the ortho:para ratio of functionalized 
products derived from electrophilic bromination of phenols.9  While sterically the para position 
is preferred, switching from MeCN to CS2 can lead to a preference for the ortho position.  The 
explanation for this phenomenon stems from the nonpolar solvent’s ability to allow for stronger 
hydrogen bonding interactions between NBS and the phenolic hydrogen atom.  NBS in CS2,9 as 





decomposition by loss of ring E through an unknown pathway, and the second to an inseparable 
mixture. 
 
Scheme 3.3 Sources of bromodialkylsulfonium ions for electrophilic brominations 
 
It was evident that our cores, with several electron-rich aryl rings and numerous directing 
groups, would not be readily amenable to functionalization by ortho directing effects of free 
phenols.  However, phenols, especially when appropriately protected, have also been used in 
directed deprotonations.  Taking advantage of the phenols ortho to positions 2 and 3 we decided 
to explore their potential for directing deprotonations using butyl lithium bases and differential 
phenol protecting group patterns as a way to achieve a highly controllable alternative to 
electrophilic aromatic substitution.   
3.4 Directed Lithiations on the Resveratrol Core 
3.4.1 General Considerations for the Directed Lithiation Mechanisms and Relevant 
Directing Groups 
  Ever since the initial studies of Bebb,13 as well as by Wittig and Fuhrman,14 in 1939-



























regioselective installation of numerous functional groups and the generation of new C-C bonds.15  
The basic mechanism for these types of transformations is described in Scheme 3.4 as presented 
in the review by Victor Snieckus,15 an individual who has dramatically expanded the scope of 
this process in his recent work.      
 
Scheme 3.4 The Snieckus directed lithiation mechanism. 
 
The most common bases utilized are alkyl lithium in flavor, unless their nucleophilicity is 
problematic.  Due to lithium’s preference for complexes with a coordination number of four, 
alkyllithiums exist as aggregates.  While switching from a hydrocarbon solvent, such as hexanes, 
to a Lewis basic one, like Et2O or THF, brings the nBuLi aggregation state down from six to 
four, its basicity is still not optimal.  As is well known, addition of strongly coordinating 
bidentate co-solvents allows for an increase in basicity by further decreasing the aggregation 
state.  Tetramethylethylenediamine (TMEDA) and 1,2-dimethoxyethane (DME) are the most 
commonly utilized co-solvents for these purposes, with the first generating dimeric aggregates.16  
As for the directing groups (DG in Scheme 3.4), they rely on the presence of a heteroatom and 
generally employ sterics to decrease their electrophilicity for the alkyllithiums.  The strongest of 















heteroatom-containing phenol protecting groups, such as MOM19 and THP,20 have also been 
successfully employed for such processes.  With these general considerations in mind, we 
commenced our explorations for conditions that would allow directed lithiation at positions 2 
and 3 on our resveratrol cores.        
3.4.2 Intrinsic Selectivity of Permethylated Resveratrol 
We started with permethylated resveratrol (27) as our first model substrate, in order to 
probe the inherent preference of the resveratrol core for directed lithiation.  Deprotonation with 
nBuLi in the presence of TMEDA and anion capture by Br2C2H4 generated monobromide 28 in 
~ 10% yield, with the remainder of the material balance being unreacted and recovered started 
material.  Position 3 (Figure 3.1 A) was thus favored, potentially due to its more sterically 
accessible nature.   
 
Scheme 3.5 Intrinsic selectivity of protected resveratrol (27) for directed lithiation 
 
3.4.3 Functionalization at Position 3 
In order to try and improve the overall degree of conversion in this established preference 









    TMEDA
    then Br2C2H4
~10% yield
Reagents and conditions: a) nBuLi (2.0 equiv), TMEDA (2.0 equiv), 
THF, -25 to -10 ºC, 20 min, then Br2C2H4 (2.0 equiv), -10 ºC,10 min, 





ortho to that site and by protecting the top aryl ring’s phenols as benzyl ethers (i.e. 29 in Scheme 
3.6). While the benzyl ethers could be subject to benzylic deprotonation, they were chosen 
because of their ability to be readily deprotected under mild Lewis acidic conditions, without 
affecting the stilbene olefin, at the end of the dihydrofuran installation sequence.  We hoped that 
our directing group would allow the desired deprotonation to be the dominant one, especially 
since the sp2 anion would be more stable due to its higher s character than that the benzylic sp3 
one.  Protected resveratrol 29, however, was unreactive to deprotonations followed by attempted 
anion trapping with Br2C2H4 or D2O.  Before abandoning this steric strategy for blocking 
deprotonation at position 2, we tried a stronger directing group adjacent to position 3.  
Carbamate 31 (Scheme 3.6)18a, 21 was thus synthesized.18a, 21  Since in our previously developed 
dihydrofuran installation sequence the aromatic bromides are markers for the subsequent 
generation of anions that add into protected 3,5-dihydroxybenzaldehyde (32), we attempted to 
bypass the bromination step and use the requisite aldehyde directly as the electrophile in these 
studies.  Fortuitously, carbamate 31 was successfully deprotonated and the resulting anion added 
smoothly into aldehyde 32, generating alcohol 33 in 53% yield, with the remaining material 
balance being unreacted starting material.  Deprotonation with the larger sBuLi predictably 
decreased the yield to 25%, likely due the steric hindrance of the bulky carbamate group in 






Scheme 3.6 Attempts to facilitate functionalization at position 3 
 
Starting with alcohol 33, we next attempted oxidation to ketone 34 in preparation for the 
homologation to aldehyde 35 (Scheme 3.7).  While the first step worked in near quantitative 
yield, the homologation sequence (Corey Chaykovsky, Lewis acid rearrangement) led to loss of 
the carbamate group and subsequent decomposition.   
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Reagents and conditions: a) nBuLi (3.0 equiv), TMEDA, THF, -78 ºC, 30 min, then 32 (2.0 equiv), -78 to 25 ºC, overnight, 53% yield; b) sBuLi 
(1.2 equiv), TMEDA, THF, -78 ºC, 1 h, then 32 (2.0 equiv), -78 to 25 ºC, overnight, 25% yield.
b) sBuLi
    TMEDA











































With the carbamate directing group unable to survive these operations, we returned to the 
MOM directing group and, since the presence of both benzyl and silyl protecting groups on ring 
A (Scheme 3.8) made protected resveratrol unreactive to the deprotonation conditions, we 
replaced these groups with methyl ethers (36).  Although this choice meant that removal of the 
methyl protecting groups would require exposure to BBr3 conditions that, from our experience 
trying to deprotect permethylated ε-viniferin (8), were expected to lead to decomposition, this 
problem however would be a substrate-specific one, pertaining only to cores with the stilbene 
olefin.  In addition, the natural product resulting from installation of this heterocyclic motif at the 
3 position of resveratrol, δ-viniferin (4) (Figure 3.1 B) can be synthesized biomimetically in 97% 
yield22, making the pursuit of its total synthesis not worthwhile here outside of proof of principle 
for later, more challenging substrates. 
3.4.3.1 Synthesis of Protected δ-viniferin 
 We decided to target a protected version of δ-viniferin (4), in order to test the ability of 
the MOM group, which we viewed essential for the functionalization at position 3, to survive our 
sequence.  Thus, protected resveratrol (36) was smoothly deprotonated and bromide 37 was 
obtained in 76% yield.  Trying to use aldehyde 32 as the electrophile trap for the lithium anion 
generated alcohol 39 in 41% yield.  Lithium halogen exchange, starting with bromide 37, 
following its addition into aldehyde 32 also generated alcohol 39 in 62% yield, making this two-
step procedure slightly more efficient overall in this case.  Interestingly, the anion at position 3 
was more efficiently functionalized with Br2C2H4 as an electrophile than with 3,5-
dimethoxybenzaldehyde (32), an observation that was also encountered in subsequent 






Scheme 3.8 Functionalization of resveratrol derivative 36 at the 3 position 
 
With these operations complete, subsequent oxidation of alcohol 39 and homologation to 
aldehyde 40 proceeded smoothly.  The final aryl ring was then added in the form of a benzyl-
protected Grignard reagent (41), designed to allow for selective deprotection ultimately 
facilitating the dihydrofuran closing. Thus, to reach these steps, alcohol 42 was treated with 
ZnCl2 for the deprotection of the MOM group.  Surprisingly, the desired trans dihydrofuran 43 
was obtained as the major product.  The benzyl group was still present, but under these Lewis 
acidic conditions there was no decrease in the diastereocontrol observed in the heterocycle 
formation.  A comparison of the resultant material with the published 1H NMR spectrum of the 
natural product23 supported our original assignment of structure 43.  Attempts to deprotect 
compound 43 using BBr3 from -78 to 25 ºC generated a monomethylated compound as the main 
product, and did not lead to decomposition as was expected based on the presence of the highly 
acid-sensitive stilbene alkene.  Unfortunately, the material obtained was difficult to purify and of 
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Reagents and conditions: a) nBuLi (1.6 M in hexanes, 3.3 equiv), TMEDA (3.3 equiv), THF, -25 ºC, 2 h, then Br2C2H4 (3.3 equiv), -78 ºC, 






structure.  Signals corresponding to the dihydrofuran ring protons (doublets at 5.49 ppm with J = 
8.0 Hz and 4.40 ppm with J = 7.0 Hz), the stilbene olefin (doublets at 6.59 ppm with J = 12.0 Hz 
and 6.46 ppm with J = 11.5 Hz), as well as several of the aromatic hydrogens were visible.  
Attempts to heat the reaction to afford complete deprotection resulted in decomposition of the 
material.  The presence of the dihydrofuran system, one involving the phenol on ring B (Scheme 
3.9), could be envisioned to decrease the nucleophilicity of the stilbene olefin and thus prevent 
its reaction if the BBr3 deprotection reaction is performed at relatively low temperatures, such as 
25 ºC.   
 
Scheme 3.9 Synthesis of protected δ-viniferin (43) 
Reagents and conditions: a) DMP (2.0 equiv), NaHCO3 (3.3 equiv), CH2Cl2, 25 ºC, 2 
h, 85% yield; b) Me3SI (25.0 equiv), nBuLi (23.0 equiv), THF, 0 ºC, 2 min, then ketone, 0 
ºC, 1 h; c) ZnI2 (1.5 equiv), benzene, 25 ºC, 1 h, 48% yield over 2 steps; d) 41 (8.5 












































Installation of a functional handle at position 3 of resveratrol was thus accomplished using 
the directing effects of the MOM protecting group for selective lithiation.  Unfortunately, 
attempts to expand the functionalization at position 3 using the directing effects of the MOM 
group to ε-viniferin derivative 44 proved unsuccessful (Scheme 3.10).  The reaction generated an 
inseparable mixture of starting material and several functionalized products, with the main 
product having the MOM-ether-substituted ring B untouched.  Clearly, the addition of two new 
aromatic rings in this structure, compared to 36, introduces two new competing positions with 
our desired site of reactivity.  These results suggest that stronger donor groups should be 
explored when such a functionalization is required.   
 
Scheme 3.10 Attempts to functionalize 36 and 44 at position 3 
 
A less elegant, but perhaps more efficient solution, for installation of functional handles at 
position 3 would be to pre-functionalize the aryl ring prior to its inclusion in the core structure 



































optimizing the use of biomimetic methods24 to take an appropriately protected substrate (51), and 
use the stability of the radical at position 3 (52 in Scheme 3.11, bottom) to attempt a one-step 
installation of the dihydrofuran unit, noting that experiments without such selectively 
deprotected materials afford a multiplicity of products.  Our modular synthesis of the resveratrol 
cores should allow access to differentially protected materials, such as 50, which could be 
deprotected at the optimal time.      
 



































































3.4.4 Explorations on Permethoxymethylated Resveratrol 
The difficulties we encountered above in attempting to deprotect derivative 43 to access 
the natural product δ-viniferin (4) were expected to hamper access to the dimer gnetin C (2).  
While δ-viniferin (4) can easily and efficiently be synthesized biomimetically, as discussed in 
Chapter 1, gnetin C (2) would rely on total synthesis for accessing reasonable amounts for 
biological testing.  We therefore turned to MOM protecting groups for resveratrol, as they could 
serve as lithiation directors, could survive our dihydrofuran installation sequence, and should be 
easy to remove at the end of the sequence.  The presence of the two directing groups on the top 
aryl ring would probably introduce significant competition from functionalization at position 2.  
While the bottom ring only has one directing group, it benefits from less steric hindrance.  We 
first set out to check whether the intrinsic preference would parallel that for position 3 observed 
on permethylated resveratrol (27 in Scheme 3.5).  Our next task was the development of 
methodologies that would allow divergent functionalization of protected resveratrol (54, Scheme 
3.12) at either position 2 or 3.  
Initial reaction with nBuLi and Br2C2H4 as the electrophilic trap between -78 and 0 ºC only 
returned unreacted starting material.  Changing the electrophile to aldehyde 55 led to the 
formation of alcohol 56 in 81% yield.  An interesting result was obtained when nBuLi and 
Br2C2H4 were used in concert at 25 ºC: the new bromide 57 was formed in 53% yield, with no 
discernible trace of bromine installation at position 2.  Interestingly, use of an aldehyde 
electrophilic trap for the same anion at 25 ºC generated a 1:1 mixture of alcohols 56 and 58.  A 
combination of carefully chosen temperature and electrophilic trap could thus be used to access 





electrophile, and position 3 by warmer reaction conditions and Br2C2H4 as a source of 
electrophilic bromine.       
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    -40 to -25 ºC
c) nBuLi
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Reagents and conditions: a) nBuLi (1.6 M in hexanes, 1.2 equiv), THF, 10 ºC, 10 min, then 55, -40 to 25 ºC, 12 h, 81% yield; b) nBuLi 
(2.5 M in hexanes, 1.7 equiv), THF, 25 ºC, 15 min, then Br2C2H4 (3.9 equiv), 25 ºC, 5 h, 53% yield; c) nBuLi (2.5 M in hexanes, 1.0 





3.4.5 Functionalization at Position 2 
3.4.5.1 Synthesis of gnetin C  
Alcohol 56 was elaborated to gnetin C (2) by my colleague Ms. Pei Gan.  Pei’s work 
showed that our dihydrofuran installation sequence can be optimized to tolerate the highly acid 
sensitive MOM groups.  The final deprotection of the phenols using TMSBr allowed access to 
gnetin C (2), a dimer that contains the unstable combination of the stilbene double bond with the 
free phenol on the bottom aryl ring.  MOM groups were not only compatible with our 
dihydrofuran installation method, but they had served as the ideal protecting groups for 
deprotection in the presence of the stilbene olefin.   
 
Scheme 3.13 Gnetin C (2) can be accessed from alcohol 56 
 
3.4.5.2 Synthesis of Leachianols D and E 
Leachianol D (3) and leachianol E (60) were isolated in 1994 by Ohyama et al. from 
Sophora leachiana.25  The isolation chemists did not perform any preliminary biological studies 


















Synthetically accessing these materials would thus allow their biological testing, and would 
refine some ambiguity regarding the relative stereochemistry of the two unassigned centers in 60 
(Scheme 3.14).   
 
Scheme 3.14 Trimers derived from the pallidol dimer (59) 
 
These two trimers appear to be regioisomers deriving from the same dimeric core of 
pallidol (59) and display the carbon-carbon bond attaching the dihydrofuran unit to the core at 
the same position.  What differs is which of the phenols ortho to this new bond closes the 
heterocyclic ring.  Carasiphenol C (61), another trimer sharing the dimeric pallidol core, has 
been shown to have cytotoxic effects26 and a plant extract containing it also displayed an ability 
to promote the proliferation and maturation of osteoblasts in vitro.27   Access to leachianols D (3) 
and E (60) should allow for a comparison of the activity in the set of oligomers from Scheme 










































unit.  In addition, as already noted, while the structure of leachianol D (3) is fully assigned, the 
relative stereochemistry of the trans-dihydrofuran ring and the pallidol core in leachianol E (62) 
was not defined.  
Accessing trimeric natural products with dihydrofuran attachment points at position 2, such 
as leachianols D (3) and E (60) (Scheme 3.14), would require the ability to translate our directed 
lithiation method onto a dimeric core.  As we can easily synthesize gram quantities of 
permethylated pallidol (62), we tried to extend the directed lithiation protocol to this substrate, 
one which only contains moderately activating methoxy directing groups15, 20, 28 (Scheme 3.15).  
Adventitiously, the synergistic action of the two adjacent methoxy groups allowed us to 
functionalize ring A ortho to both phenols, at the equivalent of position 2 on resveratrol (Figure 
3.1 A), and obtain monobromide 63 in 14% yield by trapping with Br2C2H4.  In order to test 
whether the low yield was due to incomplete formation of the anion or to its inefficient capture, 
we deprotonated once again using nBuLi and quenched the anion with D2O this time.  The major 
product was the expected monodeuterated material.  Using sBuLi as base, we generated the 
dianion (at position 2 on both A rings), as evidenced by the dideuterated pallidol obtained as the 






Scheme 3.15 Functionalizations of the pallidol core 62 at position 2 
 
During our initial work on the permethoxymethyl-protected resveratrol (Scheme 3.12) we 
observed the preference of the anion at position 2 for aldehyde electrophiles, as opposed to that 
of the anion at position 3 for Br2C2H4.  Using an aldehyde as an electrophilic trap for the anion 
also saves one step in the sequence, so we decided to use nBuLi as the base, and 3,5-
dimethoxybenzaldehyde (32) as the electrophile.  The temperature and the duration of anion 
formation were optimized, allowing the formation of alcohol 64 as an inconsequential mixture of 
diastereomers about the newly generated chiral center in 58% yield, with 16% recovered starting 
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Reagents and conditions: a) nBuLi (1.6 M in hexanes, 2.0 equiv), TMEDA (2.0 equiv), THF, 25 ºC, 20 min, then Br2C2H4 (2.0 equiv), 25 ºC, 
1 h, 14% yield; b) nBuLi (1.6 M in hexanes, 2.0 equiv), TMEDA (16.0 equiv), THF, -40 to -20 ºC over 30 min, -20 ºC, 2 h, then 32 (10.0 








reaction further led to the formation of significant amounts of diol 65, resulting from the 
formation of the dianion.  Protected pallidol’s (62) propensity for double functionalization is a 
tendency we had already observed in the electrophilic aromatic bromination reaction as 
discussed in Chapter 2, Scheme 2.20. 
 
Scheme 3.16 Synthesis of aldehyde 67 
 
Following our established protocol for dihydrofuran synthesis (Chapter 2) we were able 
to access aldehyde 67 as a 1:1 mixture of diastereomers.  The lack of substrate diastereocontrol is 
attributed to the remote nature of the stereocenters of the pallidol core.  Modifying the Lewis 
acid used for the rearrangement of the epoxide derived from ketone 66 to aldehyde 67 did not 
improve the diastereomeric ratio, as ZnI2, BF3•Et2O, as well as Bi(OTf)3, all led to the same 1:1 
mixture of aldehyde diastereomers.  While this lack of diastereocontrol was detrimental to our 
pursued total syntheses in terms of material throughput, the formation of the both aldehyde 
isomers should, in principle, allow us to access both diastereomers of leachianol E (60) and, by 
comparing their spectral characteristics to the natural isolate’s, establish its structure.  However, 




































    K2CO3
60% yield
Reagents and condition: a) DMP (5.7 equiv), NaHCO3 (6.0 equiv), CH2Cl2, 25 ºC, 2 h, 98% yield; b) BBr3 (1.0 M in CH2Cl2, 35.0 equiv), CH2Cl2, 
sealed tube, 70 ºC, 48 h, 86% yield; c) BnBr (50.0 equv), K2CO3 (43.0 equiv), nBu4NI (2.3 equiv), acetone, 70 ºC, overnight, 71% yield; d) Me3SI (58.0 





techniques at this stage, the mixture of products was carried forward and treated with 4-
benzyloxyphenylmagnesium bromide (41, Scheme 3.17).  The resulting mixture of alcohols 
(68ab) was also effectively inseparable, and was carried forward through the deprotection and 
cyclization steps.  The resulting mixture of products contained four different sets of diagnostic 
dihydrofuran signals in 1H NMR, two of which were identified as belonging to the natural 
products.  Although we were strongly encouraged by this result, attempts to purify this mixture 
did not allow access to single compounds.   
 
Scheme 3.17 Initial elaboration of aldehyde 67 towards dihydrofurans-containing compounds 
 
Going back, we attempted to reduce the aldehyde within 67 to a mixture of new 
diastereomers hoping that the more polar functionality would facilitate purification and 
separation.  This hypothesis, however, did not turn out to be true. Luckily, enough 
experimentation showed that gradient preparative thin layer chromatography 


















































alcohols at the stage of compound 68ab into intermediates 68a and 68b (Scheme 3.18).  These 
two isomers were the only expected components of the mixture (68ab), though this fact was hard 
to discern in the crude 1H NMR due to the presence of the eight benzyl protecting groups shared 
by the materials.  In Chapter 2, when we were pursuing the synthesis of the trimer carasiphenol 
B, we obtained the corresponding aldehyde as a single diastereomer.  Addition of the Grignard 
reagent 41 into this aldehyde generated a single diastereomer of the ensuing benzylic alcohol as 
well.  If the Felkin-Ahn control proposed to account for this diastereoselective addition (Chapter 
2, Scheme 2.25) is indeed active, then the structures of the two alcohols 68a and 68b are those 
drawn in Scheme 3.18.  The presence of four dihydrofuran-containing products in the mixture 
mentioned above (Scheme 3.17) suggests the involvement of two quinonemethides, each with 
two possible nucleophilic phenols leading to two different final products.  Therefore, the two 
alcohols (68a and 68b) must derive from different aldehyde isomers, confirming the structures of 
68a and 68b, at least at the stereocenter of carbon that will become the C3 position in the 






Scheme 3.18 Elaboration of aldehyde 67 into deprotected alcohols 69a and 69b 
 
Each of the two alcohols 68a and 68b would be elaborated to the final dihydrofuran-
containing product separately.  These alcohols were thus deprotected independently, leading to 
intermediates 69a and 69b (Scheme 3.18).  Each of these new alcohols was exposed to acidic 
conditions to afford the dihydrofuran unit, generating two regioisomeric products in the process, 
dependent on which ortho-phenol attacked the intermediate quinonemethide (Scheme 3.19).  Our 
method delivers trans–dihydrofurans with stereochemical information derived from the initial 
aldehyde stereocenter, therefore each of the alcohols 69a and 69b should lead to a set of 
regioisomeric products with the same stereochemistry at the C3 position.  The reliability of this 































































c) H2, 30% Pd/C
Reagents and conditions: a) 41 (8.0 equiv), THF, 25 ºC, 45 min, 26% yield 70, 26% yield 71; b) H2 (balloon), 30% Pd/C, 

















information with leachianol D (3), based on whether they derive from the same isomer of the 
alcohol 69.  Both natural products 3 and 60 derived from the same alcohol 69a in that final 
closure, while the other two isomers (70 and 71) observed in the mixture described in Scheme 
3.17 were formed from 69b.  Thus, based the intermediacy of the common precursor 69a for the 
two natural products, assuming that the relative assignment for 3 is correct in its dihydrofuran 
domain, we were able to complete the structural assignment of leachianol E (60), as shown in 
Scheme 3.19.  
 
Scheme 3.19 Synthesis of leachianol D (3) and leachianol E (60) and of their diastereomers 70 
and 71 
 
The separation of the resulting dihydrofuran-containing compounds was achieved after 


























































Reagents and conditions: a) Amberite (IR-12-OH), MeOH, 25 ºC, 2.5 h, 86% yield; b) Amberite (IR-12-OH), MeOH, 25 



















compounds obtained, leachianol D (3) alone appeared relatively unstable to these conditions, 
with the ratio of isolated leachianol D (3) to leachianol E (62) being lower than that observed in 
the NMR of the crude mixture.  The limited amounts of materials obtained for 60, and especially 
for the unstable 3 (on the order of a few milligrams), prevented the 2D NMR spectroscopic 
studies required to unequivocally confirm our assignments without relying on the previously 
published structural data.  Future efforts will attempt to achieve regiocontrol in the dihydrofuran 
closure, which should lead to single compounds, circumventing the need to the problematic 
purifications that significantly limit the material throughput in the case of this set of natural 
products.   
 Leachianols D (3) and E (62), two trimers in the family displaying dihydrobenzofuran 
units at position 2, were thus synthesized in 9% combined overall yield from protected pallidol 
(62) by exploiting the synergistic action of the two methoxy groups for directing lithiation.  Our 
previously-developed sequence for the dihydrofuran architecture installation proved robust at 
position 2 as well, thus proving its potential applicability for accessing this motif elsewhere in 
the resveratrol family.  The common alcohol (69a) that led to the synthesis of both natural 
products, in conjunction with our robust synthetic pathway, allowed full stereochemical 
assignment of leachianol E (60), as shown in Scheme 3.19, dependent upon the accuracy of the 
reported structure for leachianol D (3).  In addition, two unnatural isomers were also obtained 
(70 and 71).  A comparison of their biological activity to that of the natural materials (3 and 60) 
should establish the relative importance of diastereocontrol in the dihydrofuran installation from 





3.5 Assignment of the Structures of the Trimers Derived from the Pallidol Dimeric Core 
From a literature search of the structures of resveratrol oligomers isolated to date, the 
dimeric core of pallidol (59 in Scheme 3.14) appears to lead to four different trimers.  The first 
one, carasiphenol C (61) was synthesized by my colleague Dr. Andreas Gollner, as mentioned in 
Chapter 2.29  In the work described in this chapter, we have shown the synthesis of two 
additional trimers, leachianol D (3) and leachianol E (60).  The fourth such trimer is gnetin I, 
proposed by the isolation team to have the structure shown in Figure 3.3, left.30  This structure 
coincides with the one later assigned to leachianol D (3).25b The only other report which shows a 
structure for gnetin I is a bioactivity study from Iliya et al.26 reporting cytotoxicity for a 
compound they label gnetin I, for which they draw the structure shown in Figure 3.3, right.  This 
new structure corresponds to that of carasiphenol C (61).27   The basis of the structural 
assignment in this second study is unclear. 
 
Figure 3.3 The two structures proposed for gnetin I 
 
The structures of carasiphenol C (61), leachianol D (3) and leachianol E (60) were 
























oligomers with that of the natural isolates. Comparison of the 1H NMR of gnetin I with those of 
the first three pallidol-derived trimers is shown in Table 3.1.  From this analysis, the structure of 
gnetin I appears to be the same as that of carasiphenol C (61).  Table 3.2 confirms this 
assignment by a comparison of the 13C NMR data of gnetin I and carasiphenol C (61).  The 
complete set of trimers derived from the pallidol core (59) is therefore depicted in Figure 3.4.    
 


































Table 3.1 Comparison of the 1H NMR data of gnetin I to that of carasiphenol C (61), leachianol 
D (3) and leachianol E (60) 
Gnetin I Carasiphenol C Δ  Leachianol D Δ  Leachianol E Δ  
7.25 7.22 0.03 7.18 0.07 7.06 0.19 
7 6.98 0.02 7.01 -0.01 7.01 -0.01 
6.82 6.86 -0.04 6.97 -0.15 6.76 0.06 
6.73 6.70 0.03 6.8 -0.07 6.73 0 
6.64 6.61 0.03 6.73 -0.09 6.73 -0.09 
6.46 6.44 0.02 6.71 -0.25 6.67 -0.21 
6.36 6.35 0.01 6.69 -0.33 6.66 -0.3 
6.33 6.31 0.02 6.64 -0.31 6.62 -0.29 
6.27 6.25 0.02 6.21 0.06 6.26 0.01 
6.27 6.25 0.02 6.17 0.1 6.18 0.09 
6.18 6.17 0.01 6.12 0.06 6.14 0.04 
5.27 5.25 0.02 5.32 -0.05 5.34 -0.07 
4.85 4.82 0.03 4.65 0.2 4.59 0.26 
4.63 4.61 0.02 4.63 0 4.57 0.06 
4.53 4.51 0.02 4.37 0.16 4.2 0.33 
3.68 3.66 0.02 3.83 -0.15 3.99 -0.31 







Table 3.2 Comparison of the 13C NMR data of gnetin I to that of carasiphenol C (61) 
Gnetin I Carasiphenol C Δ+0.7 Δ  
162.4 163.1 0.0 -0.7 
159.6 160.3 0.0 -0.7 
159.6 159.6 0.7 0.0 
158.5 158.7 0.5 -0.2 
157.9    
155.8 156.3 0.2 -0.5 
155 156.2 -0.5 -1.2 
155 155.6 0.1 -0.6 
154.8 155.6 -0.1 -0.8 
150 150.7 0.0 -0.7 
145 145.8 -0.1 -0.8 
144.7 145.4 0.0 -0.7 
137.1 138.0 -0.2 -0.9 
136.4 137.0 0.1 -0.6 
132.8 133.5 0.0 -0.7 
128.8 129.6 -0.1 -0.8 
128.4    
128.4 129.4 -0.3 -1.0 
125.4 126.1 0.0 -0.7 
122.9 123.3 0.3 -0.4 
116 116.6 0.1 -0.6 
116 116.5 0.2 -0.5 
115.8 116.2 0.3 -0.4 
115.2 115.6 0.3 -0.4 
107.4    
107.4 107.8 0.3 -0.4 
103.4 103.6 0.5 -0.2 
102.4 102.8 0.3 -0.4 
102.2 102.6 0.3 -0.4 
96.7 97.2 0.2 -0.5 
94.4 95.1 0.0 -0.7 
59.6 60.4 -0.1 -0.8 
59.6 60.3 0.0 -0.7 
56.7 57.4 0.0 -0.7 
53 53.7 0.0 -0.7 






Chapter 2 introduced a reliable method for the elaboration of aromatic bromides on 
resveratrol cores into dihydrobenzofuran units.  The limitation of that work was the inability to 
install those bromides at any position other than that preferred by electrophilic aromatic 
bromination, namely position 1 as denoted in Scheme 3.1 A.  This chapter completes the 
spectrum of functionalizations required for the range of dihydrofuran installation patterns in the 
class by employing some unique directed lithiations to target positions 2 and 3.  Explorations of 
phenol protecting groups for optimal directing effect and for compatibility with the dihydrofuran 
installation sequence have revealed the MOM group as instrumental in functionalizing position 
3.  The most compatible electrophile for the capture of this anion generated at position 3 turned 
out to be the halogen from Br2C2H4.   
By taking advantage of the cooperation between two meta directing groups and using an 
aldehyde as the electrophile trap, we were also able to effect the final functionalization at 
position 2.  Three natural products derived from this regioselective marking method have been 
synthesized to date: gnetin C (2), leachianol D (3) and leachianol E (60).  Our reliable 
dihydrofuran installation method, together with the completely elucidated structure of the trimer 
leachianol D (3), have allowed us to fully assign the configuration of leachianol E (60) as well.          
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3.9 Experimental Procedures  
General Procedures. All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise noted. Dry tetrahydrofuran (THF), 
toluene, benzene, diethyl ether (Et2O) and dichloromethane were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns.  
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated.  Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light as visualizing agent, and an ethanolic solution of 
phosphomolybdic acid and cerium sulfate, and heat as developing agents. SiliCycle silica gel 
(60, academic grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
Preparative thin-layer chromatography separations were carried out on 0.50 mm E. Merck silica 
gel plates (60F-254).  NMR spectra were recorded on Bruker 300, 400, 500, 600 and 800 MHz 
instruments and calibrated using residual undeuterated solvent as an internal reference.  The 
following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = 
triplet, br = broad, app = apparent.  IR spectra were recorded on a Perkin-Elmer 1000 series FT-
IR spectrometer.  High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (fast 
atom bombardment) and APCI (atmospheric pressure chemical ionization) techniques. 
Abbreviations. BnBr = benzyl bromide, DMP = Dess-Martin periodinane, EtOAc = 





quantum coherence, KOtBu = potassium tert-butoxide, Me3SI = trimethylsulfonium iodide, 
MeOH = methanol, MOM = methoxymethyl, MOMCl = chloromethyl methyl ether, N,N-iPr2Net 
= N,N-diisopropylethylamine, NBS = N-bromosuccinimide, nBu4NI = tetrabutylammonium 
iodide, nBuLi = n-butyllithium, PPTS = pyridinium p-toluenesulfonate, sBuLi = sec-
butyllithium, TMEDA = Tetramethylethylenediamine.  
3.9.1 Attempts to Access Ortho-bromophenols 
For monodeprotected ketone 14 please see Chapter 2, compound S14. 
 Monobromide 15.  Ketone 14 (0.029 g, 0.07 mmol, 1.0 equiv) was dissolved in dry 
CH2Cl2 (1.0 mL) and the solution was cooled to –78 ºC.  Solid NBS (0.0086 g, 0.048 mmol, 0.7 
equiv) was added to the solution at –78 ºC.  The reaction was allowed to warm to –30 ºC over 2 
h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (2 mL) and 
saturated aqueous NaHCO3 (2 mL), poured into water (2 mL) and extracted with CH2Cl2 (3 × 5 
mL).  The combined organic layers were washed with water (3 mL) and brine (3 mL), dried 
(MgSO4) and concentrated to afford a crude mixture containing 3:4 ratio of 15:14. 15:  1H NMR 
(300 MHz, CDCl3) δ 10.18 (s, 1 H), 7.04–7.00 (m, 3 H), 6.80 (d, J = 2.4 Hz, 2 H), 6.78–6.74 (m, 
2 H), 6.74 (s, 2 H), 6.58 (d, J = 16.1 Hz, 1 H), 6.54 (t, J = 2.3 Hz, 1 H), 4.04 (s, 3 H), 3.79 (s, 3 






Experimental Scheme 3.1 Structures of bromides S1 and S2 
 
 To verify the structure of ketone 15, the free phenol was protected and the 1H NMR of 
the resulting permethylated monobromide S1 was compared with that of monobromide S2.  As 
expected, the two ketones were not identical.  In addition, the stilbene carbon and hydrogen 
showed HMBC correlations to the unsubstituted aromatic position ortho to the olefin as 
highlighted in Experimental Scheme 3.1.  (Note: Ketone S1 appears to be unstable, so the HSQC 
and the HMBC spectra collected the day following its isolation show additional peaks.)  
Ketone S1.  1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 2.1 Hz, 1H), 7.03–6.97 (m, 2 H), 
6.95 (d, J = 2.3 Hz, 2 H), 6.85–6.79 (m, 2 H), 6.68 (d, J = 16.1 Hz, 1 H), 6.64 (t, J = 2.3 Hz, 1 
H), 4.03 (s, 3 H), 3.79 (d, J = 0.7 Hz, 9 H), 3.73 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 196.3, 
161.0, 159.9, 157.8, 155.8, 139.9, 136.5, 131.6, 129.4, 128.3, 127.3, 122.3, 114.2, 107.6, 106.1, 
105.9, 103.8, 62.4, 56.8, 55.7, 55.5. 
Ketone S2.  1H NMR (400 MHz, CDCl3) δ 7.18 (d, J = 8.7 Hz, 2 H), 6.88–6.81 (m, 3 H), 
6.78 (d, J = 8.8 Hz, 2 H), 6.58 (t, J = 2.3 Hz, 1 H), 6.51 (t, J = 8.2 Hz, 2 H), 3.98 (s, 3 H), 3.78 (s, 





















Experimental Scheme 3.2 Synthesis of derivative 16 
 
Phenol 63.  Phosphonate S3 (0.055 g, 0.125 mmol, 1.0 equiv) was dissolved in dry THF 
(2.0 mL) and the solution was cooled to –78 ºC.  KOtBu (1.0 M in THF, 0.131 mL, 0.131 mmol, 
1.05 equiv).  The anion was allowed to stir at –78 ºC for 30 min.  A solution of aldehyde S4 
(0.020 g, 0.119 mmol, 0.95 equiv) in dry THF (1.0 mL) was added dropwise to the bright yellow 
anion solution and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the 
reaction was quenched with saturated aqueous NH4Cl (3 mL), poured into water (3 mL) and 
extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with water (10 
mL) and brine (10 mL), dried (MgSO4), filtered and concentrated to afford a yellow crude oil.  
This material was purified by flash column chromatography (silica gel, hexanes:EtOAc, 
9:1→7:3) to afford the desired resveratrol derivative S5 (0.051 g, 90% yield).  S5: 1H NMR (400 
MHz, CDCl3) δ 7.51–7.31 (m, 12 H), 7.10–6.98 (m, 3 H), 6.92 (d, J = 16.2 Hz, 1 H), 6.78 (d, J = 
2.2 Hz, 2 H), 6.56 (t, J = 2.2 Hz, 1 H), 5.21 (s, 2 H), 5.09 (s, 4 H), 3.51 (s, 3 H).  Derivative S5 
was initially synthesized for functionalization, however it was unreactive to deprotonations with 
nBuLi and capture with D2O, Br2C2H4 and aldehyde 32.  The MOM group on this derivative was 
surprisingly difficult to deprotect, with various sources of acid, even under heating, only 




















Derivative S5 (0.105 g, 0.23 mmol, 1.0 equiv) was dissolved in MeOH (5.0 mL).  PPTS (0.119 
g, 0.47 mmol, 2.1 equiv) was added to this solution and the reaction was heated to 60 ºC 
overnight.  Upon completion, the reaction was quenched with saturated aqueous NaHCO3 (10 
mL), poured into water (5 mL) and extracted with EtOAc (3 × 15 mL).  The combined organic 
layers were washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and 
concentrated to afford the desired phenol 16 (0.085 g, 90% yield).  16: 1H NMR (400 MHz, 
CDCl3) δ 7.49–7.30 (m, 13 H), 7.01 (d, J = 16.2 Hz, 1 H), 6.88 (d, J = 16.2 Hz, 1 H), 6.82 (d, J = 
8.6 Hz, 2 H), 6.76 (d, J = 2.2 Hz, 2 H), 6.55 (t, J = 2.2 Hz, 1 H), 5.08 (s, 4 H). 
3.9.2 Directed Lithiations on Protected Resveratrol Derivatives 
Monobromide 28.  Permethylated resveratrol 27 (0.075 g, 0.28 mmol, 1.0 equiv) was 
azeotroped with benzene (3 × 5 mL) and dissolved in dry THF (2 mL).  The solution was cooled 
to –25 ºC and TMEDA (0.1 mL, 0.55 mmol, 2.0 equiv) and nBuLi (1.6 M, 0.34 mL, 0.55 mmol, 
2.0 equiv) were added sequentially to the solution.  The dark orange anion solution was allowed 
to warm to –10 ºC over 20 min and Br2C2H4 (0.05 mL, 0.55 mmol, 2.0 equiv) was added 
dropwise.  The reaction was allowed to stir at –10 ºC for 10 min and then was removed from the 
ice bath and allowed to stir at 25 ºC for 30 min.  Upon completion, the reaction was quenched 
with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The combined organic layers were washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered and concentrated to afford a mixture of ~ 1:9 28:27.  28: 1H NMR (400 MHz, 
CDCl3) δ 7.73 (d, J = 2.2 Hz, 1 H), 7.39 (dd, J = 8.6, 2.2 Hz, 1 H), 6.95 (s, 1 H), 6.93–6.85 (m, 2 





Carbamate 31.2  Phenol 16 (0.132 g, 0.32 mmol, 1.0 equiv) was dissolved in pyridine 
(0.5 mL) and diisopropylcarbamoyl chloride (0.053 g, 0.32 mmol, 1.0 equiv) was added to the 
solution.  The reaction mixture was heated to 100 ºC for 18 h.  Upon completion, the reaction 
was cooled, poured into water (5 mL) and extracted with Et2O (3 × 10 ml).  The combined 
organic layers were washed with 1 M HCl solution (2 × 5 mL), 1 M NaOH solution (5 mL), water 
(10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The crude mixture was 
purified by flash column chromatography to afford the desired carbamate 31 (0.053 g, 31% 
yield) as an off-white foam and recovered starting material (0.060 g, 45% yield).  31: 1H NMR 
(400 MHz, CDCl3) δ 7.57–7.27 (m, 13 H), 7.19–7.11 (m, 2 H), 7.08 (d, J = 16.2 Hz, 1 H), 6.98 
(d, J = 16.2 Hz, 1 H), 6.80 (d, J = 2.2 Hz, 2 H), 6.58 (t, J = 2.2 Hz, 1 H), 5.09 (s, 4 H), 4.01 (s, 2 
H), 1.35 (s, 14 H). 
Alcohol 33.3 Carbamate 31 (0.016 g, 0.03 mmol, 1.0 equiv) was azeotroped with benzene 
(3 × 3 mL) and dissolved in dry THF (0.5 mL).  The solution was cooled –78 ºC and 1 drop of 
TMEDA was added.  Then nBuLi (1.6 M, 0.03 mL, 0.048 mmol, 3.0 equiv) was added dropwise 
over 5 min and the anion was allowed to stir at –78 ºC for 30 min.  A solution of aldehyde 32 
(0.010 g, 0.06 mmol, 2.0 equiv) azeotroped in benzene (3 × 1 mL) and dissolved in THF (0.1 
mL) was added dropwise to the anion.  The reaction was allowed to warm to 25 ºC overnight.  
Upon completion, the reaction was quenched with saturated aqueous NH4Cl (3 mL), poured into 
water (3 mL) and extracted with EtOAc (3 × 5 mL).  The combined organic layers were washed 
with water (3 mL) and brine (3 mL), dried (MgSO4), filtered and concentrated.  The crude 
material was purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) 





carbamate 31 (0.037 g, 0.07 mmol, 1.0 equiv) was azeotroped with benzene (3 × 3 mL) and 
dissolved in dry Et2O (0.5 mL).  The solution was cooled –78 ºC and 3 drops of TMEDA were 
added.  Then nBuLi (1.7 M, 0.05 mL, 0.085 mmol, 1.2 equiv) was added dropwise over 5 min 
and the anion was allowed to stir at –78 ºC for 1 h.  A solution of aldehyde 32 (0.023 g, 0.14 
mmol, 2.0 equiv) azeotroped in benzene (3 × 1 mL) and dissolved in THF (0.1 mL) was added 
dropwise to the anion.  The reaction was allowed to warm to 25 ºC overnight.  Upon completion, 
the reaction was quenched with saturated aqueous NH4Cl (3 mL), poured into water (3 mL) and 
extracted with EtOAc (3 × 5 mL).  The combined organic layers were washed with water (3 mL) 
and brine (3 mL), dried (MgSO4), filtered and concentrated.  The crude material was purified by 
preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the desired 
alcohol 33 (0.012 g, 25% yield) as an off-white foam.  33: 1H NMR (400 MHz, CDCl3) δ 7.50–
7.28 (m, 12 H), 7.04 (d, J = 8.3 Hz, 1 H), 6.99 (d, J = 16.3 Hz, 1 H), 6.91 (d, J = 16.3 Hz, 1 H), 
6.74 (d, J = 2.3 Hz, 2 H), 6.59 (dd, J = 2.3, 0.8 Hz, 2 H), 6.54 (t, J = 2.2 Hz, 1 H), 6.38 (t, J = 2.3 
Hz, 1 H), 5.90 (s, 1 H), 5.07 (s, 4 H), 3.98 (d, J = 17.3 Hz, 2 H), 3.78 (s, 6 H), 1.29 (dd, J = 6.8, 
2.2 Hz, 13 H). 
Ketone 34.  Alcohol 33 (0.023 g, 0.033 mmol, 1.0 equiv) was dissolved in CH2Cl2 (2.0 
mL).  Solid NaHCO3 (0.014 g, 0.165 mmol, 5.0 equiv) and Dess-Martin periodinane (0.042 g, 
0.099 mmol, 3.0 equiv) were added sequentially to this solution.  The reaction was allowed to 
stir for 2 h at 25 ºC.  Upon completion, the reaction was quenched with saturated aqueous 
Na2SO3 (3 mL) and saturated aqueous NaHCO3 (3 mL), poured into water (3 mL) and extracted 
with CH2Cl2 (3 × 5 mL).  The combined organic layers were washed with water (5 mL) and brine 





34: 1H NMR (400 MHz, CDCl3) δ 7.68–7.61 (m, 2 H), 7.49–7.30 (m, 10 H), 7.24–7.17 (m, 1 H), 
7.07 (d, J = 16.2 Hz, 1 H), 7.04–6.95 (m, 3 H), 6.77 (d, J = 2.3 Hz, 2 H), 6.65 (t, J = 2.3 Hz, 1 
H), 6.57 (t, J = 2.2 Hz, 1 H), 5.08 (s, 4 H), 3.79 (s, 6 H), 3.75–3.57 (m, 1 H), 1.17 (d, J = 6.8 Hz, 
7 H), 0.98 (d, J = 6.9 Hz, 7 H). 
3.9.3 Synthesis of Protected δ-viniferin (43) 
 
Experimental Scheme 3.3 Synthesis of derivative 36 
 
Brominated resveratrol derivative S7.  A solution of phosphonate S6 (3.15 g, 8.6 
mmol, 1.0 equiv) in dry THF (40 mL) was cooled to –78 ºC.  A solution of KOtBu (1.0 M in 
THF, 9.0 mL, 9.0 mmol, 1.05 equiv) was added dropwise over 5 minutes and the bright yellow 
anion was allowed to stir at that temperature for 30 min.  Then a solution of aldehyde S4 (1.35 g, 
8.2 mmol, 0.95 equiv) in dry THF (10 mL) was added dropwise to the anion solution at –78 ºC 
and the reaction was allowed to warm to 25º C overnight.  Upon completion, the reaction was 
quenched with saturated aqueous NH4Cl (20 mL), poured into water (20 mL) and extracted with 
EtOAc (3 × 50 mL).  The combined organic layers were then washed with water (30 mL), brine 
(30 mL), dried (MgSO4), filtered and concentrated.  The desired product S7 (2.3 g, 71% yield) 
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CDCl3) δ 7.49 (d, J = 8.6 Hz, 2 H), 7.41 (d, J = 16.1 Hz, 1 H), 7.08–7.01 (m, 2 H), 6.97 (d, J = 
16.1 Hz, 1 H), 6.80 (d, J = 2.7 Hz, 1 H), 6.42 (d, J = 2.7 Hz, 1 H), 5.20 (s, 2 H), 3.89 (s, 3 H), 
3.87 (s, 3 H), 3.49 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 159.5, 157.2, 156.80, 138.80, 131.0, 
130.8, 128.1, 126.2, 116.4, 102.4, 98.7, 94.3, 56.2, 56.0, 55.5.  
Resveratrol derivative 36.  A solution of azeotroped brominated resveratrol derivative 
S7 (0.36 g, 0.95 mmol, 1.0 equiv) was dissolved in dry THF (15 mL).  The solution was cooled 
to –78 ºC and a solution of nBuLi (1.6 M in hexanes, 1.2 mL, 1.9 mmol, 2.0 equiv) was added 
dropwise.  The resulting bright yellow solution was allowed to stir at that temperature for 20 min 
and was then quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and 
extracted with CH2Cl2 (3 × 20 mL).  The combined organic layers were then washed with water 
(10 mL), brine (10 mL), dried (MgSO4), filtered and concentrated.  The desired product 36 
(0.205 g, 72% yield) was obtained an off-white foam and did not require further purification.  36: 
1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.7 Hz, 2 H), 7.10–7.00 (m, 3 H), 6.93 (d, J = 16.3 
Hz, 1 H), 6.67 (d, J = 2.3 Hz, 2 H), 6.40 (t, J = 2.3 Hz, 1 H), 5.20 (s, 2 H), 3.83 (s, 6 H), 3.50 (s, 
3 H); 13C NMR (100 MHz, CDCl3) δ 161.0, 157.0, 139.6, 131.0, 128.6, 127.8, 127.0, 116.4, 
104.3, 99.7, 94.3, 56.0, 55.2. 
Monobromide 37.  Resveratrol derivative 36 (0.203 g, 0.68 mmol, 1.0 equiv) was 
azeotroped with benzene (3 × 5 mL) and dissolved in dry THF (3.0 mL).  The solution was 
cooled to –25 ºC and TMEDA (0.36 mL, 2.3 mmol, 3.3 equiv) and nBuLi (1.6 M in hexanes, 1.5 
mL, 2.3 mmol, 3.3 equiv) were added sequentially.  The resulting anion was allowed to stir at –
25 ºC for 2 h.  Br2C2H4 (0.2 mL, 2.3 mmol, 3.3 equiv) was then added dropwise and the reaction 





allowed to stir at 25 ºC for 30 min.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The 
combined organic layers were washed with water (5 mL) and brine (5 mL), dried (MgSO4), 
filtered and concentrated.  The crude material was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the desired monobromide 37 (0.197 g, 
76% yield) and dibromide 38 (0.024 g, 8% yield).  37: 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J 
= 2.2 Hz, 1 H), 7.39 (dd, J = 8.6, 2.2 Hz, 1 H), 6.97 (d, J = 16.3 Hz, 1 H), 6.93–6.82 (m, 2 H), 
6.64 (d, J = 2.3 Hz, 2 H), 6.39 (t, J = 2.3 Hz, 1 H), 3.92 (s, 3 H), 3.83 (s, 7 H).   38: 1H NMR 
(400 MHz, CDCl3) δ 7.75 (d, J = 2.2 Hz, 1 H), 7.38 (dd, J = 8.6, 2.2 Hz, 1 H), 7.15 (d, J = 8.6 
Hz, 1 H), 7.00 (d, J = 16.2 Hz, 1 H), 6.93 (d, J = 16.2 Hz, 1 H), 6.70 (d, J = 3.2 Hz, 2 H), 5.27 (s, 
2 H), 3.95 (s, 7 H), 3.54 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 157.3, 137.7, 132.4, 131.2, 
128.0, 127.7, 127.0, 116.2, 103.0, 95.2, 56.6. 
Alcohol 39.  Monobromide 37 (0.120 g, 0.32 mmol, 1.0 equiv) was azeotroped with 
benzene (3 × 3 mL) and dissolved in dry THF (4.0 mL).  The solution was cooled to –78 ºC and 
nBuLi (1.6 M in hexanes, 0.3 mL, 0.48 mmol, 1.5 equiv) was added to the solution.  The anion 
was allowed to stir at –78 ºC for 20 min.  A solution of aldehyde 32 (0.160 g, 0.96 mmol, 3.0 
equiv), azeotroped with benzene (3 × 3 mL), in dry THF (4.0 mL) was added dropwise and the 
reaction was allowed to warm to 25 ºC overnight.  Upon completion, the reaction was quenched 
with saturated aqueous NH4Cl (10 mL), poured into water (10 mL) and extracted with EtOAc (3 
× 30 mL).  The combined organic layers were washed with water (15 mL) and brine (15 mL), 
dried (MgSO4), filtered and concentrated.  The crude material was purified by flash column 





62% yield).  Alternatively, resveratrol derivative 36 (0.172 g, 0.58 mmol, 1.0 equiv) was 
azeotroped with benzene (3 × 3 mL) and dissolved in dry THF (10 mL).  The solution was 
cooled to –40 ºC and sBuLi (1.7 M in hexanes, 0.5 mL, 0.85 mmol, 1.5 equiv) was added to the 
solution.  The anion was allowed to stir at –40 ºC for 2 h.  A solution of aldehyde 32 (0.193 g, 
1.16 mmol, 2.0 equiv), azeotroped with benzene (3 × 3 mL), in dry THF (3.0 mL) was added 
dropwise and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the 
reaction was quenched with saturated aqueous NH4Cl (10 mL), poured into water (10 mL) and 
extracted with EtOAc (3 × 30 mL).  The combined organic layers were washed with water (15 
mL) and brine (15 mL), dried (MgSO4), filtered and concentrated.  The crude material was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1→3:2) to afford the 
desired alcohol 39 (0.112 g, 41% yield).  39: 1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 2.1 Hz, 
1 H), 7.39 (dd, J = 8.6, 2.2 Hz, 1 H), 7.07 (dd, J = 8.5, 1.7 Hz, 1 H), 7.02 (d, J = 16.3 Hz, 1 H), 
6.91 (d, J = 16.3 Hz, 1 H), 6.64 (d, J = 2.3 Hz, 2 H), 6.59 (d, J = 2.4 Hz, 2 H), 6.52 (d, J = 2.2 
Hz, 4 H), 6.38 (ddd, J = 8.8, 3.9, 1.9 Hz, 4 H), 6.03 (s, 1 H), 5.17 (d, J = 1.7 Hz, 2 H), 3.83 (d, J 
= 0.8 Hz, 5 H), 3.77 (d, J = 1.2 Hz, 6 H). 
 


















Ketone S8.  Alcohol 39 (0.092 g, 0.20 mmol, 1.0 equiv) was dissolved in CH2Cl2 (8.0 
mL) and NaHCO3 (0.033 g, 0.40 mmol, 2.0 equiv) and Dess-Martin periodinane (0.280 g, 0.65 
mmol, 3.3 equiv) were added sequentially.  The reaction was allowed to stir for 2 h at 25 ºC.  
Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (10 mL) and 
NaHCO3 (10 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 30 mL).  The 
combined organic layers were washed with water (10 mL) and brine (10 mL), dried (MgSO4), 
filtered and concentrated.  The crude material was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 4:1→7:3) to afford the desired ketone S8 (0.078 g, 85% yield).  S8: 
1H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 8.7, 2.3 Hz, 1 H), 7.48 (d, J = 2.3 Hz, 1 H), 7.20 (d, 
J = 8.7 Hz, 1 H), 7.04 (d, J = 16.2 Hz, 1 H), 7.00 (d, J = 2.3 Hz, 2 H), 6.94 (d, J = 16.3 Hz, 1 H), 
6.67 (t, J = 2.3 Hz, 1 H), 6.64 (d, J = 2.3 Hz, 2 H), 6.39 (t, J = 2.2 Hz, 1 H), 5.09 (s, 2 H), 3.82 (s, 
6 H), 3.81 (s, 6 H), 3.34 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 196.0, 161.2, 160.9, 154.5, 
139.8, 139.4, 131.2, 130.3, 129.9, 128.4, 127.9, 127.2, 115.5, 107.8, 105.8, 104.6, 100.2, 94.8, 
56.4, 55.8, 55.5. 
Aldehyde 40.  Ketone S8 (0.020 g, 0.043 mmol, 1.0 equiv) was dissolved in dry THF 
(1.0 mL).  To a slurry of Me3SI (0.223 g, 1.09 mmol, 25.0 equiv) in dry THF (2.0 mL) at 0 ºC 
was added nBuLi (1.6 M in hexanes, 0.61 mL, 0.98 mmol, 23.0 equiv).  The ylide was allowed to 
stir at 0 ºC for 2 min and then ketone S8 solution was added dropwise on the sides of the flask.  
The reaction was allowed to stir at 0 ºC for 1 h.  Upon completion, the reaction was quenched 
with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted with EtOAc (3 × 
10 mL).  The combined organic layers were washed with water (5 mL) and brine (5 mL), dried 





(d, J = 2.3 Hz, 1 H), 7.43 (dd, J = 8.6, 2.3 Hz, 1 H), 7.11 (d, J = 8.6 Hz, 1 H), 7.07–6.99 (m, 1 
H), 6.94 (d, J = 16.3 Hz, 1 H), 6.64 (d, J = 2.2 Hz, 2 H), 6.48 (d, J = 2.3 Hz, 2 H), 6.38 (t, J = 2.3 
Hz, 1 H), 6.36 (t, J = 2.3 Hz, 1 H), 5.20 (d, J = 6.8 Hz, 1 H), 5.15 (d, J = 6.7 Hz, 1 H), 3.82 (s, 7 
H), 3.74 (s, 6 H), 3.33 (s, 3 H), 3.30 (d, J = 5.6 Hz, 1 H), 3.22 (d, J = 5.7 Hz, 1 H).  The crude 
epoxide S9 was carried forward without purification.  The resulting epoxide S9 was dissolved in 
benzene (0.5 mL) and ZnI2 (0.020 g, 0.063 mmol, 1.5 equiv) was added to the solution at 25 ºC.  
The reaction was allowed to stir at 25 ºC for 1h.  Upon completion, the reaction was quenched 
with water (5 mL) and extracted with EtOAc (3 × 10 mL).  The combined organic layers were 
washed with water (5 mL) and brine (5 mL), dried (MgSO4), filtered and concentrated.  This 
crude material was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford the desired aldehyde 40 (0.010 g, 48% yield).  40: 1H NMR (400 
MHz, CDCl3) δ 9.95 (d, J = 1.5 Hz, 1 H), 7.43 (dd, J = 8.6, 2.2 Hz, 1 H), 7.20 (d, J = 2.3 Hz, 1 
H), 7.15 (d, J = 8.6 Hz, 1 H), 6.98 (d, J = 16.0 Hz, 1 H), 6.85 (d, J = 16.2 Hz, 1 H), 6.62 (d, J = 
2.3 Hz, 2 H), 6.43–6.41 (m, 1 H), 6.40 (d, J = 2.2 Hz, 2 H), 6.37 (t, J = 2.2 Hz, 1 H), 5.23–5.16 
(m, 2 H), 5.11–5.07 (m, 1 H), 3.82 (s, 6 H), 3.78 (s, 6 H), 3.42 (s, 3 H). 
Protected δ-viniferin 43.  Aldehyde 40 (0.010 g, 0.021 mmol, 1.0 equiv) was azeotroped 
with benzene (3 × 1 mL) and dissolved in dry THF (1.0 mL).  The solution was degassed with 
argon for 10 min.  Grignard reagent 41 (1.0 M in THF, 0.18 mL, 0.18 mmol, 8.5 equiv) was 
added dropwise to the solution and the reaction was allowed to stir at 25 ºC overnight.  Upon 
completion, the reaction was quenched with NH4Cl (5 mL), poured into water (5 mL) and 
extracted with EtOAc (3 ×10 mL).  The combined organic layers were washed with water (5 





purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the 
desired alcohol 42 (0.008 g, 57% yield).  This alcohol was dissolved in dry benzene (1.0 mL) 
and solid ZnCl2 (0.060 g, 0.44 mmol, 36.5 equiv) was added.  The solution was allowed to stir at 
25 ºC for 4 h.  Upon completion, the reaction was quenched with water (5 mL) and extracted 
with CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with water (5 mL) and 
brine (5 mL), dried (MgSO4), filtered and concentrated.  The resulting crude material was 
purified by preparative thin layer chromatography (silica gel, hexanes: EtOAc, 7:3) to afford 
protected δ-viniferin 43 (0.003 g, 42 % yield).  43: 1H NMR (400 MHz, CDCl3) δ 7.49–7.30 (m, 
6 H), 7.20 (s, 1 H), 7.05–6.98 (m, 1 H), 6.98–6.94 (m, 2 H), 6.92 (d, J = 8.3 Hz, 1 H), 6.84 (d, J 
= 16.2 Hz, 1 H), 6.61 (d, J = 2.2 Hz, 2 H), 6.40 (t, J = 2.3 Hz, 1 H), 6.36 (t, J = 2.3 Hz, 1 H), 
6.34 (d, J = 2.3 Hz, 2 H), 5.53 (d, J = 8.3 Hz, 1 H), 5.07 (s, 2 H), 4.49 (d, J = 8.3 Hz, 1 H), 3.81 





3.9.4 Synthesis of a Monomethoxymethyl-protected ε-viniferin Derivative (44) 
 
Experimental Scheme 3.5 Synthesis of derivative 44 
 
Aldehyde 46.  Alcohol S10 (0.373 g, 0.88 mmol, 1.0 equiv) was dissolved in CH2Cl2 (10 
mL), Dess-Martin periodinane (0.576 g, 1.36 mmol, 1.5 equiv) was added to the solution and the 
reaction was allowed to stir at 25 ºC for 15 min.  Upon completion, the reaction was quenched 
with saturated aqueous Na2SO3 (15 mL) and saturated aqueous NaHCO3 (15 mL), poured into 
water (15 mL) and extracted with CH2Cl2 (3 × 30 mL).  The combined organic layers were 
washed with water (15 mL) and brine (15 mL), dried (MgSO4), filtered and concentrated to 
afford the desired aldehyde 46 (0.360 g, 97% yield).  This material was taken forward without 
additional purification.  46: 1H NMR (400 MHz, CDCl3) δ 9.76 (s, 1 H), 7.24 (d, J = 8.6 Hz, 2 














































Hz, 1 H), 6.28 (d, J = 2.3 Hz, 2 H), 5.58 (d, J = 5.6 Hz, 1 H), 4.80 (d, J = 5.6 Hz, 1 H), 3.87 (s, 3 
H), 3.80 (s, 3 H), 3.73 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 190.4, 162.4, 161.6, 161.33, 
159.8, 145.9, 133.2, 133.1, 127.0, 124.0, 114.3, 106.5, 105.9, 102.2, 98.8, 94.0, 56.0, 56.0, 55.4. 
Derivatives S12 and S13.  Phosphonate S11 (1.3 g, 3.63 mmol, 4.1 equiv) was dissolved 
in dry THF (15 mL) and the reaction was cooled to 0 ºC.  KOtBu (1.0 M in THF, 3.73 mL, 3.73 
mmol, 1.0 equiv) was added at 0 ºC and the resulting anion was allowed to stir at that 
temperature for 30 min.  A solution of aldehyde 46 (0.360 g, 0.86 mmol, 0.97 equiv) in dry THF 
(5 mL) was added to the anion at 0 ºC and the resulting reaction was allowed to warm in the 
water bath overnight.  Upon completion, the reaction was quenched with saturated aqueous 
NH4Cl (20 mL), poured into water (20 mL) and extracted with CH2Cl2 (3 × 50 mL).  The 
combined organic layers were washed with water (30 mL) and brine (30 mL), dried (MgSO4), 
filtered and concentrated.  The resulting orange crude mixture was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1→7:3) to afford derivative S12 (0.080 g, 15% 
yield), aldehyde 46 (0.033 g, 9% yield) and desilated product S13 (0.300 g, 68% yield).   S12: 1H 
NMR (400 MHz, CDCl3) δ 7.75–7.67 (m, 11 H), 7.67–7.60 (m, 2 H), 7.46–7.39 (m, 7 H), 7.35 
(dd, J = 7.9, 6.3 Hz, 10 H), 7.30 (t, J = 7.4 Hz, 2 H), 7.27–7.21 (m, 5 H), 7.16 (d, J = 8.6 Hz, 2 
H), 6.99–6.92 (m, 4 H), 6.92–6.82 (m, 7 H), 6.78 (d, J = 16.4 Hz, 2 H), 6.67 (d, J = 2.2 Hz, 2 H), 
6.66–6.61 (m, 4 H), 6.58 (d, J = 8.6 Hz, 1 H), 6.53 (d, J = 16.2 Hz, 2 H), 6.45 (d, J = 2.2 Hz, 2 
H), 6.39 (d, J = 2.2 Hz, 1 H), 6.32 (s, 6 H), 6.29 (t, J = 2.3 Hz, 1 H), 6.15–6.09 (m, 2 H), 5.98 (d, 
J = 12.1 Hz, 1 H), 5.51 (d, J = 5.9 Hz, 2 H), 5.38 (d, J = 6.5 Hz, 1 H), 4.46 (d, J = 5.9 Hz, 2H), 
4.05 (d, J = 6.5 Hz, 1 H), 3.84 (s, 5 H), 3.79 (s, 6 H), 3.73 (s, 3 H), 3.68 (s, 11 H), 3.64 (s, 5 H), 





H), 7.09 (d, J = 8.7 Hz, 2 H), 7.08–7.02 (m, 8 H), 6.97 (d, J = 8.5 Hz, 1 H), 6.87 (dd, J = 8.4, 1.8 
Hz, 10 H), 6.85–6.81 (m, 4 H), 6.74–6.67 (m, 12 H), 6.59 (s, 2 H), 6.58–6.54 (m, 3 H), 6.47 (d, J 
= 2.2 Hz, 4 H), 6.44 (d, J = 2.3 Hz, 1 H), 6.36 (s, 13 H), 6.33–6.29 (m, 1 H), 6.24 (d, J = 12.1 
Hz, 1 H), 6.17 (d, J = 2.3 Hz, 2 H), 6.06 (d, J = 12.1 Hz, 1 H), 5.52 (d, J = 6.0 Hz, 4 H), 5.39 (d, 
J = 5.5 Hz, 1 H), 4.50 (d, J = 6.0 Hz, 4 H), 3.93 (d, J = 5.5 Hz, 1 H), 3.86 (s, 12 H), 3.80 (d, J = 
1.5 Hz, 16 H), 3.73 (s, 25 H), 3.71 (s, 5 H), 3.71 (s, 3 H).   
Derivative 44.  Phenol S13 (0.300 g, 0.59 mmol) was dissolved in dry acetone (5 mL) 
and solid K2CO3 (1.3 g, 9.4 mmol, 16 equiv) and MOMCl (1.1 mL, 14.5 mmol, 24.6 equiv) were 
added sequentially to the solution at 25 ºC.  The reaction was allowed to stir for 30 min.  Upon 
completion, the reaction was quenched with NaHCO3 (30 mL), poured into water (30 mL) and 
extracted with CH2Cl2 (3 × 50 mL).  The combined organic layers were washed with saturated 
aqueous NH4Cl (20 mL), water (20 mL) and brine (20 mL), dried (MgSO4), filtered and 
concentrated.  The resulting crude material was purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 9:1→7:3) to afford the desired 44 (0.108 g, 33% yield) and unreacted 
starting material S13 (0.160 g, 53% yield).  The reaction was stopped at an incomplete 
conversion due to the formation of a baseline decomposition spot on TLC at reaction times 
longer than 30 min.  The recovered phenol S13 could, however, be recycled.  44: 1H NMR (400 
MHz, CDCl3) δ 7.33–7.24 (m, 2 H), 7.19–7.08 (m, 2 H), 6.97–6.92 (m, 2 H), 6.92–6.84 (m, 3 H), 
6.75 (d, J = 2.2 Hz, 1 H), 6.63 (d, J = 16.3 Hz, 1 H), 6.49 (d, J = 2.2 Hz, 1 H), 6.38 (s, 3 H), 5.54 
(d, J = 6.1 Hz, 1 H), 5.16 (s, 2 H), 4.54 (d, J = 6.1 Hz, 1 H), 3.87 (s, 3 H), 3.81 (s, 3 H), 3.75 (s, 6 





135.4, 133.8, 131.2, 129.4, 127.8, 127.1, 123.9, 119.8, 116.4, 114.2, 106.1, 102.7, 99.1, 95.3, 
94.4, 93.2, 57.1, 56.1, 55.7, 55.5, 55.4. 
3.9.5 Explorations on Permethoxymethyl-protected Resveratrol (54) 
Protected resveratrol (54).  Resveratrol (1, 0.250 g, 1.1 mmol, 1.0 equiv) was dissolved 
in dry CH2Cl2 (20 mL) and N,N-diisopropylethylamine (1.7 mL, 9.9 mmol, 9.0 equiv) and 
MOMCl (0.75 mL, 9.9 equiv, 9.0 equiv) were added sequentially.  The reaction was allowed to 
stir at 25 ºC overnight.  Upon completion, the reaction was quenched with saturated aqueous 
NaHCO3 (15 mL), poured into water (15 mL) and extracted with CH2Cl2 (3 × 20 mL).  The 
combined organic layers were washed with water (10 mL) and brine (10 mL), dried (MgSO4), 
filtered and concentrated.  The crude material was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 9:1→7:3) to afford the desired product 54 (0.203 g, 51% yield).  54: 
Rf = 0.50 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3007, 2954, 2901, 2826, 2072, 1999, 
1696, 1593, 1510, 1441, 1400, 1291, 1238, 1204, 1148, 1080, 1031, 999, 966, 923, 840, 771, 
684, 655, 614, 518 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.44 (d, J = 8.7 Hz, 2 H), 7.06-7.00 (m, 3 
H), 6.91 (d, J = 16.3 Hz, 1 H), 6.85 (d, J = 2.2 Hz, 2 H), 6.64 (t, J = 2.2 Hz, 1 H), 5.19 (s, 6 H), 
3.50 (s, 6 H), 3.49 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 158.6, 157.1, 139.9, 131.2, 129.0, 
127.9, 126.9, 116.6, 107.8, 104.2, 94.6, 94.5, 56.2, 56.2. 
Bromide 57.  Protected resveratrol 54 (0.021 g, 0.06 mmol, 1.0 equiv) was azeotroped in 
benzene (3 × 2 mL) and dissolved in dry THF (0.5 mL).  nBuLi (2.5 M in hexanes, 0.04 mL, 0.1 
mmol, 1.7 equiv) was added to the solution at 25 ºC and the reaction was allowed to stir at that 
temperature for 15 min before the addition of Br2C2H4 (0.002 mL, 0.23 mmol, 3.9 equiv) was 





quenched with saturated aqueous NH4Cl (2 mL), poured into water and extracted with CH2Cl2 (3 
× 5 mL).  The combined organic layers were washed with water (3 mL) and brine (3 mL), dried 
(MgSO4), filtered and concentrated to afford a 1:1.4 mixture of 57:54.  The crude mixture was 
purified by preparative thin layer chromatography (silica gel, CHCl3:hexanes, 4:1) to afford the 
desired bromide 57 (0.014 g, 53% yield).  57: Rf = 0.53 (silica gel, hexanes:EtOAc, 7:3); IR 
(film) νmax 2954, 2900, 2826, 2790, 2071, 1998, 1589, 1510, 1494, 1440, 1400, 1314, 1290, 
1238, 1204, 1141, 1079, 1024, 994, 963, 921, 839, 772, 684, 655, 613, 505 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.72 (d, J = 2.2 Hz, 1 H), 7.36 (dd, J = 8.6, 2.2 Hz, 1 H), 7.13 (d, J = 8.5 Hz, 1 
H), 6.96 (d, J = 15.4 Hz, 1 H), 6.90 (d, J = 16.3 Hz, 1 H), 6.84 (d, J = 2.2 Hz, 2 H), 6.65 (t, J = 
2.2 Hz, 1 H), 5.26 (s, 2 H), 5.19 (s, 4 H), 3.53 (s, 3 H), 3.50 (s, 6 H); 13C NMR (125 MHz, 
CDCl3) δ 158.7, 153.4, 139.4, 132.7, 131.2, 128.2, 127.5, 126.9, 116.2, 113.3, 107.9, 104.6, 95.2, 
94.6, 56.6, 56.2; HRMS (FAB+) calcd for C20H23O6Br+ [M+] 438.0678, found 438.0693 (for 
79Br). 
Shorter anion formation.  Protected resveratrol 54 (0.108 g, 0.31 mmol, 1.0 equiv) was 
azeotroped in benzene (3 ×5 mL) and dissolved in dry THF (3 mL).  nBuLi (2.5 M in hexanes, 
0.21 mL, 0.51 mmol, 1.7 equiv) was added to the solution at 25 ºC and the reaction was allowed 
to stir at that temperature for 2 min before the addition of Br2C2H4 (0.002 mL, 0.23 mmol, 3.9 
equiv) was added.  The resulting reaction was stirred at 25 ºC for 5 h.  Upon completion, the 
reaction was quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and 
extracted with CH2Cl2 (3 × 15 mL).  The combined organic layers were washed with water (10 
mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  The crude mixture was 





desired bromide 57 (0.0231 g, 17% yield), bromide S14 (0.024 g, 18% yield), dibromide S15 
(0.0144 g, 9% yield), as well as unreacted starting material 54 (0.021 g, 19%). 
 
Experimental Scheme 3.6 Structure of bromides S14 and S15 
 
Bromide S14.  Rf = 0.47 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2955, 2904, 
2850, 2827, 2071, 1697, 1509, 1494, 1465, 1432, 1391, 1314, 1237, 1203, 1151, 1107, 1081, 
1040, 998, 921, 869, 838, 785, 760, 718, 694, 654, 619, 516 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.44 (d, J = 8.6 Hz, 2 H), 7.08-7.00 (m, 3 H), 6.98 (s, 2 H), 6.89 (d, J = 16.3 Hz, 1 H), 5.30 (s, 4 
H), 5.20 (s, 2 H), 3.55 (s, 6 H), 3.49 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 157.3, 155.2, 138.3, 
130.9, 129.3, 128.0, 126.3, 116.6, 107.5, 102.6, 100.1, 95.3, 94.5, 56.6, 56.2. 
Dibromide S15.  Rf = 0.50 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2956, 2908, 
2851, 2828, 2071, 1698, 1578, 1493, 1465, 1431, 1391, 1311, 1276, 1245, 1204, 1152, 1107, 
1086, 1039, 982, 921, 861, 827, 760, 716, 673, 646, 628, 575, 524 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.73 (d, J = 2.1 Hz, 1 H), 7.37 (dd, J = 8.6, 2.2 Hz, 1 H), 7.13 (d, J = 8.6 Hz, 1 H), 6.98 
(s, 2 H), 6.95 (s, 1 H), 6.89 (d, J = 16.3 Hz, 1 H), 5.30 (s, 4 H), 5.27 (s, 2 H), 3.55 (s, 6 H), 3.53 
(s, 3 H); 13C NMR (125 MHz, CDCl3) δ 155.2, 153.5, 137.8, 132.4, 131.3, 127.9, 127.7, 127.0, 
116.2, 113.4, 107.6, 103.1, 100.1, 95.3, 95.2, 56.6. 















Experimental Scheme 3.7 Synthesis of ketone S16 from bromide 57 
 
Alcohol 58.  Bromide 57 (0.016 g, 0.036 mmol, 1.0 equiv) was dissolved in dry THF (1 
mL) and the solution was cooled to –78 ºC.  nBuLi (2.5 M in hexanes, 0.03 mL, 0.075 mmol, 2.1 
equiv) was added to the solution and the reaction was allowed to stir for 2 min.  A solution of 
aldehyde 55 (0.0165 g, 0.073 mmol, 2.0 equiv) in dry THF (0.5 mL) was added to the anion at –
78 ºC and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the reaction 
was quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted 
with CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with water (5 mL) and 
brine (5 mL), dried (MgSO4), filtered and concentrated.  The crude mixture was purified to 
afford the desired alcohol 58 (0.007 g, 33% yield), as well as protected resveratrol 54 (0.007 g, 
56% yield).  58: 1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 2.3 Hz, 1 H), 7.37 (dd, J = 8.6, 2.3 
Hz, 1 H), 7.07 (d, J = 8.5 Hz, 1 H), 7.02 (d, J = 16.3 Hz, 1 H), 6.91 (d, J = 16.3 Hz, 1 H), 6.84 (d, 
J = 2.2 Hz, 2 H), 6.77 (dd, J = 2.2, 0.6 Hz, 2 H), 6.64 (s, 1 H), 6.63 (d, J = 2.2 Hz, 1 H), 6.02 (s, 































NMR (125 MHz, CDCl3) δ 158.6, 158.4, 154.0, 146.2, 139.9, 132.7, 131.3, 129.0, 127.3, 127.1, 
126.1, 114.5, 108.3, 107.9, 104.3, 103.7, 71.9, 56.2. 
Addition of the anion into aldehyde 55.  Protected resveratrol 54 (0.085 g, 0.23 mmol, 
1.0 equiv) was dissolved in dry THF (2 mL) and nBuLi (2.5 M in hexanes, 0.09 mL, 0.23 mmol, 
1.0 equiv) was added to the solution at 25 ºC.  The anion was allowed to form for 15 min.  A 
solution of aldehyde 55 (0.035 g, 0.65 mmol, 2.8 equiv) in dry THF (1.0 mL) was added to the 
anion and the reaction was allowed to stir overnight.  Upon completion, the reaction was 
quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted with 
CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with water (5 mL) and brine (5 
mL), dried (MgSO4), filtered and concentrated.  The crude mixture was purified to afford the an 
inseparable ~1:1 mixture of alcohols 56:58 (0.024 g, 18% yield).  The mass balance was 
unreacted started material.  (Note: Alcohol 56 was confirmed to be present in the mixture by 
comparing this crude NMR with one of the pure compound provided by Ms. Pei Gan.) 
Ketone S16.  Alcohol 58 (0.007 g, 0.012 mmol, 1.0 equiv) was dissolved in CH2Cl2 (2 
mL) and solid NaHCO3 (0.009 g, 0.0065 mmol, 5.4 equiv) and Dess-Martin periodinane (0.012 
g, 0.028 mmol, 2.4 equiv) were added sequentially.  The reaction was allowed to stir at 25 ºC for 
15 min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) 
and saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 
× 15 mL).  The combined organic layers were washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered and concentrated.  The crude material was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford the desired ketone S16 (0.005 g, 71% 





2071, 1999, 1670, 1589, 1492, 1450, 1399, 1290, 1245, 1211, 1141, 1106, 1079, 1023, 980, 920, 
865, 838, 803, 780, 736, 685, 621, 551, 515 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.55 (dd, J = 
8.7, 2.3 Hz, 1 H), 7.48 (d, J = 2.3 Hz, 1 H), 7.20 (d, J = 8.6 Hz, 1 H), 7.16 (d, J = 2.3 Hz, 2 H), 
7.09-6.98 (m, 1 H), 6.98-6.88 (m, 2 H), 6.84 (d, J = 2.2 Hz, 2 H), 6.64 (t, J = 2.2 Hz, 1 H), 5.18 
(s, 4 H), 5.17 (s, 4 H), 5.09 (s, 2 H), 3.49 (s, 6 H), 3.46 (s, 6 H), 3.35 (s, 3 H); 13C NMR (100 
MHz, CDCl3) δ 195.4, 158.7, 158.3, 154.7, 139.6, 131.1, 130.1, 128.1, 128.1, 127.4, 115.5, 
111.3, 109.7, 108.0, 104.5, 94.9, 94.7, 56.3, 56.2; HRMS (FAB+) calcd for C31H36O11+ [M+] 
584.2258, found 584.2247. 
3.9.6 Synthesis of Leachianols D (3) and E (60) 
 
 
Experimental Scheme 3.8 Supplementary structures for the synthesis of leachianols D (3) and E 
(60) 
 
Monobromide 63.  Permethylated pallidol (62, 0.012 g, 0.022 mmol, 1.0 equiv) was 
azeotroped with benzene (3 × 1 mL) and dissolved in dry THF (1 mL) at 25 ºC.  TMEDA (0.08 



































the solution and the anion was allowed to form for 20 min at 25 ºC.  Br2C2H4 (4 µL, 0.044 mmol, 
2.0 equiv) was added and the reaction mixture was allowed to stir for an additional 1 h.  The 
reaction was quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and 
extracted with EtOAc (3 × 5 mL).  The combined organic layers were washed with water (5 mL), 
brine (5 mL), dried (MgSO4), filtered and concentrated.  The resultant light yellow oil was 
purified by preparative plate chromatography (silica gel, hexanes:EtOAc 7:3) to afford the 
desired monobromide 63 (0.002 g, 14% yield) as a light yellow amorphous solid as well as 
recovered starting material 62 (0.010 g, 83% yield) as a light pink amorphous solid.  63: Rf = 
0.49 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2923, 2852, 1719, 1601, 1510, 1490, 1464, 
1328, 1249, 1175, 1143, 1111, 1035, 833 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.06 (d, J = 8.8 Hz, 
2 H), 7.05 (d, J = 8.4 Hz, 2 H), 6.82 (s, 1 H), 6.80 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 
6.66 (d, J = 1.6 Hz, 1 H), 6.26 (d, J = 2.0 Hz, 1 H), 5.39 (s, 1 H), 4.68 (s, 1 H), 4.54 (s, 1 H), 3.98 
(s, 1 H), 3.95 (s, 3 H), 3.85 (s, 3 H), 3.76 (s, 6 H), 3.61 (s, 3 H), 3.48 (s, 3 H); 13C NMR (100 
MHz, CHCl3) δ 161.5, 158.2, 158.0, 157.2, 148.7, 148.2, 143.5, 138.4, 138.0, 137.9, 137.2, 
130.0, 128.4, 128.3, 124.9, 114.0, 113.9, 102.2, 100.4, 97.9, 60.1, 59.7, 59.7, 59.7, 56.7, 55.8, 
55.4, 55.4, 54.6, 54.0; HRMS could not be obtained.   
Alcohol 64.  Permethylated pallidol (62, 0.244 g, 0.453 mmol, 1.0 equiv) was azeotroped 
with benzene (3 × 5 mL), dissolved in dry THF (9 mL) and cooled to –40 ºC.  TMEDA (1.06 
mL, 7.1 mmol, 16.0 equiv) and nBuLi (1.6 M in hexanes, 0.58 mL, 0.928 mmol, 2.0 equiv) were 
added dropwise and the reaction mixture was warmed to –20 ºC over 90 min and then kept at –
20 ºC for 2 h.  A solution of 3,5-dimethoxybenzaldehyde (32, 0.753 g, 4.6 mmol, 10.0 equiv) 





The reaction was then allowed to warm to 25 ºC overnight.  The reaction was quenched with 
saturated aqueous NH4Cl (10 mL), poured into water (10 mL) and extracted with EtOAc (3 × 15 
mL).  The combined organic layers were then washed with water (10 mL) and brine (10 mL), 
dried (MgSO4), filtered and concentrated.  The resultant crude oil was purified by flash 
chromatography (silica gel, hexanes:EtOAc, 9:1→1:1) to afford the desired alcohol 64 product 
as a mixture of diastereomers (0.185 g, 58% yield), as well as recovered starting material (0.04 g, 
16% yield).  64: 1H NMR (400 MHz, CDCl3) δ 7.05 (dd, J = 8.9, 2.2 Hz, 3 H), 7.03–6.96 (m, 1 
H), 6.89 (d, J = 2.9 Hz, 1 H), 6.82–6.75 (m, 4 H), 6.66 (d, J = 2.0 Hz, 1 H), 6.47 (dt, J = 2.3, 1.2 
Hz, 2 H), 6.28 (dt, J = 7.7, 2.2 Hz, 2 H), 6.08 (d, J = 11.8 Hz, 1 H), 6.03 (d, J = 11.6 Hz, 1 H), 
4.68 (d, J = 7.2 Hz, 1 H), 4.57 (d, J = 4.6 Hz, 1 H), 4.03–3.91 (m, 2 H), 3.85 (dd, J = 5.1, 2.6 Hz, 
6 H), 3.78-3.74 (m, 6 H), 3.70 (d, J = 1.1 Hz, 6 H), 3.64 (d, J = 2.9 Hz, 3 H), 3.35 (s, 1 H), 3.23 
(s, 1 H).  The diol 65 was often isolated as a side product from this reaction.  To confirm its 
structure, this material was oxidized to the symmetrical ketone S17.  S17:  1H NMR (400 MHz, 
CDCl3) δ 7.08 (d, J = 8.7 Hz, 2 H), 7.02 (d, J = 2.4 Hz, 3 H), 6.97 (d, J = 2.3 Hz, 2 H), 6.86 (s, 1 
H), 6.85–6.78 (m, 2 H), 6.71 (t, J = 2.4 Hz, 1 H), 6.62 (t, J = 2.3 Hz, 1 H), 4.69 (s, 1 H), 4.10 (s, 
1 H), 3.85 (s, 9 H), 3.80 (s, 3 H), 3.77 (s, 3 H), 3.76 (s, 6 H), 3.31 (s, 3 H).   
 Ketone S18.  Alcohol 64 (0.185 mg, 0.262 mmol, 1.0 equiv) was dissolved in CH2Cl2 
(20 mL), and solid NaHCO3 (135 mg, 1.6 mmol, 6.0 equiv) and Dess-Martin periodinane (0.625 
g, 1.5 mmol, 5.7 equiv) were added sequentially at 25 ºC.  The reaction was stirred at 25 ºC for 2 
h.  Upon completion the reaction was quenched with saturated aqueous Na2SO3 (20 mL) and 
saturated aqueous NaHCO3 (20 mL), poured into water and extracted with EtOAc (3 ×40 mL).  





(MgSO4), filtered and concentrated.  The resulting crude oil was purified by flash 
chromatography (silica gel, hexanes:EtOAc, 9:1→3:1) to afford ketone S18 (0.180 mg, 98% 
yield) as an amorphous white solid.  S18: Rf = 0.56 (silica gel, hexanes:EtOAc, 7:3); IR (film) 
νmax 3003, 2935, 2836, 1674, 1599, 1510, 1462, 1426, 1406, 1325, 1300, 1249, 1204, 1175, 
1156, 1143, 1108, 1082, 1064, 1034, 940, 832, 558 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.08 (d, J 
= 8.8 Hz, 2 H), 7.05 (d, J = 8.4 Hz, 2 H), 6.95 (d, J = 2.4 Hz, 2 H), 6.89 (s, 1 H), 6.81 (d, J = 8.4 
Hz, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 6.66 (d, J = 1.6 Hz, 1 H), 6.61 (t, J = 2.4 Hz, 1 H), 6.31 (d, J 
= 1.6 Hz, 1 H), 4.68 (s, 1 H), 4.61 (s, 1 H), 4.04 (d, J = 6.8 Hz, 1 H), 4.02 (d, J = 6.8 Hz, 1 H), 
3.87 (s, 3 H), 3.79 (s, 3 H), 3.77 (s, 3 H), 3.76 (s, 3 H), 3.75 (s, 6 H), 3.66 (s, 3 H), 3.29 (s, 3 H); 
13C NMR (125 MHz, CHCl3) δ 195.4, 161.6, 160.8, 158.3, 158.1, 158.1, 157.2, 154.7, 150.7, 
148.3, 140.0, 137.9, 137.8, 129.1, 128.3, 128.2, 125.0, 121.7, 114.1, 113.9, 107.4, 105.9, 102.5, 
100.4, 97.9, 61.3, 59.8, 59.7, 56.3, 55.8, 55.6, 55.4 (2 C), 55.4, 54.5, 53.9; HRMS (FAB+) calcd 
for C43H42O9+ [M+] 702.2829, found 702.2853. 
Deprotected Ketone S19.  Permethylated ketone S18 (0.110 g, 0.156 mmol, 1.0 equiv) 
was dissolved in CH2Cl2 (1.5 mL), transferred to a sealed tube, and then BBr3 (1.0 M in CH2Cl2, 
5.5 mL, 5.5 mmol, 35.0 equiv) was added quickly in a single portion at 25 °C.  The resulting 
orange reaction mixture was then heated at 70 °C for 48 h.  Upon completion, the reaction 
contents were cooled to 25 °C, diluted with EtOAc (5 mL) and quenched with water (10 mL).  
After stirring the resultant biphasic mixture for 15 min at 25 °C, the reaction contents were 
extracted with EtOAc (5 × 10 mL).  The combined organic layers were washed with water (5 
mL) and brine (5 mL), dried (MgSO4), filtered, and concentrated.  The resultant ketone S19 





(500 MHz, Acetone-d6) δ 7.07–7.04 (m, 2 H), 7.04–7.00 (m, 2 H), 6.81 (s, 1 H), 6.78–6.73 (m, 5 
H), 6.68 (d, J = 2.2 Hz, 3 H), 6.51 (t, J = 2.2 Hz, 1 H), 6.28 (d, J = 2.0 Hz, 1 H), 4.67 (s, 1 H), 
4.64 (s, 1 H), 3.91 (s, 2 H).  
Perbenzylated Ketone 66.  The crude deprotected ketone S19 (0.080 g, 0.135 mmol, 1.0 
equiv) was dissolved in dry acetone (5 mL) and solid K2CO3 (0.800 g, 5.789 mmol, 43 equiv), 
BnBr (0.8 mL, 6.735 mmol, 50.0 equiv) and nBu4NI (0.113 g, 0.3 mmol, 2.3 equiv) were added 
sequentially at 25 ºC.  The reaction was then heated at 70 ºC overnight and then cooled back to 
25 ºC and quenched with saturated aqueous NH4Cl (20 mL).  The biphasic mixture was then 
extracted with CH2Cl2 (3 × 40 mL), washed with water (10 mL) and brine (10 mL), dried 
(MgSO4), filtered and concentrated.  The resulting crude yellow oil was purified by flash 
chromatography (silica gel, hexanes:EtOAc, 19:1→4:1) to afford the perbenzylated ketone 66 
(0.125 g, 71% yield).  66: Rf = 0.93 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3094, 3066, 
3031, 2916, 2873, 1674, 1600, 1508, 1454, 1373, 1298, 1243, 1174, 1151, 1101, 1028, 831, 736, 
696 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.45–7.43 (m, 4 H), 7.39–7.38 (m, 8 H), 7.36–7.29 (m, 14 
H), 7.24–7.18 (m, 4 H), 7.17–7.06 (m, 8 H), 7.04–6.98 (m, 6 H), 6.90 (d, J = 8.8 Hz, 2 H), 6.89 
(d, J = 8.8 Hz, 2 H), 6.85 (s, 1 H), 6.83 (d, J = 6.8 Hz, 2 H), 6.76 (t, J = 2.4 Hz, 1 H), 6.69 (d, J = 
1.2 Hz, 1 H), 6.38 (d, J = 1.6 Hz, 1 H), 5.06 (s, 2 H), 5.05 (d, J = 2.8 Hz, 2 H), 4.98 (s, 4 H), 4.94 
(s, 2 H), 4.93 (s, 2 H), 4.83 (s, 2 H), 4.62 (s, 1 H), 4.59 (d, J = 7.6 Hz, 1 H), 4.58 (s, 1 H), 4.21 
(d, J = 10.4 Hz, 1 H), 4.11 (d, J = 7.2 Hz, 1 H), 4.06 (d, J = 6.8 Hz, 1 H); 13C NMR (100 MHz, 
CHCl3) δ 195.1, 160.5, 159.8, 157.4, 157.3, 157.2, 155.9, 153.7, 150.8, 148.0, 140.4, 138.1, 
138.1, 137.2, 137.0, 136.9, 136.9, 136.6, 136.5, 128.6, 128.5, 128.5, 128.3, 128.3, 128.2, 128.0, 





99.6, 75.5, 70.5, 70.4, 70.1, 70.0, 69.9, 69.4, 60.1, 59.4, 54.7, 54.4; LRMS calcd for C91H74O9+ 
[M+] 1310.53, found 1310.83. 
Perbenzylated Aldehyde 67.  nBuLi (1.6 M in hexanes, 3.7 mL, 5.92 mmol, 42.0 equiv) 
was added to a slurry of Me3SI (1.670 g, 8.18 mmol, 58.0 equiv) in THF (12 mL) cooled to 0 ºC 
and the reaction was stirred at that temperature for 2 min.  A solution of perbenzylated ketone 66 
(0.185 g, 0.141 mmol, 1.0 equiv) in THF (12 mL) was precooled to 0 ºC and added dropwise on 
the sides of flask over 2 min and the reaction was stirred at 0 ºC for 1 h.  Upon completion, the 
reaction contents were quenched with saturated aqueous NH4Cl (10 mL) and extracted with 
EtOAc (3 × 40 mL).  The combined organic layers were then washed with water (10 mL) and 
brine (10 mL), dried (MgSO4), filtered, and concentrated.  The resultant epoxide was carried 
forward without purification.  This epoxide was dissolved in dry benzene (12 mL) and ZnI2 
(0.385 g, 1.20 mmol, 8.5 equiv) was added as a solid.  The reaction was allowed to stir at 25 ºC 
for 1 h.  Upon completion, the reaction was quenched with water (5 mL) and extracted with 
EtOAc (3 × 20 mL).  The combined organic layers were washed with water (5 mL) and brine (5 
mL), dried (MgSO4), filtered and concentrated.  The resulting yellow oil was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 19:1→4:1) to afford aldehyde 67 (0.121 g, 
65% yield over 2 steps) as a mixture of diastereomers (~1.0:1.0 as determined by 1H NMR).  The 
stereoisomers could not be separated at this stage by flash column chromatography, so they were 
was carried forward as a mixture.  67: Rf = 0.95 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 
2960, 2923, 2858, 1726, 1602, 1454, 1381, 1244, 1178, 1148 cm-1; 1H NMR (400 Hz, CDCl3) 
δ 9.77 (s, 1 H), 9.72 (s, 1 H), 7.46–7.44 (m, 8 H), 7.41–7.36 (m, 18 H), 7.34–7.28 (m, 31 H), 





6.72 (broad s, 1 H), 6.70 (d, J = 1.6 Hz, 1 H), 6.47 (d, J = 2.4 Hz, 4 H), 6.42 (d, J = 2.0 Hz, 4 H), 
5.07–5.05 (m, 13 H), 4.98-4.94 (m, 5 H), 4.88 (d, J = 4.4 Hz, 2 H), 4.85 (d, J = 2.4 Hz, 2 H), 
4.83–4.69 (m, 10 H), 4.67 (d, J = 7.6 Hz, 2 H), 4.59 (d, J = 4.0 Hz, 2 H), 4.49 (d, J = 11.6 Hz, 1 
H), 4.26 (d, J = 10.4 Hz, 1 H), 4.23 (d, J = 10.8 Hz, 1 H), 4.09–4.06 (m, 3 H); 13C NMR (125 
MHz, CHCl3) δ 201.3, 200.9, 160.7, 160.0, 159.9, 157.7, 157.6, 157.4, 157.3, 156.2, 156.1, 
156.1, 155.0, 154.5, 149.5, 149.5, 148.3, 148.3, 140.2, 140.0, 138.4, 138.3, 138.2, 137.8, 137.4, 
137.2, 137.2, 137.0, 136.5, 136.5, 129.7, 128.7, 128.7, 128.6, 128.6, 128.6, 128.4, 128.3, 128.2, 
128.1, 128.0, 128.0, 127.9, 127.9, 127.8, 127.8, 127.7, 127.6, 127.6, 127.3, 126.0, 120.6, 119.9, 
115.2, 114.9, 108.4, 108.2, 104.4, 104.3, 101.9, 101.4, 101.1, 99.7, 74.8, 74.2, 71.0, 70.9, 70.6, 
70.6, 70.3, 70.2, 70.1, 70.0, 70.0, 69.7, 69.6, 60.4, 60.4, 59.3, 55.7, 55.3 (2 C), 55.1, 54.7, 54.5 (2 
C); LRMS calcd for C92H76O9+ [M+] 1324.55, found 1324.38. 
Alcohols 68a and 68b.  To a degassed solution of aldehyde 67 (0.057 g, 0.043 mmol, 1.0 
equiv, 1.0:1.0 mixture of diastereomers) in THF (2 mL) at 25 °C was added 4–
benzyloxyphenylmagnesium bromide (1.0 M in THF, 0.35 mL, 0.35 mmol, 8.0 equiv), and the 
resultant reaction mixture was stirred for 45 min at 25 °C.  Upon completion, the reaction 
contents were quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL), and 
extracted with EtOAc (3 × 10 mL).  The combined organic layers were washed with water (5 
mL) and brine (5 mL), dried (MgSO4), filtered, and concentrated.  The resultant crude product 
was purified by preparative thin layer chromatography (silica gel, hexanes:CHCl3, 1:1, 2:3, 3:7 – 
2 runs at each polarity) to afford 68a (0.017 g, 26% yield) and 68b (0.017 g, 26% yield) as off-





Leachianols D (3) and E (60).  Alcohol 68a (14.0 mg, 0.009 mmol, 1.0 equiv) was 
dissolved in a mixture of 1:1 EtOAc:MeOH (4 mL total) and solid Pd/C (30%, 14.0 mg) was 
added. H2 was then bubbled directly through the stirred reaction mixture for 30 min.  Additional 
MeOH was added to replace any evaporated solvent to rereach ~4 mL reaction volume.  The 
reaction was then stirred under H2 for 12 h.  Upon completion, the reaction solution was filtered 
through simple filtration paper to remove Pd/C and washed with MeOH (3 × 3 mL).  Upon 
concentration of the organic layer the desired deprotected alcohol 69a was obtained (0.006 g, 
93% yield).  69a: Rf = 0.13 (silica gel, CH2Cl2:MeOH, 4:1); IR (film) νmax 3349, 2958, 2923, 
2854, 1702, 1601, 1512, 1461, 1376, 1260, 1172, 1043, 836 cm-1; 1H NMR (400 Hz, acetone-d6) 
δ 7.10 (d, J = 8.4 Hz, 2 H), 6.96–6.94 (m, 4 H), 6.82 (d, J = 8.0 Hz, 2 H), 6.71 (d, J = 8.8 Hz, 2 
H), 6.70 (s, 1 H), 6.68 (d, J = 8.4 Hz, 2 H), 6.50 (s, 1 H), 6.49 (d, J = 2.0 Hz, 1 H), 6.21 (d, J = 
1.6 Hz, 1 H), 6.15 (t, J = 2.0 Hz, 1 H), 5.53 (broad s, 1 H), 5.05 (d, J = 3.2 Hz, 1 H), 4.61 (s, 1 
H), 4.51 (s, 1 H), 3.77 (d, J = 6.8 Hz, 1 H), 3.71 ( d, J = 6.4 Hz, 1 H); 13C NMR (100 MHz, 
acetone-d6) δ 159.4, 158.9 (2 C), 157.5, 157.4, 157.0, 156.3, 156.2, 155.4, 150.6, 147.4, 145.8, 
138.0, 134.8, 129.4, 129.0, 129.0, 128.1, 123.3, 115.9, 115.8 (2 C), 115.8, 115.2, 108.3, 103.6, 
102.6, 101.3, 77.8, 60.5, 60.5, 55.1, 54.0, 49.2; HRMS could not be obtained.  Amberlite (IR-
12OH, 0.050 g, pre-washed with MeOH × 5) was added to a solution of alcohol 68a (0.006 g, 
0.009 mmol, 1.0 equiv) in MeOH (2 mL) and the resultant mixture was stirred at 25 °C for 2.5 h.  
Upon completion, the solution was filtered through simple filtration paper to remove the 
Amberlite, and the filtrate was concentrated directly to afford a mixture of leachianol D (3) and 
leachianol E (60) (0.005 g, 86 % yield), which were separated by preparative thin layer 





and leachianol E (60, 0.003 g, 51% yield).  3: Rf = 0.20 (silica gel, CH2Cl2:MeOH, 4:1); IR 
(film) νmax 3349, 2958, 2923, 2854, 1702, 1601, 1512, 1461, 1376, 1260, 1172, 1045, 836 cm-1; 
1H NMR (500 Hz, acetone-d6) δ 7.22 (d, J = 8.5 Hz, 2 H), 7.05 (d, J = 8.5 Hz, 2 H), 7.01 (d, J = 
8.5 Hz, 2 H), 6.84 (d, J = 8.5 Hz, 2 H), 6.77 (s, 1 H), 6.75 (d, J = 7.5 Hz, 2 H), 6.73 (d, J = 8.5 
Hz, 2 H), 6.68 (s, 1 H), 6.26 (d, J = 1.5 Hz, 1 H), 6.22 (t, J = 2.0 Hz, 1 H), 6.16 (d, J = 2.0 Hz, 2 
H), 5.36 (d, J = 5.5 Hz, 1 H), 4.69 (s, 1 H), 4.67 (s, 1 H), 4.41 (d, J = 5.0 Hz, 1 H), 3.88 (d, J = 
6.0 Hz, 1 H), 3.85 (d, J = 6.5 Hz, 1 H); 13C NMR (150 MHz, acetone-d6) δ 162.8, 159.6, 159.4, 
158.2, 156.4, 155.4, 151.5*, 150.6, 150.2, 146.2, 137.7, 137.1, 133.8, 129.3, 129.1, 128.1, 124.6, 
123.3, 116.1, 115.9, 115.8, 114.9, 106.7, 103.3, 102.6, 102.0, 97.7, 94.2, 61.0, 60.4, 55.7, 53.9, 
53.5 (Note: the starred peak not reported by the isolation team, but was confirmed to be a part of 
the structure by HMBC); HRMS could not be obtained.  60: Rf = 0.15 (silica gel, CH2Cl2:MeOH, 
4:1); IR (film) νmax 3348, 2958, 2923, 2854, 1701, 1611, 1602, 1512, 1457, 1448, 1375, 1362, 
1340, 1241, 1171, 1134, 1044, 1014, 1004, 836 cm-1; 1H NMR (500 Hz, acetone-d6) δ 7.09 (d, J 
= 8.0 Hz, 2 H), 7.05 (d, J = 8.0 Hz, 2 H), 6.80 (d, J = 8.0 Hz, 2 H), 6.77 (d, J = 8.5 Hz, 2 H), 6.76 
(d, J = 8.5 Hz, 2 H), 6.71 (broad s, 1 H), 6.70 (broad s, 1 H), 6.66 (d, J = 8.5 Hz, 2 H), 6.30 (s, 1 
H), 6.22 (s, 1 H), 6.18 (s, 2 H), 5.38 (d, J = 4.0 Hz, 1 H), 4.63 (s, 1 H), 4.61 (s, 1 H), 4.24 (d, J = 
4.0 Hz, 1 H), 4.03 (d, J = 6.5 Hz, 1 H), 3.99 (d, J = 6.5 Hz, 1 H); 13C NMR (125 MHz, acetone-
d6) δ 159.6 (2 C), 158.3, 157.6, 156.7, 156.4, 155.5, 155.5, 150.5, 150.4, 146.6, 138.0, 137.7, 
134.4, 129.3, 129.0, 126.9, 123.3, 119.3, 116.0, 115.9, 115.9, 114.6, 106.6, 104.7, 103.5, 102.8, 
101.9, 93.4, 61.0, 60.4, 56.8, 54.9, 54.8; HRMS (FAB) calcd for C42H32O9+ [M+] 680.2046, 
found 680.2070.  The spectroscopic data for 3 and 60 match that reported by Ohyama and co-





Experimental Table 3.1 Comparison of 1H NMR for leachianol D (3) 
1H Literature 1H Observed 
Chemical Shift Appearance Chemical Shift Chemical Shift 
7.18 d, J = 8.0 Hz, 2 H 7.22 d, J = 8.5 Hz, 2 H 
7.01 d, J = 8.0 Hz, 2 H 7.05 d, J = 8.5 Hz, 2 H 
6.97 d, J = 9.0 Hz, 2 H 7.01 d, J = 8.5 Hz, 2 H 
6.8 d, J = 8.0 Hz, 2 H 6.84 d, J = 7.5 Hz, 2 H 
6.73 broad s, 1 H 6.77 broad s, 1 H 
6.71 d, J = 8.0 Hz, 2 H 6.75 d, J = 7.5 Hz, 2 H 
6.69 d, J = 9.0 Hz, 2 H 6.73 d, J = 8.5 Hz, 2 H 
6.64 broad s, 1 H 6.68 broad s, 1 H 
6.21 broad s, 1 H 6.26 d, J = 1.5 Hz, 1 H 
6.17 m, 1 H 6.22 t, J = 2.0 Hz, 1 H 
6.12 broad s, 2 H 6.16 d, J = 2.0 Hz, 2 H 
5.32 d, J = 6.0 Hz, 1 H 5.36 d, J = 5.5 Hz, 1 H 
4.65 s 4.69 s 
4.63 s 4.67 s 
4.37 d, J = 6.0 Hz, 1 H 4.41 d, J = 5.0 Hz, 1 H 
3.83 d, J = 7.0 Hz, 1 H 3.88 d, J = 6.0 Hz, 1 H 







Experimental Table 3.2 Comparison of 13C NMR for leachianol D (3) 











































Experimental Table 3.3 Comparison of 1H NMR for leachianol E (60) 
1H Literature 1H Observed 
Chemical Shift Appearance Chemical Shift Chemical Shift 
7.06 d, J = 9.0 Hz, 2 H 7.09 d, J = 8.0 Hz, 2 H 
7.01 d, J = 8.0 Hz, 2 H 7.05 d, J = 8.0 Hz, 2 H 
6.76 d, J = 9.0 Hz, 2 H 6.80 d, J = 8.0 Hz, 2 H 
6.73 d, J = 8.0 Hz, 2 H 6.76 d, J = 8.5 Hz, 2 H 
6.73 d, J = 8.0 Hz, 2 H 6.77 d, J = 8.5 Hz, 2 H 
6.67 broad s, 1 H 6.71 broad s, 1 H 
6.66 broad s, 1 H 6.70 broad s, 1 H 
6.62 d, J = 8.0 Hz, 2 H 6.66 d, J = 8.5 Hz, 2 H 
6.26 broad s, 1 H 6.30 broad s, 1 H 
6.18 m, 1 H 6.22 broad s, 1 H 
6.14 d, J = 2.0 Hz, 2 H 6.18 broad s, 2 H 
5.34 d, J = 4.0 Hz, 1 H 5.38 d, J = 4.0 Hz, 1 H 
4.59 s, 1 H 4.63 s, 1 H 
4.57 s, 1 H 4.61 s, 1 H 
4.20 d, J = 4.0 Hz, 1 H 4.24 d, J = 4.0 Hz, 1 H 
3.99 d, J = 7.0 Hz, 1 H 4.03 d, J = 6.5 Hz, 1 H 







Experimental Table 3.4 Comparison of 13C NMR for leachianol E (60) 
13C Literature 13C Observed 
159.6 







































“Iso-leachianols” D (70) and E (71).  Alcohol 68b (13.0 mg, 0.009 mmol, 1.0 equiv) 
was dissolved in a mixture of 1:1 EtOAc:MeOH (4 mL total) and solid Pd/C (30%, 13.0 mg) was 
added.  H2 was then bubbled directly through the stirred reaction mixture for 30 min.  Additional 
MeOH was added to replace any evaporated solvent to rereach ~4 mL reaction volume.  The 
reaction was then stirred under H2 for 12 h.  Upon completion, the reaction solution was filtered 
through simple filtration paper to remove Pd/C and washed with MeOH (3 × 3 mL).  Upon 
concentration of the organic layer the desired deprotected alcohol 69b was obtained (0.006 g, 
99% yield).  69b: Rf = 0.13 (silica gel, CH2Cl2:MeOH, 4:1); IR (film) νmax 3340, 2962, 2924, 
2854, 1703, 1600, 1511, 1446, 1376, 1338, 1260, 1171, 1044, 1001, 836, 570, 536 cm-1; 1H 
NMR (500 Hz, acetone-d6) δ 7.19 (d, J = 8.0 Hz, 2 H), 6.98 (d, J = 8.5 Hz, 2 H), 6.76 (d, J = 8.0 
Hz, 2 H), 6.71 (d, J = 8.5 Hz, 2 H), 6.68–6.62 (m, 3 H), 6.60 (broad s, 1 H), 6.48 (d, J = 1.5 Hz, 
1 H), 6.23 (d, J = 1.5 Hz, 1 H), 6.16 (t, J = 1.5 Hz, 1 H), 5.64 (d, J = 3.0 Hz, 1 H), 5.12 (d, J = 
4.0 Hz, 1 H), 4.59 (s, 1 H), 4.56 (s, 1 H), 3.77 (d, J = 5.5 Hz, 1 H), 3.66 (broad s, 1 H); 13C NMR 
(125 MHz, acetone-d6) δ 159.3, 158.9, 157.0, 156.3, 156.3, 156.2, 155.4, 155.3, 155.3, 150.4, 
148.0, 145.3, 137.9, 134.9, 129.2, 129.0, 128.9, 128.5, 127.9, 123.4, 116.0, 115.8, 115.3, 114.9, 
108.2, 103.4, 102.6, 101.2, 76.9, 61.2, 60.1, 53.8 (2 C), 48.2; HRMS could not be obtained   
Amberlite (IR-12OH, 0.050 g, pre-washed with MeOH × 5) was added to a solution of alcohol 
68b (0.006 g, 0.009 mmol, 1.0 equiv) in MeOH (2 mL) and the resultant mixture was stirred at 
25 °C for 2.5 h.  Upon completion, the solution was filtered through simple filtration paper to 
remove the Amberlite, and the filtrate was concentrated directly to afford a mixture of “iso-
leachianol D” (70) and iso-“leachianol E” (71) (0.005 g, 86 % yield), which were separated by 





leachianol D” (70, 0.003 g, 51% yield) and “iso-leachianol E” (71, 0.002 g, 26% yield).  70: Rf = 
0.20 (silica gel, CH2Cl2:MeOH, 4:1); IR (film) νmax 3350, 2962, 2923, 2856, 1702, 1601, 1511, 
1452, 1375, 1341, 1258, 1171, 1079, 1045, 999, 835, 537 cm-1; 1H NMR (500 Hz, acetone-d6) 
 δ 7.24 (d, J = 8.0 Hz, 2 H), 7.06 (d, J = 8.0 Hz, 2 H), 7.01 (d, J = 8.0 Hz, 2 H), 6.87 (d, J = 8.5 
Hz, 2 H), 6.78 (s, 1 H), 6.76 (d, J = 8.5 Hz, 2 H), 6.73 (d, J = 8.5 Hz, 2 H), 6.65 (s, 1 H), 6.30 (s, 
1 H), 6.20 (d, J = 2.0 Hz, 1 H), 6.13 (s, 2 H), 5.40 (d, J = 5.5 Hz, 1 H), 4.70 (s, 1 H), 4.61 (s, 1 
H), 4.37 (d, J = 5.5 Hz, 1 H), 3.92 (d, J = 5.0 Hz, 1 H), 3.87 (d, J = 6.5 Hz, 1 H); 13C NMR (125 
MHz, acetone-d6) δ 162.7, 159.6 (2 C), 159.5, 158.2, 156.5, 156.4, 155.5, 151.2, 150.3, 145.7, 
137.8, 137.6, 133.8, 129.1, 129.1, 128.0, 125.2, 123.2, 116.2, 115.9, 115.9, 115.4, 106.9, 103.4, 
102.8, 102.1, 97.9, 94.2, 60.8, 60.7, 56.1, 54.3, 53.9; HRMS could not be obtained.  71: Rf = 0.15 
(silica gel, CH2Cl2:MeOH, 4:1); IR (film) νmax 3348, 2958, 2923, 2854, 1703, 1602, 1512, 1448, 
1375, 1340, 1259, 1170, 1092, 1044, 1001, 835, 691, 612, 542 cm-1; 1H NMR (500 Hz, acetone-
d6) δ 7.13 (d, J = 8.5 Hz, 2 H), 7.10 (d, J = 9.0 Hz, 2 H), 7.03 (d, J = 8.5 Hz, 2 H), 6.80 (d, J = 
7.0 Hz, 2 H), 6.79 (d, J = 8.0 Hz, 2 H), 6.75 (d, J = 8.5 Hz, 2 H), 6.73 (s, 1 H), 6.69 (s, 1 H), 6.26 
(s, 1 H), 6.25 (s, 1 H), 6.17 (d, J = 1.5 Hz, 2 H), 5.24 (d, J = 5.5 Hz, 1 H), 4.63 (s, 1 H), 4.59 (s, 1 
H), 4.39 (d, J = 6.0 Hz, 1 H), 3.94 (d, J = 6.0 Hz, 1 H), 3.90 (d, J = 6.5 Hz, 1 H); 13C NMR (125 
MHz, acetone-d6) δ 159.5 (2 C), 158.5, 158.2, 156.5, 156.4, 155.4, 155.2, 151.0, 150.3, 146.3, 
137.7, 137.5, 133.7, 129.1, 129.0, 128.3, 123.3, 118.3, 116.1, 115.9 (2 C), 114.8, 107.0, 104.8, 
103.4, 102.6, 101.9, 94.2, 61.1, 60.5, 56.1, 54.2, 54.0; HRMS could not be obtained. 
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Chapter 4 -  Explorations into the Selectivity of Permethylated Ampelopsin F in 







 In Chapter 2, we employed the power of electrophilic aromatic bromination to install 
functional handles that were elaborated into dihydrofuran units on various cores of the 
resveratrol family.  Attempts to regioselectively functionalize permethylated ampelopsin F (1) 
yielded two interesting observations: 1) the consistent selectivity of all neutral brominating 
reagents for ring A (Figure 4.1), and 2) a complete switch of this selectivity to ring B in the 
reaction with bromodiethylsulfonium bromopentachloroantimonate (BDSB), a novel 
electrophilic bromine source developed by our group.  Exploitation of these complementary 
preferences has enabled the syntheses of two monobromides (2 and 3 in Figure 4.3 B), each of 
which was further elaborated into a trimeric resveratrol natural product.  Several conjectural 
hypotheses for the origin of this divergent regioselectivity are examined in this chapter.  
Ampelopsin F derivatives, as well as the permethylated versions of the dimer heimiol A (7), the 
trimer carasiphenol B (56) and the polyphenolic cassigarol B (8) were employed in our attempts 
to correlate the structural parameters of the substrates with their regioselectivity towards either 
NBS or BDSB.  Throughout the chapter, unless otherwise noted, the ratios of monobromides 
presented were calculated from the integral ratios in the crude NMR.     
 From the data we have collected so far, we believe that the preference for reactivity of 
ring A stems from a combination of factors, including steric accessibility of the incoming 
electrophile, and a productive interaction between the halogen atom and the methoxy group 
highlighted in Figure 1.1.  The carbonyl group oxygen of the N-haloimides and amides employed 
could also be participating in an interaction with the bisbenzylic C-H bond, further stabilizing the 





 The larger BDSB reagent is less likely to be able to approach ring A in a way that would 
allow it to benefit from the stabilization of the adjacent methoxy and C-H functional groups.  
This novel reagent could, however, take advantage of its cationic nature to use ring C in a 
halonium-π interaction and thus facilitate electrophile attack by ring B.  Data correlating the 
selectivity in bromination reactions with the electronics of ring C in three ampelopsin F 
derivatives supports this hypothesis.  The acidic conditions of the reaction with BDBS, a reagent 
that does not have a competent basic counterion, could also contribute to its unique selectivity, 
however probing this hypothesis has proved quite difficult.  In short, we believe the electrophilic 
aromatic substitution of the ampelopsin F bicyclic core (1) is likely influenced by multiple subtle 
effects, contributing to various degrees, and we will proceed to detail these hypotheses and the 
experiments conducted to assess their validity.    
 
Figure 4.1 Selectivity of electrophilic brominations on permethylated ampelopsin F (1) 
 
4.2 Selectivity of Neutral Electrophilic Bromination Reagents  
Permethylated ampelopsin F (1) is a protected resveratrol dimer with two dimethoxy, 
dialkyl-substituted aromatic rings (rings A and B, as labeled in Figure 4.2).  These aryl rings are 



















seen in Chapter 2, using 2 or fewer equivalents of bromine sources.  Theoretical calculations do 
not distinguish between the nucleophilicity of the two aryl rings; however, the majority of 
electrophilic bromination reagents in practice prefer ring A.   
 
Figure 4.2 Optimized geometry of permethylated ampelopsin F (1) 
 
The three-dimensional model of this dimer, and its Avogadro-optimized geometry, 
indicate the most favorable conformation to be that shown in Figure 4.2.  The bicyclic core 
resembles a propellane configuration, as shown in the Avogadro picture, with three potential 
angles of electrophile approach.  The first is approach between rings A and B (arrows 1 and 3 in 
Figure 4.3).  This appears to be the least hindered approach with a dihedral angle of ~110º 
between the two aryl rings.  The second approach towards ring A (arrow 2) is also plausible, as 
ring D points away from the trajectory of the electrophile.  Lastly, electrophiles may approach 
ring B (arrow 4) in between rings B and C, as the latter is twisted away from the nucleophilic 























Figure 4.3 A: Sterically reasonable directions of electrophile attack for 1; B: Monobromides 
derived from 1 and reagents that selectively generate 2 
 
In short, while it is difficult to appraise the facial bias of attack for a given nucleophilic 
ring, ring A appears to be more accessible than ring B (Figure 4.3 A) on accounts of the steric 
influence of ring C.  Indeed, as shown in Chapter 2, numerous brominating reagents (Figure 4.3 
B) delivered monobromide 2 exclusively, with no trace of 3.  Thus, the nucleophilic position on 
ring A of 1 could be the kinetic site of reactivity in electrophilic aromatic bromination due to its 
accessibility, however, no calculations as of yet support this tentative assignment.  Furthermore, 
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the perfect levels of selectivity observed for this position in the permethylated compound (1) 
could have other contributing factors, as the difference in approachability of the two rings does 
not appear to be substantial.  
The nucleophilic carbon on ring A, while potentially more accessible than that on ring B, 
bears a more hindered substituent.  This is due to the presence of the methoxy group on ring B 
(Figure 4.4), and to an A1,3 interaction between the aromatic proton that would need to be 
substituted and the one on the ortho aliphatic carbon (H1 and H2 highlighted in pink in Figure 
4.4).  On ring B, the steric constraints are much smaller, with no methoxy group pointing 
towards the reactive position, and a more staggered relationship between H3 and H4 shown in 
Figure 4.4.  From these considerations, the sterically less encumbered product should arise from 
functionalization of ring B.  
 




















The reagents that prefer to react on ring A (Figure 4.3 B) all carry basic counterions, 
making the rearomatization step reasonably fast and potentially keeping the formation of the 
arenium ion the rate determining step.  With such a reactive nucleophilic aryl ring, the notion 
that the reaction could be under kinetic control appears reasonable, while, once again, 
unsupported by theoretical calculations to date.  NCS and NIS, reagents analogous to NBS but 
bearing different electrophilic atoms, display selectivities in agreement with arenium formation 
being the rate-determining step (Figure 4.5).  The highly reactive NCS delivers chloride 4, while 
the larger and less reactive NIS generates a mixture (3:1), favoring the less sterically hindered 6 
over 5.   
 
Figure 4.5 Products of the reaction of 1 with NCS and NIS 
 
Whether the inherent electrophile reactivity or its size is the cause of this dichotomy is 
difficult to appraise.  The methoxy group on ring B pointing towards the nucleophilic position on 
ring A could act as a halogen bond acceptor towards incoming electrophiles and increase the 
local concentration of reagent (Figure 4.6).  As such, relatively small electrophiles, such as 
chlorine and bromine, could benefit from this interaction, while the larger iodine might not be 
able to do so, thus decreasing their selectivity for ring A.  The nucleophilic position on ring B 
does not benefit from such a nearby directing group, making it less reactive if this type of 


























halogen bonding for the regioselectivity of the ampelopsin F core (1), we will first introduce this 
relatively novel type of intermolecular bonding and discuss relevant findings for the specific 
interaction we propose.   
 
Figure 4.6 Potential halogen bonding interaction favoring ring A for electrophilic halogenation 
 
4.2.1 Halogen Bonding 
Conventionally, halogens are assigned a partial negative charge when bound to carbon 
atoms, an electron distribution that explains their ability to act as hydrogen bond acceptors, as 
well as the electrophilicity of the adjacent carbon atom.  Attractive interactions of halogens with 
Lewis bases cannot be explained by this classical theory and require the consideration of an 
anisotropic distribution of electrons in the bound halogen atoms.1  The region of partial positive 
charge shown in Figure 4.7 has been called a σ-hole and is positioned diametrically opposite the 
covalent bond.2  While the IUPAC definition of the halogen bond has not yet been released, the 
working definition in the field comes from the work of Legon and states that “the halogen bond 
is an attractive interaction between a halogen atom X from a molecule or fragment R-X in which 
R is more electronegative than X or X itself, and an atom or group of atoms A in the same 















often, the halogen bond acceptor is a Lewis base, with the acceptor ability increasing in the order 
π-system < O sp2 < O sp3 S < N, and the donor one in the order F << Cl < Br < I.1  
 
Figure 4.7 Erdelyi's anisotropic electron distribution in bound halogen atoms 
 
This non-covalent bond has been observed spectroscopically by UV-Vis,4 IR,5,6 and more 
recently by NMR.7  The characterization of the exact type of interaction is still being debated, 
with an electrostatic model based on the correlation between the electrostatic potential surfaces 
of halogen bond acceptors and their binding energy proposed by Politzer,2 and with a charge 
transfer complex supported and developed on the pioneering work done by Mulliken in the 
1950’s.8  Inorganic acceptors such as I2 have been shown to be better characterized by a charge-
transfer complex, while organic acceptors like I-CN and I-alkynyl have been often attributed to 
electrostatic interactions.6  
Arenes are known to form charge transfer complexes with halogens in non-polar 
solvents, particularly with the polarizable halogen sources such as Br2 and I2.9  These donor-
acceptor complexes are important in the formation of the arenium ion intermediates, as supported 
by a linear correlation between the activation energy of electrophilic bromination reactions and 
the charge transfer transition energy (Scheme 4.1).10  Essentially the charge transfer leads to a 
destabilization of both the HOMO of the arene and of the LUMO of bromine, facilitating the 














Scheme 4.1 Charge transfer complex as pre-reactive intermediate in electrophilic aromatic 
bromination 
 
Initial X-ray crystallographic studies on the structure of the bromine-benzene charge 
transfer complex revealed a delocalized interaction with the bromine molecule almost 
perpendicular to the plane of the benzene and centered along the C6 axis.12  Since that initial 
discovery, it has been shown that while the original structure is accurate at 230 K.  At lower 
temperatures (120 K), the structure displays over-the-rim coordination with a hapticity of 
η = 1.70 - 1.86 (Figure 4.8 A)..11  The analogous complex of toluene with bromine displays 
similar structural characteristics, this time with the shortest distance between the proximal 
bromine atom and the electronically rich ortho and para positions (Figure 4.8 B).  The distances 
between the bromine atom and the nearest carbon are significantly shorter than the sum of their 
van de Waals radii, which would be 3.55 Å (Figure 4.8), supporting the presence of an attractive 
interaction.11  The highly localized nature of these interactions above the most nucleophilic 
positions is analogous to that of the transition state for the electrophilic bromination reaction, 
further supporting the involvement of the donor acceptor complex as a pre-reactive intermediate 















Figure 4.8 A: Structure for the benzene•Br2 charge complex at 120 K; B: Structure for the 
benzene•Br2 charge complex at 120 K 
 
The distance between the bromine atom and the acceptor varies with the strength of the 
acceptor, and thus with the strength of the interaction.13  As evidenced by numerous examples, n-
type acceptors are preferred over π-acceptors, both in interactions with molecular bromine and 
with CBr4.9b  The crystals obtained upon addition of hexanes to CCl4 solutions of CBr4 with 2,6-
dimethylnaphtalene (DMN) and with 9,10-dimethoxy-1,4;5,8-dimethano-1,2,3,4,5,6,7,8-
octahydroanthracene (DMA) both reveal the formation of chains of alternating donor and 
acceptor molecules (Figure 4.9).  While in DMN only π-type acceptors are available (Figure 4.9 
A), in DMA, where both aryl rings (π-acceptors) and the methoxy groups (n-acceptor) are 
present, the preference for the latter is clear (Figure 4.9 B).  The distance between the bromine 
atom and the aryl π-acceptor in DMN is longer than that between the bromine atom and the 
oxygen n-type acceptor in DMA (3.324 Å vs. 2.821 Å), once again supporting a stronger 



















Figure 4.9 A: X-ray crystal structure of the CBr4 complex with DMN; B: X-ray crystal structure 
of the CBr4 complex with DMA 
 
Table 4.1 Distance between the bromine atom and the halogen bond acceptor in complexes with 
molecular bromine 
Halogen 
Acceptor Bond Measured Bond Length Sum of van der Waals Radii 
benzene C – Br 3.18-3.36 Å  3.55 Å 
toluene C – Br 3.20-3.29 Å  3.55 Å 
acetone O – Br 2.82 Å  3.37 Å 
acetonitrile N – Br 2.84 Å  3.40 Å 
 
The interaction of the bromine atom in NBS with halogen bond acceptors has been 
proposed based on X-ray crystal structures of complexes of this reagent with strong nitrogen 
Lewis bases, such as 1,4-diazobicyclo[2.2.2]octane (DABCO) and hexamethylenetetramine 
(HMTA).14  In these complexes, the distance between the bromine atom and the nitrogen atom is 
~30% shorter than the sum of the van der Waals radii, adding further evidence to the hypothesis 
of an attractive interaction.  In addition, ab initio calculations support the stronger halogen bond 
with a halogen attached to a nitrogen atom that with one attached to a carbon atom,15 consistent 
with the electrostatic σ-hole theory.2  Overall, the interaction energies for NBS with different 













Table 4.2 Interaction energy for NBS with various Lewis bases 








4.2.2 Halogen Bonding as a Potential Explanation for the Intrinsic Selectivity of 
Ampelopsin F for Ring A 
As shown above, halogen bonding between NBS and n-type nitrogen-based halogen 
acceptors has been observed by X-ray crystallography.14  Looking at Table 4.1, which shows a 
correlation between the length of the halogen bond and the acceptor strength, in particular the 
last two entries (Br-acetonitrile distance 2.84 Å, Br-acetone distance 2.82 Å), it is reasonable to 
assume that an n-type oxygen-based donor could also interact with N-haloimides.  Furthermore, 
theoretical calculations suggest a binding energy between NBS and an ether acceptor to be in the 
–7.26 kcal/mol range (Table 4.2).15  Therefore, our N-haloimides and amides (NBS, NBA and 
NBSac) could benefit from this type of intermolecular attractive interaction to increase the local 
concentration of halogenating reagent close to the nucleophilic position on ring A because of the 
proximal methoxy group.  While several such groups are present on this resveratrol dimer, the 
one on ring B, pointing towards ring A, is the only one with a proper orientation close to one of 
the potential and likely reactive sites on the molecule (Figure 4.6 and 4.10).  This fact is a 





the halogen’s covalent bond with its halogen bond in order to ensure the donation of the Lewis 
base into the σ-hole (Figure 4.7).  While the σ-hole on molecular bromine and TBCO is probably 
smaller, as the halogen atom is not attached to an electronegative atom like in the N-haloimides, 
halogen bonding with oxygen acceptors has been shown for these types of reagents as well, with 
a higher charge transfer character.9a  Therefore, every neutral electrophilic bromine source 
attempted is a viable candidate for halogen bonding.   
 
Figure 4.10 Sterically accessible and halogen bonding-assisted nucleophilic carbons on 
resveratrol dimers (1 and 7) and on the polyphenolic derivative cassigarol B (8) 
 
In the case of permethylated ampelopsin F (1), the more sterically accessible position is 
the same as the one that could be aided by halogen bonding (Figure 4.10).  A similar example is 
the core of heimiol A (7), which also reacts with NBS to from monobromide 9 in 97% yield, 






























































reactive position on ring B and thus further hinders this ring’s ability to attack an electrophile 
from the top face, making the preference for ring A more pronounced.  In addition, ring A on this 
core (7) can also benefit from halogen bonding (Figure 4.10), reinforcing the preference for that 
nucleophilic position.  In the case of permethylated cassigarol B (8, Figure 4.10), however, the 
sterically preferred position is clearly that on ring B, with the reactive position removed from the 
bridgehead.  Indeed this position is preferred by 3:1 over that on ring A (Scheme 4.2).  However, 
the formation of monobromide 11 supports the ability of halogen bonding of NBS with methoxy 
group on ring B (Figure 4.10) facilitating reaction on ring A and thus yielding some of this 
sterically disfavored product.   
 
Scheme 4.2 Bromination of permethylated heimiol A (7) and cassigarol B (8) with NBS 
 
4.2.3 Synthesis and Selective Bromination of Simplified Ampelopsin F Analogs 
 Ampelopsin F derivatives 13–15, 17 and 18 (Scheme 4.3) were synthesized in order to 
attempt to further understand and explore the relationship between the selectivity of electrophilic 























Reagents and conditions: a) NBS (0.9 equiv), CH2Cl2, -78 to 25 ºC, 5 h, 97% yield;  b) NBS (0.7 equiv), 






































sterics for the observed selectivity for ring A in 1 (Figure 4.10) we attempted to disfavor attack 
from that position.  We believe this goal could be accomplished by either increasing the steric 
strain of ring A, in structures 17 and 18, or by decreasing that of ring B, in derivatives 13, 14 and 
15 (Scheme 4.3). 
 
Scheme 4.3 Synthesis of ampelopsin F derivatives 13–15, 17 and 18 
 
 During the development of his synthesis of permethylated heimiol A (7), Dr. Nathan 
Wright accessed alcohol 13 (Scheme 4.3) as a side product and optimized the conditions for its 
efficient production.16  This compound can be synthesized in two steps from ketone 12 by a 
Corey-Chaykovsky epoxidation, followed by zinc iodide-induced double cyclization.  Simple 
oxidation of alcohol 13 afforded ketone 14.  The reduction of this ketone occurs from the more 
accessible face, leading to alcohol 15, the diastereomer of the original alcohol 13.  Addition of 4-
methoxyphenylmagnesium bromide (16) into ketone generates derivative 17.  Another important 






















































Reagents and conditions: a) Me3SI (10.5 equiv), nBuLi (1.6 M in hexanes, 8.8 equiv), THF, 0 ºC, 2 min, then 12, 0 ºC, 3h; b) ZnI2 
(0.8 equiv), benzene, 3 h, 49% yield over 2 steps; c) DMP (1.7 equiv), NaHCO3, CH2Cl2, 25 ºC, 3 h, then DMP (0.6 equiv), 25 ºC, 
1 h, 51% yield; d) NaBH4 (10.0 equiv), MeOH:CH2Cl2 10:1, 25 ºC, 45 min, 97% yield; e) 16 (3.0 equiv), THF, 25 ºC, overnight, 87% 





















ampelopsin F (1).16  This compound could be accessed by the ionization of the benzylic alcohol 
in 17, followed by the reduction of the ensuing quinonemethide from the more accessible side, 
namely that above ring B.          
All of the above derivatives also showed a preference for ring A, in the bromination 
reactions with NBS (Figure 4.11).  Of the substrates that were supposed to generate more steric 
strain for attack by ring A, alcohol 17 showed no decrease in selectivity, most likely due to the 
potent directing effects of the hydroxyl group.  The diastereomer of ampelopsin F (18), however, 
generated a 2:1 mixture of monobromides, with ring A still favored but with lower selectivity 
than in the case of 1.  This observation supports the importance of the steric accessibility for the 
selectivity observed on 1.  Derivatives 13, 14 and 15 all showed at least a strong preference for 
ring A, even though ring B is, in these cases, significantly more accessible.  The only one that 
showed any bromination of ring B was alcohol 13, an effect which, once again, can be explained 
by the directing ability of the neighboring alcohol being a significant contributing factor to 
selectivity.   
 
































































 The proposed halogen bonding interaction between the methoxy group on ring B and the 
brominating reagents, an intermolecular attractive force that could increase the local 
concentration around that nucleophilic position on ring A, could be preserved in all of these 
derivatives as well.  The selectivities exhibited by the derivatives in Figure 4.11 support the 
potential involvement of halogen bonding in directing bromination, oftentimes at the sterically 
disfavored position.  Thus, while the steric accessibility of ring A is likely a contributing factor 
in the selectivity observed on permethylated ampelopsin F (1), halogen bonding may also 
contribute to the excellent selectivity, being reinforcing.  This interaction is also expected to be 
activating the electrophile, as shown in the extensive body of work by Denmark17, thus leading 
not only to a higher local concentration of reagent, but also to a more reactive species.  In 
addition, the extreme case of this interaction could actually be the transfer of the halogen atom 
onto the methoxy group, leading to an internal bromine delivery from a significantly more 
reactive electrophile: an oxonium ion.  The formation of such an intermediate would also 
deactivate ring B, by introducing an electron withdrawing substituent on the ring, further 
improving the relative nucleophilicity of ring A over that of ring B.       
4.2.4 Potential Directing Effects of a Bisbenzylic C-H Bond  
 Another type of interaction that could explain the preference of NBS, NBA and NBSac 
for ring A in ampelopsin F (1 in Figure 4.12 A) relies on a potential hydrogen bond between the 
adjacent bisbenzylic hydrogen on the substrate and the carbonyl oxygen of the reagents.  While 
usually it is sp2 C-H bonds that serve as hydrogen bond donors, as shown in several 
crystallographic studies of ligand targets interactions relevant to drug discovery,18 a recent 





C-H and a hydroxyl group.19  In our case, the ability of the bisbenzylic carbon to stabilize 
negative charge could allow the hydrogen atom to participate in hydrogen bonding with the 
negative charge that develops on the carbonyl oxygen during the halogen delivery to either the 
adjacent methoxy group or to the aryl sing itself (Figure 4.12 A).  Such an associative force 
could explain the selectivity of the protected natural products we examined previously (1, 7 and 
8 in Figure 4.12 B), all of the nucleophilic positions which lead to the major products (ring A in 
1, 7 and 8) being ortho to such a C-H bond.  All of the derivatives synthesized in Scheme 4.3 
could also be taking advantage presence of the bisbenzylic C-H for selective bromination of ring 
A.   
 
Figure 4.12 A: Proposed hydrogen bonding interaction between the bisbenzylic hydrogen of 
ampelopsin F (1) and the carbonyl oxygen of N-bromoimides or amides; B: Highlighted 
hydrogen atoms that can participate in such an interaction 
 
 In conclusion, derivatives 13–15, 17 and 18 established that steric accessibility is not 























































determined by the pocket formed by rings A and B, must be at play.  Halogen bonding, potential 
bromine transfer to an internal oxonium ion electrophile, as well as a stabilizing interaction 
relying on a bisbenzylic C-H donor were proposed as possible contributing factors.  Theoretical 
calculations of the energy of the four possible transition states of bromination on rings A and B, 
from either face, could provide a better understating of the direction of electrophile approach and 
thus help elucidate what intermolecular forces are facilitating the reaction on ring A.          
4.3 Selectivity of Cationic Brominating Reagents  
 In Chapter 2, we attempted to find conditions that would allow us to overcome the 
intrinsic substrate selectivity for bromination on ring A and synthesize monobromide 3, with the 
bromine atom installed on ring B (Scheme 4.4).  Using [Collidine2Br](OTf), we obtained a 1:1 
mixture of monobromides 2 and 3.  In an attempt to improve upon this selectivity we attempted 
another source of electrophilic bromine, BDSB, and obtained a selectivity of > 10:1 for 3 over 2.  
The exceptional selectivity displayed by this reagent was essential for the synthesis of trimer 
ampelopsin G (Chapter 2), but its unusual behavior was quite puzzling.  Three main differences 
arise upon careful consideration of the structure of BDSB in comparison to that of the other 
electrophilic bromine sources in Scheme 4.4: 1) its steric bulk, 2) the highly acidic reaction 
conditions as rearomatization must afford HEt2S+ (pKa = -7), and 3) the cationic nature of the 






Scheme 4.4 Bromination selectivity of permethylated ampelopsin F (1) with various 
electrophilic bromine sources 
 
4.3.1 Steric Arguments 
As seen above, ring A would actually be slightly more accessible sterically, so the larger 
size is probably not the determining factor in BDSB’s unusual selectivity on methyl-protected 
ampelopsin F (1).  However, sterics do appear to play a role in the selectivity of BDSB for some 
of the ampelopsin F derivatives.  For example, ketone 14, while selective for NBS on ring A, 
displays a ~5:1 preference for functionalization of the more accessible ring B when treated with 
BDSB (Figure 4.13).  Furthermore, while alcohol 15 shows unselective bromination with BDSB, 
the introduction of the aryl ring C (derivative 17), hindering approach of the electrophile from 
the top face of ring B, leads to complete selectivity for ring A.  The possibility of BDSB 
transferring the bromine atom to the hydroxyl functional group and leading to a hypobromous 
species is not unreasonable, since the alcohol group is the lone difference between 1 (Scheme 



































































functional group could lead to an intramolecular delivery of electrophilic bromine to the 
nucleophilic position of ring A.  While on alcohol 15, this directing effects of the alcohol 
opposes the steric preference, on derivative 17 the two work constructively, installing the 
bromine atom on ring A exclusively.      
 
Figure 4.13 Selectivity of derivatives 14, 15 and 17 for NBS and BDSB 
 
Looking at ketone 14 it is interesting to note that even though in this case ring B is 
significantly more accessible than ring A, the selectivity observed in the reaction with BDSB is 
only ~5:1.  With a relatively large reagent, such as BDSB, this derivative should display 
excellent selectivity for the sterically accessible position.  However, the preference for ring B in 
14 (Figure 4.13) is not as strong as it was in permethylated ampelopsin F (1, Scheme 4.4).  The 
structure of the latter must therefore be able to provide a more subtle incentive for the 
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4.3.2 Slow Rearomatization Hypothesis 
 
Scheme 4.5 Equilibration of the two possible σ-complexes 
 
One reason for BDSB’s strong preference for ring B could stem from the acidic reaction 
conditions.  While the reagents that prefer ring A have basic counterions that can easily 
deprotonate the sp3 carbon of the arenium ion, BDSB does not.  Therefore, the arenium ion is 
expected to be longer lived, with the rearomatization potentially becoming the rate-determining 
step.  The reversibility of the sigma complex formation is known in electrophilic aromatic 
substitution, and in our case it could allow for the arenium ion to initially form at the more 
accessible position on ring A (19), and then equilibrate to the less hindered one on ring B (20 in 
Scheme 4.5).  Ring B is expected to be able to accommodate the sp3 carbon much better than ring 
A, the methoxy group on the front side of ring B making the presence of an sp3 center 
impractical on ring A.  The most important aspect of arenium 20 would be its more sterically 
favored deprotonation, which could be critical for selectivity if the rearomatization is the rate-
























































Scheme 4.6 Attempts to effect a bromine migration under acidic condition 
 
To test the hypothesis that a slow rearomatization is the cause for BDSB’s unique 
selectivity we first attempted to mimic the acidic reaction conditions (Scheme 4.6).  Use of 
bromine in acetic acid as a solvent could lead to a decrease in the selectivity for ring A, as 
bromide is a fairly weak base and the acidic conditions could further slow down deprotonation.  
However, this experiment only generated monobromide 2.  We next attempted to mimic the 
BDSB reaction conditions more closely and possibly effect a migration of the bromine atom 
from monobromide 2 by exposing it to the superacid byproduct of BDSB, HDSB 
([HEt2S][SbBrCl5]).  This attempt also proved futile.  Finally we treated monobromide 2 with 
half an equivalent of BDSB expecting to see a mixture of dibromide 21 and monobromide 3, if 
the migration does occur.  What we recovered were the starting monobromide 2 and dibromide 
21.  Acidic conditions did not seem to be able to shift the bromine atom from ring A to ring B 




























































Reagents and conditions: a) Br2 (0.5 equiv), AcOH, CH2Cl2, 25 ºC, 10 min, 2:21 1:1.3; b) HDSB (1.0 equiv), CH2Cl2, -78 ºC, 








whose formation from the bromide would depend on ipso protonation of the carbon bearing the 
bromine substituent.  As this was in no way guaranteed, we felt that a potentially better approach 
would be adding a base to the reaction with BDSB, hoping to facilitate the deprotonation of the 
arenium and thus shift the rate determining step back to σ complex formation.   
 
Scheme 4.7 Effects of the base present in the reaction mixture on selectivity 
 
Use of Ba(OH)2 as the base appeared to accelerate the reaction of methyl-protected 
ampelopsin F (1), but had no effect on BDSB’s selectivity, potentially due to its poor solubility 
(Scheme 4.7).  The next base we tried was pyridine, a base soluble in the reaction solvent.  This 
time, the reaction generated monobromide 2, together with unreacted starting material.  The 











































































Reagents and conditions: a) BDSB (1.3 equiv), Ba(OH)2 • 8 H2O (1.5 equiv), CH2Cl2, -78 ºC, 30 min, 3:21 1.3:1; b) BDSB (0.9 
equiv), pyridine (1.7 equiv), CH2Cl2, -78 to -10 ºC over 3 h, 1:2 1:1;  c) [Collidine2Br](OTf) (0.5 equiv), CH2Cl2, -78 ºC, 1.5 h, 





counterion.  In this case the base that should deprotonate the arenium ion on ring A (19 in 
Scheme 4.5) is the sterically hindered collidine.  As its approach is probably difficult due to the 
sterically hindered environment, some of the less hindered arenium on ring B (20 in Scheme 4.5) 
forms as well, leading to a 1:1 mixture of the two monobromides (2 and 3).  In light of these 
experiments the initial formation of the arenium ion on ring A, followed by an equilibration, in 
the absence of a competent base, could lead to the formation of the arenium on ring B and 
ultimately to monobromide 3.  The ratio of monobromide 3 to 2 appears to be dependent upon 
the ability of the base present in the system to deprotonate the encumbered arenium on ring A.  A 
similar dependence was observed for cationic iodine sources (Figure 4.14), with IDSI delivering 
iodide 6 exclusively and the more basic pyridinium iodide a mixture of 5 and 6.     
 
Figure 4.14 Selectivity of cationic chlorinating and iodinating reagents on permethylated 
ampelopsin F (1) and structures of chloride 4 and iodides 5 and 6 
 
However, CDSC, which also lacks a competent base, delivered monochloride 4 
selectively (Figure 4.13).  Revisiting the bromination of 1 with BDSB in the presence of pyridine 
(Scheme 4.7), we must acknowledge the likely possibility that the high reactivity of BDSB as an 
electrophilic bromine sources will lead to facile transfer of the halogen to the Lewis basic 
pyridine.  Thus, an alternate explanation for the ability of added pyridine to reverse the 






































slower reaction observed in this case could serve as evidence for a different active brominating 
reagent.  This reagent is relatively smaller than BDSB and carries a bromine atom with a much 
more pronounced sigma hole (Figure 4.7).  If the methoxy group on ring B is indeed 
participating in halogen bonding which facilitates functionalization of ring A, pyridinium 
bromide might also benefit from this type on intermolecular interaction.  The polarity of the N-
Br bond in [Collidine2Br](OTf) is similar to that in pyridinium bromide, however this latter 
reagent is larger and thus less likely to fit in the pocket required for halogen bonding, explaining 
the mixture of monobromides 2 and 3 obtained when this reagent was employed (Scheme 4.7).  
Therefore, while we cannot rule out the possible transfer of the bromine atom from an 
initial arenium ion on ring A to one on ring B in the functionalization of 1 with BDSB, we have 
found it difficult to assess its validity by substrate or reagent modifications as they have all 
introduced significant variations of the system.  Deuterium labeling experiments and kinetic 
isotope effects calculations should allow for a much better understanding of the mechanism for 
each of the reagents employed by establishing the rate determining step and allow for a more 
critical evaluation of this hypothesis.  
The final hypothesis we explored stems from the cationic nature of BDSB.  Ring C, 
which encumbers the attack of an incoming electrophile from above ring B could be envisioned 
to actually aid halogenation at that position by an interaction between its π system and the 






Figure 4.15 Potential cation-π interaction favoring ring B for electrophilic halogenation 
 
4.3.3 Cation – π  Interactions 
While the term cation-π interaction was coined by Dennis Dougherty in 1990, the 
attractive interaction between a cationic species and benzene was first described in gas phase in 
1981 by Kerbale.20  This work showed that K+ prefers to interact with benzene over water, the 
interaction with the first being worth 19 kcal/mol, compared to 18 kcal/mol with the later.  In 
1985, the same type of interaction was described for core complex cations, such as NH4+ and 
NMe4+.21  This observation opened the gate for explorations of cation-π interactions within 
proteins, where positively charged side chains (lysine and arginine) could interact with aromatic 
residues (phenylalanine, tyrosine, tryptophan).  Indeed, this type of noncovalent bond has been 
identified for one out of every 77 amino acids in the Protein Database, and has been proposed to 
play a crucial role in binding of charged neurotransmitters to their receptors (which often contain 
high densities of aromatic residues), in Na+ and K+ ion channels, as well as in the activity of 
cyclases for terpene synthesis.22  The unique ability of aromatic rings to be hydrophobic, but at 
the same time use their often-significant quadrapole moments to bind cations in areas of proteins 
that are not exposed to water, makes then ideal for molecular recognition in enzyme pockets, as 















While the interaction energy is huge in the gas phase, the majority of studies looking at 
the effects of such an interaction on biological systems were performed in water, where the 
desolvation energy penalty must be paid when a cationic species binds to such hydrophobic 
residues, foregoing the interaction with the solvent.  Under these conditions, the cation-π 
interaction is measured to range from 2 to 5 kcal/mol, making it competitive with hydrogen 
bonding and ion pair interactions.22a  X-ray crystallographic studies have shown that the optimal 
distance for this type of non-covalent interaction is close to the van der Waals sum of the radii of 
the atoms involved and that its strength varies as 1/r, as expected for an electrostatic attraction.  
While nitrogen-based cations have been extensively studied in cation-π interactions, 
sulfur-based ones have not benefitted from as much attention.  X-ray studies have identified 
important sulfonium cation-π interactions as being responsible for the selective binding of SAM 
to methyltransefrases.23  Furthermore, in 1998, Peter Schultz used unnatural amino acid 
mutagenesis to engineer a sulfonium cation-π interaction in a staphylococcal nuclease.  The 
strength of this interaction was proposed to be ~2.5 kcal/mol, in agreement with the values 
obtained for nitrogen-based cations.24  
Quite often the protein areas that interact with cationic species display more than one 
aromatic residue.  An excellent example of this phenomenon is the “aromatic box,” a set of such 
residues present in G-protein coupled receptors.22  The additive effects of the cation interacting 
with multiple aryl rings are still being investigated, but computational studies support this 
hypothesis and reveal a 71º angle as optimal for two aryl rings binding to the same cation.25 
In the series of amino acids that display aromatic regions, the electrostatic potential 





best and phenylalanine the worst.  The effects of varying substituents of the aryl rings on the 
strength of the interaction has been examined in computational studies.  Dougherty showed that, 
surprisingly, a phenol is no better at binding Na+ than benzene.26  A correlation between the σm 
Hammett constant of the substituent and the strength of the interaction was observed, supporting 
the importance of inductive effects for the electrostatic potential of the π system and the 
irrelevance of resonance effects.26  Work by Houk and co-workers supported the same through-
space effects of substituents as good predictive tools for the strength of cation-π interactions.16   
While this type of interaction has only recently been recognized, despite its wide 
representation in molecular recognition, it has already found applications in asymmetric 
catalysis.  Two very elegant examples from Eric Jacobsen’s work are described in Scheme 4.8.  
Inspired from the active sites of the enzymes performing similar transformations, two catalysts 
that use cation-π interactions to stabilize transition states have been engineered, the first 
providing excellent stereoselectivity for Claisen rearrangement27 and the second for polyene 
cyclization.28  The electronics of the aryl groups believed to participate in this non-covalent 
interaction were varied in both cases, and the observed ee correlated quite well with the 






Scheme 4.8 Applications of cation-π interactions in asymmetric catalysis 
 
4.3.4 Potential Involvement of Cation – π  Interactions in the Selectivity of BDSB for 
Ampelopsin F Derivatives 
In our system, ring C of protected ampelopsin F (1) could engage the sulfonium group of 
BDSB in a cation-π interaction and help direct bromination to the nucleophilic ring below 
(Figure 4.15).  The dihedral angle between the rings B and C is ~80 º, supporting the potential 
for an interaction of the cation with the two aryl rings.  The distance between the two aryl rings 
ranges from ~3 Å  to ~7 Å , as measures in the crystal structure of the closely related tribromide 
34 (Figure 4.15).  Both these values are in agreement with the specifics of the cation-π 


















































29: Ar = phenyl
30: Ar = naphtyl


































23: R = Me

























Figure 4.16 X-ray structure of tribromide 34 
 
The cation-π interaction’s ability to facilitate an electrophilic aromatic substitution 
reaction has been proposed in a computational study which compared the reactivity of toluene 
with that of biphenyl compounds with linear alkyl chain linkers in the methylation reaction with 
Me2Cl+.29  This work showed that a 1,3 relationship between the two phenyl groups is ideal 
leading to calculated difference in activation energy of ~8kcal/mol compared to toluene.  The 
authors propose a stabilization of the transition state leading to the sigma complex, as well as of 
the arenium ion itself, as the reason for a significantly faster reaction in the case of 1,3-
diphenylpropane.  The structure of the ampelopsin F (1) core, if indeed engaged in a cation-π 
interaction between ring C and BDSB, could therefore accelerate the reaction with ring B as the 
nucleophile in the case of this cationic reagent. 
As shown by Dougherty,26 the ability of an aromatic system to act as an electron donor in 
an interaction with a cation appears to correlate with its electrostatic potential, which in turn 
correlates with the σm Hammett coefficient of the substituent present.  The first substrate 














the phenol on ring C, from methyl ether to an acetoxy group (35, Figure 4.17).  This however, 
seemed to have no impact on the selectivity of BDSB.  While the σm’s for the two substituents 
are quite different, the acetoxy group has an additional oxygen atom, which could be 
coordinating to the cation, and thus artificially favoring ring B.  We therefore decided to attempt 
to replace the para-methoxyphenyl group with a para-trifluoromethylphenyl (36) or with a 
simple phenyl (37), hoping to see a decrease in the selectivity for ring B.  Unfortunately the 
synthesis of derivatives 36 and 37 was not ultimately accomplished (for details of some attempts 
see the Experimental Procedures section).   
 
Figure 4.17 Derivatives of ampelopsin F with variable electronics of ring C 
 
Turning our attention to the ampelopsin F derivatives used earlier (Scheme 4.3), we 
decided to use ketone 14 as a branching point and add the phenyl and the para-
trifluoromethylphenyl rings as nucleophiles (Scheme 4.9).  We had also synthesized alcohol 17, 
which could provide a derivative bearing the para methoxy group for comparison.  In order to 
prevent the potential formation of a hypobromous species with BDSB and the free alcohol (vide 
supra), we methylated the hydroxyl group (42).  We therefore had access to derivatives 39, 41 
and 42, with different substituents on ring C.  While the aliphatic methoxy group above ring A, 






















as a directing groups favoring formation of bromides on ring A (50 and 51 in Scheme 4.10), they 
would be constant in the series. 
 
Scheme 4.9 Synthesis of derivatives 39, 41 and 42 
 
Bromination of derivative 39, 41 and 42 with BDSB for fifteen minutes at –78 ºC 
afforded the ratios of bromides listed in Table 4.3.  These values were obtained from the average 
integrals corresponding to one proton for each of the monobromides in the crude NMR.  All 
three brominations were run twice and the values listed are the ratios of ring B monobromide to 




































   NaH
a) 38
b) MeI




    NaH
51% yield
Reagents and conditions: a) 38 (3.0 equiv), THF, 25 ºC, overnight, 99% yield; b) NaH (60% dispersion in mineral oil, 4.3 
equiv), 0 ºC, 30 min, then MeI (27.0 equiv), 0 to 25 ºC overnight, 74% yield; c) 40 (4.3 equiv), nBuLi (1.6 M in hexanes, 4.6 
equiv), THF, 0 ºC, 1 h, then 14, 0 ºC, overnight, 52% yield; d) NaH (60% dispersion in mineral oil, 5.0 equiv), 0 ºC, 30 min, then 
MeI (33.3 equiv), 0 to 25 ºC overnight, 99% yield; e) 16 (3.0 equiv), THF, 25 ºC, overnight, 87% yield; f) NaH (60% dispersion in 














Table 4.3 Ratio of ring B monobromide to ring A monobromide depending on the substituent σm 








   
2.0:1.7 0 
   
2.3:2.0 0 
   
1.1:1.0 0.1 
   
1.4:1.2 0.1 
   
1.2:1.5 0.46 
   
1.2:1.7 0.46 
 
A linear correlation is indeed observed between the logarithm of the ratio of the ring B 
bromide to the ring A bromide with the σm value of the substituent (Chart 4.1).  This correlation 
supports the potential involvement of ring C in either a directing interaction with the BDSB 
















































































































































Chart 4.1 Correlation of the logarithm of the ratio of ring B to ring A monobromides with the 
σm of the substituent on ring C 
 
The effects of the electronics of ring C on product mixture composition suggest a 
potential importance of the equilibrium between the two arenium ions (49 and 53 in Scheme 
4.10) in the case of the substrates from Scheme 4.9.  The pre-association of the aryl ring C with 
BDSB is likely to affect the energy of activation leading to arenium ion 53, but would probably 
have a smaller influence on the deprotonation step.  The rate-determining step appears to once 
again be the formation of the arenium ion, as observed with the neutral reagents on protected 
ampelopsin F (1).  The basicity of the aliphatic ether now present in the molecule could facilitate 
the deprotonation of the arenium ions, especially if the cation-π interaction leads to attack from 
the top side of ring B forcing the proton down into the more accessible area below this aryl ring.  





expansion of this Hammett study would also be necessary to unequivocally determine whether 
the interaction of ring C and BDSB is significant for the functionalization selectivity.  
 
Scheme 4.10 Mechanism of formation for monobromides 54 and 55 
 
A very similar system with permethylated ampelopsin F is protected heimiol A (7).  The 
difference in the optimized geometry is that the aryl ring C in the case of heimiol A (7) is 
pointing towards the nucleophilic spot on ring B, blocking attack from the top face and also 
preventing the possibility of a productive cation–π interaction.  Reaction of the heimiol A core 
with BDSB, however, leads to a ~3:1 ratio of monobromides 9 and 56.  The formation of 
monobromide 56 could indicate the ability of ring C to rotate in position for a directing effect, 
but the probability of this phenomenon appears much lower than in the case of protected 
ampelopsin F (1).  Bromination of permethylated trimer carasiphenol B (57), with both NBS and 
BDSB, showed a preference for functionalization of ring B.  However, BDSB delivered 














































































Sterically ring E is significantly more accessible, however the potential cation cradle formed by 
rings B and C is unperturbed, likely contributing to this excellent selectivity on 57.  
 
Scheme 4.11 Functionalizations of permethylated heimiol A (7) and carasiphenol B (57) 
 
 In conclusion BDSB’s selectivity on protected ampelopsin F (1) could be the result of its 
larger size preventing its productive association with the methoxy group on ring B, an interaction 
which directs smaller reagents to ring A.  In addition, a potential attractive interaction between 
aryl ring C and this highly cationic reagent could increase the concentration of brominating 
reagent and accelerate the reaction of ring B, and thus facilitating the formation of the 




















































































Reagents and conditions: a) BDSB (1.0 equiv), CH2Cl2, -78 ºC, 1.5 h, 28% yield 9, 7 % yield 56; b) BDSB (0.9 equiv), CH2Cl2, -78 






The experiments described in this chapter have sought to uncover the structural parameters 
of the ampelopsin F core (1) that are responsible for its regioselective electrophilic aromatic 
brominations.  The intrinsic site of selectivity (on ring A in 1) appears to benefit from a more 
accessible approach of the electrophile and from a halogen bonding interaction, or potentially a 
transfer of the halogen atom to an internal oxonium electrophilic species, using the optimally 
positioned methoxy group on ring B.  The unique selectivity displayed by BDSB for ring B 
could be a consequence its larger size preventing participating in the above-mentioned 
interactions.  However, BDSB’s cationic nature could also be envisioned to allow a directing 
interaction with the aryl ring C by a halonium-π interaction.  Variation of the electrostatic 
potential of ring C in a series of closely related derivatives of 1 has shown a linear correlation 
with the ratio of monobromides formed, supporting this final hypothesis.      
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4.7 Experimental Procedures  
General Procedures. All reactions were carried out under an argon atmosphere with dry 
solvents under anhydrous conditions, unless otherwise noted. Dry tetrahydrofuran (THF), 
toluene, benzene, diethyl ether (Et2O) and dichloromethane were obtained by passing 
commercially available pre-dried, oxygen-free formulations through activated alumina columns.  
Yields refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated.  Reactions were magnetically 
stirred and monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. Merck 
silica gel plates (60F-254) using UV light as visualizing agent, and an ethanolic solution of 
phosphomolybdic acid and cerium sulfate, and heat as developing agents. SiliCycle silica gel 
(60, academic grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
Preparative thin-layer chromatography separations were carried out on 0.50 mm E. Merck silica 
gel plates (60F-254).  NMR spectra were recorded on Bruker 300, 400, 500, 600 and 800 MHz 
instruments and calibrated using residual undeuterated solvent as an internal reference.  The 
following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = 
triplet, br = broad, app = apparent.  IR spectra were recorded on a Perkin-Elmer 1000 series FT-
IR spectrometer.  High-resolution mass spectra (HRMS) were recorded in the Columbia 
University Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (fast 
atom bombardment) and APCI (atmospheric pressure chemical ionization) techniques. 
 Abbreviations. (iPr)2NEt = N,N-diisopropylethylamine, (TMS)3SiH = triethylsilane 
(TMS)3SiH = tris(trimethylsilyl)silane, AcCl = acetyl chloride, AIBN = azobisisobutyronitrile, 
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BDSB = bromodiethylsulfonium bromopentachloroantimonate, BF3•Et2O = boron trifluoride 
diethyl etherate, CDSC = chlorodiethylsulfonium hexachloroantimonate, Et = ethyl, EtOAc = 
ethyl acetate, HMBC = heteronuclear multiple-bond correlation, HSQC = heteronuclear single 
quantum coherence, IDSI = iododiethylsulfonium hexachloroantimonate, KOtBu = potassium 
tert-butoxide, mCPBA = meta-chloroperbenzoic acid, Me3SI = trimethylsulfonium iodide, MeI = 
iodomethane, MeOH = methanol, MOM = methoxymethyl, MOMCl = chloromethyl methyl 
ether, MsOH = methanesulfonic acid, NBS = N-bromosuccinimide, nBuLi = n-butyllithium,  
NCS = N-chlorosuccinimide, NIS = N-iodosuccinimide, OTf = trifluoromethanesulfonate, pTSA 
= para-toleunesulfonic acid, Pyr = pyridine, TBCO = 2,4,4,6-tetrabromocyclohexa-2,5-dienone, 
tBuOH = tert-butanol, TFA = trifluoroacetic acid. 
For characterization data for permethylated ampelopsin F (1), as well as for monobromides 
2 and 3, and dibromide 21, and for experimental procedures for brominations of 1 please see 
Chapter 2. 
4.7.1 Chlorine and Iodine Electrophiles 




Halide on ring 
A 
Halide on ring 
B 
Dihalide 
NCS 1.1 1 - - 
CDSC - 1 - 2.6 
NIS 3.6 0.3 0.9 - 
IDSI 1 - 1.7 - 




Experimental Scheme 4.1 Structure of dichloride S1 
 
Reaction of Permethylated Ampelopsin F (1) with NCS.  Permethylated ampelopsin F 
(1, 0.033g, 0.06 mmol, 1.0 equiv) was dissolved in CH2Cl2 (4 mL) and the solution was cooled 
to –78 ºC.  NCS (0.0082 g, 0.06 mmol, 1.0 equiv) was added as a solid to the solution at –78 ºC 
and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the reaction was 
quenched with saturated aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured 
into water (10 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were combined, 
washed with water (10 mL) and brine (10 mL), dried (MgSO4) filtered, and concentrated to 
afford a 1.1:1 mixture of 1:4. 
Reaction of Permethylated Ampelopsin F (1) with CDSC.  Permethylated ampelopsin 
F (1, 0.01 g, 0.018 mmol, 1.0 equiv) was dissolved in CH2Cl2 (0.5 mL) and the solution was 
cooled to –78 ºC.  CDSC (0.0085 g, 0.018 mmol, 1.0 equiv) was added as a solid to the solution 
at –78 ºC and the reaction was allowed to warm to –30 ºC over 45 min.  Upon completion, the 
reaction was quenched with saturated aqueous Na2SO3 (2 mL) and saturated aqueous NaHCO3 (2 
mL), poured into water (3 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were 
combined, washed with water (5 mL) and brine (5 mL), dried (MgSO4) filtered, and concentrated 
to afford a 1:1.7 mixture of 4:S1.  This mixture was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford monochloride 4 (0.0026 g, 25% yield) 











Monochloride 4.  Rf = 0.34 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3002, 2934, 
2836, 1596, 1510, 1462, 1325, 1249, 1205, 1179, 1132, 1078, 1036, 906, 830, 782, 731 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.07 (d, J = 8.6 Hz, 2 H), 6.83 (t, J = 8.3 Hz, 4 H), 6.65 (d, J = 8.6 
Hz, 2 H), 6.56 (d, J = 2.0 Hz, 1 H), 6.31 (s, 1 H), 6.19 (d, J = 2.0 Hz, 1 H), 4.96 (s, 1 H), 4.23 (d, 
J = 1.9 Hz, 1 H), 3.88 (s, 3 H), 3.80 (s, 3 H), 3.77 (s, 3 H), 3.73 (s, 4 H), 3.68 (s, 4 H), 3.44 (s, 3 
H), 3.39 (d, J = 5.9 Hz, 1 H), 13C NMR (125 MHz, CDCl3) δ 160.9, 157.9, 157.7, 157.7, 155.6, 
154.3, 146.2, 143.6, 139.1, 135.3, 128.9, 128.7, 128.7, 117.8, 113.6, 113.6, 111.4, 101.3, 97.1, 
95.4, 57.0, 56.4, 55.7, 55.6, 55.5, 55.4, 55.3, 49.6, 46.4, 45.0; HRMS (FAB+) calcd for 
C34H33O6Cl [M+] 572.1966, found 572.1979 (for 35Cl). 
Dichloride S1.  Rf = 0.24 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3003, 2935, 
2836, 1590, 1510, 1461, 1434, 1326, 1249, 1204, 1179, 1078, 1035, 907, 809, 782, 731, 533 cm-
1; 1H NMR (400 MHz, CDCl3) δ 7.10 (d, J = 8.6 Hz, 2 H), 6.89–6.83 (m, 2 H), 6.83–6.77 (m, 2 
H), 6.67 (d, J = 8.7 Hz, 1 H), 6.33 (s, 1 H), 6.23 (s, 1 H), 5.00 (t, J = 0.9 Hz, 1 H), 4.35 (d, J = 
1.8 Hz, 1 H), 3.89 (s, 3 H), 3.84 (s, 3 H), 3.79 (s, 3 H), 3.74 (s, 3 H), 3.70 (d, J = 1.6 Hz, 1 H), 
3.69 (s, 3 H), 3.67 (s, 1 H), 3.45 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 158.0, 157.8, 157.8, 
155.3, 154.4, 153.9, 144.0, 142.9, 138.7, 134.6, 129.1, 128.7, 117.6, 113.6, 111.3, 110.4, 96.0, 
95.5, 56.6, 56.4, 55.9, 55.7, 55.4, 55.3, 55.0, 49.0, 46.5, 43.9; HRMS (FAB+) calcd for 
C34H32O6Cl2 [M+] 606.1576, found 606.1588 (for 35Cl). 
Reaction of Permethylated Ampelopsin F (1) with NIS.  Permethylated ampelopsin F 
(1, 0.012 g, 0.022 mmol, 1.0 equiv) was dissolved in CH2Cl2 (1 mL).  NIS (0.005 g, 0.022 mmol, 
1.0 equiv) was added as a solid to the solution at 25 ºC and the reaction was allowed to stir for 2 
h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (3 mL) and 
saturated aqueous NaHCO3 (3 mL), poured into water (3 mL) and extracted with CH2Cl2 (3 × 10 
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mL).  The organic layers were combined, washed with water (5 mL) and brine (5 mL), dried 
(MgSO4) filtered, and concentrated to afford a 3.9:0.3:0.9 mixture of 1:5:6.  (Note: the structure 
of 5 was assigned in the crude 1H NMR based on the comparison with the NMR spectrum of the 
corresponding bromide 2). 
Reaction of Permethylated Ampelopsin F (1) with IDSI.  Permethylated ampelopsin F 
(1, 0.016 g, 0.030 mmol, 1.0 equiv) was dissolved in CH2Cl2 (1.0 mL) and the solution was 
cooled to –78 ºC.  IDSI (0.022 g, 0.023 mmol, 0.75 equiv) was added as a solid to the solution at 
–78 ºC and the reaction was allowed to stir at that temperature for 1.5 h.  Upon completion, the 
reaction was quenched with saturated aqueous Na2SO3 (3 mL) and saturated aqueous NaHCO3 (3 
mL), poured into water (3 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were 
combined, washed with water (5 mL) and brine (5 mL), dried (MgSO4) filtered, and concentrated 
to afford a 1:1.7 mixture of 1:6.  The crude mixture was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford monoiodide 6 (0.014 g, 70% yield). 
 
Experimental Scheme 4.2 Tentative structure for diiodide S2 
 
Reaction of Permethylated Ampelopsin F (1) with [Pyridine2I](BF4). 
Permethylated ampelopsin F (1, 0.013 g, 0.024 mmol, 1.0 equiv) was dissolved in 
CH2Cl2 (2.0 mL) and the solution was cooled to –78 ºC.  [Pyidiner2I](BF4) (0.009 g, 0.024 mmol, 
1.0 equiv) was added as a solid to the solution at –78 ºC and the reaction was allowed to stir at 










Na2SO3 (3 mL) and saturated aqueous NaHCO3 (3 mL), poured into water (3 mL) and extracted 
with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (5 mL) and 
brine (5 mL), dried (MgSO4) filtered, and concentrated to afford a 1:1.1:2.7:1.8 mixture of 
1:5:6:S2.  (Note: the structures of 5 and S2 were assigned in the crude 1H NMR based on the 
comparison with the NMR spectrum of the corresponding bromide 2 and dibromide 21). 
Monoiodide 6.  1H NMR (400 MHz, CDCl3) δ 7.25–7.14 (m, 2 H), 6.87–6.83 (m, 2 H), 
6.83–6.77 (m, 2 H), 6.67 (d, J = 8.8 Hz, 1 H), 6.50 (d, J = 2.4 Hz, 1 H), 6.27 (d, J = 2.4 Hz, 1 H), 
6.13 (s, 1 H), 4.35 (d, J = 1.8 Hz, 1 H), 4.33 (s, 1 H), 3.83 (s, 3 H), 3.81 (s, 3 H), 3.79 (s, 3 H), 
3.74 (s, 3 H), 3.71 (s, 1 H), 3.68 (s, 3 H), 3.61 (t, J = 1.6 Hz, 1 H), 3.44 (s, 3 H). 
 
4.7.2 Functionalization of Protected Natural Products Heimiol A (7), Cassigarol B (8) 
and Carasiphenol B (56) 
Experimental Table 4.2 Brominations of permethylated heimiol A (7) 
Reagent  
Conditions 
    
NBS 
1.1 equiv, –78 ºC,  
4.5 h 
1.7 (50%) 1.0 (23%) not detected not detected 
NBS 
0.7 equiv, –78 to  
25 ºC, 1.5 h 
1 2.2 not detected not detected 
BDSB 
1.0 equiv, –78 ºC, 
10 min 
5.7 (37%) 5.1 (28%) 1.4 (7%) 1 (6%) 
BDSB 
0.7 equiv, –78 ºC,  
1.5 h 
1.0 3.2 1.0 2.0 
BDSB 
1.0 equiv, –78 ºC, 
2 h 














































Experimental Table 4.3 Average bromides ratio for permethylated heimiol A (7) 
Reagent 
  
NBS 1.0 - 
BDSB 3.3 1.0 
 
For characterization of permethylated heimiol A (7), monobromide 9 and dibromide S3, 
please see Chapter 2.  Procedures for the reaction of permethylated heimiol A (7) with NBS 
optimized for the synthesis of monobromide 9 and dibromide S3 can also be found in Chapter 2. 
Reaction with NBS.  A solution of permethylated heimiol A (7, 0.008 g, 0.014 mmol, 
1.0 equiv) in dry CH2Cl2 (2 mL) was cooled to –60 ºC.  NBS (0.0027 g, 0.015 mmol, 1.1 equiv) 
was added as a solid to this solution at –78 ºC.  The reaction mixture was allowed to warm to 5 
ºC over 4 h and was then removed from the bath and allowed to stir at 25 ºC for an additional 30 
min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude oil (7:9 1.7:1 by crude NMR 
integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford monobromide 9 (0.002 g, 23% yield), as well as recovered 
starting material 7 (0.004 g, 50% yield). 
Reaction with BDSB. (10 min)  A solution of permethylated heimiol A (7, 0.0046 g, 
0.008 mmol, 1.0 equiv) in dry CH2Cl2 (1 mL) was cooled to –78 ºC.  BDSB (0.004 g, 0.007 
























stirred at this temperature for 10 min.  Upon completion, the reaction was quenched with 
saturated aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (10 
mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with 
water (10 mL) and brine (10 mL), dried (MgSO4) filtered, and concentrated.  The resulting crude 
oil (7:9:56:S3 5.7:5.1:1.4:1.0 by crude NMR integral ratios) was purified by preparative thin 
layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford 9 (0.0014 g, 28% yield), an 
inseparable mixture of 56 and S3* as well as starting material 7 (0.0017 g, 37% yield). 
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford 56 (0.0003 g, 7% yield) and S3 (0.0003 g, 6% yield). 
Reaction with BDSB. (2 h)  A solution of permethylated heimiol A (7, 0.004 g, 0.007 
mmol, 1.0 equiv) in dry CH2Cl2 (1 mL) was cooled to –78 ºC.  BDSB (0.004 g, 0.007 mmol, 1.0 
equiv) was added as a solid to this solution at –78 ºC and the reaction mixture was stirred at this 
temperature for 2 h.  Upon completion, the reaction was quenched with saturated aqueous 
Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted 
with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (10 mL) and 
brine (10 mL), dried (MgSO4) filtered, and concentrated.  The resulting crude oil (9:56:S3 
3.0:1.0:5.5 by crude NMR integral ratios) was purified by preparative thin layer chromatography 
(silica gel, hexanes:EtOAc, 7:3) to afford 9 (0.001 g, 23% yield) and S3 (0.0025 g, 50% yield).  
The monobromide 56 could not be isolated on preparative thin layer chromatography from this 
mixture. 
Monobromide 56.  Rf = 0.61 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3003, 2960, 
2918, 2852, 1605, 1583, 1510, 1463, 1435, 1333, 1302, 1247, 1214, 1175, 1146, 1097, 1035, 812 
cm-1; 1H NMR (400 Hz, CDCl3) δ 7.20 (d, J = 8.8 Hz, 2 H), 6.96 (d, J = 8.4 Hz, 2 H), 6.83 (d, J 
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= 8.8 Hz, 2 H), 6.69 (d, J = 8.4 Hz, 2 H), 6.46 (d, J = 2.4 Hz, 1 H), 6.35 (s, 1 H), 6.27 (d, J = 2.4 
Hz, 1 H), 5.66 (s, 1 H), 5.64 (d, J = 3.2 Hz, 1 H), 4.42 (d, J = 3.2 Hz, 1 H), 4.33 (s, 1 H), 3.87 (s, 
3 H), 3.81 (s, 3 H), 3.78 (s, 3 H), 3.72 (s, 3 H), 3.64 (s, 3 H), 3.41 (s, 3 H); 13C NMR (100 MHz, 
CHCl3) δ 160.1, 159.2, 158.8, 157.8, 155.5, 155.2, 145.3, 140.2, 137.1, 136.1, 128.7, 127.2, 
120.5, (2 C), 113.6, 113.4, 104.9, 101.3, 97.7, 96.5, 80.9, 79.5, 56.6, 56.5, 55.7, 55.4, 55.3 (2 C), 
47.9, 45.9; HRMS could not be obtained. 
Experimental Table 4.4 Brominations of permethylated cassigarol B (8) 
Reagent  
Conditions 
    
NBS 
0.7 equiv, –78 to 25 ºC,  
3 h 
4.0 (29%) 4.3 (35%) 1.0 (13%) 1.0 (13%) 
NBS 
0.7 equiv, –78 ºC, 1.5 h 13.3 6.4 2.4 1.0 
BDSB 
0.8 equiv, –78 ºC, 15 min 1.8 (20%) 2.8 (42%) 1 (17%) 1.2 (15%) 
BDSB 
0.7 equiv, –78 ºC, 1.5 h 1.0 4.2 1.1 2.5 
 
Experimental Table 4.5 Average bromides ratio for permethylated cassigarol B (8) 
Reagent 
  
NBS 3.5 1.0 
BDSB 3.3 1.0 
 
Reaction with NBS.  A solution of permethylated cassigarol B (8, 0.017 g, 0.038 mmol, 
1.0 equiv) in dry CH2Cl2 (3 mL) was cooled to –78 ºC.  NBS (0.005 g, 0.028 mmol, 0.7 equiv) 


















































ºC over 3 h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (10 
mL) and saturated aqueous NaHCO3 (10 mL), poured into water (10 mL) and extracted with 
CH2Cl2 (3 ×10 mL).  The organic layers were combined, washed with water (10 mL) and brine 
(10 mL), dried (MgSO4) filtered, and concentrated.  The resulting crude oil (8:10:11:S4 
4.0:4.3:1.0:1.0 by crude NMR integral ratios) was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford 10 (0.007 g, 35% yield), an 
inseparable mixture of 1:1 11:S4* as well as recovered starting material (8, 0.005 g, 29% yield). 
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford 11 (0.0025 g, 13% yield) and S4 (0.003 g, 13% yield). 
Reaction with BDSB.  A solution of permethylated cassigarol B (8, 0.004 g, 0.009 
mmol, 1.0 equiv) in dry CH2Cl2 (1 mL) was cooled to –78 ºC.  BDSB (0.004 g, 0.007 mmol, 0.8 
equiv) was added as a solid to this solution at –78 ºC and the reaction mixture was stirred at this 
temperature for 15 min.  Upon completion, the reaction was quenched with saturated aqueous 
Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted 
with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (10 mL) and 
brine (10 mL), dried (MgSO4) filtered, and concentrated.  The resulting crude oil (8:10:11:S4 
1.8:2.8:1.0:1.2 by crude NMR integral ratios) was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford 10 (0.002 g, 42% yield), an 
inseparable mixture of 11 and S4* as well as starting material (8, 0.0008 g, 20% yield). 
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford 11 (0.0008 g, 17% yield) and S4 (0.0008 g, 15% yield). 
Monobromide 10.  Rf = 0.50 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2923, 2852, 
1589, 1508, 1495, 1460, 1434, 1322, 1255, 1201, 1143, 1113, 1090, 1076 cm-1; 1H NMR (400 
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Hz, CDCl3) δ 6.95 (s, 1 H), 6.86 (s, 1 H), 6.52 (d, J = 2.4 Hz, 1 H), 6.37 (s, 1 H), 6.31 (d, J = 2.4 
Hz, 1 H), 5.62 (s, 1 H), 4.68 (t, J = 4.0 Hz, 1 H), 3.97 (s, 3 H), 3.87 (s, 3 H), 3.85 (s, 6 H), 3.80 
(s, 3 H), 3.77 (s, 3 H), 3.06 (d, J = 3.6 Hz, 2 H); 13C NMR (100 MHz, CHCl3) δ 159.2, 156.1, 
155.3, 154.8, 147.6, 147.2, 147.0, 136.8, 136.5, 134.0, 124.7, 121.4, 110.0, 109.4, 108.9, 102.3, 
96.5, 95.2, 56.8, 56.5, 56.3 (2 C), 55.7, 55.6, 42.1, 38.5, 36.5; HRMS (FAB+) calcd for 
C27H27BrO6+ [M+] 526.0991, found 526.0972 (for 79Br). 
Monobromide 11.  Rf = 0.56 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2923, 2852, 
1601, 1580, 1508, 1462, 1437, 1324, 1298, 1248, 1210, 1195, 1137, 1081 cm-1; 1H NMR (400 
Hz, CDCl3) δ 6.93 (s, 1 H), 6.92 (s, 1 H), 6.35 (s, 1 H), 6.25 (d, J = 2.4 Hz, 1 H), 6.20 (s, 1 H), 
6.01 (d, J = 2.4 Hz, 1 H), 4.61 (t, J = 3.6 Hz, 1 H), 3.93 (s, 3 H), 3.87 (s, 3 H), 3.87 (s, 3 H), 3.86 
(s, 3 H), 3.84 (s, 3 H), 3.65 (s, 3 H), 3.13 (d, J = 3.2 Hz, 2 H); 13C NMR (100 MHz, CHCl3) 
δ 159.0, 157.0, 155.1, 154.9, 147.5, 147.4, 147.0, 137.5, 137.1, 133.5, 123.8, 122.0, 110.0, 109.7, 
107.9, 102.0, 96.8, 95.0, 56.8, 56.4, 56.4, 56.3, 56.1, 55.3, 41.2, 36.9, 36.2; HRMS (FAB+) calcd 
for C27H27BrO6+ [M+] 526.0991, found 526.0975 (for 79Br). 
Dibromide S4.  Rf = 0.56 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2924, 2855, 
1588, 1513, 1460, 1438, 1324, 1202, 1076 cm-1; 1H NMR (400 Hz, CDCl3) δ 6.94 (s, 1 H), 6.92 
(s, 1 H), 6.39 (s, 1 H), 6.37 (s, 1 H), 6.30 (s, 1 H), 4.72 (t, J = 4.0 Hz, 1 H), 3.90 (s, 3 H), 3.89 (s, 
3 H), 3.87 (s, 6 H), 3.85 (s, 3 H), 3.81 (s, 3 H), 3.05 (d, J = 4.0 Hz, 2 H); 13C NMR (125 MHz, 
CHCl3) δ 155.9, 155.2, 155.1, 154.9, 147.8, 147.5, 146.1, 136.8, 136.2, 133.3, 123.6, 123.3, 
109.9, 109.6, 108.4, 101.9, 95.2, 95.0, 56.8 (2 C), 56.5, 56.3 (2 C), 56.0, 41.2, 38.3, 36.8; HRMS 
(FAB+) calcd for C27H26Br2O6+ [M+] 604.0096, found 604.0103 (for 79Br).  
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Experimental Table 4.6 Brominations of permethylated carasiphenol B (57) 
Reagent  
Conditions 
    
NBS 
0.9 equiv, –78 to 25 ºC,  
4 h 
 1.6 1.0 3.1 1.3 
BDSB 
1.0 equiv, –78 ºC, 2 h  not detected not detected 1 not detected 
TBCO 
0.5 equiv, –78 ºC, 1.5 h 6.6  1.2  3.9  1.0  
 
The conditions for the reaction of protected carasiphenol B (57), as well as the 
characterization data for compounds 58, 59 and S5 were shown in Chapter 2. 
Reaction with TBCO.  Permethylated carasiphenol B (57, 0.004 g, 0.005 equiv, 1.0 
equiv) was dissolved in dry CH2Cl2 (0.5 mL) and the solution was cooled to –78 ºC.  TBCO 
(0.001 g, 0.0025 mmol, 0.5 equiv) was added as a solid and the reaction was allowed to stir at –
78 ºC for 1.5 h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (2 
mL) and saturated aqueous NaHCO3 (2 mL), poured into water (2 mL) and extracted with 
CH2Cl2 (3 × 5 mL).  The organic layers were combined, washed with water (3 mL) and brine (3 
mL), dried (MgSO4), filtered and concentrated.  The resulting crude orange oil contained a 
6.6:1.2:3.9:1.0 mixture of 57:59:58:S5. 
4.7.3 Synthesis of Non-natural Resveratrol Oligomers Analogues for Selective 
Functionalization  
Alcohol 13.  Me3SI (4.6 g, 22.5 mol, 10.5 equiv) was added to THF (100 mL), cooled to 


















































solution.  The resulting off-white slurry was stirred for 2 min at 0 °C.  A solution of ketone 12 
(0.935 g, 2.15 mmol, 1.0 equiv) in THF (75 mL), precooled to 0 ºC, was then added dropwise, 
and the resulting mixture was allowed to stir for an additional 1 h at 0 °C.  Upon completion, the 
reaction contents were quenched with NH4Cl (30 mL), poured into water (30 mL) and extracted 
with EtOAc (3 × 50 mL).  The combined organic extracts were then washed with water (20 mL) 
and brine (20 mL), dried (MgSO4), filtered, and concentrated to afford the desired epoxide 
intermediate.  Next, this unstable intermediate was immediately dissolved in benzene (20 mL) at 
25 °C and solid ZnI2 (0.580 g, 1.8 mmol, 0.8 equiv) was added in a single portion.  After stirring 
the resultant mixture for 3 h at 25 °C, the reaction contents were quenched with water (20 mL) 
and extracted with EtOAc (3 × 30 mL).  The combined organic extracts were then washed with 
water (10 mL) and brine (10 mL), dried (MgSO4), filtered, and concentrated.  The resultant crude 
orange oil was purified by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→3:2) 
to give alcohol 13 (0.470 g, 49% yield over 2 steps) as a white amorphous solid.  13: Rf = 0.51 
(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3474, 2938, 2836, 1602, 1509, 1487, 1462, 1320, 
1247, 1206, 1172, 1139, 1095, 1044, 972, 833, 737 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.02 (d, J 
= 8.8 Hz, 2 H), 6.80 (d, J = 8.8 Hz, 2 H), 6.63 (d, J = 2.0 Hz, 1 H), 6.45 (d, J = 2.4 Hz, 1 H), 6.24 
(d, J = 2.0 Hz, 1 H), 6.22 (d, J = 2.4 Hz, 1 H), 4.59 (d, J = 8.0 Hz, 1 H), 4.19 (d, J = 1.6 Hz, 1 H), 
4.04 (s, 1 H), 3.81 (s, 3 H), 3.79 (s, 6 H), 3.77 (s, 3 H), 3.39 (s, 3 H), 3.25 (s, 1 H), 1.70 (d, J = 
8.0 Hz, 1 H); 13C NMR (100 MHz, CHCl3) δ 161.0, 159.4, 159.4, 157.8, 156.3, 144.4, 144.0, 
138.8, 128.8, 128.1, 115.3, 113.6, 103.4, 102.5, 97.7, 97.4, 77.2, 58.5, 55.7, 55.5, 55.5, 55.4, 
55.3, 51.2, 46.3; HRMS (FAB+) calcd for C27H28O6+ [M+] 448.1886, found 449.1870. 
Permethylated Ketone 14.  Alcohol 13 (0.343 g, 0.765 mmol, 1.0 equiv) was dissolved 
in CH2Cl2 (25 mL) at 25 ºC.  Solid NaHCO3 (0.322 g, 3.833 mmol, 5.0 equiv) and Dess–Martin 
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periodinane (0.550 g, 1.296 mmol, 1.7 equiv) were added sequentially and the reaction was 
allowed to stir at 25 ºC for 3 h.  At this point another portion of Dess–Martin periodinane (0.200 
g, 0.472 mmol, 0.6 equiv) was added and the reaction was allowed to stir for another 1 h.  Upon 
completion, the reaction was quenched with saturated aqueous Na2SO3 (25 mL) and saturated 
aqueous NaHCO3 (25 mL) and extracted with CH2Cl2 (3 × 50 mL).  The combined organic layers 
were then washed with water (15 mL) and brine (15 mL), dried (MgSO4) filtered, and 
concentrated to afford the crude ketone 14 as an orange oil.  The crude product was purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 9:1→3:1) to afford ketone 14 (0.175 
g, 51% yield) as a light pink solid.  14: Rf = 0.72 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 
3003, 2961, 2930, 2837, 1765, 1604, 1510, 1488, 1463, 1318, 1248, 1207, 1176, 1160, 1122, 
1086, 1038, 973, 831, 736 cm-1; 1H NMR (400 Hz, CDCl3) δ 6.94 (d, J = 8.8 Hz, 2 H), 6.78 (d, J 
= 8.8 Hz, 2 H), 6.60 (d, J = 2.0 Hz, 1 H), 6.40 (d, J = 2.4 Hz, 1 H), 6.29 (d, J = 2.4 Hz, 1 H), 6.21 
(d, J = 2.4 Hz, 1 H), 4.66 (d, J = 2.4 Hz, 1 H), 4.23 (s, 1 H), 3.81 (s, 6 H), 3.78 (s, 3 H), 3.77 (s, 3 
H), 3.41 (t, J = 1.2 Hz, 1 H), 3.39 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 208.1, 160.7, 160.0, 
159.3, 158.2, 154.9, 143.6, 141.0, 136.2, 128.4, 116.6, 113.7, 104.0, 103.7, 100.5, 98.2, 98.0, 
59.6, 55.7, 55.6, 55.6, 55.5, 55.3, 52.6, 50.9; HRMS (FAB+) calcd for C27H26O6+ [M+] 447.1808, 
found 447.1798. 
Alcohol 15.  Permethylated ketone 14 (0.075 g, 0.167 mmol, 1.0 equiv) was dissolved in 
a mixture of MeOH and CH2Cl2 (5 mL MeOH, 0.5 mL CH2Cl2) at 25 ºC.  Solid NaBH4 (0.063 g, 
1.67 mmol, 10.0 equiv) was added to the solution and the reaction was allowed to stir at 25 ºC 
for 45 min.  Upon completion, the reaction was quenched with water (10 mL) and extracted with 
CH2Cl2 (3 × 20 mL).  The combined organic layers were washed with water (5 mL), brine (5 
mL), dried (MgSO4) filtered, and concentrated to afford the desired alcohol 15 as a white 
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amorphous solid (0.073 g, 97% yield).  15: Rf = 0.58 (silica gel, hexanes:EtOAc, 7:3); IR (film) 
νmax 3491, 2998, 2935, 2836, 2079, 1601, 1509, 1487, 1462, 1438, 1332, 1314, 1264, 1245, 
1207, 1171, 1140, 1112, 1088, 1060, 1040, 995, 962, 937, 894, 826, 788, 775, 759, 734, 702, 
636, 592, 539, 476 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.12 (d, J = 8.4 Hz, 2 H), 6.81 (d, J = 8.8 
Hz, 2 H), 6.57 (d, J = 2.0 Hz, 1 H), 6.54 (d, J = 2.4 Hz, 1 H), 6.30 (d, J = 2.4 Hz, 1 H), 6.22 (d, J 
= 2.0 Hz, 1 H), 4.51 (d of d, J = 2.4, 4.8 Hz, 1 H), 4.09 (s, 1 H), 4.04 (d, J = 4.4 Hz, 1 H), 3.84 (s, 
3 H), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.75 (s, 3 H), 3.52 (d, J = 5.2 Hz, 1 H), 3.45 (s, 3 H), 1.91 (d, J 
= 7.2 Hz, 1 H) ; 13C NMR (100 MHz, CHCl3) δ 160.4, 159.6, 159.3, 157.5, 154.9, 145.3, 140.9, 
136.9, 129.0, 127.7, 115.0, 113.6, 105.4, 101.0, 97.3, 97.3, 76.0, 55.6, 55.4 (2 C), 55.3, 55.1, 
52.0, 47.5, 42.1; HRMS (FAB+) calcd for C27H28O6+ [M+] 448.1886, found 448.1893. 
Alcohol 17.  Ketone 14 (0.200 g, 0.4 mmol, 1.0 equiv) was azeotroped (10 mL benzene) 
and dissolved in dry THF (20 mL).  4-methoxyphenylmagnesium bromide solution (16, 1.0 M in 
THF, 1.4 mL, 3.0 equiv) was added dropwise to the ketone solution and the reaction mixture was 
allowed to stir overnight at 25 ºC.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (10 mL), poured into water (10 mL) and extracted with EtOAc (3 × 30 mL).  The 
combined organic layers were washed with water (10 mL), brine (10 mL), dried (MgSO4), 
filtered and concentrated to afford the desired crude alcohol 17.  This crude material was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→2:1) to afford alcohol 17 as a 
white amorphous solid (0.192 g, 87% yield).  17: Rf = 0.21 (silica gel, hexanes:EtOAc, 7:3); IR 
(film) νmax 3576, 3470, 2997, 2926, 2853, 1721, 1604, 1510, 1489, 1317, 1248, 1204, 1178, 
1143, 1095, 1037, 978, 941, 910, 831, 777, 736, 702, 675, 638, 606, 539 cm-1; 1H NMR (400 Hz, 
CDCl3) δ 7.28 (s, 1 H), 7.18 (d, J = 8.8 Hz, 2 H), 6.80 (d, J = 8.8 Hz, 2 H), 6.69 (d, J = 8.8 Hz, 2 
H), 6.61 (d, J = 2.4 Hz, 1 H), 6.54 (d, J = 1.6 Hz, 1 H), 6.32 (d, J = 2.4 Hz, 1 H), 6.10 (d, J = 2.0 
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Hz, 1 H), 4.29 (s, 2 H), 3.86 (s, 3 H), 3.82 (s, 1 H), 3.78 (s, 3 H), 3.75 (s, 3 H), 3.70 (s, 3 H), 3.68 
(s, 3 H), 3.47 (s, 3 H); 13C NMR (100 MHz, CHCl3) 
δ 160.4, 159.6, 159.3, 158.5, 157.4, 154.7, 146.2, 143.1, 138.0, 137.1, 129.4, 127.8, 115.2, 113.4, 
113.3, 105.1, 100.7, 97.2, 97.1, 83.2, 56.8, 55.5, 55.5, 55.4, 55.3, 55.2, 55.2, 53.5, 45.2; HRMS 
(FAB+) calcd for C38H34O4+ [M+] 554.2457, found 554.2452. 
Derivative 18.  Alcohol 17 (0.03 g, 0.054 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 
(5 mL) and the solution was cooled to –78 ºC.  Et3SiH (0.18 mL, 1.13 mmol, 21.0 equiv) and 
BF3•Et2O (0.05 mL, 0.4 mmol, 7.5 equiv) were added sequentially to the solution and the 
reaction was allowed to stir at –78 ºC for 10 min.  Upon completion, the red solution was 
quenched with water (3 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined organic 
layers were combined, washed with water (5 mL), brine (5 mL), dried (MgSO4) filtered, and 
concentrated to afford the crude product 18 as a yellow oil.  This crude material was purified by 
preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford derivative 18 
(0.024 g, 83 % yield).  18: Rf = 0.32 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2996, 2928, 
2853, 2836, 1718, 1603, 1511, 1487, 1462, 1311, 1247, 1208, 1178, 1139, 1122, 1090, 1039, 
995, 964, 937, 826, 766, 735, 648, 547, 522 cm-1; 1H NMR (500 Hz, CDCl3) δ 6.71 (d, J = 8.5 
Hz, 2 H), 6.68 (d, J = 2.0 Hz, 2 H), 6.38 (d, J = 8.5 Hz, 2 H), 6.35 (broad s, 2 H), 6.23 (d, J = 1.5 
Hz, 1 H), 6.20 (d, J = 1.5 Hz, 1 H), 4.40 (d, J = 3.5 Hz, 1 H), 3.95 (s, 1 H), 3.94 (d, J = 5.0 Hz, 1 
H), 3.88 (s, 3 H), 3.81 (s, 3 H), 3.79 (s, 3 H), 3.78 (d, J = 4.5 Hz, 1 H), 3.70 (s, 3 H), 3.67 (s, 3 
H), 3.34 (s, 3 H); 13C NMR (100 MHz, CHCl3) δ 160.1, 159.4, 159.3, 157.2, 156.3, 154.2, 149.0, 
143.1, 136.3, 131.9, 129.6, 128.6, 115.2, 113.0, 112.4, 104.3, 100.9, 96.9, 96.5, 55.7, 55.5, 55.5, 
55.3, 55.3, 55.1, 53.2, 50.9, 44.9, 42.7 ; HRMS (FAB+) calcd for C34H34O6+ [M+] 538.2355, 
found 538.2358. 
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4.7.4 Functionalization of Ampelopsin F Analogues 
Experimental Table 4.7 Brominations of alcohol 13 
Reagent  
Conditions 
    
NBS 
0.9 equiv, –60 to 25 ºC,  
2 h 
1.6 (6%) 6.6 (58%) 1.0 (5%) 2.0 (19%) 
BDSB 
0.8 equiv, –78 ºC,  
10 min 
1.0 (46%) not detected 1.3 (47%) not detected 
 
Reaction with NBS.  A solution of alcohol 13 (0.008 g, 0.018 mmol, 1.0 equiv) in dry 
CH2Cl2 (2 mL) was cooled to –60 ºC.  NBS (0.003 g, 0.0017 mmol, 0.9 equiv) was added as a 
solid to this solution at –60 ºC.  The reaction mixture was allowed to warm to 0 ºC over 2 h and 
was then removed from the bath for 2 min.  Upon completion, the reaction was quenched with 
saturated aqueous Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water (10 
mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with 
water (10 mL) and brine (10 mL), dried (MgSO4) filtered, and concentrated.  The resulting crude 
oil (13:S6:S7:S8 1.6:6.6:1.0:2.0 by crude NMR integral ratios) was purified by preparative thin 
layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford S7 (0.0005 g, 5% yield), an 
inseparable mixture of S6 and S8* as well as recovered starting material (0.0005 g, 6% yield). 
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford monobromide 1 (0.0055 g, 58% yield) and dibromide (0.002 g 
19% yield). 
Reaction with BDSB.  A solution of alcohol 13 (0.0065 g, 0.014 mmol, 1.0 equiv) in dry 






































solid to this solution at –78 ºC and the reaction mixture was stirred at this temperature for 10 
min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude oil (13:S7 1:5 by crude NMR 
integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford S7 (0.0035 g, 47% yield) as well as recovered starting material 13 
(0.003 g, 46% yield).  
Monobromide S6.  Rf = 0.59 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3413, 3007, 
2924, 2852, 1597, 1509, 1461, 1435, 1322, 1247, 1205, 1146, 1102, 1076, 968, 833, 738 cm-1; 
1H NMR (400 Hz, CDCl3) δ 6.98 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.7 Hz, 2 H), 6.63 (d, J = 2.1 
Hz, 1 H), 6.27 (s, 1 H), 6.24 (d, J = 2.1 Hz, 1 H), 4.83 (s, 1 H), 4.57 (broad s, 1 H), 4.22 (d, J = 
1.8 Hz, 1 H), 3.86 (s, 3 H), 3.80 (s, 3 H), 3.79 (s, 3 H), 3.75 (s, 3 H), 3.41 (s, 3 H), 3.24 (s, 1 H), 
1.74 (broad s, 1 H); 13C NMR (100 MHz, CHCl3) δ 161.2, 158.3, 157.9, 156.9, 155.6, 145.0, 
143.2, 138.7, 128.7, 128.6, 127.2, 117.7, 113.6, 102.2, 97.6, 95.6, 77.1, 58.1, 56.4, 55.7, 55.6, 
55.4, 55.3, 50.1, 46.4; HRMS (FAB+) calcd for C27H27BrO6+ [M+] 526.0991, found 526.1003 
(for 79Br). 
Monobromide S7.  Rf = 0.44 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3493, 2934, 
2837, 1606, 1582, 1508, 1461, 1434, 1338, 1247, 1208, 1175, 1140, 1095, 1049, 972, 832, 767, 
738 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.08 (d, J = 8.8 Hz, 2 H), 6.81 (d, J = 8.8 Hz, 2 H), 6.43 
(d, J = 2.0 Hz, 1 H), 6.27 (s, 1 H), 6.24 (d, J = 2.4 Hz, 1 H), 4.58 (d, J = 6.4 Hz, 1 H), 4.32 (s, 1 
H), 4.14 (s, 1 H), 3.85 (s, 3 H), 3.81 (s, 3 H), 3.80 (s, 3 H), 3.80 (s, 3 H), 3.49 (s, 1 H), 3.41 (s, 3 
H), 1.66 (d, J = 7.2 Hz, 1 H); 13C NMR (100 MHz, CHCl3) δ 159.5, 159.5, 157.8, 156.4, 155.2, 
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144.2, 143.3, 138.4, 128.7, 115.1, 113.6, 103.5, 100.9, 97.6, 96.3, 77.4, 76.5, 59.4, 56.8, 55.9, 
55.5, 55.4, 55.4, 52.3, 43.9; HRMS (FAB+) calcd for C27H27BrO6+ [M+] 526.0991, found 
526.0993 (for 79Br). 
Dibromide S8.  Rf = 0.59 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3433, 2923, 
2853, 1719, 1587, 1509, 1461, 1434, 1393, 1324, 1247, 1205, 1178, 1140, 1103, 1075, 1033, 
967, 897, 834, 810, 776, 739, 609, 539 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.04 (d, J = 8.4 Hz, 2 
H), 6.81 (d, J = 8.8 Hz, 2 H), 6.29 (s, 1 H), 6.27 (s, 1 H), 4.94 (s, 1 H), 4.57 (broad s, 1 H), 4.35 
(d, J = 1.6 Hz, 1 H), 3.87 (s, 3 H), 3.86 (s, 3 H), 3.80 (s, 3 H), 3.79 (s, 3 H), 3.49 (s, 1 H), 3.43 (s, 
3 H); 13C NMR (100 MHz, CHCl3) δ 158.4, 157.9, 156.6, 155.9, 155.9, 144.7, 142.6, 138.3, 
128.6, 127.8, 117.4, 113.7, 102.4, 100.5, 96.2, 95.8, 76.4, 58.9, 56.8, 56.5, 55.8, 55.6, 55.4, 51.3, 
44.0; HRMS (FAB+) calcd for C27H26Br2O6+ [M+] 604.0096, found 604.0107 (for 79Br). 
Experimental Table 4.8 Brominations of alcohol 15 
Reagent  
Conditions 
    
NBS 
0.9 equiv,  
–78 ºC  to –10 ºC, 2 h 
1.2 (50%) 1.0 (43%) not detected not detected 
BDSB 
0.8 equiv, –78 ºC,  
40 min  
1 (15%) 1.4 (25%) 1.2 (21%) 1.2 (19%) 
 
Reaction with NBS.  A solution of alcohol 15 (0.016 g, 0.035 mmol, 1.0 equiv) in dry 
CH2Cl2 (3 mL) was cooled to –60 ºC.  NBS (0.006 g, 0.034 mmol, 0.9 equiv) was added as a 
solid to this solution at –60 ºC.  The reaction mixture was allowed to warm to –10 ºC over 40 
min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (10 mL) and 









































10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude orange oil (15:S9 1.2:1 by crude 
NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford S9 (0.008 g, 43% yield), as well as recovered starting material 15 
(0.008 g, 50% yield). 
Reaction with BDSB.  A solution of alcohol 15 (0.02 g, 0.045 mmol, 1.0 equiv) in dry 
CH2Cl2 (3 mL) was cooled to –78 ºC.  BDSB (0.019 g, 0.035 mmol, 0.8 equiv) was added as a 
solid to this solution at –78 ºC and the reaction mixture was allowed to stir at this temperature for 
40 min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (10 mL) 
and saturated aqueous NaHCO3 (10 mL), poured into water (10 mL) and extracted with CH2Cl2 
(3 × 10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude orange oil (15:S9:S10:S11 
1.0:1.4:1.2:1.2 by crude NMR integral ratios) was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford S9 (0.006 g, 25% yield), S10 (0.005 
g, 21% yield) and an inseparable mixture of 1:2 15:S11.*  
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford starting material 15 (0.003 g, 15% yield) and S11 (0.005 g, 19% 
yield). 
Monobromide S9.  Rf = 0.62 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3530, 2924, 
2853, 1718, 1595, 1510, 1489, 1461, 1434, 1394, 1332, 1315, 1246, 1208, 1178, 1144, 1112, 
1093, 1077, 1041, 998, 968, 938, 901, 851, 813, 783, 734, 634, 564 cm-1; 1H NMR (400 Hz, 
CDCl3) δ 7.10 (d, J = 8.4 Hz, 2 H), 6.80 (d, J = 8.8 Hz, 2 H), 6.56 (d, J = 1.6 Hz, 1 H), 6.35 (s, 1 
H), 6.22 (d, J = 2.0 Hz, 1 H), 4.92 (d, J = 4.8 Hz, 1 H), 4.57 (d of d, J = 5.2, 10.8 Hz, 1 H), 4.11 
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(s, 1 H), 3.89 (s, 3 H), 3.79 (s, 6 H), 3.74 (s, 3 H), 3.49 (d, J = 4.8 Hz, 1 H), 3.46 (s, 3 H), 1.80 
(d, J = 6.0 Hz, 1 H); 13C NMR (100 MHz, CHCl3) δ 160.7, 158.2, 157.6, 155.8, 155.6, 145.9, 
140.4, 137.0, 129.1, 126.8, 117.6, 113.6, 104.9, 100.7, 97.4, 95.4, 75.8, 56.5, 55.7, 55.5, 55.4, 
55.4, 51.9, 46.4, 42.3; HRMS (FAB+) calcd for C27H27BrO6+ [M+] 526.0991, found 526.0999 
(for 79Br). 
Monobromide S10.  Rf = 0.51 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3534, 
2924, 2853, 1718, 1595, 1510, 1488, 1461, 1434, 1393, 1332, 1315, 1246, 1208, 1178, 1144, 
1112, 1093, 1077, 1041, 998, 968, 939, 901, 851, 814, 783, 733, 635, 564, 540 cm-1; 1H NMR 
(400 Hz, CDCl3) δ 7.20 (d, J = 8.4 Hz, 2 H), 6.82 (d, J = 8.8 Hz, 2 H), 6.52 (d, J = 2.4 Hz, 1 H), 
6.32 (d, J = 2.4 Hz, 1 H), 6.26 (s, 1 H), 4.51 (d of d, J = 4.8, 11.2 Hz, 1 H), 4.20 (s, 1 H), 4.14 (d, 
J = 4.4 Hz, 1 H), 3.85 (s, 6 H), 3.79 (s, 6 H), 3.75 (d, J = 5.2 Hz, 1 H), 3.46 (s, 3 H), 1.92 (d, 6.8 
Hz, 1 H); 13C NMR (100 MHz, CHCl3) δ 159.7, 159.4, 157.6, 155.9, 154.0, 144.9, 140.2, 136.7, 
128.9, 128.0, 114.8, 113.7, 105.4, 99.5, 97.5, 95.9, 75.1, 56.7, 55.9, 55.5, 55.3, 55.2, 52.5, 48.7, 
39.7; HRMS (FAB+) calcd for C27H27BrO6+ [M+] 526.0991, found 526.1006 (for 79Br). 
Dibromide S11.  Rf = 0.58 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3443, 2956, 
2925, 2854, 1605, 1582, 1509, 1461, 1434, 1378, 1334, 1310, 1265, 1243, 1211, 1196, 1176, 
1146, 1112, 1091, 1073, 1041, 998, 969, 938, 867, 814, 778, 762, 736, 702, 684, 648, 598, 537, 
475 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.18 (d, J = 8.4 Hz, 2 H), 6.81 (d, J = 8.8 Hz, 2 H), 6.37 
(s, 1 H), 6.26 (s, 1 H), 5.02 (d, J = 4.4 Hz, 1 H), 4.58 (t, J = 5.2 Hz, 1 H), 4.21 (s, 1 H), 3.90 (s, 3 
H), 3.85 (s, 3 H), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.73 (d, J = 4.8 Hz, 1 H), 3.47 (s, 3 H), 1.82 (d, J = 
5.6 Hz, 1 H); 13C NMR (125 MHz, CHCl3) δ 158.3, 157.6, 156.2, 155.8, 154.7, 145.4, 139.8, 
136.8, 129.0, 127.0, 117.3, 113.6, 104.8, 99.1, 95.9, 95.5, 74.8, 56.7, 56.5, 55.8, 55.5, 55.4, 52.3, 
47.6, 39.9; HRMS (FAB+) calcd for C27H26Br2O6+ [M+] 604.0096, found 604.0110 (for 79Br). 
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Experimental Table 4.9 Brominations of ketone 14 
Reagent  
Conditions 
    
NBS 
0.9 equiv, –60 to 
25 ºC,  
2 h 
1.3 (50%) 1.0 (42%) not detected not detected 
BDSB (2 h) 
0.7 equiv, –78 to  
0 ºC, 
2 h 
1.9 (17%) 1.0 (8%) 5.2 (52%) 1.5 (not isolable)  
BDSB (2 h) 
0.7 equiv, –78 to 0 
ºC,  
2 h 
2.8 1.7 7.6 3.4 
 
Reaction with NBS.  A solution of permethylated ketone 14 (0.007 g, 0.016 mmol, 1.0 
equiv) in dry CH2Cl2 (1 mL) was cooled to –60 ºC.  NBS (0.002 g, 0.001 mmol, 0.7 equiv) was 
added as a solid to this solution at –60 ºC.  The reaction mixture was allowed to warm to 0 ºC 
over 2 h and was then removed from the bath and allowed to come to 25 ºC over 10 min.  Upon 
completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and saturated 
aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 10 mL).  
The organic layers were combined, washed with water (10 mL) and brine (10 mL), dried 
(MgSO4) filtered, and concentrated.  The resulting crude yellow oil (14:S12 1.3:1.0 by crude 
NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford S12 (0.0035 g, 42 % yield) as well as recovered starting material 
14 (0.0035 g, 50% yield).  
Reaction with BDSB.  A solution of permethylated ketone 14 (0.006 g, 0.013 mmol, 1.0 





































added as a solid to this solution at –78 ºC and the reaction mixture was allowed to warm to 0 ºC 
over 2 h.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) 
and saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 
× 10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude yellow oil (14:S12:S13:S14 
1.9:1.0:5.2:1.5 by crude NMR integral ratios) was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford S12 (0.0006 g, 8% yield), S13* 
(0.0035 g, 52% yield) as well as recovered starting material 14 (0.001 g, 17% yield).  
* An additional purification by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 3:7) was necessary for the separation of S13 and S14.  The dibromide S14 was 
not isolable in sufficient quantity for characterization and an analytical sample was synthesized 
using 2 equiv of NBS according to the same procedure described above. 
Monobromide S12.  Rf = 0.72 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3006, 
2961, 2919, 2853, 1771, 1722, 1597, 1513, 1462, 1437, 1325, 1252, 1211, 1127, 1072 cm-1; 1H 
NMR (400 Hz, CDCl3) δ 6.92 (d, J = 8.4 Hz, 2 H), 6.78 (d, J = 8.8 Hz, 2 H), 6.59 (d, J = 2.4 Hz, 
1 H), 6.29 (d, J = 2.0 Hz, 1 H), 6.26 (s, 1 H), 5.03 (s, 1 H), 4.67 (d, J = 2.0 Hz, 1 H), 3.85 (s, 3 
H), 3.81 (s, 3 H), 3.78 (s, 3 H), 3.77 (s, 3 H), 3.42 (s, 3 H), 3.40 (broad s, 1 H); 13C NMR (100 
MHz, CHCl3) δ 207.4, 160.9, 158.3, 158.1, 156.2, 155.4, 142.8, 141.3, 135.9, 128.3, 124.8, 
118.7, 113.8, 102.4, 100.2, 97.9, 96.0, 59.4, 56.5, 55.8, 55.7, 55.4, 55.3, 51.4, 50.5; HRMS 
(FAB+) calcd for C27H26BrO6+ [M+] 525.0913, found 525.0925 (for 79Br). 
Monobromide S13.  Rf = 0.60 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2960, 
2924, 2851, 1769, 1606, 1510, 1461, 1340, 1246, 1080, 830 cm-1; 1H NMR (400 Hz, CDCl3) 
δ 6.97 (d, J = 8.8 Hz, 2 H), 6.79 (d, J = 8.8 Hz, 2 H), 6.38 (d, J = 2.0 Hz, 1 H), 6.32 (s, 1 H), 6.24 
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(d, J = 2.4 Hz, 1 H), 4.80 (d, J = 2.0 Hz, 1 H), 4.32 (s, 1 H), 3.88 (s, 3 H), 3.83 (s, 3 H), 3.81 (s, 3 
H), 3.78 (s, 3 H), 3.64 (s, 1 H), 3.41 (s, 3 H); 13C NMR (100 MHz, CHCl3) 
δ 206.9, 160.1, 159.4, 158.3, 156.2, 153.9, 143.2, 141.1, 135.7, 128.3, 126.0, 116.2, 113.8, 103.7, 
99.1, 98.3, 96.0, 60.2, 56.7, 56.0, 55.6, 55.6, 55.3, 53.8, 48.9; HRMS (FAB+) calcd for 
C27H26BrO6+ [M+] 525.0913, found 525.0916 (for 79Br). 
Dibromide S14.  Rf = 0.39 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3010, 2961, 
2940, 2843, 1771, 1610, 1587, 1510, 1462, , 1427, 1322, 1249, 1212, 1197, 1183, 1127, 1077 
cm-1; 1H NMR (400 Hz, CDCl3) δ 6.95 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 6.32 (s, 1 
H), 6.28 (s, 1 H), 5.13 (s, 1 H), 4.80 (d, J = 2.0 Hz, 1 H), 3.88 (s, 3 H), 3.86 (s, 3 H), 3.82 (s, 3 
H), 3.78 (s, 3 H), 3.64 (s, 1 H), 3.43 (s, 3 H); 13C NMR (125 MHz, CHCl3) δ 206.3, 158.4, 158.3, 
156.5, 156.3, 154.6, 142.5, 141.4, 135.5, 128.2, 125.0, 118.3, 113.8, 102.4, 98.7, 96.2, 96.0, 60.1, 
56.6, 56.5, 55.9, 55.8, 55.3, 52.7, 48.6; HRMS (FAB+) calcd for C27H24Br2O6+ [M+] 604.0096 , 
found 601.9954 (for 79Br). 
Experimental Table 4.10 Brominations of alcohol 17 
Reagent  
Conditions 
    
NBS 
1.3 equiv, –78 to  
25 ºC,  
4 h 
not detected 1.9 (36%) not detected 1 (19%) 
BDSB 
1.0 equiv, –78 ºC,  
15 min 
not detected 1 (15%) not detected 1.8 (30%) 
 
Reaction with NBS.  A solution of alcohol 17 (0.006 g, 0.011 mmol, 1.0 equiv) in dry 


































solid to this solution at –78 ºC.  The reaction mixture was allowed to warm to 25 ºC over 4 h.  
Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude orange oil (S15:S17 1.9:1 by 
crude NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford S15 (0.0025 g, 36% yield) and S17 (0.0015 g, 19% yield). 
Reaction with BDSB.  A solution of alcohol 17 (0.006 g, 0.011 mmol, 1.0 equiv) in dry 
CH2Cl2 (1 mL) was cooled to –78 ºC.  BDSB (0.006 g, 0.011 mmol, 1.0 equiv) was added as a 
solid to this solution at –78 ºC and the reaction mixture was stirred at this temperature for 15 
min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude orange oil (S15:S17 1:1.8 by 
crude NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford S15 (0.001 g, 14 % yield) and S17 (0.0025 g, 32% yield). 
Monobromide S15.  Rf = 0.61 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3354, 
3198, 2924, 2852, 1661, 1610, 1510, 1458, 1435, 1392, 1322, 1249, 1206, 1179, 1133, 1076, 
1037, 1076, 1037, 831, 568, 458 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.30 (d, J = 8.8 Hz, 2 H), 
7.16 (d, J = 8.8 Hz, 2 H), 6.79 (d, J = 8.0 Hz, 2 H), 6.71 (d, J = 8.8 Hz, 2 H), 6.54 (s, 1 H), 6.37 
(s, 1 H), 6.11 (s, 1 H), 5.17 (s, 1 H), 4.31 (s, 1 H), 3.91 (s, 3 H), 3.78 (s, 4 H), 3.75 (s, 3 H), 3.70 
(s, 3 H), 3.67 (s, 3 H), 3.48 (s, 3 H); 13C NMR (100 MHz, CHCl3) 
δ 160.7, 158.6, 158.1, 157.4, 155.7, 155.4, 146.9, 142.5, 137.9, 137.3, 129.5, 127.9, 127.2, 118.0, 
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113.4, 113.3, 104.5, 100.4, 97.0, 95.3, 83.1, 56.6, 56.5, 55.5, 55.5, 55.4, 55.3, 55.3, 52.3, 45.4; 
HRMS could not be obtained. 
Dibromide S17.  Rf = 0.60 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3354, 3202, 
2963, 2925, 2855, 1664, 1623, 1568, 1394, 1347, 1036, 742, 572 cm-1; 1H NMR (400 Hz, 
CDCl3) δ 7.29 (d, J = 8.8 Hz, 2 H), 7.25 (d, J = 8.4 Hz, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 6.73 (d, J 
= 8.8 Hz, 2 H), 6.39 (s, 1 H), 6.13 (s, 1 H), 5.25 (s, 1 H), 4.39 (s, 1 H), 4.05 (s, 1 H), 3.91 (s, 4 
H), 3.81 (s, 3 H), 3.78 (s, 3 H), 3.71 (s, 3 H), 3.68 (s, 3 H), 3.49 (s, 3 H); 13C NMR (100 MHz, 
CHCl3) δ 158.8, 158.2, 157.5, 156.0, 155.7, 154.5, 146.7, 141.8, 137.5, 137.1, 129.4, 127.8, 
127.1, 117.8, 113.6, 113.3, 104.3, 98.3, 95.6, 95.4, 82.4, 56.5, 56.5, 56.4, 55.7, 55.5, 55.4, 55.3, 
54.0, 42.9; HRMS could not be obtained. 
Experimental Table 4.11 Brominations of derivative 18 
Reagent  
Conditions 
    















Reaction with NBS.  A solution of derivative 18 (0.0048 g, 0.009 mmol, 1.0 equiv) in 
dry CH2Cl2 (1 mL) was cooled to –78 ºC.  NBS (0.0013 g, 0.007 mmol, 0.8 equiv) was added as 
a solid to this solution at –78 ºC.  The reaction mixture was allowed to warm to 25 ºC over 5 h.  
Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (2 mL) and 
saturated aqueous NaHCO3 (2 mL), poured into water (2 mL) and extracted with CH2Cl2 (3 × 5 









































(MgSO4), filtered and concentrated.  The resulting crude oil (18:S18:S19:S20 1.0:2.3:1.0:1.2 by 
crude NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford S18 (0.0022 g, 40% yield), S19 (0.0013 g, 24% yield), S20 
(0.0008 g, 13% yield) as well as recovered starting material 18 (0.0011 g, 23% yield).  
Reaction with BDSB.  A solution of permethylated derivative 18 (0.0057 g, 0.011 mmol, 
1.0 equiv) in dry CH2Cl2 (2 mL) was cooled to –78 ºC.  BDSB (0.0046 g, 0.0084 mmol, 0.8 
equiv) was added as a solid to this solution at –78 ºC and the reaction mixture was allowed to stir 
at this temperature for 15 min.  Upon completion, the reaction was quenched with saturated 
aqueous Na2SO3 (10 mL) and saturated aqueous NaHCO3 (2 mL), poured into water (2 mL) and 
extracted with CH2Cl2 (3 × 5 mL).  The organic layers were combined, washed with water (3 
mL) and brine (3 mL), dried (MgSO4), filtered and concentrated.  The resulting crude oil 
(18:S18:S19:S20 1.4:1.0:9.4:3.8 by crude NMR integral ratios) was purified by preparative thin 
layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford S19 (0.0036 g, 55% yield) and 
S20 (0.0023 g, 31% yield).    
Monobromide S18.  Rf = 0.26 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2997, 
2934, 2835, 2062, 1734, 1595, 1511, 1487, 1461, 1434, 1392, 1325, 1247, 1207, 1179, 1141, 
1122, 1097, 1078, 1038, 998, 971, 938, 895, 831, 808, 789, 736, 703, 675, 643, 603, 568, 524 
cm-1; 1H NMR (500 Hz, CDCl3) δ 6.67 (d, J = 2.0 Hz, 1 H), 6.65 (d, J = 8.5 Hz, 2 H), 6.40 (d, J 
= 8.5 Hz, 2 H), 6.36 (broad s, 2 H), 6.24 (s, 1 H), 6.23 (d, J = 2.0 Hz, 1 H), 5.23 (d, J = 4.0 Hz, 1 
H), 4.00 (s, 1 H), 3.94 (d, J = 4.0 Hz, 1 H), 3.90 (s, 3 H), 3.86–3.84 (m, 1 H), 3.82 (s, 3 H), 3.78 
(s, 3 H), 3.70 (s, 3 H), 3.67 (s, 3 H), 3.40 (s, 3 H); 13C NMR (125 MHz, CHCl3) δ 160.4, 158.2, 
157.3, 156.5, 155.3, 154.9, 149.6, 142.2, 136.4, 131.6, 130.3, 129.4, 128.5, 117.7, 113.1, 112.5, 
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103.8, 100.6, 96.8, 94.8, 56.3, 55.7, 55.5, 55.3, 52.8, 51.3, 43.6, 42.8; HRMS (FAB+) calcd for 
C34H33BrO6+ [M+] 616.1461, found 616.1483 (for 79Br). 
Monobromide S19.  Rf = 0.26 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2999, 
2928, 2837, 2062, 1721, 1604, 1583, 1511, 1461, 1434, 1329, 1310, 1247, 1210, 1178, 1144, 
1092, 1078, 1035, 998, 970, 894, 823, 808, 774, 735, 702, 676, 645, 602, 568, 523 cm-1; 1H 
NMR (400 Hz, CDCl3) δ 6.72 (d, J = 8.5 Hz, 2 H), 6.66 (d, J = 2.4 Hz, 1 H), 6.39 (d, J = 8.4 Hz, 
2 H), 6.38 (broad s, 2 H), 6.27 (s, 1 H), 6.22 (d, J = 2.0 Hz, 1 H), 4.49 (d, J = 3.2 Hz, 1 H), 4.15 
(d, J = 4.8 Hz, 1 H), 4.06 (s, 1 H), 3.88 (s, 3 H), 3.87 (s, 3 H), 3.83 (s, 3 H), 3.80–3.78 (m, 1 H), 
3.70 (s, 3 H), 3.67 (s, 3 H), 3.35 (s, 3 H); 13C NMR (125 MHz, CHCl3) δ 159.5, 159.4, 157.3, 
156.4, 155.6, 153.2, 148.4, 142.3, 136.1, 131.6, 131.3, 129.6, 128.6, 115.0, 113.0, 112.4, 104.3, 
99.4, 96.6, 95.6, 56.8, 55.9, 55.5, 55.4, 55.3, 55.1, 53.8, 50.0, 46.1, 40.2; HRMS (FAB+) calcd 
for C34H33BrO6+ [M+] 616.1461, found 615.3210 (for 79Br). 
Dibromide S20.  Rf = 0.24 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3003, 2928, 
2837, 1723, 1586, 1511, 1461, 1434, 1392, 1328, 1248, 1209, 1179, 1150, 1098, 1079, 1036, 
972, 896, 823, 735, 566, 524 cm-1; 1H NMR (400 Hz, CDCl3) δ 6.65 (d, J = 8.0 Hz, 2 H), 6.40 
(d, J = 8.4 Hz, 3 H), 6.39 (broad s, 1 H), 6.27 (s, 1 H), 6.26 (s, 1 H), 5.33 (d, J = 3.6 Hz, 1 H), 
4.17 (d, J = 4.8 Hz, 1 H), 4.10 (s, 1 H), 3.90 (s, 3 H), 3.87 (s, 4 H), 3.81 (s, 3 H), 3.70 (s, 3 H), 
3.67 (s, 3 H), 3.35 (s, 3 H); 13C NMR (125 MHz, CHCl3) δ 158.3, 157.3, 156.5, 155.8, 155.3, 
153.9, 141.4, 136.2, 131.0, 130.6, 129.4, 128.4, 117.4, 113.1, 103.5, 98.9, 95.5, 94.9, 56.7, 56.3, 
55.9, 55.3, 53.3, 50.4, 44.8, 40.3; HRMS (FAB+) calcd for C34H33Br2O6+ [M+] 695.0644, found 
695.0673 (for 79Br). 
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4.7.5 Attempts to Effect a Bromine Migration under Acidic Conditions 
Reaction with Br2 in acetic acid.  Permethylated ampelopsin F (1, 0.018 g, 0.033 mmol, 
1.0 equiv) was dissolved in acetic acid (6 mL).  Br2 (0.17 M in CH2Cl2, 0.1 mL, 0.017 mmol, 0.5 
equiv) was added and the solution was allowed to stir at 25 ºC for 10 min.  Upon completion, the 
reaction was quenched with saturated aqueous Na2SO3 (2 mL) and saturated aqueous NaHCO3 (2 
mL), poured into water and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers 
were washed with water (2 mL), brine (2 mL), dried (MgSO4), filtered and concentrated to afford 
a 1:1.3 mixture of monobromide 2:dibromide 21. 
Reaction of monobromide 2 with [HEt2S][SbBrCl5].  Monobromide 2 (0.005 g, 0.008 
mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (1 mL) and the solution was cooled to –78 ºC.  
Solid [HEt2S][SbBrCl5] (0.0035 g, 0.009 mmol, 1.1 equiv) was added and the reaction was 
allowed to stir at that temperature for 2.5 h.  Upon completion, the reaction was quenched with 
saturated aqueous Na2SO3 (2 mL) and saturated aqueous NaHCO3 (2 mL), poured into water and 
extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were washed with water (2 
mL), brine (2 mL), dried (MgSO4), filtered and concentrated to afford monobromide 2 
exclusively. 
Reaction of monobromide 2 with BDSB.  Monobromide 2 (0.012 g, 0.019 mmol, 1.0 
equiv) was dissolved in dry CH2Cl2 (3 mL) and the solution was cooled to –78 ºC.  Solid BDSB 
(0.0053 g, 0.01 mmol, 0.5 equiv) was added and the reaction was allowed to stir at that 
temperature for 30 min.  Upon completion, the reaction was quenched with saturated aqueous 
Na2SO3 (5 mL) and saturated aqueous NaHCO3 (5 mL), poured into water and extracted with 
CH2Cl2 (3 × 10 mL).  The combined organic layers were washed with water (5 mL), brine (5 
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mL), dried (MgSO4), filtered and concentrated to afford a mixture of 1:4 monobromide 
2:dibromide 21. 
4.7.6 Effects of the Base Present in the System on Selectivity 
Reaction with BDSB and Ba(OH)2.  Permethylated ampelopsin F (1, 0.04 g, 0.074 
mmol, 1.0 equiv) was dissolved in CH2Cl2 (10 mL) and Ba(OH)2 • 8 H2O (0.035 g, 0.11 mmol, 
1.5 equiv) was added to the solution.  The solution was cooled to –78 ºC and BDSB (0.055 g, 0.1 
mmol, 1.3 equiv) was added as a solid and the reaction was allowed to stir at that temperature for 
30 min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (10 mL) 
and saturated aqueous NaHCO3 (10 mL), poured into water and extracted with CH2Cl2 (3 × 20 
mL).  The combined organic layers were washed with water (10 mL), brine (10 mL), dried 
(MgSO4), filtered and concentrated to afford a crude mixture of ~ 1.3:1 monobromide 
3:dibromide 21. 
Reaction with BDSB and pyridine.  Permethylated ampelopsin F (1, 0.077 g, 0.143 
mmol, 1.0 equiv) was dissolved in CH2Cl2 (5 mL) and pyridine (0.02 mL, 0.25 mmol, 1.7 equiv) 
was added to the solution.  The solution was cooled to –78 ºC and BDSB (0.07 g, 0.13 mmol, 0.9 
equiv) was added as a solid and the reaction was allowed to warm to –10 ºC over 3 h.  Upon 
completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and saturated 
aqueous NaHCO3 (5 mL), poured into water and extracted with CH2Cl2 (3 × 10 mL).  The 
combined organic layers were washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered 
and concentrated to afford a crude mixture of ~ 1:1 monobromide 2:starting material 1. 
For the reaction of ampelopsin F (1) with [Collidine2Br](OTf) please see Chapter 2. 
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4.7.7 Synthesis and Bromination of Monoacetylated Ampelopsin F (35) 
 
Experimental Scheme 4.3 Synthesis of derivative 35 
 
 Triaryl alcohol S23.  Bromide S21 (1.94 g, 5.11 mmol, 1.0 equiv) was dissolved in dry 
THF (36 mL) and the solution was cooled to –78 ºC.  nBuLi (1.6 M in hexanes, 3.4 mL, 5.44 
mmol, 1.1 equiv) was added dropwise at –78 ºC and the resulting bright yellow anion was 
allowed to stir at that temperature for 20 min.  A solution of aldehyde S22 (0.85 g, 5.1 mmol, 1.0 
equiv) in dry THF (18 mL) was added slowly to this anion at –78 ºC and the reaction was 
allowed to warm to 25 ºC overnight.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (30 mL), poured into water (30 mL) and extracted with EtOAc (3 × 30 mL).  The 
combine organic layers were washed with water (20 mL) and brine (20 mL), dried (MgSO4), 
filtered and concentrated to afford the desired alcohol S23 (1.8 g, 76% yield), which was carried 
forward without additional purification.  S23: 1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 8.7 Hz, 
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2.4 Hz, 1 H), 6.51 (dd, J = 2.3, 1.0 Hz, 2 H), 6.44 (d, J = 2.4 Hz, 1 H), 6.33–6.30 (m, 1 H), 6.17 
(d, J = 9.8 Hz, 1 H), 5.17 (s, 2 H), 3.87 (s, 3 H), 3.74 (s, 6 H), 3.73 (s, 3 H), 3.48 (s, 3 H). 
Sulfide S25.  Triaryl alcohol S23 (1.3 g, 2.8 mmol, 1.0 equiv) was dissolved in CH2Cl2  
(60 mL) and TFA (0.64 mL, 8.4 mmol, 3.0 equiv) was added to the reaction at 25 ºC in two 
portions 2 min apart and the reaction was allowed to run for an additional 5 min.  Upon 
completion, the reaction was quenched with a solution of K2CO3 (4.6 g) in MeOH (40 mL).  This 
bright yellow solution was allowed to stir at 25 ºC for 30 min and was then extracted with 
CH2Cl2 (3 × 60 mL).  The combined organic layers were washed with water (30 mL) and brine 
(30 mL), dried (MgSO4), filtered and concentrated.  The crude product was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 7:3→2:3) to afford the desired cyclized 
alcohol (0.52 g, 40% yield).  This alcohol (1.25 g, 2.7 mmol, 1.0 equiv) was then dissolved in a 
minimum amount of benzene and p-methoxybenzylthiol (S24, 1.16 mL, 8.4 mmol, 3.0 equiv) 
and pTSA (monohydrate, 0.490 g, 2.6 mmol, 0.95 equiv) were added sequentially.  The reaction 
was run under constant azeotroping of the resulting water on the rotavapory evaporator.  The 
benzene was replenished every time the reaction ran to almost dryness.  The consumption of the 
entire starting material was apparent by TLC after 5 h.  The reaction was then quenched with 
saturated aqueous NaHCO3 (30 mL) and extracted with CH2Cl2 (3 × 30 mL).  The combined 
organic layers were washed with water (20 mL) and brine (20 mL), dried (MgSO4), filtered and 
concentrated.  The resulting crude product was purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 7:3→2:3) to afford the desired sulfide (0.765 g, 51% yield) without the 
MOM group.  This intermediate (0.765 g, 1.4 mmol, 1.0 equiv) was then dissolved in dry CH2Cl2 
(30 mL) and N,N-diisopropylethylamine (0.5 mL, 2.9 mmol, 2.1 equiv) and MOMCl (0.15 mL, 
1.97 mmol, 1.4 equiv) were added sequentially.  The reaction was allowed to stir overnight at 25 
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ºC.  Upon completion, the reaction was quenched with saturated aqueous NaHCO3 (20 mL), 
poured into water (20 mL) and extracted with CH2Cl2 (3 × 40 mL).  The combined organic layers 
were washed with water (20 mL) and brine (20 mL), dried (MgSO4), filtered and concentrated.  
The resulting crude product was purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 7:3→2:3) to afford the desired sulfide S25 (0.591 g after the recycling, 62% 
yield, ~ 2:1 d.r.) and unreacted starting material, which was recycled once to full conversion.  
S25: 1H NMR (400 MHz, CDCl3) δ 7.11 (d, J = 8.6 Hz, 1 H), 7.09–7.05 (m, 1 H), 7.05–6.99 (m, 
4 H), 6.98–6.88 (m, 3 H), 6.77 (d, J = 8.7 Hz, 1H), 6.76–6.70 (m, 3 H), 6.55–6.49 (m, 1 H), 6.46 
(d, J = 2.1 Hz, 1 H), 6.35 (td, J = 6.1, 5.5, 2.2 Hz, 2 H), 6.28 (dt, J = 4.1, 2.3 Hz, 2 H), 6.18 (t, J 
= 2.3 Hz, 3 H), 5.17 (s, 2 H), 5.15 (s, 1 H), 4.54 (t, J = 5.3 Hz, 2 H), 4.24 (d, J = 6.7 Hz, 1 H), 
4.20 (d, J = 7.0 Hz, 1 H), 3.82 (s, 3 H), 3.80 (s, 2 H), 3.77 (d, J = 1.5 Hz, 5 H), 3.69 (s, 4 H), 3.68 
(s, 7 H), 3.61 (s, 2 H), 3.57 (s, 4 H), 3.49 (s, 3 H), 3.46 (s, 2 H), 3.32 (d, J = 12.8 Hz, 1 H), 3.19 
(d, J = 12.8 Hz, 1 H). 
Alkene S26.  Sulfide S25 (0.591 g, 0.98 mmol, 1.0 equiv) was dissolved in CH2Cl2 (44 
mL) and NaHCO3 (0.46 g, 5.5 mmol, 5.6 equiv) and mCPBA (77%, 0.75 g, 3.3 mmol, 3.4 equiv) 
were added sequentially.  The reaction was allowed to stir at 25 ºC for 2 h.  Upon completion, 
the reaction was quenched with saturated aqueous Na2SO3 (30 mL) and saturated aqueous 
NaHCO3 (30 mL), poured into water (20 mL) and extracted with CH2Cl2 (3 × 50 mL).  The 
combined organic layers were washed with water (30 mL) and brine (30 mL), dried (MgSO4), 
filtered and concentrated.  This crude material was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 4:1→1:1) to afford the desired sulfone (0.44 g, 72 % yield).  The 
intermediate sulfone (0.213 g, 0.34 mmol, 1.0 equiv) was dissolved in a 1:1 mixture of tBuOH 
and CCl4 (7 mL total) and a KOH (0.43 g ) solution in water (0.8 mL) was added to the solution 
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at 25 ºC.  The reaction was then refluxed at 80 ºC for 12 h.  Additional CCl4 (2 mL) was added 
and the reaction was allowed to reflux for another 12 h.  Upon completion, the reaction was 
quenched with NH4Cl (15 mL), poured into water (15 mL) and extracted with CH2Cl2 (3 × 30 
mL).  The combined organic layers were washed with water (15 mL) and brine (15 mL), dried 
(MgSO4), filtered and concentrated.  The crude material was purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1→3:2) to afford the desired alkene S26 (0.07 g, 
58% yield, 3:1 d.r. about the olefin).  S26: 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.5 Hz, 2 
H), 7.30 (d, J = 8.6 Hz, 1 H), 7.21–7.17 (m, 6 H), 7.17–7.12 (m, 6 H), 7.08 (d, J = 1.8 Hz, 4 H), 
6.97–6.86 (m, 11 H), 6.83 (d, J = 2.0 Hz, 3 H), 6.72 (d, J = 8.8 Hz, 5 H), 6.51 (d, J = 2.1 Hz, 1 
H), 6.37 (s, 1 H), 6.31 (dt, J = 5.3, 1.9 Hz, 7 H), 5.15 (s, 2 H), 5.12 (s, 5 H), 4.63 (s, 1 H), 4.35 (s, 
3 H), 4.23 (s, 3 H), 3.92 (s, 8 H), 3.85 (s, 1 H), 3.82 (d, J = 1.2 Hz, 3 H), 3.81 (s, 2 H), 3.73 (s, 15 
H), 3.70 (s, 6 H), 3.70 (s, 17 H), 3.61 (d, J = 1.8 Hz, 11 H), 3.56 (s, 3 H), 3.48 (s, 3 H), 3.45 (s, 8 
H). 
Ampelopsin F derivative S27.  Alkene S26 (0.07 g, 0.123 mmol, 1.0 equiv) was 
dissolved in dry CH2Cl2 (15 mL) and solid NBS (0.044 g, 0.247 mmol, 2.0 equiv) was added to 
the solution.  The reaction was allowed to stir for 30 min at 25 ºC and was then cooled to 0 ºC.  
A solution of Br2 (1.0 M, 0.08 mL, 0.08 mmol, 0.65 equiv) was added and the reaction was 
allowed to stir at that temperature for another 3 min.  Upon completion, the reaction was 
quenched with saturated aqueous Na2SO3 (10 mL) and saturated aqueous NaHCO3 (10 mL), 
poured into water (10 mL) and extracted with CH2Cl2 (3 × 20 mL).  The combined organic layers 
were washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated.  
This crude material was purified by flash column chromatography (silica gel, hexanes:EtOAc, 
9:1→7:3) to afford the desired tribromide (0.06 g, 61% yield).  This intermediate tribromide 
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(0.06 g, 0.075 mmol, 1.0 equiv) was dissolved in toluene (10 mL) and (TMS)3SiH (0.2 mL, 0.65 
mmol, 8.6 mmol) and AIBN (0.013 g, 0.079 mmol, 1.1 mmol) were added sequentially at 25 ºC.  
The reaction was then heated to 80 ºC overnight.  Upon completion, the reaction was 
concentrated and the resulting crude material was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 17:3) to afford pure derivative S27 (0.014 g, 33% 
yield).  S27: 1H NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.6 Hz, 2 H), 6.85–6.75 (m, 5 H), 6.57 
(d, J = 2.0 Hz, 1 H), 6.51 (d, J = 2.4 Hz, 1 H), 6.25 (d, J = 2.5 Hz, 1 H), 6.18 (d, J = 2.0 Hz, 1 H), 
5.05 (s, 2 H), 4.20 (d, J = 1.9 Hz, 1 H), 4.18 (s, 1 H), 3.83 (s, 3 H), 3.80 (s, 3 H), 3.77 (s, 3 H), 
3.74 (s, 2 H), 3.72 (s, 1 H), 3.43 (s, 3 H), 3.41 (d, J = 2.4 Hz, 1 H), 3.40 (s, 3 H). 
Alcohol S28.  Compound S27 (0.014 g, 0.025 mmol, 1.0 equiv) was dissolved in CH2Cl2 
(2 mL) and pTSA (0.007 g, 0.037 mmol, 1.5 equiv) was added to the solution.  The reaction was 
allowed to stir overnight at 25 ºC.  Upon completion, the reaction was quenched with saturated 
aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  
The combined organic layers were washed with water (5 mL) and brine (5 mL), dried (MgSO4), 
filtered and concentrated.  The resulting crude mixture was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc, 7:3) to afford pure derivative S28 (0.002 g, 16% 
yield).  S28: 1H NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.5 Hz, 2 H), 6.81 (d, J = 8.5 Hz, 2 H), 
6.77 (d, J = 8.4 Hz, 2 H), 6.62–6.53 (m, 3 H), 6.50 (d, J = 2.4 Hz, 1 H), 6.24 (d, J = 2.4 Hz, 1 H), 
6.18 (d, J = 2.0 Hz, 1 H), 4.20 (d, J = 1.9 Hz, 1 H), 4.16 (s, 1 H), 3.82 (s, 3 H), 3.80 (s, 10 H), 
3.76 (s, 3 H), 3.74 (s, 3 H), 3.70 (s, 1 H), 3.42 (s, 3 H), 3.39 (s, 1 H). 
Monoacetylated ampelopsin F (35).  Alcohol S28 (0.002 g, 0.004 mmol, 1.0 equiv) was 
dissolved in CH2Cl2 (1 mL) and AcCl (0.012 mL, 0.17 mmol, 42.0 equiv) was added to the 
solution.  The reaction was allowed to stir at 25 ºC overnight.  Upon completion, the reaction 
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was quenched with saturated aqueous NaHCO3 (2 mL), poured into water (2 mL) and extracted 
with CH2Cl2 (3 × 5 mL).  The combined organic layers were washed with water (3 mL) and 
brine (3 mL), dried (MgSO4), filtered and concentrated.  The resulting crude mixture was 
purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford pure 
derivative 35 (0.001 g, 47% yield).  35: 1H NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.5 Hz, 2 H), 
6.90 (d, J = 8.5 Hz, 2 H), 6.81 (d, J = 6.3 Hz, 2 H), 6.79 (d, J = 6.3 Hz, 2 H), 6.56 (d, J = 2.1 Hz, 
1 H), 6.50 (d, J = 2.4 Hz, 1 H), 6.25 (d, J = 2.5 Hz, 1 H), 6.18 (d, J = 2.0 Hz, 1 H), 4.21 (d, J = 
1.9 Hz, 1 H), 4.18 (s, 1 H), 3.83 (s, 3 H), 3.80 (s, 3 H), 3.77 (s, 3 H), 3.74 (d, J = 2.0 Hz, 4 H), 
3.43 (s, 3 H), 2.22 (s, 3H). 
 
Experimental Scheme 4.4 Structure of bromide S29 
 
 Reaction of monoacetylated ampelopsin F (35) with BDSB.  Compound 35 (0.001 g, 
0.002 mmol, 1.0 equiv) was dissolved in dry CH2Cl2 (2 mL) and the solution was cooled to –78 
ºC.  BDSB (0.001 g, 0.002 mmol, 1.0 equiv) was added as a solid to the solution at –78 ºC and 
the reaction was allowed to stir at –78 ºC for 45 min.  Upon completion, the reaction was 
quenched with saturated aqueous Na2SO3 (2 mL) and saturated aqueous NaHCO3 (2 mL), poured 
into water (2 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were 
washed with water (3 mL) and brine (3 mL), dried (MgSO4), filtered and concentrated.  The 
resulting crude mixture showed monobromide S29 as the major product.  This crude material 









pure monobromide S29 (0.001 g, 88% yield).  S29: 1H NMR (400 MHz, CDCl3) δ 7.14 (d, J = 
8.6 Hz, 2 H), 6.96 6.89 (m, 2 H), 6.84–6.82 (m, 2 H), 6.82–6.78 (m, 2 H), 6.49 (d, J = 2.4 Hz, 1 
H), 6.27 (d, J = 2.5 Hz, 1 H), 6.19 (s, 1 H), 4.34 (d, J = 1.8 Hz, 1 H), 4.25 (s, 1 H), 3.89 (d, J = 
2.3 Hz, 1 H), 3.84 (s, 1 H), 3.83 (s, 6 H), 3.83 (s, 3 H), 3.79 (s, 3 H), 3.75 (s, 2 H), 3.44 (s, 3 H), 
2.23 (d, J = 1.1 Hz, 3 H). 
4.7.8 Attempts to Synthesize Derivatives 36 and 37 
 As mentioned in the text, derivatives 36 and 37 could not be synthesized.  In the case of 
triaryl alcohol S33, the reduced nucleophilicity of the stilbene olefin could not afford the desired 
cyclization to the indane core under conditions mild enough to preserve the benzylic alcohol.  
Elimination to alkene S34 was observed instead.  Triaryl alcohol S37 did allow the cyclization to 
S38, however, this alcohol proved unstable to the acidic conditions required to install the final 
aryl ring as the thiol nucleophile. 
 
































































 Stilbene S32.  Phosphonate S30 (1.27 g, 2.37 mmol, 1.0 equiv) was dissolved in dry THF 
(11 mL) and the solution was cooled to –78 ºC.  KOtBu (1.0 M in THF, 2.5 mL, 2.5 mmol, 1.1 
equiv) was added and the resulting orange solution was allowed to stir at –78 ºC for 30 min.  A 
solution of aldehyde S31 (0.413 g, 2.37 mmol, 1.0 equiv) in dry THF (2.3 mL) was added to the 
anion at –78 ºC and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the 
reaction was quenched with saturated NH4Cl (10 mL), poured into water (10 mL), and extracted 
with CH2Cl2 (3 × 40 mL).  The combined organic layers were washed with water (30 mL) and 
brine (30 mL), dried (MgSO4), filtered and concentrated to afford a crude yellow product.  This 
material was purified by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→3:2) to 
afford the desired product S32 (0.664 g, 70% yield).  S32: 1H NMR (400 MHz, CDCl3) δ 7.73–
7.50 (m, 5 H), 7.02 (d, J = 16.2 Hz, 1 H), 6.81 (d, J = 2.7 Hz, 1 H), 6.47 (d, J = 2.7 Hz, 1 H), 
3.90 (s, 3 H), 3.88 (s, 3 H). 
 Triaryl Alcohol S33.  Stilbene S32 (0.664 g, 1.7 mmol, 1.0 equiv) was dissolved in dry 
THF (10 mL) and the resulting solution was cooled to –78 ºC.  nBuLi (1.6 M in hexanes, 1.2 mL, 
1.8 mmol, 1.05 equiv) was added and the resulting anion was allowed to stir at –78 ºC for 20 
min.  A solution of aldehyde S22 (0.20 g, 1.7 mmol, 1.0 equiv) was added to the anion at –78 ºC 
and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the reaction was 
quenched with saturated NH4Cl (10 mL), poured into water (10 mL), and extracted with EtOAc 
(3 × 20 mL).  The combined organic layers were washed with water (15 mL) and brine (15 mL), 
dried (MgSO4), filtered and concentrated to afford a crude yellow product.  This material was 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1→1:1) to afford the 
desired alcohol S33 (0.484 g, 60% yield).  S33: 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 8.2 
Hz, 2 H), 7.51–7.42 (m, 3 H), 6.91 (d, J = 16.0 Hz, 1 H), 6.73 (d, J = 2.4 Hz, 1 H), 6.56–6.45 (m, 
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3 H), 6.31 (t, J = 2.3 Hz, 1 H), 6.20 (d, J = 9.3 Hz, 1 H), 3.88 (s, 3 H), 3.75 (s, 3 H), 3.73 (s, 6 
H), 3.60 (d, J = 9.4 Hz, 1 H). 
 Alkene S34.  Triaryl alcohol S33 (0.067 g, 0.14 mmol, 1.0 equiv) was dissolved in dry 
THF (3 mL) and MsOH (0.6 mL, 9.23 mmol, 67 equiv) was added to the solution at 25 ºC.  The 
reaction was heated to 45 ºC for 3 h.  Upon completion, the reaction was quenched with NaHCO3 
(10 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 15 mL).  The combined 
organic layers were washed with water (10 mL) and brine (10 mL), dried (MgSO4), filtered and 
concentrated to afford alkene S34 as the major product.  S34: 1H NMR (400 MHz, CDCl3) δ 
7.60–7.53 (m, 2 H), 7.48 (d, J = 8.3 Hz, 2 H), 7.27 (d, J = 1.3 Hz, 1 H), 6.63 (d, J = 2.0 Hz, 1 H), 
6.35 (d, J = 2.3 Hz, 2 H), 6.29 (d, J = 2.0 Hz, 1 H), 6.23 (t, J = 2.3 Hz, 1 H), 4.95 (d, J = 1.3 Hz, 
1 H), 3.83 (s, 3 H), 3.68 (s, 6 H), 3.67 (s, 3 H). 
 Stilbene S36.  Phosphonate S30 (0.541 g, 1.47 mmol, 1.0 equiv) was dissolved in dry 
THF (5 mL) and the solution was cooled to –78 ºC.  KOtBu (1.0 M in THF, 1.57 mL, 1.57 mmol, 
1.1 equiv) was added and the resulting orange solution was allowed to stir at –78 ºC for 30 min.  
A solution of aldehyde S35 (0.15 mL, 1.47 mmol, 1.0 equiv) in dry THF (1.5 mL) was added to 
the anion at –78 ºC and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, 
the reaction was quenched with saturated NH4Cl (5 mL), poured into water (5 mL), and extracted 
with CH2Cl2 (3 × 20 mL).  The combined organic layers were washed with water (15 mL) and 
brine (15 mL), dried (MgSO4), filtered and concentrated to afford a crude yellow product.  This 
material was purified by flash column chromatography (silica gel, hexanes:EtOAc, 9:1→3:2) to 
afford the desired product S36 (0.265 g, 56% yield).  S36: 1H NMR (400 MHz, CDCl3) δ 7.59–
7.50 (m, 3 H), 7.43–7.34 (m, 2 H), 7.33–7.27 (m, 1 H), 7.02 (d, J = 16.2 Hz, 1 H), 6.83 (d, J = 
2.7 Hz, 1 H), 6.45 (d, J = 2.7 Hz, 1 H), 3.89 (s, 3 H), 3.87 (s, 3 H). 
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Triaryl Alcohol S37.  Stilbene S36 (0.265 g, 0.83 mmol, 1.0 equiv) was dissolved in dry 
THF (5 mL) and the resulting solution was cooled to –78 ºC.  nBuLi (1.6 M in hexanes, 0.54 mL, 
0.86 mmol, 1.05 equiv) was added and the resulting anion was allowed to stir at –78 ºC for 20 
min.  A solution of aldehyde S22 (0.138 g, 0.83 mmol, 1.0 equiv) was added to the anion at –78 
ºC and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the reaction was 
quenched with saturated NH4Cl (5 mL), poured into water (5 mL), and extracted with EtOAc (3 
× 10 mL).  The combined organic layers were washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered and concentrated to afford a crude yellow product.  This material was purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 4:1→1:1) to afford the desired 
alcohol S37 (0.231 g, 68% yield).  S37: 1H NMR (400 MHz, CDCl3) δ 7.50–7.37 (m, 3 H), 7.37–
7.29 (m, 2 H), 7.30–7.24 (m, 1 H), 6.93 (d, J = 16.0 Hz, 1 H), 6.76 (d, J = 2.4 Hz, 1 H), 6.54 (dd, 
J = 2.3, 0.9 Hz, 2 H), 6.47 (d, J = 2.4 Hz, 1 H), 6.33 (t, J = 2.4 Hz, 1 H), 6.23 (s, 1 H), 3.87 (s, 3 
H), 3.74 (s, 6 H), 3.74 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 160.6, 160.0, 158.8, 147.5, 138.6, 
137.2, 132.2, 128.7, 127.9, 126.8, 126.7, 122.0, 104.0, 103.3, 99.1, 98.5, 70.1, 55.8, 55.5, 55.3. 
 Cyclized alcohol S38.  Triaryl alcohol S37 (0.081 g, 0.2 mmol, 1.0 equiv) was dissolved 
in dry CH2Cl2 (3 mL) and TFA (0.025 mL, 0.3 mmol, 1.5 equiv) was added to the solution at 25 
ºC and the reaction was allowed to stir at 25 ºC for 3 min.  Upon completion, the reaction was 
poured into a mixture of K2CO3 (2.0 g) and MeOH (25 mL) and the resulting yellow solution 
was allowed to stir for 30 min.  This solution was then extracted with CH2Cl2 (4 × 30 mL).  The 
combined organic layers were washed with water (10 mL) and brine (10 mL), dried (MgSO4), 
filtered and concentrated to afford alcohol S38 as the major product.  S38: 1H NMR (400 MHz, 
CDCl3) δ 7.32–7.25 (m, 4 H), 7.25–7.21 (m, 1 H), 7.18–7.14 (m, 2 H), 6.66 (d, J = 2.1 Hz, 1 H), 
6.43 (d, J = 2.1 Hz, 1 H), 6.28 (t, J = 2.4 Hz, 1 H), 6.18 (d, J = 2.3 Hz, 2 H), 5.18 (d, J = 6.2 Hz, 
 522 
1 H), 4.25 (d, J = 6.9 Hz, 1 H), 3.86 (s, 3 H), 3.67 (s, 6 H), 3.59 (s, 3 H), 3.25 (t, J = 6.5 Hz, 1 
H). 
4.7.9 Synthesis of New Ampelopsin F Derivatives 
 
Experimental Scheme 4.6 Structures of alcohols S39 and S40 
 
Derivative 42.  Alcohol 17 (0.058 g, 0.099 mmol, 1.0 equiv) was azeotroped (3 mL 
benzene) and dissolved in dry THF (8 mL).  Solid NaH (60% dispersion in mineral oil, 0.025 g, 
0.625 mmol, 6.3 equiv) was added to the solution at 0 ºC and the anion was allowed to stir at that 
temperature for 30 min. MeI (0.5 mL, 8.3 mmol, 83.8 equiv) was then and the reaction was 
allowed to warm to 25 ºC overnight.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (15 mL), poured into water (15 mL) and extracted with CH2Cl2 (3 × 30 mL).  
The organic layers were combined, washed with water (15 mL) and brine (15 mL), dried 
(MgSO4), filtered and concentrated.  The resulting crude product was purified by preparative thin 
layer chromatography (silica gel, hexanes:EtOAc 7:3) to afford derivative 42 (0.049 g, 87 % 
yield), as well as unreacted starting material 17 (0.007 g, 12% yield).  42: Rf = 0.29 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax 3003, 2926, 2852, 2836, 1605, 1510, 1489, 1463, 1316, 
1248, 1203, 1178, 1141, 1095, 1066, 1037, 944, 831, 737, 607, 536 cm-1; 1H NMR (400 Hz, 
CDCl3) δ 7.20 (d, J = 9.2 Hz, 2 H), 7.16 (d, J = 8.8 Hz, 2 H), 6.78 (d, J = 8.8 Hz, 2 H), 6.70 (d, J 
= 8.8 Hz, 2 H), 6.61 (d, J = 2.4 Hz, 1 H), 6.49 (d, J = 2.0 Hz, 1 H), 6.30 (d, J = 2.4 Hz, 1 H), 6.08 















3 H), 3.71 (s, 3 H), 3.69 (s, 3 H), 3.44 (s, 3 H), 2.30 (s, 3 H); 13C NMR (100 MHz, 
CHCl3) δ 160.4, 159.2, 159.1, 158.3, 157.0, 154.4, 145.9, 142.5, 138.0, 134.6, 129.9, 128.9, 
128.1, 116.6, 113.2, 112.6, 104.7, 101.0, 97.0 (2 C), 87.9, 55.5, 55.5, 55.4, 55.3, 55.3, 55.2, 55.2, 
51.8, 51.2, 45.5; HRMS (FAB+) calcd for C35H36O7+ [M+] 568.2461, found 568.2473 
Derivative 39.  Ketone 14 (0.012 g, 0.03 mmol, 1.0 equiv) was azeotroped (3 mL benzene) 
and dissolved in dry THF (1 mL).  Phenylmagnesium bromide solution (38, 3.0 M in ether, 0.03 
mL, 3.0 equiv) was added dropwise to the degassed ketone solution and the reaction mixture was 
allowed to stir overnight at 25 ºC.  Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (3 mL), poured into water (3 mL) and extracted with EtOAc (3 × 10 mL).  The 
combined organic layers were washed with water (5 mL), brine (5 mL), dried (MgSO4), filtered 
and concentrated to afford the desired alcohol S39 as a white foam (0.012, 99% yield).  Alcohol 
S39: 1H NMR (400 MHz, CDCl3) δ 7.41–7.31 (m, 2 H), 7.24–7.04 (m, 5 H), 6.81 (d, J = 8.7 Hz, 
2 H), 6.63 (d, J = 2.5 Hz, 1 H), 6.56 (d, J = 2.0 Hz, 1 H), 6.34 (d, J = 2.4 Hz, 1 H), 6.11 (d, J = 
2.0 Hz, 1 H), 4.34 (d, J = 1.1 Hz, 1 H), 4.33–4.29 (m, 1 H), 3.87 (s, 4 H), 3.79 (s, 3 H), 3.75 (s, 3 
H), 3.68 (s, 3 H), 3.48 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 160.5, 159.6, 159.3, 157.4, 154.7, 
146.0, 145.7, 143.1, 137.0, 129.4, 127.9, 127.0, 126.7, 115.2, 113.4, 105.1, 100.7, 100.1, 97.3, 
97.1, 83.5, 56.6, 55.5, 55.5, 55.4, 55.3, 55.2, 53.4, 45.1.  The resulting alcohol S39 (0.012 g, 0.03 
mmol, 1.0 equiv) was azeotroped (3 mL benzene) and dissolved in dry THF (2 mL).  The 
solution was cooled to 0 ºC and solid NaH (60% dispersion in mineral oil, 0.005 g, 0.13 mmol, 
4.3 equiv) was added to the solution and the anion was allowed to stir at that temperature for 30 
min.  MeI (0.05 mL, 0.8 mmol, 2.7 equiv) was then added and the reaction was allowed to warm 
to 25 ºC overnight.  Upon completion, the reaction was quenched with saturated aqueous NH4Cl 
(5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The organic layers 
 524 
were combined, washed with water (5 mL) and brine (5 mL), dried (MgSO4), filtered and 
concentrated.  The resulting crude product was purified by preparative thin layer 
chromatography (silica gel, hexanes:EtOAc 7:3) to afford derivative 39 (0.012 g, 74% yield).  
39: Rf = 0.90 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3002, 2937, 2834, 1604, 1510, 
1490, 1462, 1317, 1247, 1204, 1141, 1097, 1043, 829, 701 cm-1; 1H NMR (400 Hz, CDCl3) 
δ 7.30 (d, J = 8.8 Hz, 2 H), 7.19–7.15 (m, 4 H), 7.12–7.10 (m, 1 H), 6.79 (d, J = 8.8 Hz, 2 H), 
6.62 (d, J = 2.4 Hz, 1 H), 6.50 (d, J = 2.0 Hz, 1 H), 6.31 (d, J = 2.4 Hz, 1 H), 6.09 (d, J = 2.0 Hz, 
1 H), 4.45 (s, 1 H), 4.21 (s, 1 H), 3.90 (s, 1 H), 3.86 (s, 3 H), 3.80 (s, 3 H), 3.72 (s, 3 H), 3.69 (s, 
3 H), 3.45 (s, 3 H), 2.31 (s, 3 H); 13C NMR (125 Hz, CDCl3) δ 160.4, 159.2, 159.1, 157.0, 154.4, 
145.7, 142.6, 142.5, 137.9, 129.9, 128.0, 127.9, 127.8, 126.9, 116.6, 112.7, 104.7, 101.0, 97.1, 
97.1, 88.2, 55.5, 55.5 (2 C), 55.3, 55.3, 55.2, 52.0, 51.0, 45.6; HRMS (FAB+) calcd for 
C34H34O6+ [M+] 538.2355, found 538.2344. 
Derivative 41.  4-bromobenzotrifluoride (40, 0.03 mL, 0.21 mmol, 4.3 equiv) was 
dissolved in dry Et2O (0.25 mL) and cooled to 0 ºC.  nBuLi (2.5 M in hexanes, 0.09 mL, 0.23 
mmol, 4.6 equiv) was added dropwise to this solution and the resulting yellow solution was 
allowed to stir for 1 h.  A solution of azeotroped (3 mL benzene) ketone 14 (0.023 g, 0.05 mmol, 
1.0 equiv) in dry THF (0.1 mL) was added dropwise to the anion at 0 ºC and the reaction mixture 
was allowed to warm to 25 ºC overnight.  Upon completion, the reaction was quenched with 
saturated aqueous NH4Cl (2 mL), poured into water (2 mL) and extracted with EtOAc (3 × 5 
mL).  The combined organic layers were washed with water (3 mL), brine (3 mL), dried 
(MgSO4), filtered and concentrated to afford the desired alcohol S40 as a white foam (0.016 g, 
52% yield).  Alcohol S40: 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.4 Hz, 2 H), 7.41 (d, J = 
8.6 Hz, 2 H), 7.19 (d, J = 8.6 Hz, 2 H), 6.91–6.77 (m, 2 H), 6.62 (d, J = 2.4 Hz, 1 H), 6.55 (d, J = 
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2.0 Hz, 1 H), 6.35 (d, J = 2.4 Hz, 1 H), 6.13 (d, J = 2.0 Hz, 1 H), 4.34 (s, 1 H), 4.31 (s, 1 H), 3.87 
(s, 3 H), 3.85 (s, 1 H), 3.79 (s, 3 H), 3.75 (s, 3 H), 3.70 (s, 3 H), 3.49 (s, 3 H); 13C NMR (100 
MHz, CDCl3) δ 160.7, 159.8, 159.4, 157.6, 154.7, 149.7, 145.4, 142.5, 136.5, 129.2, 127.6, 
127.2, 124.9, 124.9, 124.8, 124.8, 114.8, 113.6, 105.1, 100.7, 97.4, 97.3, 83.4, 56.7, 55.6, 55.5, 
55.4, 55.3, 55.2, 53.3, 45.0.  The resulting alcohol S40 (0.016 g, 0.03 mmol, 1.0 equiv) was 
azeotroped (3 mL benzene) and dissolved in dry THF (2 mL).  Solid NaH (60% dispersion in 
mineral oil, 0.006 g, 0.15 mmol, 5.0 equiv) was added to the solution at 0 ºC and the anion was 
allowed to stir at that temperature for 30 min.  MeI (0.06 mL, 1.0 mmol, 3.33 equiv) was then 
added and the reaction was allowed to warm to 25 ºC overnight.  Upon completion, the reaction 
was quenched with saturated aqueous NH4Cl (5 mL), poured into water (5 mL) and extracted 
with CH2Cl2 (3 × 10 mL).  The organic layers were combined, washed with water (5 mL) and 
brine (5 mL), dried (MgSO4), filtered and concentrated.  The resulting crude product was 
purified by preparative thin layer chromatography (silica gel, hexanes:EtOAc, 7:3) to afford 
derivative 41 (0.018 g, 99% yield).  41: Rf = 0.48 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 
2998, 2937, 2836, 1734, 1603, 1510, 1490, 1462, 1436, 1409, 1324, 1300, 1280, 1246, 1204, 
1165, 1141, 1123, 1096, 1068, 1041, 1017, 979, 943, 919, 833, 784, 736, 703, 657, 636, 605, 
568, 532 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.40 (d of d, J = 8.8, 16.0 Hz, 4 H), 7.16 (d, J = 8.4 
Hz, 2 H), 6.79 (d, J = 8.8 Hz, 2 H), 6.61 (d, J = 2.4 Hz, 1 H), 6.48 (d, J = 1.6 Hz, 1 H), 6.32 (d, J 
= 2.4 Hz, 1 H), 6.11 (d, J = 2.0 Hz, 1 H), 4.43 (s, 1 H), 4.22 (s, 1 H), 3.86 (s, 3 H), 3.84 (s, 1 H), 
3.80 (s, 3 H), 3.73 (s, 3 H), 3.71 (s, 3 H), 3.45 (s, 3 H), 2.34 (s, 3 H); 13C NMR (100 MHz, 
CHCl3) δ 160.7, 159.3, 159.2, 157.1, 154.4, 147.1, 145.1, 141.9, 137.7, 129.9, 129.2, 128.2, 
127.5, 124.8, 124.8, 116.4, 112.7, 104.7, 100.9, 97.2, 97.1, 88.1, 55.7, 55.5, 55.4 (2 C), 55.3, 
55.2, 52.0, 50.6, 45.6; HRMS (FAB+) calcd for C35H33O6F3+ [M+] 606.2229, found 606.2260. 
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4.7.10 Functionalization of New Ampelopsin F Derivatives 
Experimental Table 4.12 Brominations of derivative 42 
Reagent  
Conditions 
    
BDSB 
0.85 equiv, –78 ºC,  
15 min 
not detected 1 (15%) 1.1 (15%) 2.8 (49%) 
BDSB 
0.8 equiv, –78 ºC,  
15 min 
1.0 (13%) 1.2 (14%) 1.4 (16%) 1.4 (16%) 
 
Reaction with BDSB.  A solution of derivative 42 (0.0058 g, 0.01 mmol, 1.0 equiv) in 
dry CH2Cl2 (1 mL) was cooled to –78 ºC.  BDSB (0.0047 g, 0.0085 mmol, 0.85 equiv) was 
added as a solid to this solution at –78 ºC and the reaction mixture was stirred at this temperature 
for 15 min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) 
and saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 
× 10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude orange oil (45:46:S41 1:1:2.5 by 
crude NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford 45 (0.001 g, 15% yield) and an inseparable mixture of 46 and S41 
mixture.*   
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford 46 (0.001 g, 15% yield) and S41 (0.0035 g, 49% yield). 
Monobromide 45.  Rf = 0.71 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2958, 2923, 
2853, 1725, 1602, 1510, 1463, 1322, 1248, 1208, 1179, 1141, 1079, 1037, 831 cm-1; 1H NMR 


































6.70 (d, J = 8.8 Hz, 2 H), 6.41 (d, J = 2.0 Hz, 1 H), 6.36 (s, 1H), 6.11 (d, J = 2.0 Hz, 1 H), 5.34 
(s, 1 H), 4.20 (s, 1 H), 3.91 (s, 3 H), 3.81 (s, 3 H), 3.73 (s, 3 H), 3.72 (s, 1 H), 3.71 (s, 3 H), 3.71 
(s, 3 H), 3.44 (s, 3 H), 2.47 (s, 3 H); 13C NMR (125 Hz, CDCl3) δ 160.6, 158.4, 158.0, 157.0, 
155.1, 154.9, 146.3, 141.6, 138.3, 134.3, 129.8, 129.0, 127.3, 119.5, 113.2, 112.6, 112.6, 100.7, 
97.0, 95.4, 88.0, 57.2, 56.5, 55.6, 55.5, 55.4, 55.3, 55.2, 51.4, 48.2, 46.0; HRMS (FAB+) calcd 
for C35H35BrO7+ [M+] 646.1566, found 646.1556 (for 79Br). 
Monobromide 46.  Rf = 0.67 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2924, 2853, 
1736, 1607, 1584, 1510, 1462, 1378, 1338, 1314, 1248, 1200, 1178, 1146, 1096, 1076, 1036, 
972, 831, 738 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.19 (d, J = 8.0 Hz, 2 H), 6.79 (d, J = 8.0 Hz, 2 
H), 6.72 (d, J = 8.0 Hz, 2 H), 6.59 (s, 1 H), 6.32 (s, 1 H), 6.10 (broad s, 1 H), 4.42 (s, 1 H), 4.29 
(s, 1 H), 4.18 (s, 1 H), 3.85 (s, 3 H), 3.78 (s, 6 H), 3.72 (s, 3 H), 3.68 (s, 3 H), 3.46 (s, 3 H), 2.16 
(s, 3 H); 13C NMR (125 Hz, CDCl3) δ 159.3, 159.2, 158.5, 157.1, 155.7, 153.5, 145.9, 141.9, 
137.4, 134.2, 129.8, 128.9, 128.1, 116.0, 113.4, 112.8, 104.6, 99.0, 97.2, 95.6, 87.1, 56.5, 55.8, 
55.4, 55.3, 55.2, 55.2, 54.0 (2 C), 52.4, 42.7; HRMS could not be obtained. 
Dibromide S41.  Rf = 0.67 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3003, 2961, 
2925, 2853, 1608, 1586, 1510, 1461, 1434, 1338, 1324, 1248, 1210, 1179, 1136, 1100, 1078, 
1036, 974, 918, 862, 831, 809, 783, 737 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.21 (d, J = 8.8 Hz, 4 
H), 6.78 (d, J = 8.4 Hz, 2 H), 6.72 (d, J = 8.4 Hz, 2 H), 6.37 (s, 1 H), 6.12 (s, 1 H), 5.37 (s, 1 H), 
4.30 (s, 1 H), 4.07 (s, 1 H), 3.91 (s, 3 H), 3.80 (s, 3 H), 3.78 (s, 3 H), 3.72 (s, 6 H), 3.46 (s, 3 H), 
2.31 (s, 3 H); 13C NMR (125 Hz, CDCl3) δ 158.6, 158.1, 157.1, 156.0, 155.3, 154.1, 146.2, 
141.1, 137.6, 133.8, 129.7, 128.9, 127.5, 127.2, 118.9, 113.4, 112.7, 98.8, 95.6, 95.5, 87.2, 56.5 
(2 C), 55.8, 55.7, 55.5, 55.3, 55.2, 52.0, 51.0, 43.2; HRMS (FAB) calcd for C35H34Br2O7+ [M+] 
724.0671, found 724.0646 (for 79Br). 
 528 
Experimental Table 4.13 Brominations of derivative 39 
Reagent  
Conditions 
    
BDSB 
0.7 equiv, –78 ºC,  
15 min 
2.6 (33%) 1.7 (22%) 2.0 (29%) 1.0 (14%) 
BDSB 
0.7 equiv, –78 ºC,  
15 min 
1.0 (8%) 2.0 (22%) 2.3 (24%) 4.0 (46%) 
 
Reaction with BDSB.  A solution of derivative 39 (0.012 g, 0.022 mmol, 1.0 equiv) in 
dry CH2Cl2 (3 mL) was cooled to –78 ºC.  BDSB (0.009 g, 0.016 mmol, 0.7 equiv) was added as 
a solid to this solution at –78 ºC and the reaction mixture was stirred at this temperature for 15 
min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (10 mL) and extracted with CH2Cl2 (3 × 
10 mL).  The organic layers were combined, washed with water (10 mL) and brine (10 mL), 
dried (MgSO4) filtered, and concentrated.  The resulting crude oil (39:43:44:S42 2.6:1.7:2:1 by 
crude NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford 43 (0.003 g, 22% yield), an inseparable mixture of 44 and S42 
mixture*, as well as recovered starting material 39 (0.004 g, 33% yield).  
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford 44 (0.004 g, 29% yield) and S42 (0.002 g, 14% yield). 
Monobromide 43.  Rf = 0.86 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2961, 2922, 
2852, 1587, 1510, 1462, 1378, 1326, 1246, 1210, 1137, 1078, 1037, 974, 922, 809, 765, 701 cm-
1; 1H NMR (400 Hz, CDCl3) δ 7.28 (d, J = 7.2 Hz, 2 H), 7.19–7.11 (m, 5 H), 6.78 (d, J = 8.8 Hz, 






























H), 3.91 (s, 3 H), 3.81 (s, 3 H), 3.75 (s, 1 H), 3.73 (s, 3 H), 3.70 (s, 3 H), 3.44 (s, 3 H), 2.48 (s, 3 
H); 13C NMR (100 MHz, CHCl3) δ 160.7, 158.0, 157.0, 155.2, 154.9, 146.0, 142.4, 141.5, 138.2, 
129.8, 127.9, 127.8, 127.3, 127.0, 119.6, 112.6, 103.9, 100.7, 97.1, 95.4, 88.4, 57.2, 56.4, 55.5, 
55.5, 55.4, 55.3, 51.5, 48.0, 46.0; HRMS (FAB+) calcd for C34H33BrO6+ [M+] 616.1461, found 
616.1465 (for 79Br). 
Monobromide 44.  Rf = 0.67 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2925, 2854, 
1666, 1608, 1584, 1510, 1461, 1435, 1396, 1339, 1316, 1280, 1247, 1199, 1178, 1145, 1094, 
1078, 1037, 974, 946, 921, 865, 828, 809, 762, 701, 636, 571, 458 cm-1; 1H NMR (400 Hz, 
CDCl3) δ 7.30–7.28 (m, 3 H), 7.27–7.10 (m, 4 H), 6.79 (d, J = 8.8 Hz, 2 H), 6.60 (d, J = 2.4 Hz, 
1 H), 6.33 (d, J = 2.0 Hz, 1 H), 6.09 (s, 1 H), 4.46 (s, 1 H), 4.31 (s, 1 H), 4.22 (s, 1 H), 3.86 (s, 3 
H), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.68 (s, 3 H), 3.47 (s, 3 H), 2.17 (s, 3 H); 13C NMR (125 Hz, 
CDCl3) δ 159.3, 159.3, 157.2, 155.8, 153.6, 145.7, 142.2, 141.8, 137.4, 129.9, 128.1, 128.0, 
127.8, 127.2, 116.1, 112.8, 104.6 99.1, 97.3, 95.7, 87.5, 56.5, 55.8, 55.5, 55.3, 55.3, 54.0, 53.8, 
52.6, 42.8; HRMS (FAB+) calcd for C34H33BrO7+ [M+] 616.1461, found 616.1439 (for 79Br). 
Dibromide S42.  Rf = 0.69 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2961, 1922, 
2852, 1587, 1510, 1462, 1378, 1326, 1246, 1210, 1137, 1078, 1037, 974, 922, 809, 765, 701 cm-
1; 1H NMR (400 Hz, CDCl3) δ 7.30 (d, J = 8.4 Hz, 2 H), 7.29–7.18 (m, 4 H), 7.14–7.13 (m, 1 H), 
6.79 (d, J = 9.2 Hz, 2 H), 6.38 (s, 1 H), 6.12 (s, 1 H), 5.42 (d, J = 1.2 Hz, 1 H), 4.31 (s, 1 H), 4.10 
(s, 1 H), 3.91 (s, 3 H), 3.80 (s, 3 H), 3.78 (s, 3 H), 3.72 (s, 3 H), 3.47 (s, 3 H), 2.32 (s, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 158.2, 157.2, 156.0, 155.4, 154.1, 146.0, 141.8, 141.0, 137.6, 129.7, 
128.0, 127.8, 127.3, 127.3, 119.0, 112.7, 103.9, 98.8, 95.6, 95.5, 87.6, 56.5, 55.8, 55.6, 55.5, 
55.3, 52.1, 50.9, 43.2; HRMS (FAB) calcd for C34H33Br2O6+ [M+] 695.0644, found 695.0623 
(for 79Br). 
 530 
Experimental Table 4.14 Brominations of derivative 41 
Reagent  
Conditions 
    
BDSB 
0.9 equiv, –78 ºC,  
15 min 
1.0 (19%)  1.5 (32%) 1.2 (29%) 1.1 (18%) 
BDSB 1.1 (30%) 1.7 (33%) 1.2 (21%) 1.3 (25%) 
 
Reaction with BDSB.  A solution of derivative 41 (0.007 g, 0.012 mmol, 1.0 equiv) in 
dry CH2Cl2 (2 mL) was cooled to –78 ºC.  BDSB (0.0057 g, 0.010 mmol, 0.9 equiv) was added 
as a solid to this solution at –78 ºC and the reaction mixture was stirred at this temperature for 15 
min.  Upon completion, the reaction was quenched with saturated aqueous Na2SO3 (5 mL) and 
saturated aqueous NaHCO3 (5 mL), poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 
mL).  The organic layers were combined, washed with water (5 mL) and brine (5 mL), dried 
(MgSO4), filtered and concentrated.  The resulting crude orange oil (41:47:48:S43 1.0:1.5:1.2:1.1 
by crude NMR integral ratios) was purified by preparative thin layer chromatography (silica gel, 
hexanes:EtOAc, 7:3) to afford 47 (0.0025 g, 32% yield), an inseparable mixture of 48 and S43*, 
as well as recovered starting material (0.0013 g, 19% yield).  
* This mixture was separated by preparative thin layer chromatography (silica gel, 
hexanes:CHCl3, 1:4) to afford 48 (0.0023 g, 29% yield) and S43 (0.0016 g, 18% yield). 
Monobromide 47.  Rf = 0.40 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2998, 2936, 
2836, 2062, 1734, 1597, 1510, 1491, 1461, 1434, 1408, 1322, 1301, 1267, 1246, 1207, 1164, 
1122, 1097, 1067, 1039, 1016, 976, 939, 919, 836, 810, 784, 736, 700, 658, 628, 605, 569, 532, 
474 cm-1; 1H NMR (400 Hz, CDCl3) δ 7.40 (d of d, J = 8.8, 15.6 Hz, 4 H), 7.11 (d, J = 7.2 Hz, 2 


































H), 3.92 (s, 3 H), 3.82 (s, 3 H), 3.75 (s, 3 H), 3.71 (s, 4 H), 3.45 (s, 3 H), 2.51 (s, 3 H); 13C NMR 
(100 MHz, CHCl3) δ 160.9, 158.1, 157.1, 155.3, 154.9, 146.9, 145.5, 141.0, 137.9, 129.8, 129.3, 
129.0, 128.3, 126.8, 126.8, 124.8, 124.8, 119.3, 112.6, 103.8, 100.7, 97.2, 95.5, 88.3, 57.4, 56.4, 
55.5 (2 C), 55.4, 55.3, 51.7, 47.8, 46.0; HRMS (FAB+) calcd for C35H32O6BrF3+ [M+] 684.1334, 
found 684.1315 (for 79Br). 
Monobromide 48.  Rf = 0.33 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2999, 2937, 
2836, 1607, 1585, 1510, 1462, 1435, 1409, 1324, 1279, 1247, 1200, 1169, 1146, 1115, 1098, 
1070, 1050, 1116, 973, 946, 919, 865, 836, 810, 769, 736, 709, 654, 635, 609, 543, 466 cm-1; 1H 
NMR (500 Hz, CDCl3) δ 7.45 (d, J = 8.0 Hz, 2 H), 7.39 (d, J = 8.5 Hz, 2 H), 6.80 (d, J = 8.5 Hz, 
2 H), 6.59 (d, J = 2.5 Hz, 1 H), 6.34 (d, J = 2.0 Hz, 1 H), 6.12 (s, 1 H), 4.44 (s, 1 H), 4.32 (3, 1 
H), 4.18 (s, 1 H), 3.86 (s, 3 H), 3.79 (s, 6 H), 3.70 (s, 3 H), 3.47 (s, 3 H), 2.20 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 159.4, 159.3, 157.3, 156.0, 153.6, 146.6, 145.2, 141.3, 137.1, 129.8, 128.2, 
127.4, 125.1, 125.1, 115.9, 112.9, 104.6, 98.9, 97.4, 95.7, 87.4, 56.5, 55.8, 55.5, 55.3, 55.3, 54.3, 
53.5, 52.7, 42.8; HRMS (FAB+) calcd for C35H32O6BrF3+ [M+] 684.1334, found 684.1339 (for 
79Br). 
Dibromide S43.  Rf = 0.33 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3000, 2934, 
2837, 1729, 1608, 1587, 1510, 1460, 1434, 1408, 1322, 1267, 1246, 1210, 1166, 1116, 1068, 
1037, 1016, 974, 920, 862, 839, 810, 784, 736, 702, 676, 654, 607, 563, 542, 467 cm-1; 1H NMR 
(500 Hz, CDCl3) δ 7.45 (d, J = 8.0 Hz, 2 H), 7.39 (d, J = 8.0 Hz, 2 H), 7.21 (d, J = 7.0 Hz, 2 H), 
6.80 (d, J = 8.0 Hz, 2 H), 6.39 (s, 1 H), 6.15 (s, 1 H), 5.40 (s, 1 H), 4.32 (3, 1 H), 4.06 (s, 1 H), 
3.92 (s, 3 H), 3.81 (s, 3 H), 3.80 (s, 3 H), 3.74 (s, 3 H), 3.47 (s, 3 H), 2.36 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 158.2, 157.2, 156.2, 155.4, 154.1, 146.3, 145.4, 140.5, 137.3, 129.7, 128.2, 
126.7 (2 C), 125.1, 125.1, 118.7, 112.8, 103.7, 98.6, 95.6, 95.5, 87.4, 56.5 (2 C), 56.0, 55.8, 55.5, 
 532 
55.3, 52.2, 50.6, 43.2; HRMS (FAB+) calcd for C35H31O6Br2F3+ [M+] 762.0439, found 762.0462 
(for 79Br). 
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